0001013606-15-000120.txt : 20150805 0001013606-15-000120.hdr.sgml : 20150805 20150805163726 ACCESSION NUMBER: 0001013606-15-000120 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20150630 FILED AS OF DATE: 20150805 DATE AS OF CHANGE: 20150805 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ENDOLOGIX INC /DE/ CENTRAL INDEX KEY: 0001013606 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 680328265 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-28440 FILM NUMBER: 151029483 BUSINESS ADDRESS: STREET 1: 2 MUSICK CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 9495957200 MAIL ADDRESS: STREET 1: 2 MUSICK CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: RADIANCE MEDICAL SYSTEMS INC /DE/ DATE OF NAME CHANGE: 19990122 FORMER COMPANY: FORMER CONFORMED NAME: CARDIOVASCULAR DYNAMICS INC DATE OF NAME CHANGE: 19960506 10-Q 1 elgx_6302015-10q.htm 10-Q ELGX_6.30.2015-10Q

 
 
 
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
__________________________________________________ 
FORM 10-Q
 __________________________________________________ 
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2015
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ________to ________
Commission file number 000-28440 
 __________________________________________________ 
ENDOLOGIX, INC.
(Exact name of registrant as specified in its charter) 
 __________________________________________________  
Delaware
68-0328265
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification Number)
2 Musick, Irvine, California 92618
(Address of principal executive offices)
(949) 595-7200
(Registrant’s telephone number, including area code)
   ________________________________________________
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x     No  o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one): 
Large accelerated filer
 
x
Accelerated filer
 
o
Non-accelerated filer
 
o  (Do not check if a smaller reporting company)
Smaller reporting company
 
o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  o    No  x
On July 31, 2015, there were 67,781,092 shares outstanding of the registrant’s only class of common stock.
 
 
 
 
 


ENDOLOGIX, INC.
QUARTERLY REPORT ON FORM 10-Q
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2015

TABLE OF CONTENTS
 


Part I. Financial Information

ENDOLOGIX, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share and par value amounts)
(Unaudited)

June 30,

December 31,

2015

2014
ASSETS



Current assets:



Cash and cash equivalents
$
36,269


$
26,798

Marketable securities
34,257


59,871

Accounts receivable, net allowance for doubtful accounts of $181 and $185, respectively.
29,138


26,113

Other receivables
121


498

Inventories
30,588


31,325

Prepaid expenses and other current assets
2,592


3,162

Total current assets
$
132,965


$
147,767

Property and equipment, net
24,808


25,696

Goodwill
28,709


28,866

Intangibles, net
42,702


43,465

Deposits and other assets
2,138


2,415

Total assets
$
231,322


$
248,209





LIABILITIES AND STOCKHOLDERS’ EQUITY



Current liabilities:



Accounts payable
$
11,760


$
11,027

Accrued payroll
11,469


13,337

Accrued expenses and other current liabilities
4,979


5,260

Total current liabilities
$
28,208


$
29,624

Deferred income tax
879


879

Deferred rent
8,078


8,060

Other liabilities
349


489

Contingently issuable common stock
14,800


14,600

Convertible notes
72,156


70,407

Total liabilities
$
124,470


$
124,059

Commitments and contingencies



Stockholders’ equity:



Convertible preferred stock, $0.001 par value; 5,000,000 shares authorized. No shares issued and outstanding.
—


—

Common stock, $0.001 par value; 100,000,000 shares authorized. 67,947,684 and 67,321,769 shares issued, respectively. 67,767,730 and 67,159,511 shares outstanding, respectively.
68


67

Treasury stock, at cost, 179,954 and 162,258 shares, respectively.
(2,619
)

(2,328
)
Additional paid-in capital
381,516


372,639

Accumulated deficit
(272,715
)

(248,500
)
Accumulated other comprehensive income
602


2,272

Total stockholders’ equity
$
106,852


$
124,150

Total liabilities and stockholders’ equity
$
231,322


$
248,209


The accompanying notes are an integral part of these condensed consolidated financial statements.

1

ENDOLOGIX, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(In thousands, except per share amounts)
(Unaudited)
 
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2015
 
2014
 
2015
 
2014
Revenue
$
39,479

 
$
38,327

 
$
76,149

 
$
71,591

Cost of goods sold
15,347

 
9,820

 
25,111

 
18,789

Gross profit
24,132

 
28,507

 
51,038

 
52,802

Operating expenses:
 
 
 
 
 
 
 
Research and development
5,993

 
4,458

 
12,224

 
8,563

Clinical and regulatory affairs
3,597

 
2,722

 
7,047

 
4,922

Marketing and sales
19,842

 
19,167

 
39,441

 
35,311

General and administrative
6,850

 
5,932

 
14,139

 
13,094

Total operating expenses
36,282

 
32,279

 
72,851

 
61,890

Loss from operations
(12,150
)
 
(3,772
)
 
(21,813
)
 
(9,088
)
Other income (expense):
 
 
 
 
 
 
 
Interest income
37

 
67

 
82

 
126

Interest expense
(1,493
)
 
(1,448
)
 
(2,955
)
 
(2,839
)
Other income (expense), net
766

 
(148
)
 
824

 
211

Change in fair value of contingent consideration related to acquisition
(100
)
 
(3,772
)
 
(200
)
 
8,028

Total other income (expense)
(790
)
 
(5,301
)
 
(2,249
)
 
5,526

Net loss before income tax (expense) benefit
$
(12,940
)
 
$
(9,073
)
 
$
(24,062
)
 
$
(3,562
)
Income tax (expense) benefit
(61
)
 
80

 
(153
)
 
(136
)
Net loss
$
(13,001
)
 
$
(8,993
)
 
$
(24,215
)
 
$
(3,698
)
Other comprehensive income (loss) foreign currency translation
84

 
68

 
(1,670
)
 
23

Comprehensive loss
$
(12,917
)
 
$
(8,925
)
 
$
(25,885
)
 
$
(3,675
)
 
 
 
 
 
 
 
 
Basic and diluted net loss per share
$
(0.19
)
 
$
(0.14
)
 
$
(0.36
)
 
$
(0.06
)
Shares used in computing basic and diluted net loss per share
67,615

 
62,699

 
67,441

 
62,403


The accompanying notes are an integral part of these condensed consolidated financial statements.


2

ENDOLOGIX, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)

Six Months Ended June 30,
 
2015

2014
Cash flows from operating activities:



Net loss
$
(24,215
)

$
(3,698
)
Adjustments to reconcile net loss to net cash used in operating activities:



Depreciation and amortization
2,933


1,213

Stock-based compensation
4,619


3,753

Change in fair value of contingent consideration related to acquisition
200


(8,028
)
Accretion of interest on convertible note
1,749


1,622

Amortization of deferred financing costs
232


198

Non-cash foreign exchange gain
(655
)

(212
)
Changes in operating assets and liabilities:





Accounts receivable and other receivables
(3,195
)

(2,108
)
Inventories
739


(8,793
)
Prepaid expenses and other current assets
413


(1,283
)
Accounts payable
2,692


3,855

Accrued payroll
(1,689
)

1,224

Accrued expenses and other liabilities
(207
)

2,097

Net cash used in operating activities
$
(16,384
)

$
(10,160
)
Cash flows from investing activities:





Purchases of marketable securities
(37,122
)

(74,114
)
Maturities of marketable securities
62,690


25,585

Purchases of property and equipment
(3,146
)

(5,743
)
Net cash provided by (used in) investing activities
$
22,422


$
(54,272
)
Cash flows from financing activities:





Proceeds from sale of common stock under employee stock purchase plan
1,631


1,446

Proceeds from exercise of stock options
2,628


1,094

Minimum tax withholding paid on behalf of employees for restricted stock units
(291
)

(1,395
)
Net cash provided by financing activities
$
3,968


$
1,145

Effect of exchange rate changes on cash and cash equivalents
(535
)

(22
)
Net increase (decrease) in cash and cash equivalents
$
9,471


$
(63,309
)
Cash and cash equivalents, beginning of period
26,798


95,152

Cash and cash equivalents, end of period
$
36,269


$
31,843

Supplemental disclosure of cash flow information:



Cash paid for interest
$
973


$
1,045

       Cash paid for income taxes
$
140


$
207

Non-cash investing and financing activities:



       Landlord funded leasehold improvements
$
46


$
3,870

Fair value of Nellix Milestone Shares (note 9)
$
—


$
38,372

       Acquisition of property and equipment included in accounts payable
$
71


$
1,403

The accompanying notes are an integral part of these condensed consolidated financial statements.

3

ENDOLOGIX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(all tabular amounts presented in thousands, except per share, per unit, and number of years)
(Unaudited)

1. Description of Business, Basis of Presentation, and Operating Segment

(a) Description of Business

Endologix, Inc. (the "Company") is a Delaware corporation with corporate headquarters and production facilities located in Irvine, California. The Company develops, manufactures, markets, and sells innovative medical devices for the treatment of aortic disorders. The Company's products are intended for the minimally invasive endovascular treatment of abdominal aortic aneurysms ("AAA"). The Company's AAA products are built on one of two platforms: (1) traditional minimally-invasive endovascular repair ("EVAR") or (2) endovascular sealing (“EVAS”), the Company's innovative solution for sealing the aneurysm sac while maintaining blood flow through two blood flow lumens. The Company's current EVAR products include the Endologix AFX Endovascular AAA System (“AFX”), the VELA Proximal Endograft (“VELA”) and the Endologix Intuitrak Endovascular AAA System (“Intuitrak”). The Company's current EVAS product is the Nellix Endovascular Aneurysm Sealing System (“Nellix EVAS System”). Sales of the Company's EVAR and EVAS platforms (including extensions and accessories) to hospitals in the U.S. and Europe, and to third-party international distributors, provide the sole source of the Company's reported revenue.
The Company's EVAR products consist of (i) a cobalt chromium alloy stent covered by polytetrafluoroethylene (commonly referred to as "ePTFE") graft material (“Stent Graft”) and (ii) an accompanying delivery system. Once fixed in its proper position within the abdominal aorta, the Company's EVAR device provides a conduit for blood flow, thereby relieving pressure within the weakened or “aneurysmal” section of the vessel wall, which greatly reduces the potential for the AAA to rupture.
The Company's EVAS product consists of (i) bilateral covered stents with endobags, (ii) a biocompatible polymer injected into the endobags to seal the aneurysm and (iii) a delivery system and polymer dispenser. The Company's EVAS product seals the entire aneurysm sac effectively excluding the aneurysm sac reducing the likelihood of future aneurysm rupture. Additionally, it has the potential to reduce post procedural re-interventions.
(b) Basis of Presentation

The accompanying Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") and the rules and regulations of the U.S. Securities and Exchange Commission ("SEC"). These financial statements include the financial position, results of operations, and cash flows of the Company, including its subsidiaries, all of which are wholly-owned. All inter-company accounts and transactions have been eliminated in consolidation. For the three and six months ended June 30, 2015 and 2014, there were no related party transactions.

The interim financial data as of June 30, 2015 is unaudited and is not necessarily indicative of the results for a full year. In the opinion of the Company's management, the interim data includes normal and recurring adjustments necessary for a fair presentation of the Company's financial results for the three and six months ended June 30, 2015. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to SEC rules and regulations relating to interim financial statements.

The accompanying Condensed Consolidated Financial Statements should be read in conjunction with the Company's audited Consolidated Financial Statements and Notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2014, filed with the SEC on March 2, 2015.

On May 28, 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU ") No. 2014-09, "Revenue from Contracts with Customers", which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. The FASB agreed to a one-year deferral of the revenue recognition standard's effective date for all entities. The new standard is effective for the Company on January 1, 2018. The standard permits the use of either the retrospective or cumulative effect transition method. Early application is permitted, but not before the original effective date, which would have been January 1, 2017 for the Company. The Company is evaluating the effect that ASU 2014-09 will have on its consolidated financial statements and related disclosures. The Company has not yet selected a transition method nor has it determined the effect of the standard on its ongoing financial reporting.

On April 7, 2015, the FASB issued ASU No. 2015-03, "Simplifying the Presentation of Debt Issuance Costs", which requires debt issuance costs related to a recognized debt liability to be presented on the balance sheet as a direct deduction from

4
ENDOLOGIX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(all tabular amounts presented in thousands, except per share, per unit, and number of years)
(Unaudited)



the debt liability, similar to the presentation of debt discounts. The ASU is effective for the Company on January 1, 2016. Early adoption is permitted. The Company is evaluating the effect that ASU 2015-03 will have on its consolidated financial statements and related disclosures.

On July 22, 2015, the FASB issued ASU No. 2015-11, “Simplifying the Measurement of Inventory,” which requires an entity to measure inventory within the scope of the amendment at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. The guidance is effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years. The Company is currently assessing the impact this guidance will have on its consolidated financial statements.
  
(c) Operating Segment

The Company has one operating and reporting segment that is focused exclusively on the development, manufacture, marketing, and sale of EVAR and EVAS product for the treatment of aortic disorders. For the three and six months ended June 30, 2015, all of the Company's revenue and related expenses were solely attributable to these activities. Substantially all of the Company's long-lived assets are located in the U.S.

2. Use of Estimates and Summary of Significant Accounting Policies

The preparation of financial statements in conformity with GAAP requires the Company's management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenue and expenses, and related disclosure of contingent liabilities. On an on-going basis, the Company's management evaluates its estimates, including those related to (i) collectibility of customer accounts; (ii) whether the cost of inventories can be recovered; (iii) the value of goodwill and intangible assets; (iv) realization of tax assets and estimates of tax liabilities; (v) likelihood of payment and value of contingent liabilities; and (vi) potential outcome of litigation. Such estimates are based on management's judgment which takes into account historical experience and various assumptions. Nonetheless, actual results may differ from management's estimates.
For a complete summary of our significant accounting policies, please refer to Note 2, "Use of Estimates and Summary of Significant Accounting Policies", in Part II, Item 8, of our 2014 Annual Report on Form 10-K for the year ended December 31, 2014, filed March 2, 2015. There have been no material changes to our significant accounting policies during the three and six months ended June 30, 2015.


3. Balance Sheet Account Detail

(a) Property and Equipment

Property and equipment consisted of the following:
 
June 30,
2015
 
December 31,
2014
Production equipment, molds, and office furniture
$
14,054

 
$
12,943

Computer hardware and software
7,075

 
6,457

Leasehold improvements
16,368

 
15,729

Construction in progress (software and related implementation, production equipment, and leasehold improvements)
573

 
2,564

Property and equipment, at cost
$
38,070

 
$
37,693

Accumulated depreciation
(13,262
)
 
(11,997
)
Property and equipment, net
$
24,808

 
$
25,696


Depreciation expense for property and equipment for the three months ended June 30, 2015 and 2014 was $1.1 million and $0.5 million, respectively. For the six months ended June 30, 2015 and 2014 depreciation expense for property and equipment was $2.2 million and $1.0 million, respectively.


5
ENDOLOGIX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(all tabular amounts presented in thousands, except per share, per unit, and number of years)
(Unaudited)



(b) Inventories

Inventories consisted of the following:
 
June 30,
2015
 
December 31,
2014
Raw materials
$
5,973

 
$
6,728

Work-in-process
8,883

 
5,946

Finished goods
15,732

 
18,651

Total Inventories
$
30,588

 
$
31,325


(c) Goodwill and Intangible Assets

The following table presents goodwill, indefinite lived intangible assets, finite lived intangible assets and related accumulated amortization: 

June 30,
2015

December 31,
2014
Goodwill (1)
$
28,709


$
28,866







Intangible assets:





Indefinite lived intangibles





Trademarks and trade names
$
2,708


$
2,708







Finite lived intangibles





Developed technology (2)
$
40,100


$
40,100

Accumulated amortization
(454
)

(285
)
Developed technology, net
$
39,646


$
39,815







License
$
100


$
100

Accumulated amortization
(85
)

(71
)
License, net
$
15


$
29







Customer relationships (1)
$
438


$
480

Accumulated amortization (1)
(438
)

(400
)
Customer relationships, net
$
—


$
80







Acquired Shonin approval (3)
$
1,000


$
1,000

Accumulated amortization
(667
)

(167
)
Acquired Shonin approval, net
$
333


$
833

 
 
 
 
Intangible assets (excluding goodwill), net
$
42,702


$
43,465

(1) Difference in the value between these dates is solely due to a foreign currency translation adjustment.
(2) Was reclassified in the first quarter of 2013 from in-process research and development to finite lived intangibles, which coincided with the European commercial launch of the product (Nellix EVAS System) associated with this intangible asset. A significant portion of this intangible asset will not begin amortization until the U.S. launch of this product, currently scheduled for 2016.
(3) Regulatory approval for Intuitrak in Japan acquired through an amendment with a distributor in the fourth quarter of 2014.

6
ENDOLOGIX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(all tabular amounts presented in thousands, except per share, per unit, and number of years)
(Unaudited)



Amortization expense for intangible assets for the three months ended June 30, 2015 and 2014 was $0.4 million and $0.1 million, respectively. For the six months ended June 30, 2015 and 2014 amortization expense for intangible assets was $0.8 million and $0.2 million, respectively.
Estimated amortization expense for the five succeeding years and thereafter (which includes amortization of intangible assets which commenced in February 2013 with the commercial launch of the Nellix System in Europe) is as follows:
Remainder of 2015
$
517

2016
949

2017
2,213

2018
3,693

2019
4,750

2020
5,416

2021 & Thereafter
22,456

Total
$
39,994


(d) Marketable securities

Investments in held-to-maturity marketable securities consist of the following at June 30, 2015 and December 31, 2014:


June 30, 2015

Amortized
Cost

Gross
Unrealized
Gain
 
Gross
Unrealized
Loss
 
Fair Value
Asset backed securities
$
857


$
—


$
—


$
857

Agency bonds
3,000


—


—


3,000

Corporate bonds
2,658


—


(1
)

2,657

Commercial paper
22,781


5


(1
)

22,785

Government securities
4,961


2


—


4,963

Total
$
34,257


$
7


$
(2
)

$
34,262










December 31, 2014

Amortized
Cost

Gross
Unrealized
Gain
 
Gross
Unrealized
Loss
 
Fair Value
Asset backed securities
$
3,633


$
—


$
—


$
3,633

Corporate bonds
15,707


—


(8
)

15,699

Commercial paper
40,531


5


—


40,536

Total
$
59,871


$
5


$
(8
)

$
59,868


At June 30, 2015, the Company’s investments included 6 held-to-maturity debt securities in unrealized loss positions with a total unrealized loss of approximately $2 thousand and a total fair market value of approximately $4.7 million. All investments with gross unrealized losses have been in unrealized loss positions for less than 4 months. The unrealized losses were caused by interest rate fluctuations. There was no change in the credit risk of the securities. The Company does not intend to sell the securities and it is not likely that the Company will be required to sell the securities before the expected recovery of their amortized cost bases. There were no realized gains or losses on the investments for the three and six months ended June 30, 2015. All of the Company's investments of held-to-maturity securities will mature within less than 12 months with an average maturity of 3 months.


7
ENDOLOGIX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(all tabular amounts presented in thousands, except per share, per unit, and number of years)
(Unaudited)



(e) Fair Value Measurements

The following fair value hierarchy table presents information about each major category of the Company’s assets and liabilities measured at fair value on a recurring basis as of June 30, 2015 and December 31, 2014:

 Fair value measurement at reporting date using:
 
Quoted prices in
active markets for
identical assets
(Level 1)

Significant other
observable
inputs
(Level 2)

Significant
unobservable
inputs
(Level 3)

Total
At June 30, 2015











Cash and cash equivalents
$
36,269


$
—


$
—


$
36,269

Contingently issuable common stock
$
—


$
—


$
14,800


$
14,800

At December 31, 2014











Cash and cash equivalents
$
26,798


$
—


$
—


$
26,798

Contingently issuable common stock
$
—


$
—


$
14,600


$
14,600


There were no re-measurements to fair value during the three months ended June 30, 2015 of financial assets and liabilities that are not measured at fair value on a recurring basis. There were no transfers between Level 1, Level 2 or Level 3 securities during the three months ended June 30, 2015.

(f) Financial Instruments Not Recorded at Fair Value on a Recurring Basis

We measure the fair value of our 2.25% Convertible Senior Notes due 2018 ("Senior Notes") carried at amortized cost quarterly for disclosure purposes. The estimated fair value of the Senior Notes is determined by Level 2 inputs and is based primarily on quoted market prices for the same or similar issues. Based on the market prices, the fair value of our long-term debt was $82.8 million as of June 30, 2015 and $84.5 million as of December 31, 2014.

We measure the fair value of our held-to-maturity marketable securities carried at amortized cost quarterly for disclosure purposes. The fair value of marketable securities is determined by Level 2 inputs and is based primarily on quoted market prices for the same or similar instruments.


4. Stock-Based Compensation

The Company classifies stock-based compensation expense in the accompanying Condensed Consolidated Statements of Operations and Comprehensive Loss, based on the department to which the recipient belongs. Stock-based compensation expense included in cost of goods sold and operating expenses during the three and six months ended June 30, 2015 and 2014, was as follows:

Three Months Ended

Six Months Ended

June 30,

June 30,

2015

2014

2015

2014
Cost of goods sold
$
226


$
197


$
474


$
404

Operating expenses:











Research and development
258


185


486


335

Clinical and regulatory affairs
243


365


428


262

Marketing and sales
839


645


1,587


1,194

General and administrative
842


748


1,644


1,558

Total operating expenses
$
2,182


$
1,943


$
4,145


$
3,349

Total
$
2,408


$
2,140


$
4,619


$
3,753


       

8
ENDOLOGIX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(all tabular amounts presented in thousands, except per share, per unit, and number of years)
(Unaudited)



5. Net Loss Per Share
Net loss per share was calculated by dividing net loss by the weighted average number of common shares outstanding for the three and six months ended June 30, 2015 and 2014.

Three Months Ended

Six Months Ended

June 30,

June 30,

2015

2014

2015

2014
Net loss
$
(13,001
)

$
(8,993
)

$
(24,215
)

$
(3,698
)
Shares used in computing basic and diluted net loss per share
67,615


62,699


67,441


62,403

Basic and diluted net loss per share
$
(0.19
)

$
(0.14
)

$
(0.36
)

$
(0.06
)

The following outstanding Company securities, using the treasury stock method, were excluded from the above calculations of net loss per share because their impact would have been anti-dilutive:

Three Months Ended

Six Months Ended

June 30,

June 30,

2015

2014

2015

2014
Common stock options
1,812


1,813


1,812


1,917

Restricted stock awards
139


420


137


422

Restricted stock units
269


143


257


202

  Total
2,220


2,376


2,206


2,541

As discussed in Note 6, in December 2013, the Company issued $86.3 million aggregate principal amount of 2.25% convertible senior notes due 2018 (the “Senior Notes”) in an underwritten public offering. Upon any conversion, the Senior Notes may be settled, at the Company’s election, in cash, shares of the Company’s common stock or a combination of cash and shares of the Company’s common stock. For purposes of calculating the maximum dilutive impact, it is presumed that the Senior Notes will be settled in common stock with the resulting potential common shares included in diluted earnings per share if the effect is more dilutive. The effect of the conversion of the Senior Notes is excluded from the calculation of diluted loss per share because the impact of these securities would be anti-dilutive. The potential dilutive effect of these securities is shown in the chart below:
 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
2015
 
2014
 
2015
 
2014
Conversion of the Notes
3,588

 
3,588

 
3,588

 
3,588


The effect of the contingently issuable common stock is excluded from the calculation of basic net loss per share until all necessary conditions for issuance have been satisfied. Refer to Note 9 of the Notes to the Condensed Consolidated Financial Statements for further discussion.

6. Credit Facilities

2.25% Convertible Senior Notes

On December 10, 2013, the Company issued $86.3 million aggregate principal amount 2.25% Convertible Senior Notes (the “Senior Notes”). The Senior Notes mature on December 15, 2018 unless earlier repurchased by the Company or converted. The Company received net proceeds of the Notes of approximately $82.6 million from the sale of the Senior Notes, after deducting underwriting discounts and commissions and offering expenses payable by the Company. Interest is payable on the Senior Notes on June 15 and December 15 of each year, beginning June 15, 2014.

The Senior Notes are governed by the terms of a base indenture (the “Base Indenture”), as supplemented by the first supplemental indenture relating to the Senior Notes (the “First Supplemental Indenture,” and together with the Base Indenture,

9
ENDOLOGIX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(all tabular amounts presented in thousands, except per share, per unit, and number of years)
(Unaudited)



the “Indenture”), between the Company and Wells Fargo Bank, National Association (the “Trustee”), each of which were entered into on December 10, 2013.

The Senior Notes are senior unsecured obligations and are (a) senior in right of payment to the Company’s future indebtedness that is expressly subordinated in right of payment to the Senior Notes; (b) equal in right of payment to the Company’s existing and future unsecured indebtedness that is not so subordinated; (c) effectively junior to any of the Company’s secured indebtedness to the extent of the value of the assets securing such indebtedness; (d) and structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company’s subsidiaries.

The Company may not redeem the Senior Notes prior to December 15, 2016. On or after December 15, 2016, the Company may redeem for cash all or any portion of the Senior Notes, at its option, but only if the closing sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period ending on, and including, the second trading day immediately preceding the date on which the Company provides notice of redemption, exceeds 130% of the conversion price on each applicable trading day. The redemption price will equal 100% of the principal amount of the Senior Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. No sinking fund is provided for the Senior Notes.

Holders may convert their Senior Notes at any time prior to the close of business on the business day immediately preceding September 15, 2018 only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on March 31, 2014, if the closing sale price of the Company’s common stock, for at least 20 trading days (whether or not consecutive) in the period of 30 consecutive trading days ending on the last trading day of the calendar quarter immediately preceding the calendar quarter in which the conversion occurs, is more than 130% of the conversion price of the Senior Notes in effect on each applicable trading day; (2) during the five consecutive business-day period following any five consecutive trading-day period in which the trading price for the Senior Notes for each such trading day was less than 98% of the closing sale price of the Company’s common stock on such date multiplied by the then-current conversion rate; (3) if the Company calls all or any portion of the notes for redemption, at any time prior to the close of business on the second scheduled trading day prior to the redemption date; or (4) upon the occurrence of specified corporate events. On or after September 15, 2018 until the close of business on the second scheduled trading day immediately preceding the stated maturity date, holders may surrender their Senior Notes for conversion at any time, regardless of the foregoing circumstances.

Upon conversion, the Company will, at its election, pay or deliver, as the case may be, cash, shares of the Company’s common stock or a combination of cash and shares of the Company’s common stock.

The initial conversion rate of the Senior Notes will be 41.6051 shares of the Company’s common stock for each $1,000 principal amount of Senior Notes, which represents an initial conversion price of approximately $24.04 per share. Following certain corporate transactions that occur on or prior to the stated maturity date or the Company’s delivery of a notice of redemption, the Company will increase the conversion rate for a holder that elects to convert its Senior Notes in connection with such a corporate transaction.

If a fundamental change (as defined in the Indenture) occurs prior to the stated maturity date, holders may require the Company to purchase for cash all or any portion of their Senior Notes at a fundamental change purchase price equal to 100% of the principal amount of the Senior Notes to be purchased, plus accrued and unpaid interest to, but excluding, the fundamental change purchase date.
The Indenture contains customary terms and covenants and events of default with respect to the Senior Notes. If an event of default (as defined in the Indenture) occurs and is continuing, either the Trustee or the holders of at least 25% in aggregate principal amount of the outstanding Senior Notes may declare the principal amount of the Senior Notes to be due and payable immediately by notice to the Company (with a copy to the Trustee). If an event of default arising out of certain events of bankruptcy, insolvency or reorganization involving the Company or a significant subsidiary (as set forth in the Indenture) occurs with respect to us, the principal amount of the Senior Notes and accrued and unpaid interest, if any, will automatically become immediately due and payable.

The Company was not required to separate the conversion option in the Senior Notes under ASC 815, "Derivatives and Hedging", and has the ability to settle the Senior Notes in cash, common stock or a combination of cash and common stock, at its option. In accordance with cash conversion guidance contained in ASC 470-20, "Debt with Conversion and Other Options", the Company accounted for the Senior Notes by allocating the issuance proceeds between the liability and the equity component. The

10
ENDOLOGIX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(all tabular amounts presented in thousands, except per share, per unit, and number of years)
(Unaudited)



equity component is classified in stockholders’ equity and the resulting discount on the liability component is accreted such that interest expense equals the Company’s nonconvertible debt borrowing rate. The separation was performed by first determining the fair value of a similar debt that does not have an associated equity component. That amount was then deducted from the initial proceeds of the Senior Notes as a whole to arrive at a residual amount, which was allocated to the conversion feature that is classified as equity. The initial fair value of the indebtedness was $66.9 million resulting in a $19.3 million allocation to the embedded conversion option. The embedded conversion option was recorded in stockholders’ equity and as debt discount, to be subsequently accreted to interest expense over the term of the Senior Notes. Underwriting discounts and commissions and offering expenses totaled $3.7 million and were allocated between the liability and the equity component in proportion to the allocation of proceeds and accounted for as debt issuance costs and equity issuance costs, respectively. As a result, $2.9 million attributable to the indebtedness was recorded as deferred financing costs in other assets, to be subsequently amortized as interest expense over the term of the Senior Notes, and $0.8 million attributable to the equity component was recorded as a reduction to additional paid-in-capital in stockholders’ equity.

As of June 30, 2015, the Company had outstanding borrowings of $72.2 million, and deferred financing costs of $2.2 million, related to the Senior Notes. There are no principal payments due during the term. Annual interest expense on these notes will range from $5.7 million to $6.9 million through maturity.

Capped Call Transactions

On December 10, 2013, in connection with the pricing of the Senior Notes and the exercise in full of their overallotment option by the underwriters, the Company entered into privately-negotiated capped call transactions (the “Capped Call Transactions”) with Bank of America, N.A., an affiliate of Merrill Lynch, Pierce, Fenner & Smith Incorporated. The Capped Call Transactions initial conversion rate and number of options substantially corresponds to each $1,000 principal amount of Senior Notes. The Company used approximately $7.4 million of the net proceeds from the Senior Notes offering to pay for the cost of the Capped Call Transactions.

The Capped Call Transactions are separate transactions entered into by the Company with Bank of America, N.A., are not part of the terms of the Senior Notes and will not change the holders’ rights under the Senior Notes. The Capped Call Transactions have anti-dilution adjustments substantially similar to those applicable to the Senior Notes. The Capped Call Transactions are derivative instruments that are recorded within stockholders’ equity because they meet an exemption from mark-to-market derivative accounting.

The Capped Call Transactions are expected generally to reduce the potential dilution and/or offset potential cash payments that the Company is required to make in excess of the principal amount upon conversion of the Senior Notes in the event that the market price per share of the Company’s common stock, as measured under the terms of the Capped Call Transactions, is greater than the strike price of the Capped Call Transactions, which initially corresponds to the $24.04 conversion price of the Senior Notes. If, however, the market price per share of the Company’s common stock, as measured under the terms of the Capped Call Transactions, exceeds the initial cap price of $29.02, there would nevertheless be dilution and/or there would not be an offset of such potential cash payments, in each case, to the extent that such market price exceeds the cap price of the Capped Call Transactions.

The Company will not be required to make any cash payments to Bank of America, N.A. or any of its affiliates upon the exercise of the options that are a part of the Capped Call Transactions, but will be entitled to receive from Bank of America, N.A. (or an affiliate thereof) a number of shares of the Company’s common stock and/or an amount of cash generally based on the amount by which the market price per share of the Company’s common stock, as measured under the terms of the Capped Call Transactions, is greater than the strike price of the Capped Call Transactions during the relevant valuation period under the Capped Call Transactions. However, if the market price of the Company’s common stock, as measured under the terms of the Capped Call Transactions, exceeds the cap price of the Capped Call Transactions during such valuation period under the Capped Call Transactions, the number of shares of common stock and/or the amount of cash the Company expects to receive upon exercise of the Capped Call Transactions will be capped based on the amount by which the cap price exceeds the strike price of the Capped Call Transactions.

For any conversions of Senior Notes prior to the close of business on the 55th scheduled trading day immediately preceding the stated maturity date of the Senior Notes, including without limitation upon an acquisition of the Company or similar business combination, a corresponding portion of the Capped Call Transactions will be terminated. Upon such termination, the portion of the Capped Call Transactions being terminated will be settled at fair value (subject to certain limitations), as determined by Bank

11
ENDOLOGIX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(all tabular amounts presented in thousands, except per share, per unit, and number of years)
(Unaudited)



of America, N.A., in its capacity as calculation agent under the Capped Call Transactions, which the Company expects to receive from Bank of America, N.A., and no payments will be due Bank of America, N.A. The capped call expires on December 13, 2018.

Wells Fargo line of credit

In October 2009, the Company entered into a revolving credit facility with Wells Fargo Bank (“Wells”), which was last amended on February 3, 2015, whereby the Company may borrow up to $20.0 million, subject to the calculation and limitation of a borrowing base (the “Wells Credit Facility”). All amounts owing under the Wells Credit Facility will become due and payable upon its expiration on November 15, 2015. A sub-feature in the line of credit allows for the issuance of up to $7.5 million in letters of credit. As of June 30, 2015, the Company had no outstanding letters of credit issued. The Wells Credit Facility is collateralized by all of the Company's assets, except its intellectual property.

The Wells Credit Facility contains financial covenants requiring the Company to (i) maintain a minimum current ratio of 2.0 , equal to the quotient of modified current assets to current liabilities, as defined in the Wells Credit Facility (the "Current Ratio Covenant"), and (ii) not to exceed pre-tax net loss (excluding non-cash contingent consideration associated with the acquisition of Nellix) of $13.5 million for the three months ended March 31, 2015; $23.0 million for the six months ended June 30, 2015; and $35.0 million for the nine months ended September 30, 2015; (the "Net Loss Covenant").  The Wells Credit Facility also includes negative covenants limiting capital expenditures in 2015 to an aggregate of $6.0 million as well as limiting operating lease expenses to $3.0 million in any calendar year. As of June 30, 2015, the Company was not in compliance with the Net Loss Covenant. The financial covenants as of and for the three and six months ended June 30, 2015 are no longer applicable due to the termination of the Wells Credit Facility on July 21, 2015.

The Wells Credit Facility also contains a “material adverse change” clause (“MAC”). If the Company encounters difficulties that would qualify as a MAC in its (i) operations, (ii) condition (financial or otherwise), or (iii) ability to repay amounts outstanding under the Wells Credit Facility, it could be canceled at Wells' sole discretion. Wells could then elect to declare the indebtedness, together with accrued interest and other fees, to be immediately due and payable and proceed against any collateral securing such indebtedness. No borrowings were outstanding at June 30, 2015 and 2014. On July 21, 2015, the Company terminated the credit facility. As of the termination date, the Company had no outstanding borrowings or letters of credits issued under the Wells Credit Facility.

Bank of America line of credit

On July 21, 2015, the Company entered into a revolving credit facility with Bank of America, N.A. (“BOA”), whereby the Company may borrow up to $20.0 million (the “BOA Credit Facility”). All amounts owing under the BOA Credit Facility will become due and payable upon its expiration on July 21, 2017. A sub-feature in the line of credit allows for the issuance of up to $10.0 million in letters of credit. The BOA Credit Facility is collateralized by all of the Company's assets, except its intellectual property. The BOA Credit Facility can be terminated at any time during the two years by Company upon three business day notice. The BOA Credit Facility usage is priced at a spread over the one, two, three and six month LIBOR rates, and is subject to a covenants related to timely providing of publicly reported information, other indebtedness and a liquidity covenant tied to “Unencumbered Liquid Assets” ("ULA") - (as defined here) of not less than $30.0 million. ULA means the following assets (excluding assets of any retirement plan) which (i) are held in the United States at BOA and/or its affiliates, (ii) are not the subject of any lien, pledge, security interest or other arrangement with any creditor (other than BOA or one of BOA’s affiliates) to have his claim satisfied out of the asset (or proceeds thereof) prior to the general creditors of the owner of the asset, (iii) are held solely in the name of one or more credit parties subject to this covenant (with no other persons or entities having ownership rights therein), (iv) may be converted to cash within five (5) days, and (v) are not being counted or included to satisfy any other liquidity requirement under any other obligation, whether with BOA or any other lender, unless otherwise expressly agreed by BOA in writing: (a) cash and cash equivalents; (b) marketable securities invested in accordance with the Company’s investment policy and (c) marketable securities invested in accordance with any update to the Company’s investment policy so long as such update been approved by BOA in its reasonable discretion.
If not in default, the Company has the ability to reduce the ULA covenant requirement by reducing the BOA Credit Facility, with the ULA maintained at 1.5 times the BOA Credit Facility.
  


12
ENDOLOGIX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(all tabular amounts presented in thousands, except per share, per unit, and number of years)
(Unaudited)




7. Revenue by Geographic Region
The Company's revenue by geographic region, was as follows:

Three Months Ended

Six Months Ended
 
June 30,

June 30,
 
2015

2014

2015

2014
United States
$
28,776


72.9%

$
27,992


73.0%

$
53,910


70.8%

$
51,980


72.6%




















Europe
$
7,888


20.0%

$
7,816


20.4%

$
15,134


19.9%

$
14,401


20.1%




















Rest of World ("ROW"):



















Latin America
$
1,221


3.1%

$
1,309


3.4%

$
3,260


4.3%

$
2,226


3.1%
Asia/Pacific
1,594


4.0%

1,210


3.2%

3,845


5.0%

2,984


4.2%
Total ROW
$
2,815


7.1%

$
2,519


6.6%

$
7,105


9.3%

$
5,210


7.3%



















Revenue
$
39,479


100.0%

$
38,327


100.0%

$
76,149


100.0%

$
71,591


100.0%
      
8. Commitments and Contingencies
(a) Leases
The Company leases its administrative, research, and manufacturing facilities located in Irvine, California and an administrative office located in Rosmalen, The Netherlands. These facility lease agreements require the Company to pay operating costs, including property taxes, insurance and maintenance. In addition, the Company has certain equipment under long-term agreements that are accounted for as operating leases.
Future minimum payments by year under non-cancelable leases with initial terms in excess of one year were as follows as of June 30, 2015:
Remainder of 2015
$
1,271

2016
2,363

2017
2,331

2018
2,258

2019
2,296

2020
2,388

2021 and thereafter
22,884

Total
$
35,791


Facilities rent expense for the three months ended June 30, 2015 and 2014 was $0.6 million and $0.7 million, respectively. For the six months ended June 30, 2015 and 2014 facilities rent expense was $1.2 million and $1.3 million, respectively.
 
On June 12, 2013, the Company entered into a lease agreement for two adjacent office, research and development, and manufacturing facilities in Irvine, California.  The premises consist of approximately 129,000 combined square feet. The lease has a 15-year term beginning January 1, 2014 and provides for one optional five year extension. The initial base rent under the lease is $1.9 million per year, payable in monthly installments, and escalates by 3% per year for years 2015 through 2019, and 4% per year for years 2020 and beyond.  The Company received a rent abatement for the first nine months of the lease. These premises replaced the Company's existing Irvine facilities. The terms of this lease agreement provide for $6.8 million of landlord-funded improvements (and certain other allowances) to this facility, in order to best suit the Company's requirements.
The Company leased two adjacent facilities aggregating approximately 57,000 square feet in Irvine, California, under separate lease agreements where manufacturing was held. The Company exited one of these leases in December 2014 and the

13
ENDOLOGIX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(all tabular amounts presented in thousands, except per share, per unit, and number of years)
(Unaudited)



other lease in April 2015. The Company's Rosmalen facility is an administrative office of approximately 2,900 square feet with lease expiration in December 2015 and renewal at its option.
(b) Employment Agreements and Retention Plan
On February 1, 2014, the Company entered into new employment agreements with certain of its executive officers under which payment and benefits would become payable in the event of termination by the Company for any reason other than cause, death or disability or termination by the employee for good reason (collectively, an “Involuntary Termination”) prior to, upon or following a change in control of the Company. The severance payment will generally be in a range of six to eighteen months of the employee’s then current salary for an Involuntary Termination prior to a change in control of the Company, and will generally be in a range of eighteen to twenty-four months of the employee’s then current salary for an Involuntary Termination upon or following a change in control of the Company.
(c) Legal Matters
We are from time to time involved in various claims and legal proceedings of a nature we believe are normal and incidental to a medical device business. These matters may include product liability, intellectual property, employment, and other general claims. Such cases and claims may raise complex factual and legal issues and are subject to many uncertainties, including, but not limited to, the facts and circumstances of each particular case or claim, the jurisdiction in which each suit is brought, and differences in applicable law. We accrue for contingent liabilities when it is probable that a liability has been incurred and the amount can be reasonably estimated. The accruals are adjusted periodically as assessments change or as additional information becomes available.

LifePort Sciences LLC v. Endologix, Inc.
On December 28, 2012, LifePort Sciences, LLC ("LifePort") filed a complaint against us in the U.S. District Court, District of Delaware, alleging that certain of our products infringe U.S. Patent Nos. 5,489,295, 6,117,167, 6,302,906, 5,993,481 and 5,676,696, which are alleged to be owned by LifePort. LifePort is seeking an unspecified amount of monetary damages for sale of our products and injunctive relief. We do not believe that we infringe on any of these patents and we intend to vigorously defend against this matter. The case is currently scheduled for trial in April 2016. We do believe, however, that the outcome will not have a material adverse effect on our financial position, results of operations, or cash flows. However, in order to avoid further legal costs and diversion of management resources, it is reasonably possible that we may reach a settlement with LifePort, which could result in a liability. However, we cannot presently estimate the amount, or range, of reasonably possible losses due to the nature of this potential litigation settlement.

9. Contingently Issuable Common Stock
On October 27, 2010, the Company entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”) with Nepal Acquisition Corporation, a wholly-owned subsidiary of the Company (“Merger Sub”), Nellix, Inc. ("Nellix"), certain of Nellix’s stockholders named therein and Essex Woodlands Health Ventures, Inc., as representative of the former Nellix stockholders. On December 10, 2010 (the “Nellix Closing Date”), the Company completed the merger (the “Merger”) of Merger Sub with and into Nellix pursuant to the terms of the Merger Agreement. The purchase price consisted of 3.2 million shares of the Company's common stock, issuable to the former Nellix stockholders as of the Nellix Closing Date, then representing a value of $19.4 million. Under the agreement, additional payments, solely in the form of shares of the Company's common stock (the “Contingent Payment”), could be made upon the achievement of a revenue milestone and a regulatory approval milestone (collectively, the “Nellix Milestones”).
Under the merger agreement, the ultimate value of each Contingent Payment would be determined on the date that each Nellix Milestone is achieved. The number of issuable shares would be established using an applicable per share price, which is subject to a ceiling and/or floor, resulting at the closing of the merger in a potential maximum of 10.2 million shares issuable upon the achievement of the Nellix Milestones. As of the Closing Date, the aggregate fair value of the cash Contingent Payment was estimated to be $28.2 million.
The Merger Agreement provides that, in addition to the shares of common stock of the Company (the “Common Stock”) issued to the former Nellix stockholders at the closing of the Merger, the former Nellix stockholders were entitled to receive shares of the Common Stock if the Company’s sales of a Nellix product (the “Nellix Product”) outside of the United States exceeded $10.0 million within a certain time period following the Company’s receipt of CE mark approval for the Nellix Product

14
ENDOLOGIX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(all tabular amounts presented in thousands, except per share, per unit, and number of years)
(Unaudited)



(the “OUS Milestone”). The aggregate dollar value of the shares of the Common Stock to be issued upon achievement of the OUS Milestone ranged from a high of $24.0 million, or 6.9 million shares, to a low of $10.0 million, or 1.3 million shares. The price per share of the Common Stock to be issued upon achievement of the OUS Milestone was subject to a floor of $3.50 per share and a ceiling of $7.50 per share.
On June 17, 2014, the Company announced its achievement of the OUS Milestone and the issuance of an aggregate of 2.7 million unregistered shares of the Common Stock (the “OUS Milestone Shares”), plus an amount of cash in lieu of fractional shares, to the former Nellix stockholders. The Company offered and sold the OUS Milestone Shares in reliance upon exemptions from registration pursuant to Section 4(2) under the Securities Act of 1933, as amended (the “Securities Act”). The former Nellix stockholders previously gave representations to the Company regarding their investment intent, experience, financial sophistication, access to information regarding the Company and certain other matters to support the Company’s reasonable belief that it could rely upon the foregoing exemptions from registration pursuant to Section 4(2) of the Securities Act. No underwriting discounts or commissions were or will be paid in conjunction with the issuance of the OUS Milestone Shares. The Company previously filed a Registration Statement on Form S-3 (Registration No. 333-171639) (the “Form S-3”) for the purpose of registering for resale shares of the Common Stock issued or issuable pursuant to the Merger Agreement, including the OUS Milestone Shares. The Securities and Exchange Commission declared the Form S-3 effective on January 18, 2011.
In addition, if the Company receives approval from the FDA to sell the Nellix Product in the United States (the “PMA Milestone”), the Company will issue additional shares of the Common Stock to the former stockholders of Nellix. The dollar value of the shares of the Common Stock to be issued upon achievement of the PMA Milestone will be equal to $15.0 million (less the dollar value of certain cash payments and other deductions). The price per share of the shares of the Common Stock to be issued upon achievement of the PMA Milestone is subject to a stock price floor of $4.50 per share, but not subject to a stock price ceiling.
As of June 30, 2015 the Company's stock price last closed at $15.34 per share. Thus, had the PMA Milestone been achieved on June 30, 2015 the Contingent Payment would have comprised 0.9 million shares (based on the 30-day average closing stock price ending 5 days prior to the announcement), representing a value of $13.8 million.
The value of the Contingent Payment is derived using a discounted income approach model, with a range of probabilities and assumptions related to the timing and likelihood of achievement of the PMA Milestone (which include Level 3 inputs - see Note 3(e) and the Company's stock price (Level 1 input) as of the balance sheet date). These varying probabilities and assumptions and changes in the Company's stock price have required fair value adjustments of the Contingent Payment in periods subsequent to the Nellix Closing Date.
The Contingent Payment fair value will continue to be evaluated on a quarterly basis until milestone achievement occurs, or until the expiration of the "earn-out period," as defined within the Nellix purchase agreement. Adjustments to the fair value of the Contingent Payment are recognized within other income (expense) in the Condensed Consolidated Statements of Operations and Comprehensive Loss.
 
Fair Value of Contingently Issuable Common Stock
December 31, 2014
$
14,600

Fair Value Adjustment of Contingent Payment for the six months ended June 30, 2015
200

June 30, 2015
$
14,800



10. Income Tax Expense
The Company applied an estimated annual effective tax rate (“ETR”) approach for calculating a tax provision for interim periods. The Company recorded a provision for income taxes of $0.1 million and $0.2 million for the three and six months ended June 30, 2015, respectively. The Company's ETR was (0.5)% and (0.7)% for the three and six months ended June 30, 2015, respectively.  The Company's ETR for the three and six months ended June 30, 2015 differs from the U.S. federal statutory tax rate of 34% primarily as a result of nondeductible expenses (including the Nellix Contingent Payment), state income taxes, foreign income taxes, and the impact of a full valuation allowance on its deferred tax assets.

The Company has evaluated the available evidence supporting the realization of its deferred tax assets, including the amount and timing of future taxable income, and has determined that it is more likely than not that its net deferred tax assets will not be

15
ENDOLOGIX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(all tabular amounts presented in thousands, except per share, per unit, and number of years)
(Unaudited)



realized in the U.S. and certain foreign jurisdictions. Due to uncertainties surrounding the realization of the deferred tax assets, the Company maintains a full valuation allowance against substantially all deferred tax assets. If/when the Company determines that it will be able to realize some portion or all of its deferred tax assets, an adjustment to its valuation allowance on its deferred tax assets would have the effect of increasing net income in the period(s) such determination is made.


16

Item 2.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Cautionary Note Concerning Forward-Looking Statements

In addition to historical information, this Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward looking statements are intended to qualify for the safe harbor established by the Private Securities Litigation Reform Act of 1995. You can identify forward-looking statements by the use of forward-looking terminology such as “anticipates,” “believes,” “can,” “continue,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “should” or “will” or the negative of these terms or other comparable terminology, or by discussions of strategies, opportunities, plans or intentions. In addition, any statements that refer to projections of our future financial performance, trends in our businesses, or other characterizations of future events or circumstances are forward-looking statements. We have based these forward-looking statements largely on our current expectations based on information currently available to us and projections about future events and trends affecting the financial condition of our business. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy. These forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results and the timing of certain events to differ materially from future results expressed or implied by such forward- looking statements. Actual results could differ materially from those projected in forward-looking statements as a result of the following factors, among others:

•
continued market acceptance of our products;
•
quality problems with our products;
•
consolidation in the health care industry;
•
the success of our clinical trials relating to products under development;
•
our ability to maintain strong relationships with certain key physicians;
•
continued growth in the number of patients qualifying for treatment of abdominal aortic aneurysms through our products;
•
our ability to effectively compete with the products offered by our competitors;
•
the level and availability of third party payor reimbursement for our products;
•
our ability to successfully commercialize products which incorporate the technology obtained in our acquisition of Nellix, Inc. (“Nellix”);     
•
our ability to effectively develop new or complementary technologies;
•
our ability to manufacture our endovascular systems to meet demand;
•
changes to our international operations including currency exchange rate fluctuations;
•
our ability to effectively manage our business and keep pace with our anticipated growth;
•
our ability to develop and retain a direct sales force in the United States and select European countries;
•
the nature of and any changes to legislative, regulatory and other legal requirements that apply to us, our products, our suppliers and our competitors;     
•
the timing of and our ability to obtain and maintain any required regulatory clearances and approvals;
•
our ability to protect our intellectual property rights and proprietary technologies;
•
our ability to operate our business without infringing the intellectual property rights and proprietary technology of third parties;
•
product liability claims and litigation expenses;
•
reputational damage to our products caused by mis-use or off-label use or government or voluntary product recalls;
•
our utilization of a single source supplier for specialized components of our product lines;
•
our ability to attract, retain, and motivate qualified personnel;
•
our ability to make future acquisitions and successfully integrate any such future-acquired businesses;
•
our ability to maintain adequate liquidity to fund our operational needs and research and developments expenses; and
•
general macroeconomic and world-wide business conditions.

Our actual results, performance or achievements may differ materially from any future results, performance or achievements expressed or implied from such forward-looking statements. Important factors that could cause our actual results, performance or achievements to differ materially from our expectations are disclosed in our Annual Report on Form 10-K for the year ended December 31, 2014, filed with the SEC on March 2, 2015, including but not limited to those factors discussed in “Management's Discussion and Analysis of Financial Condition and Results of Operations,” “Risk Factors,” “Consolidated Financial Statements” and “Notes to Consolidated Financial Statements.” All subsequent written and oral forward-looking statements attributable to us or by persons acting on our behalf are expressly qualified in their entirety by these cautionary statements. We expressly disclaim any intent or obligation to update information contained in any forward-looking statement after the date thereof to conform such information to actual results or to changes in our opinions or expectations. 


17

Our forward-looking statements speak only as of the date each such statement is made. We expressly disclaim any intent or obligation to update any forward-looking statements after the date hereof to conform such statements to actual results or to changes in our opinions or expectations, except as required by applicable law or the rules and regulations of the SEC and The NASDAQ Stock Market, LLC.

Overview
Our Business
Our corporate headquarters and manufacturing facility is located in Irvine, California. We develop, manufacture, market, and sell innovative medical devices for the treatment of aortic disorders. Our principal products are intended for the treatment of abdominal aortic aneurysms ("AAA"). Our AAA products are built on one of two platforms: (a) traditional minimally-invasive endovascular repair ("EVAR") or (b) endovascular sealing (“EVAS”), our innovative solution for sealing the aneurysm sac while maintaining blood flow through two blood flow lumens.
We sell our products through our direct U.S. and European sales forces and third-party international distributors and agents in other parts of the world.
See Item 1. of our Annual Report on Form 10-K for the year ended December 31, 2014, entitled "Business," for a discussion of:
•
Market Overview and Opportunity
•
Our Products
•
Manufacturing and Supply
•
Marketing and Sales
•
Competition
•
Product Developments and Clinical Trials

Endologix®, AFX® and Nellix® are registered trademarks of Endologix, Inc., and Intuitrak™, VELA™ and the respective product logos are trademarks of Endologix, Inc.

Recent Highlights of Our Product Development Initiatives, Clinical Trials and Regulatory Approvals

Nellix
On December 10, 2010, we completed our acquisition of Nellix. Using the technology we acquired in the Nellix acquisition, we developed the Nellix EVAS System, a next-generation device, to treat infrarenal AAA. We have the following trials in process to build independent and collective clinical and economic evidence of clinical safety and effectiveness:

•
EVAS FORWARD IDE - Pivotal clinical trial to evaluate the safety and effectiveness of the Nellix EVAS System. The study is a prospective single arm registry which enrolled 179 patients at centers in the U.S. and Europe. In November 2014, we completed enrollment in the EVAS FORWARD IDE. The patients in this study will be followed for one-year, after which we will submit the final module of the PMA to the FDA. FDA approval is anticipated by the end of 2016.
•
EVAS FORWARD Global Registry - This study is designed to provide real world clinical results to demonstrate the effectiveness and broad applicability of the Nellix EVAS System. This registry is designed to include 300 patients enrolled in up to 30 international centers. The first patient in the registry was treated in October 2013. The study utilizes an independent core lab and includes follow-up to five years. In September 2014, we announced completion of patient enrollment in the Nellix EVAS FORWARD Global Registry.
     
AFX

In February 2014, we launched a new proximal extension in the U.S., VELA, designed to be used in conjunction with our AFX bifurcated device. VELA features a circumferential graft line marker and controlled delivery system that enable predictable deployment and final positional adjustments. We began a commercial introduction of VELA in Europe in January 2015.
In September 2014, we announced a new clinical study called LEOPARD (Looking at EVAR Outcomes by Primary Analysis of Randomized Data). The study will provide a real-world comparison of the AFX system versus other commercially available EVAR devices. The LEOPARD study is designed to randomize and enroll up to 800 patients at 80 leading centers throughout the United States and commenced in the first quarter of 2015. The centers will be a mix of our current and new customers, with each investigator selecting one competitive device to randomize against AFX. The LEOPARD study is being led by an independent steering committee of leading physicians who will be involved with the study and responsible for presenting the results over the five-year follow-up period.

18


Characteristics of Our Revenue and Expenses
Revenue
We derive revenue from sales of our EVAR and EVAS products (including extensions and accessories) to hospitals upon completion of AAA repair procedures, or from sales to distributors upon title transfer (which is typically at shipment), provided our other revenue recognition criteria have been met.
Cost of Goods Sold
Cost of goods sold includes compensation (including stock-based compensation) and benefits of production personnel and production support personnel. Cost of goods sold also includes depreciation expense for production equipment, production materials and supplies expense, allocated facilities-related expenses and certain direct costs such as shipping.
Research and Development
Research and development expenses consist of compensation (including stock-based compensation) and benefits for research and development personnel, materials and supplies, research and development consultants, outsourced and licensed research and development costs and allocated facilities-related costs. Our research and development activities primarily relate to the development and testing of new devices and methods to treat aortic disorders.
Clinical and Regulatory
Clinical and regulatory expenses consist of compensation (including stock-based compensation) and benefits for clinical and regulatory personnel, regulatory and clinical payments related to studies, regulatory costs related to registration and approval activities and allocated facilities-related costs. Our clinical and regulatory activities primarily relate to gaining regulatory approval for the commercialization of our devices.
Marketing and Sales
Marketing and Sales expenses primarily consist of compensation (including stock-based compensation) and benefits for our sales force, clinical specialist, internal sales support functions and marketing personnel. It also includes costs attributable to marketing our products to our customers and prospective customers.
General and Administrative
General and administrative expenses primarily include compensation (including stock-based compensation) and benefits for personnel that support our general operations such as information technology, executive management, financial accounting, and human resources. General and administrative expenses also include bad debt expense, patent and legal fees, financial audit fees, insurance, recruiting fees, other professional services, the federal Medical Device Excise Tax and allocated facilities-related expenses.
Critical Accounting Policies and Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, and the disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the periods presented. While management believes these estimates are reasonable and consistent, they are by their very nature, estimates of amounts that will depend on future events. Accordingly, actual results could differ from these estimates. Our Audit Committee periodically reviews our significant accounting policies.
For a description of our critical accounting policies and estimates, please refer to the “Critical Accounting Policies and Estimates” section in Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations”, in our Annual Report on Form 10-K for the year ended December 31, 2014. There have been no material changes in any of our critical accounting policies and estimates during the three months ended June 30, 2015.



19

Results of Operations
Operations Overview - Three and Six Months Ended June 30, 2015 versus 2014
The following table presents our results of continuing operations and the related percentage of the period's revenue (in thousands):

Three Months Ended June 30,
 
Six Months Ended June 30,

2015

2014
 
2015

2014
Revenue
$
39,479


100.0%

$
38,327


100.0%
 
$
76,149


100.0%

$
71,591


100.0%
Cost of goods sold
15,347


38.9%

9,820


25.6%
 
25,111


33.0%

18,789


26.2%
Gross profit
24,132


61.1%

28,507


74.4%
 
51,038


67.0%

52,802


73.8%
Operating expenses:







 







Research and development
5,993


15.2%

4,458


11.6%
 
12,224


16.1%

8,563


12.0%
Clinical and regulatory affairs
3,597


9.1%

2,722


7.1%
 
7,047


9.3%

4,922


6.9%
Marketing and sales
19,842


50.3%

19,167


50.0%
 
39,441


51.8%

35,311


49.3%
General and administrative
6,850


17.4%

5,932


15.5%
 
14,139


18.6%

13,094


18.3%
Total operating expenses
36,282


91.9%

32,279


84.2%
 
72,851


95.7%

61,890


86.4%
Loss from operations
(12,150
)

(30.8)%

(3,772
)

(9.8)%
 
(21,813
)

(28.6)%

(9,088
)

12.7%
Total other income (expense)
(790
)

(2.0)%

(5,301
)

(13.8)%
 
(2,249
)

(3.0)%

5,526


7.7%
Net loss before income tax (expense) benefit
(12,940
)

(32.8)%

(9,073
)

(23.6)%
 
(24,062
)

(31.6)%

(3,562
)

(5.0)%
Income tax (expense) benefit
(61
)

(0.1)%

80


0.2%
 
(153
)

(0.2)%

(136
)

(0.2)%
Net loss
$
(13,001
)

(32.9)%

$
(8,993
)

(23.4)%
 
$
(24,215
)

(31.8)%

$
(3,698
)

(5.2)%

Comparison of the Three Months Ended June 30, 2015 versus 2014
Revenue

Three Months Ended June 30,





2015

2014

Variance

Percent Change

(in thousands)




Revenue
$
39,479


$
38,327


$
1,152


3.0%

Our 3.0% revenue increase of $1.2 million over the prior year period primarily resulted from:

(i) a $0.8 million increase in U.S. sales procedures due to continued physician adoption of AFX;

(ii) a $0.3 million increase in ROW sales volume driven by our Asia/Pacific markets; and

(iii) a $0.1 million increase in European sales volume due to strong direct sales growth related to Nellix offsetting unfavorable foreign currency.

Our 2015 revenue includes an unfavorable foreign currency impact of $1.7 million when compared to 2014, representing revenue growth of 7.6% on a constant currency basis.
       

20

Cost of Goods Sold, Gross Profit, and Gross Margin

Three Months Ended June 30,





2015

2014

Variance

Percent Change

(in thousands)




Cost of goods sold
$
15,347


$
9,820


$
5,527


56.3
 %
Gross profit
24,132


28,507


(4,375
)

(15.3
)%
Gross margin percentage (gross profit as a percent of revenue)
61.1
%

74.4
%




The $5.5 million increase in cost of goods sold was driven by our revenue increase of $1.2 million and $4.3 million inventory reserve in the second quarter of 2015.

Gross margin for the three months ended June 30, 2015 decreased to 61.1% from 74.4% for the three months ended June 30, 2014. The increase in cost of goods sold, and corresponding decrease to gross margin, is largely due to a $4.3 million increase in the reserve for product inventory related to our global transition to DURAPLY™ ePTFE Graft Material for the AFX® Endovascular AAA System, a reserve for the current AFX product in anticipation of FDA approval of AFX2 by the end of 2015 and a provision for Nellix inventory that will become obsolete due to quality and process improvements. Gross margin is also impacted by product mix with a greater proportion of sales from Nellix which has a higher cost to produce compared to AFX.
Operating Expenses

Three Months Ended June 30,





2015

2014

Variance

Percent Change

(in thousands)




Research and development
$
5,993


$
4,458


$
1,535


34.4%
Clinical and regulatory affairs
3,597


2,722


875


32.1%
Marketing and sales
19,842


19,167


675


3.5%
General and administrative
6,850


5,932


918


15.5%
Research and Development. The $1.5 million increase in research and development expenses was primarily attributable to increased product development investments related to Nellix and AFX.
Clinical and Regulatory Affairs. The $0.9 million increase in clinical and regulatory affairs expenses is due to increased regulatory fees and patient and outside services costs to support ongoing clinical activities, such as EVAS FORWARD IDE and LEOPARD.
Marketing and Sales. The $0.7 million increase in marketing and sales expenses for the three months ended June 30, 2015, as compared to the prior year period, was primarily related to increased investments in our European sales force and marketing activities. Our 2015 marketing and sales expenses include a favorable foreign currency impact of $1.0 million when compared to 2014.
General and Administrative. The $0.9 million increase in general and administrative expenses is primarily attributable to an increase in professional fees, litigation costs and stock-based compensation.
Other income (expense), net

Three Months Ended June 30,





2015

2014

Variance

Percent Change

(in thousands)




Other income (expense), net
$
(790
)

$
(5,301
)

$
4,511


(85.1)%

Other Income (Expense), Net. Other expense for the three months ended June 30, 2015 includes interest expense associated with our convertible note of $1.5 million, foreign currency gains of $0.8 million and a non-cash expense of $0.1 million which reflects an increase in the fair value of the Nellix Contingent consideration. Other expense for the three months ended June 30,

21

2014 includes non-cash expense of $3.8 million which reflects an increase in the fair value of the Nellix Contingent consideration, interest expense of $1.4 million and foreign currency loss.
Provision for Income Taxes

Three Months Ended June 30,





2015

2014

Variance

Percent Change

(in thousands)




Income tax (expense) benefit
$
(61
)

$
80


$
(141
)

>(100%)
Our income tax expense was $0.1 million and our effective tax rate was (0.5)% for the three months ended June 30, 2015 due to our tax positions in various jurisdictions. During the three months ended June 30, 2015 and 2014, we had operating legal entities in the U.S., Italy, New Zealand, Switzerland and the Netherlands (including registered sales branches in certain countries in Europe).
Comparison of the Six Months Ended June 30, 2015 versus 2014
Revenue

Six Months Ended June 30,





2015

2014

Variance

Percent Change

(in thousands)




Revenue
$
76,149


$
71,591


$
4,558


6.4%

Our 6.4% revenue increase of $4.6 million over the prior year period primarily resulted from:

(i) a $1.9 million increase in U.S. sales procedures due to continued physician adoption of AFX;

(ii) a $1.9 million increase in sales volume to our ROW markets; and

(iii) a $0.7 million increase in European sales volume due to strong direct sales growth related to Nellix offsetting unfavorable foreign currency.

Our 2015 revenue includes an unfavorable foreign currency impact of $3.2 million when compared to 2014, representing revenue growth of 10.8% on a constant currency basis.
     
Cost of Goods Sold, Gross Profit, and Gross Margin

Six Months Ended June 30,





2015

2014

Variance

Percent Change

(in thousands)




Cost of goods sold
$
25,111


$
18,789


$
6,322


33.6
 %
Gross profit
51,038


52,802


(1,764
)

(3.3
)%
Gross margin percentage (gross profit as a percent of revenue)
67.0
%

73.8
%




The $6.3 million increase in cost of goods sold was driven by our revenue increase of $4.6 million and $4.3 million inventory reserve in the second quarter of 2015.

Gross margin for the six months ended June 30, 2015 decreased to 67.0% from 73.8% for the six months ended June 30, 2014. The increase in cost of goods sold, and corresponding decrease to gross margin, is largely due to a $4.3 million increase in the reserve for product inventory related to our global transition to DURAPLY™ ePTFE Graft Material for the AFX® Endovascular AAA System, a reserve for the current AFX product in anticipation of FDA approval of AFX2 by the end of 2015 and a provision for Nellix inventory that will become obsolete due to quality and process improvements. Gross margin is also impacted by product mix with a greater proportion of sales from Nellix which has a higher cost to produce compared to AFX.
 

22

Operating Expenses

Six Months Ended June 30,





2015

2014

Variance

Percent Change

(in thousands)




Research and development
$
12,224


$
8,563


$
3,661


42.8%
Clinical and regulatory affairs
7,047


4,922


2,125


43.2%
Marketing and sales
39,441


35,311


4,130


11.7%
General and administrative
14,139


13,094


1,045


8.0%
Research and Development. The $3.7 million increase in research and development expenses was primarily attributable to increased product development investments related to Nellix and AFX.
Clinical and Regulatory Affairs. The $2.1 million increase in clinical and regulatory affairs expenses is due to increased regulatory fees and patient and outside services costs to support ongoing clinical activities, such as EVAS FORWARD IDE and LEOPARD.
Marketing and Sales. The $4.1 million increase in marketing and sales expenses for the six months ended June 30, 2015, as compared to the prior year period, was primarily related to increased investments in our European sales force and global marketing activities. Our 2015 marketing and sales expenses include a favorable foreign currency impact of $1.9 million when compared to 2014.
General and Administrative. The $1.0 million increase in general and administrative expenses is primarily attributable to increases in professional fees, litigation costs, stock-based compensation and investment in information technology projects.
Other income (expense), net

Six Months Ended June 30,





2015

2014

Variance

Percent Change

(in thousands)




Other income (expense), net
$
(2,249
)

$
5,526


(7,775
)

>100%
       
Other Income (Expense), Net. Other expense for the six months ended June 30, 2015 includes interest expense associated with our convertible note of $3.0 million, foreign currency gains of $0.7 million and a non-cash expense of $0.2 million related to the fair value of the Nellix contingent consideration. Other income for the six months ended June 30, 2014 includes $8.0 million non-cash income which was related to the fair value of the Nellix contingent consideration. Partially offsetting this fair value adjustment is interest expense associated with our convertible notes of $2.8 million.
Provision for Income Taxes

Six Months Ended June 30,





2015

2014

Variance

Percent Change

(in thousands)




Income tax expense
$
(153
)

$
(136
)

$
(17
)

12.5
%
Our income tax expense was $0.2 million and our effective tax rate was (0.7)% for the six months ended June 30, 2015. During the six months ended June 30, 2015 and 2014, we had operating legal entities in the U.S., Italy, New Zealand, Switzerland and the Netherlands (including registered sales branches in certain countries in Europe). We have certain minimum tax liabilities attributable to our operations in these countries and in the U.S (see Note 10).


23

Liquidity and Capital Resources
The chart provided below summarizes selected liquidity data and metrics as of June 30, 2015, December 31, 2014, and June 30, 2014:

June 30, 2015

December 31, 2014

June 30, 2014

(in thousands, except financial metrics data)
Cash and cash equivalents
$
36,269


$
26,798


$
31,843

Marketable securities
$
34,257


$
59,871


$
78,941

Accounts receivable, net
$
29,138


$
26,113


$
26,714

Total current assets
$
132,965


$
147,767


$
170,719

Total current liabilities
$
28,208


$
29,624


$
28,589

Working capital surplus (a)
$
104,757


$
118,143


$
142,130

Current ratio (b)
4.7


5.0


6.0

Days sales outstanding ("DSO") (c)
67


62


63

Inventory turnover (d)
1.9


1.6


1.5

(a) total current assets minus total current liabilities as of the corresponding balance sheet date.
(b) total current assets divided by total current liabilities as of the corresponding balance sheet date.
(c) net accounts receivable at period end divided by revenue for the current period multiplied by the number of days in the period.
(d) cost of goods sold divided by the average inventory balance for the corresponding period.
Operating Activities
Cash used in operating activities was $16.4 million for the six months ended June 30, 2015 as compared to cash used in operating activities of $10.2 million in the prior year period. The increase in cash usage was primarily due to (i) funding the net loss of $24.2 million, (ii) an increase in accounts receivable and other receivables of $3.2 million and (iii) a decrease in accrued payroll of $1.7 million. These increases in cash usage were partially offset by non-cash stock-based compensation of $4.6 million, depreciation and amortization of $2.9 million, an increase in accounts payable of $2.7 million and non-cash accretion of interest on convertible note of $1.7 million. Cash used in operating activities for the six months ended June 30, 2014 was $10.2 million and consisted of (i) a change in the fair value of the Nellix contingent consideration of $8.0 million and (ii) inventory purchases of $8.8 million, offset by an increase in accounts payable of $3.9 million.
During the six months ended June 30, 2015 and 2014, our cash collections from customers totaled $73.9 million and $70.9 million, respectively, representing 97.0% and 99.0% of reported revenue for the same periods.
Investing Activities
Cash provided by investing activities for the six months ended June 30, 2015 was $22.4 million, as compared to cash used in investing activities of $54.3 million in the prior year period. For the six months ended June 30, 2015, cash provided by investing activities consisted of $62.7 million in maturities of marketable securities, offset by $3.1 million used for machinery and equipment purchases and $37.1 million used to purchase marketable securities. For the six months ended June 30, 2014, cash used in investing was $54.3 million and consisted of $5.7 million used for machinery and equipment purchases and $74.1 million used to purchase marketable debt securities; offset by $25.6 million in maturities of marketable securities.

24

Financing Activities
Cash provided by financing activities was $4.0 million for the six months ended June 30, 2015, as compared to cash used in financing activities $1.1 million in the prior year period. For the six months ended June 30, 2015 cash provided by financing activities consisted of $4.3 million from the exercise of stock options and proceeds from sale of common stock under our employee stock purchase plan, offset by $0.3 million used to pay minimum tax withholdings on behalf of employees for restricted stock units vested during the period. For the six months ended June 30, 2014, cash provided by financing activities consisted of proceeds of $2.5 million from the exercise of stock options and proceeds from our employee stock purchase plan, offset by $1.4 million used to pay minimum tax withholdings on behalf of employees for restricted stock units vested during the period.
Credit Arrangements

See Note 6 of the Notes to the Condensed Consolidated Financial Statements.
Future Capital Requirements
We believe that the future growth of our business will depend upon our ability to successfully develop new technologies for the treatment of aortic disorders and successfully bring these technologies to market. We expect to incur significant expenditures in completing product development and clinical trials for the Nellix System.
The timing and amount of our future capital requirements will depend on many factors, including:

•
the need for working capital to support our sales growth;
•
the need for additional capital to fund future development programs;
•
the need for additional capital to fund our sales force expansion;
•
the need for additional capital to fund strategic acquisitions;
•
our requirements for additional facility space or manufacturing capacity;
•
our requirements for additional information technology infrastructure and systems; and
•
adverse outcomes from potential litigation and the cost to defend such litigation.
 
We believe that our world-wide cash resources are adequate to operate our business. We presently have several operating subsidiaries and branches outside of the U.S. As of June 30, 2015, these subsidiaries and branches hold an aggregate $6.8 million in foreign bank accounts to fund their local operations. A portion of these balances relate to undistributed earnings, and are deemed by management to be permanently reinvested in the corresponding country in which our subsidiary operates. Management has no present or planned intention to repatriate foreign earnings into the U.S. However, in the event that we required additional funds in the U.S. and had to repatriate any foreign earnings to meet those needs, we would then need to accrue, and ultimately pay, incremental income tax expenses on such “deemed dividend,” unless we then had sufficient net operating losses to offset this potential tax liability.

In the event we require additional financing in the future, it may not be available on commercially reasonable terms, if at all. Even if we are able to obtain financing, it may cause substantial dilution (in the case of an equity financing), or may contain burdensome restrictions on the operation of our business (in the case of debt financing). If we are not able to obtain required financing, we may need to curtail our operations and/or our planned product development.
Contractual Obligations
Contractual obligation payments by year with initial terms in excess of one year were as follows as of June 30, 2015 (in thousands):

Payments due by period



Contractual Obligations
Total
Remainder of 2015
2016
2017
2018
2019
2020
2021 and thereafter
Long-term debt obligations
$
86,250

$
—

$
—

$
—

$
86,250

$
—

$
—

$
—

Interest on debt obligations
6,793

970

1,941

1,941

1,941

$
—

$
—

$
—

Operating lease obligations
35,791

1,271

2,363

2,331

2,258

2,296

2,388

22,884

Total
$
128,834

$
2,241

$
4,304

$
4,272

$
90,449

$
2,296

$
2,388

$
22,884

Refer to Note 6 of the Notes to the Condensed Consolidated Financial Statements for a discussion of long-term debt obligations and Note 8 of the Notes to the Condensed Consolidated Financial Statements for a discussion of operating lease obligations.

25

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements (except for operating leases) that provide financing, liquidity, market or credit risk support, or involve derivatives. In addition, we have no arrangements that may expose us to liability that are not expressly reflected in the accompanying Consolidated Financial Statements.

As of June 30, 2015, we did not have any relationships with unconsolidated entities or financial partnerships, often referred to as "structured finance" or "special purpose entities," established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. As such, we are not subject to any material financing, liquidity, market or credit risk that could arise if we had engaged in such relationships.


Item 3.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

We do not believe that we currently have material exposure to interest rate or foreign currency transaction risks.

Interest Rate and Market Risk. We have investments in U.S. Government and agency securities, corporate bonds and other debt securities. As a result, we are exposed to potential loss from market risks that may occur as a result of changes in interest rates, changes in credit quality of the issuer or otherwise.

We generally place our marketable security investments in high quality credit instruments, as specified in our investment policy guidelines. A hypothetical 100 basis point decrease in interest rates would result in an approximate $27 thousand increase in the fair value of our investments as of June 30, 2015. We believe, however, that the conservative nature of our investments mitigates our interest rate exposure, and our investment policy limits the amount of our credit exposure to any one issue, issuer (with the exception of U.S. agency obligations) and type of instrument. We do not expect any material loss from our marketable security investments and therefore believe that our potential interest rate exposure is limited. We intend to hold the majority of our investments to maturity, in accordance with our business plans.

We do not use derivative financial instruments in our investment portfolio. We are averse to principal loss and try to ensure the safety and preservation of our invested funds by limiting default risk, market risk, and reinvestment risk. We attempt to mitigate default risk by investing in only high credit quality securities and by positioning our portfolio to appropriately respond to a significant reduction in the credit rating of any investment issuer or guarantor.

We are exposed to market risk for changes in interest rates on the BOA Credit Facility. All outstanding amounts under the BOA Credit Facility bear interest at a variable rate equal to LIBOR, plus 2.50%, which is payable on a monthly basis. As of June 30, 2015 and through termination on July 21, 2015, we had no amounts outstanding under the Wells Credit Facility. If we draw down the BOA Credit Facility, we may be exposed to market risk due to changes in the rate at which interest accrues.

Our Senior Notes bear fixed interest rates, and therefore, would not be subject to interest rate risk. The Capped Call transactions are derivative instruments that qualify for classification within stockholders’ equity because they meet an exemption from mark-to-market derivative accounting. The settlement amounts for the capped call transactions are each determined based upon the difference between a strike price and a traded price of the Company’s common stock.

Foreign Currency Transaction Risk. While a majority of our business is denominated in the U.S. dollar, a portion of our revenue and expenses are denominated in foreign currencies. Fluctuations in the rate of exchange between the U.S. dollar and the Euro or the British Pound Sterling may affect our results of operations and the period-to-period comparisons of our operating results. Foreign currency transaction gains and losses are caused by transactions denominated in a currency other than the functional currency and must be remeasured at each balance sheet date or upon settlement. Foreign currency transaction realized and unrealized gains and losses resulted in approximately $0.8 million and $0.7 million of gains during the three and six months ended June 30, 2015, respectively, primarily related to intercompany payables and receivables associated with our European operations. We expect to reduce our exposure through future settlements.
 
Item 4.
CONTROLS AND PROCEDURES.

We carried out an evaluation, under the supervision and with the participation of our management, including our chief executive officer and chief financial officer, of the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period covered by this report. Based on that evaluation, our chief executive officer and chief financial officer have concluded that our disclosure controls and procedures, as of the end of the period covered by this report, were effective to ensure that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and to ensure that

26

information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our chief executive officer and chief financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
There has been no change in our internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) during the second quarter of 2015 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

27

Part II. Other Information 

Item 1.
LEGAL PROCEEDINGS.

Refer to Note 8 of the Notes to the Condensed Consolidated Financial Statements for discussion of legal proceedings.

Item 6.
EXHIBIT INDEX.
The following exhibits are filed or furnished herewith: 
Exhibit 10.1
(2)
2015 Stock Incentive Plan and forms of stock option award agreement and restricted stock unit award agreement. (Incorporated by reference to Endologix, Inc. Current Report on Form 8-K, File No. 000-28440, filed June 1, 2015).
 
 
 
Exhibit 10.2
(2)
Amended and Restated 2006 Employee Stock Purchase Plan, as amended. (Incorporated by reference to Exhibit10.2 to Endologix, Inc. Current Report on Form 8-K, File No. 000-28440, Filed June 1, 2015).
 
 
 
Exhibit 31.1
 
Certification of Chief Executive Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934.
 
 
 
Exhibit 31.2
 
Certification of Chief Financial Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934.
 
 
 
Exhibit 32.1
(1)
Certification of Chief Executive Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350.
 
 
 
Exhibit 32.2
(1)
Certification of Chief Financial Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350.
 
 
 
Exhibit 101.INS
 
XBRL Instance Document
 
 
 
Exhibit 101.SCH
 
XBRL Taxonomy Extension Schema Document
 
 
 
Exhibit 101.CAL
 
XBRL Taxonomy Extension Calculation Lin Base Document
 
 
 
Exhibit 101.DEF
 
XBRL Taxonomy Extension Definition Link Base Document
 
 
 
Exhibit 101.LAB
 
XBRL Taxonomy Extension Label Link Base Document
 
 
 
Exhibit 101.PRE
 
XBRL Taxonomy Extension Presentation Link Base Document
(1)
Furnished herewith and not “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
(2)
These exhibits are identified as management contracts or compensatory plans or arrangements of Endologix.
 

28


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
 
ENDOLOGIX, INC.
 
 
 
Date:
August 5, 2015
/s/ John McDermott
 
 
Chief Executive Officer and Chairman of the Board
(Principal Executive Officer)
 
 
 
 
 
 
Date:
August 5, 2015
 /s/ Shelley B. Thunen  
 
 
Chief Financial Officer (Principal Financial and Accounting Officer)
 
 
 


29
 EX-31.1 2 elgx_ex311x6302015-q1.htm EXHIBIT 31.1 ELGX_EX31.1_6.30.2015-Q1


Exhibit 31.1
Certification of Chief Executive Officer
I, John McDermott, certify that:
1.
I have reviewed this quarterly report on Form 10-Q of Endologix, Inc.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:
a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with generally accepted accounting principals;
c)
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):
a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
Date:
August 5, 2015
By:
/s/ John McDermott
 
 
 
John McDermott
 
 
 
Chief Executive Officer and Chairman of the Board
(Principal Executive Officer)


 EX-31.2 3 elgx_ex312x6302015-q1.htm EXHIBIT 31.2 ELGX_EX31.2_6.30.2015-Q1


Exhibit 31.2
Certification of Chief Financial Officer
I, Shelley B. Thunen, certify that:
1.
I have reviewed this quarterly report on Form 10-Q of Endologix, Inc.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:
a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with generally accepted accounting principals;
c)
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):
a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
Date:
August 5, 2015
By:
/s/ Shelley B. Thunen
 
 
 
Shelley B. Thunen
 
 
 
Chief Financial Officer (Principal Financial and Accounting Officer)



 EX-32.1 4 elgx_ex321x6302015-q1.htm EXHIBIT 32.1 ELGX_EX32.1_6.30.2015-Q1


 
Exhibit 32.1
Certification of Chief Executive Officer
Pursuant to 18 U.S.C Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

I, John McDermott, certify pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350 that:
(1)
The Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2015 (the “Quarterly Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 780(d)); and
(2)
The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:
August 5, 2015
By:
/s/ John McDermott
 
 
 
John McDermott
 
 
 
Chief Executive Officer and Chairman of the Board
(Principal Executive Officer)
This certification accompanies the Quarterly Report pursuant to Rule 13a-14(b) or Rule 15d-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section.



 EX-32.2 5 elgx_ex322x6302015-q1.htm EXHIBIT 32.2 ELGX_EX32.2_6.30.2015-Q1


 
Exhibit 32.2
Certification of Chief Financial Officer
Pursuant to 18 U.S.C Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

I, Shelley B. Thunen, certify pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350 that:
(1)
The Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2015 (the “Quarterly Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 780(d)); and
(2)
The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
  
Date:
August 5, 2015
By:
/s/ Shelley B. Thunen
 
 
 
Shelley B. Thunen
 
 
 
Chief Financial Officer (Principal Financial and Accounting Officer)
This certification accompanies the Quarterly Report pursuant to Rule 13a-14(b) or Rule 15d-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section.



 EX-101.INS 6 elgx-20150630.xml XBRL INSTANCE DOCUMENT 0001013606 2015-01-01 2015-06-30 0001013606 2015-07-31 0001013606 2014-12-31 0001013606 2015-06-30 0001013606 us-gaap:ConvertiblePreferredStockMember 2014-12-31 0001013606 us-gaap:ConvertiblePreferredStockMember 2015-06-30 0001013606 2014-04-01 2014-06-30 0001013606 2015-04-01 2015-06-30 0001013606 2014-01-01 2014-06-30 0001013606 2013-12-31 0001013606 2014-06-30 0001013606 elgx:ConvertibleSeniorNotesdue2018Member us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2014-12-31 0001013606 us-gaap:CorporateDebtSecuritiesMember 2015-06-30 0001013606 elgx:ConvertibleSeniorNotesdue2018Member us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ConvertibleDebtMember 2015-06-30 0001013606 elgx:ConvertibleSeniorNotesdue2018Member us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2015-06-30 0001013606 us-gaap:CustomerRelationshipsMember 2015-06-30 0001013606 us-gaap:CustomerRelationshipsMember 2014-12-31 0001013606 us-gaap:LicensingAgreementsMember 2014-12-31 0001013606 elgx:IntuitrakShoninMember 2014-12-31 0001013606 us-gaap:LicensingAgreementsMember 2015-06-30 0001013606 elgx:DevelopedTechnologyMember 2014-12-31 0001013606 elgx:IntuitrakShoninMember 2015-06-30 0001013606 elgx:DevelopedTechnologyMember 2015-06-30 0001013606 us-gaap:TrademarksAndTradeNamesMember 2015-06-30 0001013606 us-gaap:TrademarksAndTradeNamesMember 2014-12-31 0001013606 us-gaap:CorporateBondSecuritiesMember 2014-12-31 0001013606 us-gaap:AssetBackedSecuritiesMember 2014-12-31 0001013606 us-gaap:CommercialPaperMember 2014-12-31 0001013606 us-gaap:BondsMember 2015-06-30 0001013606 us-gaap:CorporateBondSecuritiesMember 2015-06-30 0001013606 us-gaap:CommercialPaperMember 2015-06-30 0001013606 us-gaap:AssetBackedSecuritiesMember 2015-06-30 0001013606 us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2015-06-30 0001013606 us-gaap:FairValueMeasurementsRecurringMember 2014-12-31 0001013606 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2014-12-31 0001013606 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2014-12-31 0001013606 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2015-06-30 0001013606 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2015-06-30 0001013606 us-gaap:FairValueMeasurementsRecurringMember 2015-06-30 0001013606 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2015-06-30 0001013606 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2014-12-31 0001013606 us-gaap:ComputerEquipmentMember 2015-06-30 0001013606 us-gaap:LeaseholdImprovementsMember 2015-06-30 0001013606 elgx:ProductionEquipmentMoldsandOfficeFurnitureMember 2015-06-30 0001013606 us-gaap:ConstructionInProgressMember 2015-06-30 0001013606 us-gaap:ComputerEquipmentMember 2014-12-31 0001013606 us-gaap:LeaseholdImprovementsMember 2014-12-31 0001013606 elgx:ProductionEquipmentMoldsandOfficeFurnitureMember 2014-12-31 0001013606 us-gaap:ConstructionInProgressMember 2014-12-31 0001013606 us-gaap:SellingAndMarketingExpenseMember 2014-04-01 2014-06-30 0001013606 us-gaap:ResearchAndDevelopmentExpenseMember 2015-04-01 2015-06-30 0001013606 us-gaap:OperatingExpenseMember 2014-01-01 2014-06-30 0001013606 us-gaap:OperatingExpenseMember 2015-01-01 2015-06-30 0001013606 us-gaap:GeneralAndAdministrativeExpenseMember 2015-04-01 2015-06-30 0001013606 us-gaap:ResearchAndDevelopmentExpenseMember 2014-01-01 2014-06-30 0001013606 us-gaap:OperatingExpenseMember 2015-04-01 2015-06-30 0001013606 us-gaap:GeneralAndAdministrativeExpenseMember 2014-01-01 2014-06-30 0001013606 us-gaap:SellingAndMarketingExpenseMember 2015-04-01 2015-06-30 0001013606 us-gaap:SellingAndMarketingExpenseMember 2014-01-01 2014-06-30 0001013606 us-gaap:GeneralAndAdministrativeExpenseMember 2014-04-01 2014-06-30 0001013606 us-gaap:CostOfSalesMember 2015-01-01 2015-06-30 0001013606 elgx:ClinicalAndRegulatoryAffairsMember 2015-01-01 2015-06-30 0001013606 elgx:ClinicalAndRegulatoryAffairsMember 2015-04-01 2015-06-30 0001013606 us-gaap:OperatingExpenseMember 2014-04-01 2014-06-30 0001013606 us-gaap:ResearchAndDevelopmentExpenseMember 2014-04-01 2014-06-30 0001013606 us-gaap:CostOfSalesMember 2014-01-01 2014-06-30 0001013606 elgx:ClinicalAndRegulatoryAffairsMember 2014-01-01 2014-06-30 0001013606 us-gaap:GeneralAndAdministrativeExpenseMember 2015-01-01 2015-06-30 0001013606 elgx:ClinicalAndRegulatoryAffairsMember 2014-04-01 2014-06-30 0001013606 us-gaap:CostOfSalesMember 2014-04-01 2014-06-30 0001013606 us-gaap:SellingAndMarketingExpenseMember 2015-01-01 2015-06-30 0001013606 us-gaap:ResearchAndDevelopmentExpenseMember 2015-01-01 2015-06-30 0001013606 us-gaap:CostOfSalesMember 2015-04-01 2015-06-30 0001013606 us-gaap:RestrictedStockMember 2014-01-01 2014-06-30 0001013606 us-gaap:RestrictedStockUnitsRSUMember 2014-04-01 2014-06-30 0001013606 us-gaap:RestrictedStockUnitsRSUMember 2014-01-01 2014-06-30 0001013606 us-gaap:EmployeeStockOptionMember 2014-01-01 2014-06-30 0001013606 us-gaap:EmployeeStockOptionMember 2014-04-01 2014-06-30 0001013606 us-gaap:EmployeeStockOptionMember 2015-04-01 2015-06-30 0001013606 us-gaap:EmployeeStockOptionMember 2015-01-01 2015-06-30 0001013606 us-gaap:RestrictedStockUnitsRSUMember 2015-04-01 2015-06-30 0001013606 us-gaap:RestrictedStockUnitsRSUMember 2015-01-01 2015-06-30 0001013606 us-gaap:RestrictedStockMember 2015-04-01 2015-06-30 0001013606 us-gaap:RestrictedStockMember 2014-04-01 2014-06-30 0001013606 us-gaap:RestrictedStockMember 2015-01-01 2015-06-30 0001013606 us-gaap:ConvertibleDebtMember 2014-12-31 0001013606 us-gaap:ConvertibleDebtMember 2013-12-10 0001013606 elgx:ConvertibleSeniorNotesIssuedDecember2013Member us-gaap:ConvertibleDebtMember 2015-01-01 2015-06-30 0001013606 elgx:ConvertibleSeniorNotesIssuedDecember2013Member us-gaap:DebtInstrumentRedemptionPeriodOneMember us-gaap:ConvertibleDebtMember 2015-01-01 2015-06-30 0001013606 elgx:ConvertibleSeniorNotesIssuedDecember2013Member us-gaap:ConvertibleDebtMember 2015-06-30 0001013606 us-gaap:RevolvingCreditFacilityMember elgx:BankofAmericaMemberDomain us-gaap:MinimumMember 2015-04-01 2015-06-30 0001013606 elgx:ConvertibleSeniorNotesIssuedDecember2013Member us-gaap:ConvertibleDebtMember 2013-12-10 0001013606 us-gaap:RevolvingCreditFacilityMember elgx:WellsFargoBankMember 2013-12-02 2013-12-03 0001013606 us-gaap:AdditionalPaidInCapitalMember elgx:ConvertibleSeniorNotesIssuedDecember2013Member us-gaap:ConvertibleDebtMember 2015-06-30 0001013606 elgx:DebtInstrumentMeasurementPeriodThreeMember us-gaap:RevolvingCreditFacilityMember elgx:WellsFargoBankMember us-gaap:ScenarioForecastMember 2015-01-01 2015-12-31 0001013606 elgx:ConvertibleSeniorNotesIssuedDecember2013Member us-gaap:DebtInstrumentRedemptionPeriodTwoMember us-gaap:ConvertibleDebtMember 2015-01-01 2015-06-30 0001013606 us-gaap:LetterOfCreditMember elgx:WellsFargoBankMember 2013-12-03 0001013606 us-gaap:RevolvingCreditFacilityMember elgx:BankofAmericaMemberDomain 2015-06-30 0001013606 us-gaap:RevolvingCreditFacilityMember elgx:BankofAmericaMemberDomain 2015-04-01 2015-06-30 0001013606 elgx:ConvertibleSeniorNotesIssuedDecember2013Member us-gaap:ConvertibleDebtMember us-gaap:MinimumMember us-gaap:ScenarioForecastMember 2015-01-01 2015-12-31 0001013606 elgx:DebtInstrumentMeasurementPeriodOneMember us-gaap:RevolvingCreditFacilityMember elgx:WellsFargoBankMember 2015-01-01 2015-03-31 0001013606 us-gaap:OtherAssetsMember elgx:ConvertibleSeniorNotesIssuedDecember2013Member us-gaap:ConvertibleDebtMember 2015-06-30 0001013606 us-gaap:RevolvingCreditFacilityMember elgx:WellsFargoBankMember 2013-12-03 0001013606 us-gaap:LetterOfCreditMember elgx:BankofAmericaMemberDomain 2015-06-30 0001013606 elgx:ConvertibleSeniorNotesIssuedDecember2013Member us-gaap:ConvertibleDebtMember 2013-12-09 2013-12-10 0001013606 elgx:ConvertibleSeniorNotesIssuedDecember2013Member us-gaap:ConvertibleDebtMember us-gaap:MaximumMember us-gaap:ScenarioForecastMember 2015-01-01 2015-12-31 0001013606 elgx:DebtInstrumentMeasurementPeriodFourMember us-gaap:RevolvingCreditFacilityMember elgx:WellsFargoBankMember us-gaap:ScenarioForecastMember 2015-01-01 2015-12-31 0001013606 elgx:DebtInstrumentMeasurementPeriodThreeMember us-gaap:RevolvingCreditFacilityMember elgx:WellsFargoBankMember us-gaap:ScenarioForecastMember 2015-01-01 2015-09-30 0001013606 elgx:DebtInstrumentMeasurementPeriodTwoMember us-gaap:RevolvingCreditFacilityMember elgx:WellsFargoBankMember 2015-01-01 2015-06-30 0001013606 2013-12-09 2013-12-10 0001013606 us-gaap:SalesMember us-gaap:GeographicConcentrationRiskMember elgx:DirectRevenueMember country:US 2014-04-01 2014-06-30 0001013606 us-gaap:SalesMember us-gaap:GeographicConcentrationRiskMember us-gaap:EuropeMember 2014-04-01 2014-06-30 0001013606 us-gaap:SalesMember us-gaap:GeographicConcentrationRiskMember 2015-01-01 2015-06-30 0001013606 us-gaap:SalesMember us-gaap:GeographicConcentrationRiskMember elgx:DistributorRevenueMember us-gaap:AsiaPacificMember 2014-01-01 2014-06-30 0001013606 us-gaap:SalesMember us-gaap:GeographicConcentrationRiskMember 2014-04-01 2014-06-30 0001013606 us-gaap:SalesMember us-gaap:GeographicConcentrationRiskMember elgx:DistributorRevenueMember us-gaap:LatinAmericaDestinationMember 2015-04-01 2015-06-30 0001013606 us-gaap:SalesMember us-gaap:GeographicConcentrationRiskMember 2015-04-01 2015-06-30 0001013606 us-gaap:SalesMember us-gaap:GeographicConcentrationRiskMember elgx:DistributorRevenueMember us-gaap:LatinAmericaDestinationMember 2014-01-01 2014-06-30 0001013606 us-gaap:SalesMember us-gaap:GeographicConcentrationRiskMember elgx:DistributorRevenueMember us-gaap:LatinAmericaDestinationMember 2014-04-01 2014-06-30 0001013606 us-gaap:SalesMember us-gaap:GeographicConcentrationRiskMember elgx:DirectRevenueMember country:US 2015-01-01 2015-06-30 0001013606 us-gaap:SalesMember us-gaap:GeographicConcentrationRiskMember elgx:DistributorRevenueMember us-gaap:LatinAmericaDestinationMember 2015-01-01 2015-06-30 0001013606 us-gaap:SalesMember us-gaap:GeographicConcentrationRiskMember elgx:DistributorRevenueMember us-gaap:AsiaPacificMember 2015-04-01 2015-06-30 0001013606 us-gaap:SalesMember us-gaap:GeographicConcentrationRiskMember elgx:DirectRevenueMember country:US 2015-04-01 2015-06-30 0001013606 us-gaap:SalesMember us-gaap:GeographicConcentrationRiskMember elgx:DirectRevenueMember country:US 2014-01-01 2014-06-30 0001013606 us-gaap:SalesMember us-gaap:GeographicConcentrationRiskMember elgx:DistributorRevenueMember us-gaap:AsiaPacificMember 2015-01-01 2015-06-30 0001013606 us-gaap:SalesMember us-gaap:GeographicConcentrationRiskMember elgx:DistributorRevenueMember elgx:TotalRestOfWorldRowMember 2014-04-01 2014-06-30 0001013606 us-gaap:SalesMember us-gaap:GeographicConcentrationRiskMember us-gaap:EuropeMember 2014-01-01 2014-06-30 0001013606 us-gaap:SalesMember us-gaap:GeographicConcentrationRiskMember elgx:DistributorRevenueMember elgx:TotalRestOfWorldRowMember 2015-04-01 2015-06-30 0001013606 us-gaap:SalesMember us-gaap:GeographicConcentrationRiskMember us-gaap:EuropeMember 2015-01-01 2015-06-30 0001013606 us-gaap:SalesMember us-gaap:GeographicConcentrationRiskMember elgx:DistributorRevenueMember us-gaap:AsiaPacificMember 2014-04-01 2014-06-30 0001013606 us-gaap:SalesMember us-gaap:GeographicConcentrationRiskMember elgx:DistributorRevenueMember elgx:TotalRestOfWorldRowMember 2015-01-01 2015-06-30 0001013606 us-gaap:SalesMember us-gaap:GeographicConcentrationRiskMember elgx:DistributorRevenueMember elgx:TotalRestOfWorldRowMember 2014-01-01 2014-06-30 0001013606 us-gaap:SalesMember us-gaap:GeographicConcentrationRiskMember us-gaap:EuropeMember 2015-04-01 2015-06-30 0001013606 us-gaap:SalesMember us-gaap:GeographicConcentrationRiskMember 2014-01-01 2014-06-30 0001013606 2013-06-12 0001013606 2013-06-11 2013-06-12 0001013606 2014-12-01 2014-12-31 0001013606 us-gaap:ManufacturingFacilityMember 2013-06-12 0001013606 us-gaap:BuildingMember 2013-06-12 0001013606 elgx:NellixMember 2010-12-09 2010-12-10 0001013606 elgx:PMAMilestoneMember 2015-06-30 0001013606 elgx:OUSMilestoneMember us-gaap:MaximumMember us-gaap:CommonStockMember 2014-06-16 0001013606 elgx:OUSMilestoneMember 2014-06-17 2014-06-17 0001013606 elgx:OUSMilestoneMember us-gaap:CommonStockMember 2015-01-01 2015-06-30 0001013606 elgx:NelixMilestonesMember 2010-12-09 2010-12-10 0001013606 elgx:PMAMilestoneMember us-gaap:MaximumMember 2010-12-10 0001013606 elgx:PMAMilestoneMember 2015-01-01 2015-06-30 0001013606 elgx:OUSMilestoneMember us-gaap:MinimumMember us-gaap:CommonStockMember 2014-06-16 0001013606 elgx:PMAMilestoneMember 2010-12-10 0001013606 elgx:NellixMember 2010-12-10 0001013606 elgx:NelixMilestonesMember 2010-12-10 xbrli:pure elgx:segment utreg:D iso4217:USD elgx:securities utreg:sqft iso4217:USD xbrli:shares elgx:option elgx:securities xbrli:shares iso4217:USD elgx:letters_of_credit elgx:facility elgx:lease false --12-31 Q2 2015 2015-06-30 10-Q 0001013606 67781092 Yes Large Accelerated Filer ENDOLOGIX INC /DE/ 13800000 15.34 14600000 14800000 0 0 14600000 14600000 0 0 14800000 14800000 6900000 1300000 2722000 4922000 3597000 7047000 3000000 6000000 13500000 23000000 35000000 2.0 1.5 5 P5Y 0.25 22456000 5416000 6 6800000 1 2 129000 2900 57000 0.03 0.03 0.04 0.03 0.03 0.03 2388000 2 1 11027000 11760000 26113000 29138000 1622000 1749000 5260000 4979000 11997000 13262000 2272000 602000 372639000 381516000 2140000 365000 197000 748000 1943000 185000 645000 3753000 262000 404000 1558000 3349000 335000 1194000 2408000 243000 226000 842000 2182000 258000 839000 4619000 428000 474000 1644000 4145000 486000 1587000 185000 181000 198000 232000 100000 200000 400000 800000 2376000 1813000 420000 143000 2541000 1917000 422000 202000 2220000 1812000 139000 269000 2206000 1812000 137000 257000 248209000 231322000 147767000 132965000 19400000 15000000 3200000 2700000 4.50 7.50 3.50 3772000 -8028000 100000 200000 24000000 10000000 14600000 14800000 95152000 31843000 26798000 36269000 26798000 0 0 26798000 36269000 0 0 36269000 -63309000 9471000 0.001 0.001 100000000 100000000 67321769 67947684 67159511 67767730 67000 68000 -8925000 -3675000 -12917000 -25885000 1.000 0.730 0.032 0.034 0.066 0.204 1.000 0.726 0.042 0.031 0.073 0.201 1.000 0.729 0.040 0.031 0.071 0.200 1.000 0.708 0.050 0.043 0.093 0.199 28200000 70407000 72156000 86300000 9820000 18789000 15347000 25111000 30000000 19300000 24.04 24.04 41.6051 P30D P30D 1.30 0.98 20 20 86250000 66900000 0.0225 0.0225 6900000 5700000 1.00 1 800000 2900000 3700000 2200000 8060000 8078000 879000 879000 500000 1000000 1100000 2200000 1213000 2933000 29.02 -0.14 -0.06 -0.19 -0.36 -22000 -535000 -0.005 -0.007 0.34 0.34 13337000 11469000 285000 167000 400000 71000 454000 667000 438000 85000 517000 4750000 3693000 2213000 949000 40100000 1000000 480000 100000 40100000 1000000 438000 100000 39815000 833000 80000 29000 39994000 39646000 333000 0 15000 212000 655000 5932000 13094000 6850000 14139000 28866000 28709000 28507000 52802000 24132000 51038000 5000 0 5000 0 7000 0 0 5000 0 2000 8000 0 0 8000 2000 0 0 1000 1000 2000 0 59871000 3633000 40531000 15707000 34257000 857000 3000000 22781000 2658000 4961000 59868000 3633000 40536000 15699000 34262000 857000 3000000 22785000 2657000 4700000 4963000 -9073000 -3562000 -12940000 -24062000 -80000 136000 61000 153000 207000 140000 3855000 2692000 2108000 3195000 2097000 -207000 1224000 -1689000 8793000 -739000 1283000 -413000 3588000 3588000 3588000 3588000 2708000 2708000 43465000 42702000 1448000 2839000 1493000 2955000 1045000 973000 18651000 15732000 31325000 30588000 6728000 5973000 5946000 8883000 67000 126000 37000 82000 700000 1300000 600000 1200000 P5Y P15Y 124059000 124470000 248209000 231322000 29624000 28208000 10000000 20000000 7500000.0 20000000 84500000 82800000 59871000 34257000 1145000 3968000 -54272000 22422000 -10160000 -16384000 -8993000 -3698000 -13001000 -24215000 1403000 71000 -5301000 5526000 -790000 -2249000 1 1 32279000 61890000 36282000 72851000 -3772000 -9088000 -12150000 -21813000 35791000 2296000 2258000 2331000 2363000 22884000 1271000 1900000 3162000 2592000 2415000 2138000 68000 23000 84000 -1670000 489000 349000 -148000 211000 766000 824000 3870000 46000 498000 121000 38372000 0 1395000 291000 7400000 74114000 37122000 5743000 3146000 0.001 0.001 5000000 5000000 0 0 0 0 0 0 82600000 1446000 1631000 25585000 62690000 1094000 2628000 37693000 12943000 6457000 2564000 15729000 38070000 14054000 7075000 573000 16368000 25696000 24808000 4458000 8563000 5993000 12224000 -248500000 -272715000 38327000 38327000 27992000 1210000 1309000 2519000 7816000 71591000 71591000 51980000 2984000 2226000 5210000 14401000 39479000 39479000 28776000 1594000 1221000 2815000 7888000 76149000 76149000 53910000 3845000 3260000 7105000 15134000 19167000 35311000 19842000 39441000 3753000 4619000 124150000 106852000 162258000 179954000 2328000 2619000 62699000 62403000 67615000 67441000 10200000 900000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjustments to the fair value of the Contingent Payment are recognized within other income (expense) in the Condensed Consolidated Statements of Operations and Comprehensive Loss. </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.08429118773945%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="25%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value of Contingently Issuable Common Stock</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,600</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair Value Adjustment of Contingent Payment for the six months ended June 30, 2015</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">200</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,800</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's revenue by geographic region, was as follows:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.712368168744%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td width="21%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="11" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="11" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="11" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="5" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="5" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="5" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,776</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72.9%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,992</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.0%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53,910</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70.8%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51,980</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72.6%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Europe</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,888</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.0%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,816</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.4%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,134</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.9%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,401</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.1%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rest of World ("ROW"):</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Latin America</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,221</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.1%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,309</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.4%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,260</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.3%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,226</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.1%</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asia/Pacific</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,594</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.0%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,210</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.2%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,845</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.0%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,984</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.2%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total ROW</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,815</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.1%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,519</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.6%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,105</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.3%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,210</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.3%</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,479</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,327</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76,149</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,591</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0%</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Basis of Presentation</font></div><div style="line-height:120%;text-align:left;padding-left:54px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") and the rules and regulations of the U.S. Securities and Exchange Commission ("SEC"). These financial statements include the financial position, results of operations, and cash flows of the Company, including its subsidiaries, all of which are wholly-owned. All inter-company accounts and transactions have been eliminated in consolidation. For the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and 2014, there were no related party transactions. </font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The interim financial data as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;"> is unaudited and is not necessarily indicative of the results for a full year. In the opinion of the Company's management, the interim data includes normal and recurring adjustments necessary for a fair presentation of the Company's financial results for the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;">. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to SEC rules&#160;and regulations relating to interim financial statements. </font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying Condensed Consolidated Financial Statements should be read in conjunction with the Company's audited Consolidated Financial Statements and Notes thereto included in the Company's Annual Report on Form&#160;10-K for the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:10pt;">, filed with the SEC on March 2, 2015.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Contingently Issuable Common Stock</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:6px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 27, 2010, the Company entered into an Agreement and Plan of Merger and Reorganization (the &#8220;Merger Agreement&#8221;) with Nepal Acquisition Corporation, a wholly-owned subsidiary of the Company (&#8220;Merger Sub&#8221;), Nellix, Inc. ("Nellix"), certain of Nellix&#8217;s stockholders named therein and Essex Woodlands Health Ventures, Inc., as representative of the former Nellix stockholders. On December 10, 2010 (the &#8220;Nellix Closing Date&#8221;), the Company completed the merger (the &#8220;Merger&#8221;) of Merger Sub with and into Nellix pursuant to the terms of the Merger Agreement. The purchase price consisted of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">3.2 million</font><font style="font-family:inherit;font-size:10pt;"> shares of the Company's common stock, issuable to the former Nellix stockholders as of the Nellix Closing Date, then representing a value of $</font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">19.4 million</font><font style="font-family:inherit;font-size:10pt;">. Under the agreement, additional payments, solely in the form of shares of the Company's common stock (the &#8220;Contingent Payment&#8221;), could be made upon the achievement of a revenue milestone and a regulatory approval milestone (collectively, the &#8220;Nellix Milestones&#8221;). </font></div><div style="line-height:120%;padding-top:13px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under the merger agreement, the ultimate value of each Contingent Payment would be determined on the date that each Nellix Milestone is achieved. The number of issuable shares would be established using an applicable per share price, which is subject to a ceiling and/or floor, resulting at the closing of the merger in a potential maximum of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">10.2 million</font><font style="font-family:inherit;font-size:10pt;"> shares issuable upon the achievement of the Nellix Milestones. As of the Closing Date, the aggregate fair value of the cash Contingent Payment was estimated to be $</font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">28.2 million</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:13px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Merger Agreement provides that, in addition to the shares of common stock of the Company (the &#8220;Common Stock&#8221;) issued to the former Nellix stockholders at the closing of the Merger, the former Nellix stockholders were entitled to receive shares of the Common Stock if the Company&#8217;s sales of a Nellix product (the &#8220;Nellix Product&#8221;) outside of the United States exceeded </font><font style="font-family:inherit;font-size:10pt;">$10.0 million</font><font style="font-family:inherit;font-size:10pt;"> within a certain time period following the Company&#8217;s receipt of CE mark approval for the Nellix Product (the &#8220;OUS Milestone&#8221;). The aggregate dollar value of the shares of the Common Stock to be issued upon achievement of the OUS Milestone ranged from a high of </font><font style="font-family:inherit;font-size:10pt;">$24.0 million</font><font style="font-family:inherit;font-size:10pt;">, or </font><font style="font-family:inherit;font-size:10pt;">6.9 million</font><font style="font-family:inherit;font-size:10pt;"> shares, to a low of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">$10.0 million</font><font style="font-family:inherit;font-size:10pt;">, or </font><font style="font-family:inherit;font-size:10pt;">1.3 million</font><font style="font-family:inherit;font-size:10pt;"> shares. The price per share of the Common Stock to be issued upon achievement of the OUS Milestone was subject to a floor of </font><font style="font-family:inherit;font-size:10pt;">$3.50</font><font style="font-family:inherit;font-size:10pt;"> per share and a ceiling of </font><font style="font-family:inherit;font-size:10pt;">$7.50</font><font style="font-family:inherit;font-size:10pt;"> per share.</font></div><div style="line-height:120%;padding-top:13px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On June 17, 2014, the Company announced its achievement of the OUS Milestone and the issuance of an aggregate of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">2.7 million</font><font style="font-family:inherit;font-size:10pt;"> unregistered shares of the Common Stock (the &#8220;OUS Milestone Shares&#8221;), plus an amount of cash in lieu of fractional shares, to the former Nellix stockholders. The Company offered and sold the OUS Milestone Shares in reliance upon exemptions from registration pursuant to Section 4(2) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). The former Nellix stockholders previously gave representations to the Company regarding their investment intent, experience, financial sophistication, access to information regarding the Company and certain other matters to support the Company&#8217;s reasonable belief that it could rely upon the foregoing exemptions from registration pursuant to Section 4(2) of the Securities Act. No underwriting discounts or commissions were or will be paid in conjunction with the issuance of the OUS Milestone Shares. The Company previously filed a Registration Statement on Form S-3 (Registration No. 333-171639) (the &#8220;Form S-3&#8221;) for the purpose of registering for resale shares of the Common Stock issued or issuable pursuant to the Merger Agreement, including the OUS Milestone Shares. The Securities and Exchange Commission declared the Form S-3 effective on January 18, 2011.</font></div><div style="line-height:120%;padding-top:13px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, if the Company receives approval from the FDA to sell the Nellix Product in the United States (the &#8220;PMA Milestone&#8221;), the Company will issue additional shares of the Common Stock to the former stockholders of Nellix. The dollar value of the shares of the Common Stock to be issued upon achievement of the PMA Milestone will be equal to </font><font style="font-family:inherit;font-size:10pt;">$15.0 million</font><font style="font-family:inherit;font-size:10pt;"> (less the dollar value of certain cash payments and other deductions). The price per share of the shares of the Common Stock to be issued upon achievement of the PMA Milestone is subject to a stock price floor of </font><font style="font-family:inherit;font-size:10pt;">$4.50</font><font style="font-family:inherit;font-size:10pt;"> per share, but not subject to a stock price ceiling.</font></div><div style="line-height:120%;padding-top:13px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of June 30, 2015 the Company's stock price last closed at </font><font style="font-family:inherit;font-size:10pt;">$15.34</font><font style="font-family:inherit;font-size:10pt;"> per share. Thus, had the PMA Milestone been achieved on June 30, 2015 the Contingent Payment would have comprised </font><font style="font-family:inherit;font-size:10pt;">0.9 million</font><font style="font-family:inherit;font-size:10pt;"> shares (based on the 30-day average closing stock price ending 5 days prior to the announcement), representing a value of </font><font style="font-family:inherit;font-size:10pt;">$13.8 million</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:13px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> The value of the Contingent Payment is derived using a discounted income approach model, with a range of probabilities and assumptions related to the timing and likelihood of achievement of the PMA Milestone (which include Level 3 inputs - see Note 3(e) and the Company's stock price (Level 1 input) as of the balance sheet date). These varying probabilities and assumptions and changes in the Company's stock price have required fair value adjustments of the Contingent Payment in periods subsequent to the Nellix Closing Date. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Contingent Payment fair value will continue to be evaluated on a quarterly basis until milestone achievement occurs, or until the expiration of the "earn-out period," as defined within the Nellix purchase agreement. Adjustments to the fair value of the Contingent Payment are recognized within other income (expense) in the Condensed Consolidated Statements of Operations and Comprehensive Loss. </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.08429118773945%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="25%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value of Contingently Issuable Common Stock</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,600</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair Value Adjustment of Contingent Payment for the six months ended June 30, 2015</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">200</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,800</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Commitments and Contingencies</font></div><div style="line-height:120%;padding-bottom:5px;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(a) Leases</font></div><div style="line-height:120%;padding-bottom:5px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company leases its administrative, research, and manufacturing facilities located in Irvine, California and an administrative office located in Rosmalen, The Netherlands. These facility lease agreements require the Company to pay operating costs, including property taxes, insurance and maintenance. In addition, the Company has certain equipment under long-term agreements that are accounted for as operating leases. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Future minimum payments by year under non-cancelable leases with initial terms in excess of one year were as follows as of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.1783317353787%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="70%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="28%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Remainder of 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,271</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,363</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,331</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,258</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,296</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,388</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021 and thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,884</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,791</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> Facilities rent expense for the </font><font style="font-family:inherit;font-size:10pt;">three months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and 2014 was </font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. For the </font><font style="font-family:inherit;font-size:10pt;">six months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and 2014 facilities rent expense was </font><font style="font-family:inherit;font-size:10pt;">$1.2 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1.3 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On June 12, 2013, the Company entered into a lease agreement for </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> adjacent office, research and development, and manufacturing facilities in Irvine, California.&#160; The premises consist of approximately </font><font style="font-family:inherit;font-size:10pt;">129,000</font><font style="font-family:inherit;font-size:10pt;"> combined square feet. The lease has a </font><font style="font-family:inherit;font-size:10pt;">15</font><font style="font-family:inherit;font-size:10pt;">-year term beginning January 1, 2014 and provides for </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> optional </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;"> year extension. The initial base rent under the lease is </font><font style="font-family:inherit;font-size:10pt;">$1.9 million</font><font style="font-family:inherit;font-size:10pt;"> per year, payable in monthly installments, and escalates by 3% per year for years 2015 through 2019, and 4% per year for years 2020 and beyond.&#160; The Company received a rent abatement for the first nine months of the lease. These premises replaced the Company's existing Irvine facilities. The terms of this lease agreement provide for </font><font style="font-family:inherit;font-size:10pt;">$6.8 million</font><font style="font-family:inherit;font-size:10pt;"> of landlord-funded improvements (and certain other allowances) to this facility, in order to best suit the Company's requirements. </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company leased </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> adjacent facilities aggregating approximately </font><font style="font-family:inherit;font-size:10pt;">57,000</font><font style="font-family:inherit;font-size:10pt;"> square feet in Irvine, California, under separate lease agreements where manufacturing was held. The Company exited </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> of these leases in December 2014 and the other lease in April 2015. The Company's Rosmalen facility is an administrative office of approximately </font><font style="font-family:inherit;font-size:10pt;">2,900</font><font style="font-family:inherit;font-size:10pt;"> square feet with lease expiration in December 2015 and renewal at its option.</font></div><div style="line-height:120%;padding-top:18px;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(b) Employment Agreements and Retention Plan</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On February 1, 2014, the Company entered into new employment agreements with certain of its executive officers under which payment and benefits would become payable in the event of termination by the Company for any reason other than cause, death or disability or termination by the employee for good reason (collectively, an &#8220;Involuntary Termination&#8221;) prior to, upon or following a change in control of the Company. The severance payment will generally be in a range of six to eighteen months of the employee&#8217;s then current salary for an Involuntary Termination prior to a change in control of the Company, and will generally be in a range of eighteen to twenty-four months of the employee&#8217;s then current salary for an Involuntary Termination upon or following a change in control of the Company.</font></div><div style="line-height:120%;padding-top:18px;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(c) Legal Matters</font></div><div style="line-height:120%;padding-top:8px;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"> </font><font style="font-family:inherit;font-size:10pt;">We are from time to time involved in various claims and legal proceedings of a nature we believe are normal and incidental to a medical device business. These matters may include product liability, intellectual property, employment, and other general claims. Such cases and claims may raise complex factual and legal issues and are subject to many uncertainties, including, but not limited to, the facts and circumstances of each particular case or claim, the jurisdiction in which each suit is brought, and differences in applicable law. We accrue for contingent liabilities when it is probable that a liability has been incurred and the amount can be reasonably estimated. The accruals are adjusted periodically as assessments change or as additional information becomes available.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"> LifePort Sciences LLC v. Endologix, Inc.</font></div><div style="line-height:120%;padding-top:8px;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> On December 28, 2012, LifePort Sciences, LLC ("LifePort") filed a complaint against us in the U.S. District Court, District of Delaware, alleging that certain of our products infringe U.S. Patent Nos. 5,489,295, 6,117,167, 6,302,906, 5,993,481 and 5,676,696, which are alleged to be owned by LifePort. LifePort is seeking an unspecified amount of monetary damages for sale of our products and injunctive relief. We do not believe that we infringe on any of these patents and we intend to vigorously defend against this matter. The case is currently scheduled for trial in April 2016. We do believe, however, that the outcome will not have a material adverse effect on our financial position, results of operations, or cash flows. However, in order to avoid further legal costs and diversion of management resources, it is reasonably possible that we may reach a settlement with LifePort, which could result in a liability. However, we cannot presently estimate the amount, or range, of reasonably possible losses due to the nature of this potential litigation settlement.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Stock-Based Compensation</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font><font style="font-family:inherit;font-size:10pt;">The Company classifies stock-based compensation expense in the accompanying Condensed Consolidated Statements of Operations and Comprehensive Loss, based on the department to which the recipient belongs. Stock-based compensation expense included in cost of goods sold and operating expenses during the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2014</font><font style="font-family:inherit;font-size:10pt;">, was as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.90412272291466%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="69%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="5%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="5%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="5%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="5%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="7" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="7" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="7" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="7" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,</font></div></td></tr><tr><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of goods sold</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">226</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">197</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">474</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">404</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating expenses:</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">258</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">185</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">486</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">335</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Clinical and regulatory affairs</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">243</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">365</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">428</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">262</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketing and sales</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">839</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">645</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,587</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,194</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General and administrative</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">842</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">748</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,644</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,558</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total operating expenses</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,182</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,943</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,145</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,349</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,408</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,140</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,619</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,753</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net Loss Per Share</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss per share was calculated by dividing net loss by the weighted average number of common shares outstanding for the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and 2014. </font></div><div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="7" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="7" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13,001</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,993</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(24,215</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,698</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares used in computing basic and diluted net loss per share</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">67,615</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62,699</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">67,441</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62,403</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic and diluted net loss per share </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.14</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.36</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.06</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following outstanding Company securities, using the treasury stock method, were excluded from the above calculations of net loss per share because their impact would have been anti-dilutive:</font></div><div style="line-height:120%;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.81167608286252%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="68%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="5" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="5" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common stock options</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,812</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,813</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,812</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,917</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock awards</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">139</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">420</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">137</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">422</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock units</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">269</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">143</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">257</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">202</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,220</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,376</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,206</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,541</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> As discussed in Note 6, in December 2013, the Company issued </font><font style="font-family:inherit;font-size:10pt;">$86.3 million</font><font style="font-family:inherit;font-size:10pt;"> aggregate principal amount of </font><font style="font-family:inherit;font-size:10pt;">2.25%</font><font style="font-family:inherit;font-size:10pt;"> convertible senior notes due 2018 (the &#8220;Senior Notes&#8221;) in an underwritten public offering. Upon any conversion, the Senior Notes may be settled, at the Company&#8217;s election, in cash, shares of the Company&#8217;s common stock or a combination of cash and shares of the Company&#8217;s common stock. For purposes of calculating the maximum dilutive impact, it is presumed that the Senior Notes will be settled in common stock with the resulting potential common shares included in diluted earnings per share if the effect is more dilutive. The effect of the conversion of the Senior Notes is excluded from the calculation of diluted loss per share because the impact of these securities would be anti-dilutive. The potential dilutive effect of these securities is shown in the chart below:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="68%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Conversion of the Notes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,588</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,588</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,588</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,588</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> The effect of the contingently issuable common stock is excluded from the calculation of basic net loss per share until all necessary conditions for issuance have been satisfied. Refer to Note 9 of the Notes to the Condensed Consolidated Financial Statements for further discussion.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following fair value hierarchy table presents information about each major category of the Company&#8217;s assets and liabilities measured at fair value on a recurring basis as of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:10pt;">: </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="37%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#160;Fair value measurement at reporting date using:</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Quoted prices in<br clear="none"/>active markets for<br clear="none"/>identical assets<br clear="none"/>(Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Significant other<br clear="none"/>observable<br clear="none"/>inputs<br clear="none"/>(Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Significant<br clear="none"/>unobservable<br clear="none"/>inputs<br clear="none"/>(Level 3)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At June 30, 2015</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,269</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,269</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingently issuable common stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,800</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,800</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December 31, 2014</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,798</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,798</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingently issuable common stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,600</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,600</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Income Tax Expense</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company applied an estimated annual effective tax rate (&#8220;ETR&#8221;) approach for calculating a tax provision for interim periods. The Company recorded a provision for income taxes of </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;">, respectively. The Company's ETR was </font><font style="font-family:inherit;font-size:10pt;">(0.5)%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">(0.7)%</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;">, respectively.&#160; The Company's ETR for the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;"> differs from the U.S. federal statutory tax rate of </font><font style="font-family:inherit;font-size:10pt;">34%</font><font style="font-family:inherit;font-size:10pt;"> primarily as a result of nondeductible expenses (including the Nellix Contingent Payment), state income taxes, foreign income taxes, and the impact of a full valuation allowance on its deferred tax assets.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has evaluated the available evidence supporting the realization of its deferred tax assets, including the amount and timing of future taxable income, and has determined that it is more likely than not that its net deferred tax assets will not be realized in the U.S. and certain foreign jurisdictions. Due to uncertainties surrounding the realization of the deferred tax assets, the Company maintains a full valuation allowance against substantially all deferred tax assets. If/when&#160;the Company determines that it will be able to realize some portion or all of its deferred tax assets, an adjustment to its valuation allowance on its deferred tax assets would have the effect of increasing net income in the period(s) such determination is made.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investments in held-to-maturity marketable securities consist of the following at </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:10pt;">: </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="39%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amortized<br clear="none"/>Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross<br clear="none"/>Unrealized<br clear="none"/>Gain</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross<br clear="none"/>Unrealized<br clear="none"/>Loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset backed securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">857</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">857</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Agency bonds</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate bonds<br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,658</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,657</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commercial paper</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,781</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,785</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Government securities<br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,961</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,963</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,257</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,262</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amortized<br clear="none"/>Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross<br clear="none"/>Unrealized<br clear="none"/>Gain</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross<br clear="none"/>Unrealized<br clear="none"/>Loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset backed securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,633</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,633</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate bonds<br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,707</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,699</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commercial paper</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,531</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,536</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59,871</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59,868</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Description of Business, Basis of Presentation, and Operating Segment</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(a) Description of Business</font></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> Endologix, Inc. (the "Company") is a Delaware corporation with corporate headquarters and production facilities located in Irvine, California. The Company develops, manufactures, markets, and sells innovative medical devices for the treatment of aortic disorders. The Company's products are intended for the minimally invasive endovascular treatment of abdominal aortic aneurysms ("AAA"). The Company's AAA products are built on one of two platforms: (1) traditional minimally-invasive endovascular repair ("EVAR") or (2) endovascular sealing (&#8220;EVAS&#8221;), the Company's innovative solution for sealing the aneurysm sac while maintaining blood flow through two blood flow lumens. The Company's current EVAR products include the Endologix AFX Endovascular AAA System (&#8220;AFX&#8221;), the VELA Proximal Endograft (&#8220;VELA&#8221;) and the Endologix Intuitrak Endovascular AAA System (&#8220;Intuitrak&#8221;). The Company's current EVAS product is the Nellix Endovascular Aneurysm Sealing System (&#8220;Nellix EVAS System&#8221;). Sales of the Company's EVAR and EVAS platforms (including extensions and accessories) to hospitals in the U.S. and Europe, and to third-party international distributors, provide the sole source of the Company's reported revenue. </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's EVAR products consist of (i) a cobalt chromium alloy stent covered by polytetrafluoroethylene (commonly referred to as "ePTFE") graft material (&#8220;Stent Graft&#8221;) and (ii) an accompanying delivery system. Once fixed in its proper position within the abdominal aorta, the Company's EVAR device provides a conduit for blood flow, thereby relieving pressure within the weakened or &#8220;aneurysmal&#8221; section of the vessel wall, which greatly reduces the potential for the AAA to rupture. </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's EVAS product consists of (i) bilateral covered stents with endobags, (ii) a biocompatible polymer injected into the endobags to seal the aneurysm and (iii) a delivery system and polymer dispenser. The Company's EVAS product seals the entire aneurysm sac effectively excluding the aneurysm sac reducing the likelihood of future aneurysm rupture. Additionally, it has the potential to reduce post procedural re-interventions.</font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(b)</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Basis of Presentation</font></div><div style="line-height:120%;text-align:left;padding-left:54px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") and the rules and regulations of the U.S. Securities and Exchange Commission ("SEC"). These financial statements include the financial position, results of operations, and cash flows of the Company, including its subsidiaries, all of which are wholly-owned. All inter-company accounts and transactions have been eliminated in consolidation. For the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and 2014, there were no related party transactions. </font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The interim financial data as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;"> is unaudited and is not necessarily indicative of the results for a full year. In the opinion of the Company's management, the interim data includes normal and recurring adjustments necessary for a fair presentation of the Company's financial results for the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;">. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to SEC rules&#160;and regulations relating to interim financial statements. </font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying Condensed Consolidated Financial Statements should be read in conjunction with the Company's audited Consolidated Financial Statements and Notes thereto included in the Company's Annual Report on Form&#160;10-K for the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:10pt;">, filed with the SEC on March 2, 2015. </font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> On May 28, 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU ") No. 2014-09, "Revenue from Contracts with Customers", which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. The FASB agreed to a one-year deferral of the revenue recognition standard's effective date for all entities. The new standard is effective for the Company on January 1, 2018. The standard permits the use of either the retrospective or cumulative effect transition method. Early application is permitted, but not before the original effective date, which would have been January 1, 2017 for the Company. The Company is evaluating the effect that ASU 2014-09 will have on its consolidated financial statements and related disclosures. The Company has not yet selected a transition method nor has it determined the effect of the standard on its ongoing financial reporting. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:42px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On April 7, 2015, the FASB issued ASU No. 2015-03, "Simplifying the Presentation of Debt Issuance Costs", which requires debt issuance costs related to a recognized debt liability to be presented on the balance sheet as a direct deduction from the debt liability, similar to the presentation of debt discounts. The ASU is effective for the Company on January 1, 2016. Early adoption is permitted. The Company is evaluating the effect that ASU 2015-03 will have on its consolidated financial statements and related disclosures. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> On July 22, 2015, the FASB issued ASU No. 2015-11, &#8220;Simplifying the Measurement of Inventory,&#8221; which requires an entity to measure inventory within the scope of the amendment at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. The guidance is effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years. The Company is currently assessing the impact this guidance will have on its consolidated financial statements.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(c) Operating Segment</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> operating and reporting segment that is focused exclusively on the development, manufacture, marketing, and sale of EVAR and EVAS product for the treatment of aortic disorders. For the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;">, all of the Company's revenue and related expenses were solely attributable to these activities. Substantially all of the Company's long-lived assets are located in the U.S.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property and equipment consisted of the following:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June&#160;30, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Production equipment, molds, and office furniture</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,054</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,943</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer hardware and software</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,075</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,457</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leasehold improvements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,368</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,729</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Construction in progress (software and related implementation, production equipment, and leasehold improvements)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">573</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,564</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property and equipment, at cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,070</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,693</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated depreciation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13,262</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11,997</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property and equipment, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,808</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,696</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following outstanding Company securities, using the treasury stock method, were excluded from the above calculations of net loss per share because their impact would have been anti-dilutive:</font></div><div style="line-height:120%;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.81167608286252%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="68%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="5" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="5" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common stock options</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,812</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,813</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,812</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,917</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock awards</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">139</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">420</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">137</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">422</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock units</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">269</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">143</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">257</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">202</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,220</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,376</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,206</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,541</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> As discussed in Note 6, in December 2013, the Company issued </font><font style="font-family:inherit;font-size:10pt;">$86.3 million</font><font style="font-family:inherit;font-size:10pt;"> aggregate principal amount of </font><font style="font-family:inherit;font-size:10pt;">2.25%</font><font style="font-family:inherit;font-size:10pt;"> convertible senior notes due 2018 (the &#8220;Senior Notes&#8221;) in an underwritten public offering. Upon any conversion, the Senior Notes may be settled, at the Company&#8217;s election, in cash, shares of the Company&#8217;s common stock or a combination of cash and shares of the Company&#8217;s common stock. For purposes of calculating the maximum dilutive impact, it is presumed that the Senior Notes will be settled in common stock with the resulting potential common shares included in diluted earnings per share if the effect is more dilutive. The effect of the conversion of the Senior Notes is excluded from the calculation of diluted loss per share because the impact of these securities would be anti-dilutive. The potential dilutive effect of these securities is shown in the chart below:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="68%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Conversion of the Notes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,588</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,588</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,588</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,588</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="7" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="7" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13,001</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,993</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(24,215</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,698</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares used in computing basic and diluted net loss per share</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">67,615</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62,699</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">67,441</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62,403</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic and diluted net loss per share </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.14</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.36</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.06</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock-based compensation expense included in cost of goods sold and operating expenses during the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2014</font><font style="font-family:inherit;font-size:10pt;">, was as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.90412272291466%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="69%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="5%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="5%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="5%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="5%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="7" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="7" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="7" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="7" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,</font></div></td></tr><tr><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of goods sold</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">226</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">197</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">474</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">404</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating expenses:</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">258</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">185</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">486</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">335</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Clinical and regulatory affairs</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">243</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">365</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">428</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">262</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketing and sales</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">839</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">645</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,587</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,194</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General and administrative</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">842</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">748</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,644</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,558</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total operating expenses</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,182</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,943</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,145</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,349</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,408</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,140</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,619</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,753</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Future minimum payments by year under non-cancelable leases with initial terms in excess of one year were as follows as of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.1783317353787%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="70%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="28%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Remainder of 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,271</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,363</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,331</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,258</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,296</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,388</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021 and thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,884</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,791</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents goodwill, indefinite lived intangible assets, finite lived intangible assets and related accumulated amortization:</font><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June&#160;30, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2014</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill (1)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,709</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,866</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Indefinite lived intangibles</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trademarks and trade names</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,708</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,708</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Finite lived intangibles</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Developed technology (2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,100</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,100</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated amortization</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(454</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(285</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Developed technology, net</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,646</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,815</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">License</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated amortization</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(85</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(71</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">License, net</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships (1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">438</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">480</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated amortization (1)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(438</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(400</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships, net</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired Shonin approval (3)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated amortization </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(667</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(167</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired Shonin approval, net</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">333</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">833</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets (excluding goodwill), net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,702</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,465</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:left;padding-left:48px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(1) Difference in the value between these dates is solely due to a foreign currency translation adjustment.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;padding-left:48px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(2) Was reclassified in the first quarter of 2013 from in-process research and development to finite lived intangibles, which coincided with the European commercial launch of the product (Nellix EVAS System) associated with this intangible asset. A significant portion of this intangible asset will not begin amortization until the U.S. launch of this product, currently scheduled for 2016.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;padding-left:48px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(3) Regulatory approval for Intuitrak in Japan acquired through an amendment with a distributor in the fourth quarter of 2014. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories consisted of the following:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June&#160;30, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2014</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Raw materials</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,973</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,728</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Work-in-process</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,883</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,946</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finished goods</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,732</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,651</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Inventories</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30,588</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,325</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Estimated amortization expense for the five succeeding years and thereafter (which includes amortization of intangible assets which commenced in February 2013 with the commercial launch of the Nellix System in Europe) is as follows:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="82%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="16%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Remainder of 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">517</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">949</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,213</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,693</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,750</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,416</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021 &amp; Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,456</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,994</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenue by Geographic Region</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's revenue by geographic region, was as follows:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.712368168744%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td width="21%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="11" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="11" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="11" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30,</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="5" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="5" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="5" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,776</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72.9%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,992</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.0%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53,910</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70.8%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51,980</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72.6%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Europe</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,888</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.0%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,816</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.4%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,134</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.9%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,401</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.1%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rest of World ("ROW"):</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Latin America</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,221</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.1%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,309</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.4%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,260</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.3%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,226</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.1%</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asia/Pacific</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,594</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.0%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,210</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.2%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,845</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.0%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,984</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.2%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total ROW</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,815</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.1%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,519</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.6%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,105</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.3%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,210</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.3%</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,479</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,327</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76,149</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,591</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0%</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Operating Segment</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> operating and reporting segment that is focused exclusively on the development, manufacture, marketing, and sale of EVAR and EVAS product for the treatment of aortic disorders. For the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;">, all of the Company's revenue and related expenses were solely attributable to these activities. Substantially all of the Company's long-lived assets are located in the U.S.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Credit Facilities</font></div><div style="line-height:120%;text-align:left;text-indent:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"> 2.25% Convertible Senior Notes</font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> On December 10, 2013, the Company issued </font><font style="font-family:inherit;font-size:10pt;">$86.3 million</font><font style="font-family:inherit;font-size:10pt;"> aggregate principal amount </font><font style="font-family:inherit;font-size:10pt;">2.25%</font><font style="font-family:inherit;font-size:10pt;"> Convertible Senior Notes (the &#8220;Senior Notes&#8221;). The Senior Notes mature on December 15, 2018 unless earlier repurchased by the Company or converted. The Company received net proceeds of the Notes of approximately </font><font style="font-family:inherit;font-size:10pt;">$82.6 million</font><font style="font-family:inherit;font-size:10pt;"> from the sale of the Senior Notes, after deducting underwriting discounts and commissions and offering expenses payable by the Company. Interest is payable on the Senior Notes on June 15 and December 15 of each year, beginning June 15, 2014. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> The Senior Notes are governed by the terms of a base indenture (the &#8220;Base Indenture&#8221;), as supplemented by the first supplemental indenture relating to the Senior Notes (the &#8220;First Supplemental Indenture,&#8221; and together with the Base Indenture, the &#8220;Indenture&#8221;), between the Company and Wells Fargo Bank, National Association (the &#8220;Trustee&#8221;), each of which were entered into on December 10, 2013. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> The Senior Notes are senior unsecured obligations and are (a) senior in right of payment to the Company&#8217;s future indebtedness that is expressly subordinated in right of payment to the Senior Notes; (b) equal in right of payment to the Company&#8217;s existing and future unsecured indebtedness that is not so subordinated; (c) effectively junior to any of the Company&#8217;s secured indebtedness to the extent of the value of the assets securing such indebtedness; (d) and structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company&#8217;s subsidiaries.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> The Company may not redeem the Senior Notes prior to December 15, 2016. On or after December 15, 2016, the Company may redeem for cash all or any portion of the Senior Notes, at its option, but only if the closing sale price of the Company&#8217;s common stock for at least </font><font style="font-family:inherit;font-size:10pt;">20</font><font style="font-family:inherit;font-size:10pt;"> trading days (whether or not consecutive) during any </font><font style="font-family:inherit;font-size:10pt;">30</font><font style="font-family:inherit;font-size:10pt;"> consecutive trading day period ending on, and including, the second trading day immediately preceding the date on which the Company provides notice of redemption, exceeds </font><font style="font-family:inherit;font-size:10pt;">130%</font><font style="font-family:inherit;font-size:10pt;"> of the conversion price on each applicable trading day. The redemption price will equal </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> of the principal amount of the Senior Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. No sinking fund is provided for the Senior Notes. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> Holders may convert their Senior Notes at any time prior to the close of business on the business day immediately preceding September 15, 2018 only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on March 31, 2014, if the closing sale price of the Company&#8217;s common stock, for at least </font><font style="font-family:inherit;font-size:10pt;">20</font><font style="font-family:inherit;font-size:10pt;"> trading days (whether or not consecutive) in the period of </font><font style="font-family:inherit;font-size:10pt;">30</font><font style="font-family:inherit;font-size:10pt;"> consecutive trading days ending on the last trading day of the calendar quarter immediately preceding the calendar quarter in which the conversion occurs, is more than </font><font style="font-family:inherit;font-size:10pt;">130%</font><font style="font-family:inherit;font-size:10pt;"> of the conversion price of the Senior Notes in effect on each applicable trading day; (2) during the </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;"> consecutive business-day period following any </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;"> consecutive trading-day period in which the trading price for the Senior Notes for each such trading day was less than </font><font style="font-family:inherit;font-size:10pt;">98%</font><font style="font-family:inherit;font-size:10pt;"> of the closing sale price of the Company&#8217;s common stock on such date multiplied by the then-current conversion rate; (3) if the Company calls all or any portion of the notes for redemption, at any time prior to the close of business on the second scheduled trading day prior to the redemption date; or (4) upon the occurrence of specified corporate events. On or after September 15, 2018 until the close of business on the second scheduled trading day immediately preceding the stated maturity date, holders may surrender their Senior Notes for conversion at any time, regardless of the foregoing circumstances. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> Upon conversion, the Company will, at its election, pay or deliver, as the case may be, cash, shares of the Company&#8217;s common stock or a combination of cash and shares of the Company&#8217;s common stock. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> The initial conversion rate of the Senior Notes will be </font><font style="font-family:inherit;font-size:10pt;">41.6051</font><font style="font-family:inherit;font-size:10pt;"> shares of the Company&#8217;s common stock for each $1,000 principal amount of Senior Notes, which represents an initial conversion price of approximately </font><font style="font-family:inherit;font-size:10pt;">$24.04</font><font style="font-family:inherit;font-size:10pt;"> per share. Following certain corporate transactions that occur on or prior to the stated maturity date or the Company&#8217;s delivery of a notice of redemption, the Company will increase the conversion rate for a holder that elects to convert its Senior Notes in connection with such a corporate transaction. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> If a fundamental change (as defined in the Indenture) occurs prior to the stated maturity date, holders may require the Company to purchase for cash all or any portion of their Senior Notes at a fundamental change purchase price equal to </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> of the principal amount of the Senior Notes to be purchased, plus accrued and unpaid interest to, but excluding, the fundamental change purchase date. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> The Indenture contains customary terms and covenants and events of default with respect to the Senior Notes. If an event of default (as defined in the Indenture) occurs and is continuing, either the Trustee or the holders of at least </font><font style="font-family:inherit;font-size:10pt;">25%</font><font style="font-family:inherit;font-size:10pt;"> in aggregate principal amount of the outstanding Senior Notes may declare the principal amount of the Senior Notes to be due and payable immediately by notice to the Company (with a copy to the Trustee). If an event of default arising out of certain events of bankruptcy, insolvency or reorganization involving the Company or a significant subsidiary (as set forth in the Indenture) occurs with respect to us, the principal amount of the Senior Notes and accrued and unpaid interest, if any, will automatically become immediately due and payable. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> The Company was not required to separate the conversion option in the Senior Notes under ASC 815, "Derivatives and Hedging", and has the ability to settle the Senior Notes in cash, common stock or a combination of cash and common stock, at its option. In accordance with cash conversion guidance contained in ASC 470-20, "Debt with Conversion and Other Options", the Company accounted for the Senior Notes by allocating the issuance proceeds between the liability and the equity component. The equity component is classified in stockholders&#8217; equity and the resulting discount on the liability component is accreted such that interest expense equals the Company&#8217;s nonconvertible debt borrowing rate. The separation was performed by first determining the fair value of a similar debt that does not have an associated equity component. That amount was then deducted from the initial proceeds of the Senior Notes as a whole to arrive at a residual amount, which was allocated to the conversion feature that is classified as equity. The initial fair value of the indebtedness was </font><font style="font-family:inherit;font-size:10pt;">$66.9 million</font><font style="font-family:inherit;font-size:10pt;"> resulting in a </font><font style="font-family:inherit;font-size:10pt;">$19.3 million</font><font style="font-family:inherit;font-size:10pt;"> allocation to the embedded conversion option. The embedded conversion option was recorded in stockholders&#8217; equity and as debt discount, to be subsequently accreted to interest expense over the term of the Senior Notes. Underwriting discounts and commissions and offering expenses totaled </font><font style="font-family:inherit;font-size:10pt;">$3.7 million</font><font style="font-family:inherit;font-size:10pt;"> and were allocated between the liability and the equity component in proportion to the allocation of proceeds and accounted for as debt issuance costs and equity issuance costs, respectively. As a result, </font><font style="font-family:inherit;font-size:10pt;">$2.9 million</font><font style="font-family:inherit;font-size:10pt;"> attributable to the indebtedness was recorded as deferred financing costs in other assets, to be subsequently amortized as interest expense over the term of the Senior Notes, and </font><font style="font-family:inherit;font-size:10pt;">$0.8 million</font><font style="font-family:inherit;font-size:10pt;"> attributable to the equity component was recorded as a reduction to additional paid-in-capital in stockholders&#8217; equity.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> As of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;">, the Company had outstanding borrowings of </font><font style="font-family:inherit;font-size:10pt;">$72.2 million</font><font style="font-family:inherit;font-size:10pt;">, and deferred financing costs of </font><font style="font-family:inherit;font-size:10pt;">$2.2 million</font><font style="font-family:inherit;font-size:10pt;">, related to the Senior Notes. There are no principal payments due during the term. Annual interest expense on these notes will range from </font><font style="font-family:inherit;font-size:10pt;">$5.7 million</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">$6.9 million</font><font style="font-family:inherit;font-size:10pt;"> through maturity. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"> Capped Call Transactions</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> On December 10, 2013, in connection with the pricing of the Senior Notes and the exercise in full of their overallotment option by the underwriters, the Company entered into privately-negotiated capped call transactions (the &#8220;Capped Call Transactions&#8221;) with Bank of America, N.A., an affiliate of Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated. The Capped Call Transactions initial conversion rate and number of options substantially corresponds to each $1,000 principal amount of Senior Notes. The Company used approximately </font><font style="font-family:inherit;font-size:10pt;">$7.4 million</font><font style="font-family:inherit;font-size:10pt;"> of the net proceeds from the Senior Notes offering to pay for the cost of the Capped Call Transactions. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> The Capped Call Transactions are separate transactions entered into by the Company with Bank of America, N.A., are not part of the terms of the Senior Notes and will not change the holders&#8217; rights under the Senior Notes. The Capped Call Transactions have anti-dilution adjustments substantially similar to those applicable to the Senior Notes. The Capped Call Transactions are derivative instruments that are recorded within stockholders&#8217; equity because they meet an exemption from mark-to-market derivative accounting.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> The Capped Call Transactions are expected generally to reduce the potential dilution and/or offset potential cash payments that the Company is required to make in excess of the principal amount upon conversion of the Senior Notes in the event that the market price per share of the Company&#8217;s common stock, as measured under the terms of the Capped Call Transactions, is greater than the strike price of the Capped Call Transactions, which initially corresponds to the </font><font style="font-family:inherit;font-size:10pt;">$24.04</font><font style="font-family:inherit;font-size:10pt;"> conversion price of the Senior Notes. If, however, the market price per share of the Company&#8217;s common stock, as measured under the terms of the Capped Call Transactions, exceeds the initial cap price of </font><font style="font-family:inherit;font-size:10pt;">$29.02</font><font style="font-family:inherit;font-size:10pt;">, there would nevertheless be dilution and/or there would not be an offset of such potential cash payments, in each case, to the extent that such market price exceeds the cap price of the Capped Call Transactions. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> The Company will not be required to make any cash payments to Bank of America, N.A. or any of its affiliates upon the exercise of the options that are a part of the Capped Call Transactions, but will be entitled to receive from Bank of America, N.A. (or an affiliate thereof) a number of shares of the Company&#8217;s common stock and/or an amount of cash generally based on the amount by which the market price per share of the Company&#8217;s common stock, as measured under the terms of the Capped Call Transactions, is greater than the strike price of the Capped Call Transactions during the relevant valuation period under the Capped Call Transactions. However, if the market price of the Company&#8217;s common stock, as measured under the terms of the Capped Call Transactions, exceeds the cap price of the Capped Call Transactions during such valuation period under the Capped Call Transactions, the number of shares of common stock and/or the amount of cash the Company expects to receive upon exercise of the Capped Call Transactions will be capped based on the amount by which the cap price exceeds the strike price of the Capped Call Transactions.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> For any conversions of Senior Notes prior to the close of business on the 55th scheduled trading day immediately preceding the stated maturity date of the Senior Notes, including without limitation upon an acquisition of the Company or similar business combination, a corresponding portion of the Capped Call Transactions will be terminated. Upon such termination, the portion of the Capped Call Transactions being terminated will be settled at fair value (subject to certain limitations), as determined by Bank of America, N.A., in its capacity as calculation agent under the Capped Call Transactions, which the Company expects to receive from Bank of America, N.A., and no payments will be due Bank of America, N.A. The capped call expires on December 13, 2018.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"> Wells Fargo line of credit</font></div><div style="line-height:120%;text-align:left;text-indent:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> In October 2009, the Company entered into a revolving credit facility with Wells Fargo Bank (&#8220;Wells&#8221;), which was last amended on February 3, 2015, whereby the Company may borrow up to </font><font style="font-family:inherit;font-size:10pt;">$20.0 million</font><font style="font-family:inherit;font-size:10pt;">, subject to the calculation and limitation of a borrowing base (the &#8220;Wells Credit Facility&#8221;). All amounts owing under the Wells Credit Facility will become due and payable upon its expiration on November 15, 2015. A sub-feature in the line of credit allows for the issuance of up to </font><font style="font-family:inherit;font-size:10pt;">$7.5 million</font><font style="font-family:inherit;font-size:10pt;"> in letters of credit. As of June 30, 2015, the Company had no outstanding letters of credit issued. The Wells Credit Facility is collateralized by all of the Company's assets, except its intellectual property. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> The Wells Credit Facility contains financial covenants requiring the Company to (i) maintain a minimum current ratio of </font><font style="font-family:inherit;font-size:10pt;">2.0</font><font style="font-family:inherit;font-size:10pt;"> , equal to the quotient of modified current assets to current liabilities, as defined in the Wells Credit Facility (the "Current Ratio Covenant"), and (ii) not to exceed pre-tax net loss (excluding non-cash contingent consideration associated with the acquisition of Nellix) of </font><font style="font-family:inherit;font-size:10pt;">$13.5 million</font><font style="font-family:inherit;font-size:10pt;"> for the three months ended March 31, 2015; </font><font style="font-family:inherit;font-size:10pt;">$23.0 million</font><font style="font-family:inherit;font-size:10pt;"> for the six months ended June 30, 2015; and </font><font style="font-family:inherit;font-size:10pt;">$35.0 million</font><font style="font-family:inherit;font-size:10pt;"> for the nine months ended September 30, 2015; (the "Net Loss Covenant").&#160; The Wells Credit Facility also includes negative covenants limiting capital expenditures in 2015 to an aggregate of </font><font style="font-family:inherit;font-size:10pt;">$6.0 million</font><font style="font-family:inherit;font-size:10pt;"> as well as limiting operating lease expenses to </font><font style="font-family:inherit;font-size:10pt;">$3.0 million</font><font style="font-family:inherit;font-size:10pt;"> in any calendar year. As of June 30, 2015, the Company was not in compliance with the Net Loss Covenant. The financial covenants as of and for the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;"> are no longer applicable due to the termination of the Wells Credit Facility on July 21, 2015. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> The Wells Credit Facility also contains a &#8220;material adverse change&#8221; clause (&#8220;MAC&#8221;). If the Company encounters difficulties that would qualify as a MAC in its (i) operations, (ii) condition (financial or otherwise), or (iii) ability to repay amounts outstanding under the Wells Credit Facility, it could be canceled at Wells' sole discretion. Wells could then elect to declare the indebtedness, together with accrued interest and other fees, to be immediately due and payable and proceed against any collateral securing such indebtedness. No borrowings were outstanding at June 30, 2015 and 2014. On July 21, 2015, the Company terminated the credit facility. As of the termination date, the Company had no outstanding borrowings or letters of credits issued under the Wells Credit Facility.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Bank of America line of credit</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"> O</font><font style="font-family:inherit;font-size:10pt;">n </font><font style="font-family:inherit;font-size:10pt;">July&#160;21, 2015</font><font style="font-family:inherit;font-size:10pt;">, the Company entered into a revolving credit facility with Bank of America, N.A. (&#8220;BOA&#8221;), whereby the Company may borrow up to </font><font style="font-family:inherit;font-size:10pt;">$20.0 million</font><font style="font-family:inherit;font-size:10pt;"> (the &#8220;BOA Credit Facility&#8221;). All amounts owing under the BOA Credit Facility will become due and payable upon its expiration on </font><font style="font-family:inherit;font-size:10pt;">July&#160;21, 2017</font><font style="font-family:inherit;font-size:10pt;">. A sub-feature in the line of credit allows for the issuance of up to </font><font style="font-family:inherit;font-size:10pt;">$10.0 million</font><font style="font-family:inherit;font-size:10pt;"> in letters of credit. The BOA Credit Facility is collateralized by all of the Company's assets, except its intellectual property. The BOA Credit Facility can be terminated at any time during the two years by Company upon three business day notice. The BOA Credit Facility usage is priced at a spread over the one, two, three and six month LIBOR rates, and is subject to a covenants related to timely providing of publicly reported information, other indebtedness and a liquidity covenant tied to &#8220;Unencumbered Liquid Assets&#8221; ("ULA") - (as defined here) of not less than </font><font style="font-family:inherit;font-size:10pt;">$30.0 million</font><font style="font-family:inherit;font-size:10pt;">. ULA means the following assets (excluding assets of any retirement plan) which (i) are held in the United States at BOA and/or its affiliates, (ii) are not the subject of any lien, pledge, security interest or other arrangement with any creditor (other than BOA or one of BOA&#8217;s affiliates) to have his claim satisfied out of the asset (or proceeds thereof) prior to the general creditors of the owner of the asset, (iii) are held solely in the name of one or more credit parties subject to this covenant (with no other persons or entities having ownership rights therein), (iv) may be converted to cash within </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;"> (5) days, and (v) are not being counted or included to satisfy any other liquidity requirement under any other obligation, whether with BOA or any other lender, unless otherwise expressly agreed by BOA in writing: (a) cash and cash equivalents; (b) marketable securities invested in accordance with the Company&#8217;s investment policy and (c) marketable securities invested in accordance with any update to the Company&#8217;s investment policy so long as such update been approved by BOA in its reasonable discretion. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> If not in default, the Company has the ability to reduce the ULA covenant requirement by reducing the BOA Credit Facility, with the ULA maintained at </font><font style="font-family:inherit;font-size:10pt;">1.5</font><font style="font-family:inherit;font-size:10pt;"> times the BOA Credit Facility.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;padding-left:24px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates and Summary of Significant Accounting Policies</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires the Company's management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenue and expenses, and related disclosure of contingent liabilities. On an on-going basis, the Company's management evaluates its estimates, including those related to (i) collectibility of customer accounts; (ii) whether the cost of inventories can be recovered; (iii) the value of goodwill and intangible assets; (iv) realization of tax assets and estimates of tax liabilities; (v) likelihood of payment and value of contingent liabilities; and (vi) potential outcome of litigation. Such estimates are based on management's judgment which takes into account historical experience and various assumptions. Nonetheless, actual results may differ from management's estimates.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For a complete summary of our significant accounting policies, please refer to Note 2, "Use of Estimates and Summary of Significant Accounting Policies", in Part II, Item 8, of our 2014 Annual Report on Form 10-K for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:10pt;">, filed March 2, 2015. There have been no material changes to our significant accounting policies during the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance Sheet Account Detail</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(a) Property and Equipment</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property and equipment consisted of the following:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June&#160;30, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Production equipment, molds, and office furniture</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,054</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,943</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer hardware and software</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,075</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,457</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leasehold improvements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,368</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,729</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Construction in progress (software and related implementation, production equipment, and leasehold improvements)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">573</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,564</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property and equipment, at cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,070</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,693</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated depreciation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13,262</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11,997</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property and equipment, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,808</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,696</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation expense for property and equipment for the </font><font style="font-family:inherit;font-size:10pt;">three months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and 2014 was </font><font style="font-family:inherit;font-size:10pt;">$1.1 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. For the </font><font style="font-family:inherit;font-size:10pt;">six months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and 2014 depreciation expense for property and equipment was </font><font style="font-family:inherit;font-size:10pt;">$2.2 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(b) Inventories</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> Inventories consisted of the following:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June&#160;30, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2014</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Raw materials</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,973</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,728</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Work-in-process</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,883</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,946</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finished goods</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,732</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,651</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Inventories</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30,588</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,325</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(c) Goodwill and Intangible Assets</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> The following table presents goodwill, indefinite lived intangible assets, finite lived intangible assets and related accumulated amortization:</font><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June&#160;30, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2014</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill (1)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,709</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,866</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Indefinite lived intangibles</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trademarks and trade names</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,708</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,708</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Finite lived intangibles</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Developed technology (2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,100</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,100</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated amortization</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(454</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(285</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Developed technology, net</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,646</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,815</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">License</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated amortization</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(85</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(71</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">License, net</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships (1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">438</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">480</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated amortization (1)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(438</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(400</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships, net</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired Shonin approval (3)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated amortization </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(667</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(167</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired Shonin approval, net</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">333</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">833</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets (excluding goodwill), net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,702</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,465</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:left;padding-left:48px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(1) Difference in the value between these dates is solely due to a foreign currency translation adjustment.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;padding-left:48px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(2) Was reclassified in the first quarter of 2013 from in-process research and development to finite lived intangibles, which coincided with the European commercial launch of the product (Nellix EVAS System) associated with this intangible asset. A significant portion of this intangible asset will not begin amortization until the U.S. launch of this product, currently scheduled for 2016.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;padding-left:48px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(3) Regulatory approval for Intuitrak in Japan acquired through an amendment with a distributor in the fourth quarter of 2014. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization expense for intangible assets for the </font><font style="font-family:inherit;font-size:10pt;">three months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and 2014 was </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. For the </font><font style="font-family:inherit;font-size:10pt;">six months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and 2014 amortization expense for intangible assets was </font><font style="font-family:inherit;font-size:10pt;">$0.8 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Estimated amortization expense for the five succeeding years and thereafter (which includes amortization of intangible assets which commenced in February 2013 with the commercial launch of the Nellix System in Europe) is as follows:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="82%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="16%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Remainder of 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">517</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">949</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,213</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,693</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,750</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,416</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021 &amp; Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,456</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,994</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(d) Marketable securities</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> Investments in held-to-maturity marketable securities consist of the following at </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:10pt;">: </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="39%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amortized<br clear="none"/>Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross<br clear="none"/>Unrealized<br clear="none"/>Gain</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross<br clear="none"/>Unrealized<br clear="none"/>Loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset backed securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">857</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">857</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Agency bonds</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate bonds<br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,658</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,657</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commercial paper</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,781</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,785</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Government securities<br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,961</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,963</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,257</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,262</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amortized<br clear="none"/>Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross<br clear="none"/>Unrealized<br clear="none"/>Gain</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross<br clear="none"/>Unrealized<br clear="none"/>Loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset backed securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,633</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,633</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate bonds<br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,707</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,699</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commercial paper</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,531</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,536</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59,871</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59,868</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> At </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;">, the Company&#8217;s investments included </font><font style="font-family:inherit;font-size:10pt;">6</font><font style="font-family:inherit;font-size:10pt;"> held-to-maturity debt securities in unrealized loss positions with a total unrealized loss of approximately </font><font style="font-family:inherit;font-size:10pt;">$2 thousand</font><font style="font-family:inherit;font-size:10pt;"> and a total fair market value of approximately </font><font style="font-family:inherit;font-size:10pt;">$4.7 million</font><font style="font-family:inherit;font-size:10pt;">. All investments with gross unrealized losses have been in unrealized loss positions for less than </font><font style="font-family:inherit;font-size:10pt;">4</font><font style="font-family:inherit;font-size:10pt;"> months. The unrealized losses were caused by interest rate fluctuations. There was no change in the credit risk of the securities. The Company does not intend to sell the securities and it is not likely that the Company will be required to sell the securities before the expected recovery of their amortized cost bases. There were no realized gains or losses on the investments for the </font><font style="font-family:inherit;font-size:10pt;">three and six months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;">. All of the Company's investments of held-to-maturity securities will mature within less than 12 months with an average maturity of </font><font style="font-family:inherit;font-size:10pt;">3</font><font style="font-family:inherit;font-size:10pt;"> months. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(e) Fair Value Measurements</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> The following fair value hierarchy table presents information about each major category of the Company&#8217;s assets and liabilities measured at fair value on a recurring basis as of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:10pt;">: </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="37%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#160;Fair value measurement at reporting date using:</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Quoted prices in<br clear="none"/>active markets for<br clear="none"/>identical assets<br clear="none"/>(Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Significant other<br clear="none"/>observable<br clear="none"/>inputs<br clear="none"/>(Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Significant<br clear="none"/>unobservable<br clear="none"/>inputs<br clear="none"/>(Level 3)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At June 30, 2015</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,269</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,269</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingently issuable common stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,800</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,800</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December 31, 2014</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,798</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,798</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingently issuable common stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,600</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,600</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> There were no re-measurements to fair value during the three months ended </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;"> of financial assets and liabilities that are not measured at fair value on a recurring basis. There were no transfers between Level 1, Level 2 or Level 3 securities during the three months ended </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(f) Financial Instruments Not Recorded at Fair Value on a Recurring Basis</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> We measure the fair value of our </font><font style="font-family:inherit;font-size:10pt;">2.25%</font><font style="font-family:inherit;font-size:10pt;"> Convertible Senior Notes due 2018 ("Senior Notes") carried at amortized cost quarterly for disclosure purposes. The estimated fair value of the Senior Notes is determined by Level 2 inputs and is based primarily on quoted market prices for the same or similar issues. Based on the market prices, the fair value of our long-term debt was </font><font style="font-family:inherit;font-size:10pt;">$82.8 million</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$84.5 million</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> We measure the fair value of our held-to-maturity marketable securities carried at amortized cost quarterly for disclosure purposes. The fair value of marketable securities is determined by Level 2 inputs and is based primarily on quoted market prices for the same or similar instruments.</font></div></div> Was reclassified in the first quarter of 2013 from in-process research and development to finite lived intangibles, which coincided with the European commercial launch of the product (Nellix EVAS System) associated with this intangible asset. A significant portion of this intangible asset will not begin amortization until the U.S. launch of this product, currently scheduled for 2016. Difference in the value between these dates is solely due to a foreign currency translation adjustment. Regulatory approval for Intuitrak in Japan acquired through an amendment with a distributor in the fourth quarter of 2014. EX-101.SCH 7 elgx-20150630.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2104100 - Disclosure - Balance Sheet Account Detail link:presentationLink link:calculationLink link:definitionLink 2404405 - Disclosure - Balance Sheet Account Detail (Amortization) (Details) link:presentationLink link:calculationLink link:definitionLink 2404407 - Disclosure - Balance Sheet Account Detail (Fair Value Measurements) (Details) link:presentationLink link:calculationLink link:definitionLink 2404404 - Disclosure - Balance Sheet Account Detail (Goodwill and Intangible Assets) (Details) link:presentationLink link:calculationLink link:definitionLink 2404406 - Disclosure - Balance Sheet Account Detail (Held to Maturity Marketable Securities) (Details) link:presentationLink link:calculationLink link:definitionLink 2404403 - Disclosure - Balance Sheet Account Detail (Inventories) (Details) link:presentationLink link:calculationLink link:definitionLink 2404402 - Disclosure - Balance Sheet Account Detail (Property and Equipment) (Details) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - Balance Sheet Account Detail (Tables) link:presentationLink link:calculationLink link:definitionLink 2125100 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 2425402 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 2325301 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1001501 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 2126100 - Disclosure - Contingently Issuable Common Stock link:presentationLink link:calculationLink link:definitionLink 2426402 - Disclosure - Contingently Issuable Common Stock (Details) link:presentationLink link:calculationLink link:definitionLink 2326301 - Disclosure - Contingently Issuable Common Stock (Tables) link:presentationLink link:calculationLink link:definitionLink 2113100 - Disclosure - Credit Facilities link:presentationLink link:calculationLink link:definitionLink 2413401 - Disclosure - Credit Facilities (Details) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - Description of Business, Basis of Presentation, and Operating Segment link:presentationLink link:calculationLink link:definitionLink 2401402 - Disclosure - Description of Business, Basis of Presentation, and Operating Segment (Details) link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - Description of Business, Basis of Presentation, and Operating Segment (Policies) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 2128100 - Disclosure - Income Tax Expense link:presentationLink link:calculationLink link:definitionLink 2428401 - Disclosure - Income Tax Expense (Details) link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - Net Loss Per Share link:presentationLink link:calculationLink link:definitionLink 2410402 - Disclosure - Net Loss Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 2310301 - Disclosure - Net Loss Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2119100 - Disclosure - Revenue by Geographic Region link:presentationLink link:calculationLink link:definitionLink 2419402 - Disclosure - Revenue by Geographic Region (Details) link:presentationLink link:calculationLink link:definitionLink 2319301 - Disclosure - Revenue by Geographic Region (Tables) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - Stock-Based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 2102100 - Disclosure - Use of Estimates and Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 elgx-20150630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 elgx-20150630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 elgx-20150630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Balance Sheet Related Disclosures [Abstract] Property and Equipment Property, Plant and Equipment [Table Text Block] Schedule of Inventories Schedule of Inventory, Current [Table Text Block] Schedule of Intangible Assets and Goodwill Schedule of Intangible Assets and Goodwill [Table Text Block] Schedule of Expected Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Marketable Securities Marketable Securities [Table Text Block] Fair Value Measurements, Recurring and Nonrecurring Fair Value Measurements, Recurring and Nonrecurring [Table Text Block] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Document and Entity Information [Abstract] Document and Entity Information [Abstract] Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Amendment Flag Amendment Flag Current Fiscal Year End Date Current Fiscal Year End Date Entity Current Reporting Status Entity Current Reporting Status Entity Filer Category Entity Filer Category Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Contractual Obligation, Fiscal Year Maturity Schedule Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] Number of operating segments Number of Operating Segments Number of reportable segments Number of Reportable Segments Accounting Policies [Abstract] Use of Estimates and Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Current Income Tax Expense (Benefit), Continuing Operations [Abstract] Income Tax Expense Income Tax Disclosure [Text Block] Raw materials Inventory, Raw Materials, Net of Reserves Work-in-process Inventory, Work in Process, Net of Reserves Finished goods Inventory, Finished Goods, Net of Reserves Inventories Inventory, Net Fair Value Disclosures [Abstract] Schedule of Held-to-maturity Securities [Table] Schedule of Held-to-maturity Securities [Table] Major Types of Debt and Equity Securities [Axis] Major Types of Debt and Equity Securities [Axis] Major Types of Debt and Equity Securities [Domain] Major Types of Debt and Equity Securities [Domain] Asset backed securities Asset-backed Securities [Member] Agency bonds Bonds [Member] Corporate bonds Corporate Bond Securities [Member] Commercial paper Commercial Paper [Member] Government securities US Government Agencies Debt Securities [Member] Corporate debt securities Corporate Debt Securities [Member] Schedule of Held-to-maturity Securities [Line Items] Schedule of Held-to-maturity Securities [Line Items] Amortized Cost Held-to-maturity Securities, Amortized Cost before Other than Temporary Impairment Gross Unrealized Gain Held-to-maturity Securities, Accumulated Unrecognized Holding Gain Gross Unrealized Loss Held-to-maturity Securities, Accumulated Unrecognized Holding Loss Fair Value Held-to-maturity Securities, Fair Value Held-to-maturity debt securities held Held to Maturity Securities, Number of Securities Held Held to Maturity Securities, Number of Securities Held Statement of Financial Position [Abstract] ASSETS Assets [Abstract] Current assets: Assets, Current [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Marketable securities Marketable Securities Accounts receivable, net allowance for doubtful accounts of $181 and $185, respectively. Accounts Receivable, Net, Current Other receivables Other Receivables, Net, Current Inventories Prepaid expenses and other current assets Other Assets, Current Total current assets Assets, Current Property and equipment, net Property, Plant and Equipment, Net Goodwill Goodwill Intangibles, net Intangible Assets, Net (Excluding Goodwill) Deposits and other assets Other Assets, Noncurrent Total assets Assets LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Current liabilities: Liabilities, Current [Abstract] Accounts payable Accounts Payable, Current Accrued payroll Employee-related Liabilities, Current Accrued expenses and other current liabilities Accrued Liabilities, Current Total current liabilities Liabilities, Current Deferred income tax Deferred Tax Liabilities, Net, Noncurrent Deferred rent Deferred Rent Credit, Noncurrent Other liabilities Other Liabilities, Noncurrent Contingently issuable common stock Business Combination, Contingent Consideration, Liability, Noncurrent Convertible notes Convertible Notes Payable Total liabilities Liabilities Commitments and contingencies Commitments and Contingencies Stockholders’ equity: Stockholders' Equity Attributable to Parent [Abstract] Convertible preferred stock, $0.001 par value; 5,000,000 shares authorized. No shares issued and outstanding. Preferred Stock, Value, Issued Common stock, $0.001 par value; 100,000,000 shares authorized. 67,947,684 and 67,321,769 shares issued, respectively. 67,767,730 and 67,159,511 shares outstanding, respectively. Common Stock, Value, Issued Treasury stock, at cost, 179,954 and 162,258 shares, respectively. Treasury Stock, Value Additional paid-in capital Additional Paid in Capital Accumulated deficit Retained Earnings (Accumulated Deficit) Accumulated other comprehensive income Accumulated Other Comprehensive Income (Loss), Net of Tax Total stockholders’ equity Stockholders' Equity Attributable to Parent Total liabilities and stockholders’ equity Liabilities and Equity Geographic Areas, Revenues from External Customers [Abstract] Schedule of Revenue by Geographic Region Schedule of Revenues by Geographic Region [Table] Schedule of Revenues by Geographic Region [Table] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Geographic Concentration Risk Geographic Concentration Risk [Member] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Sales Sales [Member] Geographical [Axis] Geographical [Axis] Segment, Geographical [Domain] Geographical [Domain] United States UNITED STATES Europe Europe [Member] Rest of World (ROW): Latin America Destination [Member] Latin America Asia Pacific [Member] Asia/Pacific Total Rest of World (ROW) [Member] Total Rest of World (ROW) [Member] Business Segments [Axis] Segments [Axis] Segment [Domain] Segments [Domain] Direct Direct Revenue [Member] Direct Revenue [Member] Distributor Distributor Revenue [Member] Distributor Revenue [Member] Schedule of Revenue by Geographic Region [Line Items] Schedule of Revenue by Geographic Region [Line Items] Schedule of Revenue by Geographic Region [Line Items] Revenue Sales Revenue, Goods, Net Concentration risk percentage Concentration Risk, Percentage Schedule of Operating Leased Assets [Table] Schedule of Operating Leased Assets [Table] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Domain] Property, Plant and Equipment, Type [Domain] Manufacturing Facility Manufacturing Facility [Member] Building Building [Member] Operating Leased Assets [Line Items] Operating Leased Assets [Line Items] Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] Remainder of 2015 Operating Leases, Future Minimum Payments, Remainder of Fiscal Year 2016 Operating Leases, Future Minimum Payments, Due in Two Years 2017 Operating Leases, Future Minimum Payments, Due in Three Years 2018 Operating Leases, Future Minimum Payments, Due in Four Years 2019 Operating Leases, Future Minimum Payments, Due in Five Years 2020 Operating Leases, Future Minimum Payments, Due in Six Years Operating Leases, Future Minimum Payments, Due in Six Years 2021 and thereafter Operating Leases, Future Minimum Payments, Due Thereafter Total Operating Leases, Future Minimum Payments Due Rent expense Operating Leases, Rent Expense Number of facilities Operating Leases, Number of Facilities Operating Leases, Number of Facilities Aggregate square feet Operating Leases, Facility, Area Operating Leases, Facility, Area Term of contract Lessee Leasing Arrangements, Operating Leases, Term of Contract Number of renewal options Lessee Leasing Arrangements, Operating Leases, Number of Renewal Options Lessee Leasing Arrangements, Operating Leases, Number of Renewal Options Renewal term Lessee Leasing Arrangements, Operating Leases, Renewal Term Initial base rent Operating Leases, Rent Expense, Minimum Rentals Landlord-funded improvements Lessee Leasing Arrangements, Operating Leases, Landlord Improvement Allowance Lessee Leasing Arrangements, Operating Leases, Landlord Improvement Allowance Number of letters of credit Number of Offices Number of Offices Number of leases exited Operating Leases, Number of Lease Exited Operating Leases, Number of Lease Exited Operating Leases, Future Minimum Payments Due, Base Rent Increases [Abstract] Operating Leases, Future Minimum Payments Due, Base Rent Increases [Abstract] Operating Leases, Future Minimum Payments Due, Base Rent Increases [Abstract] 2015 Operating Leases, Future Minimum Payments Due, Base Rent Increase, Year Two Operating Leases, Future Minimum Payments Due, Base Rent Increase, Year Two 2016 Operating Leases, Future Minimum Payments Due, Base Rent Increase, Year Three Operating Leases, Future Minimum Payments Due, Base Rent Increase, Year Three 2017 Operating Leases, Future Minimum Payments Due, Base Rent Increase, Year Four Operating Leases, Future Minimum Payments Due, Base Rent Increase, Year Four 2018 Operating Leases, Future Minimum Payments Due, Base Rent Increase, Year Five Operating Leases, Future Minimum Payments Due, Base Rent Increase, Year Five 2019 Operating Leases, Future Minimum Payments Due, Base Rent Increase, Year Six Operating Leases, Future Minimum Payments Due, Base Rent Increase, Year Six 2020 and beyond Operating Leases, Future Minimum Payments Due, Base Rent Increase, Year Seven and Thereafter Operating Leases, Future Minimum Payments Due, Base Rent Increase, Year Seven and Thereafter Income Statement [Abstract] Cost of goods sold Cost of Goods Sold Gross profit Gross Profit Operating expenses: Operating Expenses [Abstract] Research and development Research and Development Expense Clinical and regulatory affairs Clinical And Regulatory Affairs Clinical And Regulatory Affairs Marketing and sales Selling and Marketing Expense General and administrative General and Administrative Expense Total operating expenses Operating Expenses Loss from operations Operating Income (Loss) Other income (expense): Nonoperating Income (Expense) [Abstract] Interest income Investment Income, Interest Interest expense Interest Expense Other income (expense), net Other Nonoperating Income (Expense) Change in fair value of contingent consideration related to acquisition Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Total other income (expense) Nonoperating Income (Expense) Net loss before income tax (expense) benefit Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest Income tax (expense) benefit Income Tax Expense (Benefit) Net loss Net Income (Loss) Attributable to Parent Other comprehensive income (loss) foreign currency translation Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Basic and diluted net loss per share Earnings Per Share, Basic and Diluted Shares used in computing basic and diluted net loss per share Weighted Average Number of Shares Outstanding, Basic and Diluted Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] Revenue by Geographic Region Segment Reporting Disclosure [Text Block] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value Measurements, Recurring and Nonrecurring [Table] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Convertible Debt Convertible Debt [Member] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] 2.25 % Convertible Senior Notes due 2018 Convertible Senior Notes due 2018 [Member] Convertible Senior Notes due 2018 [Member] Measurement Frequency [Axis] Measurement Frequency [Axis] Fair Value, Measurement Frequency [Domain] Fair Value, Measurement Frequency [Domain] Fair Value, Measurements, Recurring Fair Value, Measurements, Recurring [Member] Fair Value, Hierarchy [Axis] Fair Value, Hierarchy [Axis] Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value Hierarchy [Domain] Quoted prices in active markets for identical assets (Level 1) Fair Value, Inputs, Level 1 [Member] Significant other observable inputs (Level 2) Fair Value, Inputs, Level 2 [Member] Significant unobservable inputs (Level 3) Fair Value, Inputs, Level 3 [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Stated interest rate Debt Instrument, Interest Rate, Stated Percentage Cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Contingently issuable common stock Business Acquisition, Contingently Issuable Common Stock, Noncurrent Business Acquisition, Contingently Issuable Common Stock, Noncurrent Fair value of long-term debt Long-term Debt, Fair Value Revenue by Geographic Region Schedule of Revenue from External Customers, by Geographical Areas [Table Text Block] Schedule of Revenue from External Customers, by Geographical Areas [Table Text Block] Business Combinations [Abstract] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Nellix Nellix [Member] Nellix [Member] Contingent Consideration by Type [Axis] Contingent Consideration by Type [Axis] Contingent Consideration Type [Domain] Contingent Consideration Type [Domain] Nelix Milestones Nelix Milestones [Member] Nelix Milestones [Member] OUS Milestone OUS Milestone [Member] OUS Milestone [Member] PMA Milestone PMA Milestone [Member] PMA Milestone [Member] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Common Stock Common Stock [Member] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum Minimum [Member] Maximum Maximum [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Purchase price common shares Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Common shares value Business Acquisition, Equity Interest Issued or Issuable, Value Assigned Number of shares contingently issuable Weighted Average Number of Shares, Contingently Issuable Estimated fair value of contingent payment Contingent Consideration Classified as Equity, Fair Value Disclosure Contingent consideration, liability, value, low Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, Low Contingent consideration, liability, shares, low Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Shares, Low Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Shares, Low Contingent consideration, liability, value, high Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, High Contingent consideration, liability, shares, high Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Shares, High Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Shares, High Share price Business Acquisition, Share Price Closing stock price Business Acquisition, Contingent Consideration, Closing Stock Price Per Share Business Acquisition, Contingent Consideration, Closing Stock Price Per Share Contingent consideration, at fair value hypothetical value Business Acquisition, Contingent Consideration, at Fair Value Hypothetical Value Business Acquisition, Contingent Consideration, at Fair Value Hypothetical Value Fair Value of Contingently Issuable Common Stock [Roll Forward] Fair Value of Contingently Issuable Common Stock [Roll Forward] Fair Value of Contingently Issuable Common Stock [Roll Forward] December 31, 2014 Business Acquisition, Contingently Issuable Common Stock, Current Business Acquisition, Contingently Issuable Common Stock, Current Fair Value Adjustment of Contingent Payment for the six months ended June 30, 2015 June 30, 2015 Line of Credit Facility [Abstract] Credit Facilities Short-term Debt [Text Block] Schedule of Business Acquisitions by Acquisition, Fair Value of Contingent Consideration Schedule of Business Acquisitions by Acquisition, Fair Value of Contingent Consideration [Table Text Block] Schedule of Business Acquisitions by Acquisition, Fair Value of Contingent Consideration [Table Text Block] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs, by Report Line [Axis] Income Statement Location [Axis] Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Report Line [Domain] Income Statement Location [Domain] Cost of goods sold Cost of Sales [Member] Research and development Research and Development Expense [Member] Clinical and regulatory affairs Clinical and regulatory affairs [Member] Clinical and regulatory affairs [Member] Marketing and sales Selling and Marketing Expense [Member] General and administrative General and Administrative Expense [Member] Total operating expenses Operating Expense [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Allocated stock-based compensation expense Allocated Share-based Compensation Expense Earnings Per Share [Abstract] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Common stock options Employee Stock Option [Member] Restricted stock awards Restricted Stock [Member] Restricted stock units Restricted Stock Units (RSUs) [Member] Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Earnings Per Share, Basic and Diluted [Abstract] Earnings Per Share, Basic and Diluted [Abstract] Net loss Shares used in computing basic and diluted net loss per share Basic and diluted net loss per share Securities Excluded from Calculations of Earnings Per Share Because Impact Would Have Been Anti-Dilutive [Abstract] Earnings Per Share, Diluted, Other Disclosures [Abstract] Outstanding securities used in calculations Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Potential Dilutive Effect of Securities [Abstract] Dilutive Securities, Effect on Basic Earnings Per Share [Abstract] Conversion of the Notes Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Operating segment Segment Reporting, Policy [Policy Text Block] Stock-Based Compensation Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Statement [Table] Statement [Table] Convertible Preferred Stock Convertible Preferred Stock [Member] Statement [Line Items] Statement [Line Items] Allowance for doubtful accounts Allowance for Doubtful Accounts Receivable Convertible preferred stock, par value (per share) Preferred Stock, Par or Stated Value Per Share Convertible preferred stock, shares authorized Preferred Stock, Shares Authorized Convertible preferred stock, shares issued Preferred Stock, Shares Issued Convertible preferred stock, shares outstanding Preferred Stock, Shares Outstanding Common stock, par value (per share) Common Stock, Par or Stated Value Per Share Common stock, shares authorized Common Stock, Shares Authorized Common stock, shares issued Common Stock, Shares, Issued Common stock, shares outstanding Common Stock, Shares, Outstanding Treasury stock, shares Treasury Stock, Shares Contingently Issuable Common Stock Business Combination Disclosure [Text Block] Net Loss Per Share Earnings Per Share [Text Block] Schedule of Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Production equipment, molds, and office furniture Production Equipment, Molds, and Office Furniture [Member] Production Equipment, Molds, and Office Furniture [Member] Computer hardware and software Computer Equipment [Member] Leasehold improvements Leasehold Improvements [Member] Construction in progress (software and related implementation, production equipment, and leasehold improvements) Construction in Progress [Member] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Property and equipment, at cost Property, Plant and Equipment, Gross Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Property and equipment, net Depreciation expense Depreciation Statement of Cash Flows [Abstract] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Net loss Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation and amortization Depreciation, Depletion and Amortization Stock-based compensation Share-based Compensation Change in fair value of contingent consideration related to acquisition Accretion of interest on convertible note Accretion Expense Amortization of deferred financing costs Amortization of Financing Costs and Discounts Non-cash foreign exchange gain Foreign Currency Transaction Gain (Loss), before Tax Changes in operating assets and liabilities: Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract] Accounts receivable and other receivables Increase (Decrease) in Accounts Receivable Inventories Increase (Decrease) in Inventories Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Accounts payable Increase (Decrease) in Accounts Payable Accrued payroll Increase (Decrease) in Employee Related Liabilities Accrued expenses and other liabilities Increase (Decrease) in Accrued Liabilities Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Purchases of marketable securities Payments to Acquire Marketable Securities Maturities of marketable securities Proceeds from Sale and Maturity of Marketable Securities Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Proceeds from sale of common stock under employee stock purchase plan Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Excluding Stock Options Proceeds from exercise of stock options Proceeds from Stock Options Exercised Minimum tax withholding paid on behalf of employees for restricted stock units Payments for Repurchase of Preferred Stock and Preference Stock Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash and Cash Equivalents Net increase (decrease) in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Supplemental disclosure of cash flow information: Supplemental Cash Flow Information [Abstract] Cash paid for interest Interest Paid Cash paid for income taxes Income Taxes Paid Subsequent Events [Abstract] Non-cash investing and financing activities: Other Noncash Investing and Financing Items [Abstract] Landlord funded leasehold improvements Other Real Estate, Improvements Fair value of Nellix Milestone Shares (note 9) Other Significant Noncash Transaction, Value of Consideration Given Acquisition of property and equipment included in accounts payable Noncash or Part Noncash Acquisition, Other Assets Acquired Amortization expense Amortization of Intangible Assets Remainder of 2015 Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year 2016 Finite-Lived Intangible Assets, Amortization Expense, Year Two 2017 Finite-Lived Intangible Assets, Amortization Expense, Year Three 2018 Finite-Lived Intangible Assets, Amortization Expense, Year Four 2019 Finite-Lived Intangible Assets, Amortization Expense, Year Five 2020 Finite-Lived Intangible Assets, Amortization Expense, Year Six Finite-Lived Intangible Assets, Amortization Expense, Year Six 2021 & Thereafter Finite-Lived Intangible Assets, Amortization Expense, Year Seven and Thereafter Finite-Lived Intangible Assets, Amortization Expense, Year Seven and Thereafter Total Finite-Lived Intangible Assets, Net Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Goodwill, Finite-lived, and Indefinite-lived Intangible Assets Goodwill and Finite and Indefnite Lived Intangible Asset [Table] Goodwill and Finite and Indefnite Lived Intangible Asset [Table] Indefinite-lived Intangible Assets by Major Class [Axis] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] Trademarks and trade names Trademarks and Trade Names [Member] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Developed technology Developed technology [Member] Developed technology [Member] License Licensing Agreements [Member] Customer relationships Customer Relationships [Member] Acquired Shonin approval Intuitrak Shonin [Member] Intuitrak Shonin [Member] Goodwill, Finite-lived, and Indefinite-lived Intangible Assets [Line Items] Goodwill, Finite, and Indefnite Intangible Assets [Line Items] Goodwill, Finite, and Indefnite Intangible Assets [Line Items] Indefinite lived intangibles Indefinite-Lived Intangible Assets (Excluding Goodwill) Finite lived intangibles Finite-Lived Intangible Assets, Gross Accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Intangible assets (excluding goodwill), net Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Scenario [Axis] Scenario [Axis] Scenario, Unspecified [Domain] Scenario, Unspecified [Domain] Forecast Scenario, Forecast [Member] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Other Assets Other Assets [Member] Additional Paid-in Capital Additional Paid-in Capital [Member] Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period [Domain] Redemption, Period One Debt Instrument, Redemption, Period One [Member] Redemption, Period Two Debt Instrument, Redemption, Period Two [Member] Convertible Senior Notes Issued December, 2013 Convertible Senior Notes Issued December, 2013 [Member] Convertible Senior Notes Issued December, 2013 [Member] Revolving Credit Facility Revolving Credit Facility [Member] Letter of Credit Letter of Credit [Member] Lender Name [Axis] Lender Name [Axis] Line of Credit Facility, Lender [Domain] Line of Credit Facility, Lender [Domain] Wells Fargo Bank Wells Fargo Bank [Member] Wells Fargo Bank [Member] Bank of America Bank of America [Member] [Domain] Bank of America Debt Instrument, Measurement Period [Axis] Debt Instrument, Measurement Period [Axis] Debt Instrument, Measurement Period [Axis] Debt Instrument, Measurement Period [Domain] Debt Instrument, Measurement Period [Domain] Debt Instrument, Measurement Period [Axis] Measurement Period One Debt Instrument, Measurement Period One [Member] Debt Instrument, Measurement Period One [Member] Measurement Period Two Debt Instrument, Measurement Period Two [Member] Debt Instrument, Measurement Period Two [Member] Measurement Period Three Debt Instrument, Measurement Period Three [Member] Debt Instrument, Measurement Period Three [Member] Measurement Period Four Debt Instrument, Measurement Period Four [Member] Debt Instrument, Measurement Period Four [Member] Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Debt instrument face amount Debt Instrument, Face Amount Proceeds from convertible debt Proceeds from Convertible Debt Threshold trading days Debt Instrument, Convertible, Threshold Trading Days Threshold consecutive trading days Debt Instrument, Convertible, Threshold Consecutive Trading Days Threshold percentage of stock price trigger Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger Conversion of convertible securities Debt Instrument, Convertible, Conversion Ratio Redemption price percentage Debt Instrument, Redemption Price, Percentage Threshold business days Debt Instrument, Convertible, Threshold Business Days Debt Instrument, Convertible, Threshold Business Days Threshold consecutive business days Debt Instrument, Convertible, Threshold Consecutive Business Days Debt Instrument, Convertible, Threshold Consecutive Business Days Violation or event of default, declaration by note holders, percentage Debt Instrument, Debt Default, Violation Or Event Of Default, Declaration By Note Holders, Percentage Debt Instrument, Debt Default, Violation Or Event Of Default, Declaration By Note Holders, Percentage Fair value disclosure Debt Instrument, Fair Value Disclosure Beneficial conversion feature Debt Instrument, Convertible, Beneficial Conversion Feature Unamortized discount Debt Instrument, Unamortized Discount Deferred finance costs, noncurrent, net Deferred Finance Costs, Noncurrent, Net Periodic interest payment Debt Instrument, Periodic Payment, Interest Payments of derivative issuance costs Payments of Derivative Issuance Costs Convertible conversion price Debt Instrument, Convertible, Conversion Price Cap price Derivative, Cap Price Aggregate maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Credit Derivative, Liquidation Proceeds, Monetary Amount Credit Derivative, Liquidation Proceeds, Monetary Amount Minimum current ratio Debt Covenant, Minimum Current Ratio Debt Covenant, Minimum Current Ratio Maximum operating loss Debt Covenant, Maximum Operating Loss Debt Covenant, Maximum Operating Loss Maximum annual capital expenditures Debt Covenant, Maximum Annual Capital Expenditures Debt Covenant, Maximum Annual Capital Expenditures Balance Sheet Account Detail Supplemental Balance Sheet Disclosures [Text Block] Description of Business, Basis of Presentation, and Operating Segment Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Federal statutory income tax rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent EX-101.PRE 11 elgx-20150630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 12 elgxblack186ca01a01a01.jpg begin 644 elgxblack186ca01a01a01.jpg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end EXCEL 13 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0````(`&Z'!4?G?S$WN0$``)T7```3````6T-O;G1E;G1?5'EP97-= M+GAM;,V8RT[#,!!%?Z7*%C6N'=ZBW5"V@`0_8))I8S6.+=M]_3UV"@BJ@EJ@ MTMWDT3N>>Y-QSJ(WSVM+OK?23>N'61V"O6;,ES5IZ7-CJ8W*Q#@M0[QU4V9E M.9-38F(P.&>E:0.UH1]2CVQT\[`@YU1%O=N-D'H/,VEMHTH9E&G9HJVVNO;- M9*)*JDPYUW%)'J(UG40]ZSU*%^ZECBW8JF&=L#GR/.GL?PR]=20K7Q,%W>0^ MK!ORN_PWRKOSF"9RWH2#C-_>7>ZHZ6I\K>R;U=TJ=O'QMV$65;^7P_;"GY(I MG89FV^F7%>G^E\^R]1(7NAD[N51;!HNCC2F=::W?]W=`[T;/N=$1(')1#@.0H0'*<@N0X`\EQ#I+C`B3')4B.*Y`QW8OG*\M"_V/Z'D4X$G1H>)%]2-F`Q+M*;V"^GH`A3&^.R6:E((C M-Z."N[_8_`)02P,$%`````@`;H<%1PQUTFF.`0``J18``!H```!X;"]?&?/ODKC;671NJN@^S]^;:ANWP M?Y]5,?9;8T)1N<:&AZYW[;!Z[GQCX_#I2]/;XF)+9SC/E\9/YV2'W<_9L^-I MG_GCB;+9B_6EB_OLK?.74#D7@QE?]#!L,"S?>O>?[;OSN2[<8U>\-JZ-?U28 MKPTRDP[B=!!#@B0=))"@>3IH#@E:I(,6D*!E.F@)"5JE@U:0H'4Z:`T)VJ2# M-I`@RA49C-&;%;T9HSC-&;U;T9HS> MK.C-&+U9T9LQ>K.B-V/T%D5OP>@MBMZ"T5L4O05T5Z)=EF#T%D5OP>@MBMZ" MT5L4O06CMTST#I7U[O0P MFMB1ST&POW[GI&2A!-;D8;QP.7_?G>^[LY.QPMYH9G0&QDI`MDX3A2-R7GI+ M:[.1[Z-80LKQC""*5F-M4F[IT2Q\'<=2P%2+/`5E_7ZO-_1A;4%%$)UF55`O M&+LL5UF62,&MU"KX+H71J&/+;M8"DK'_$5`P*'(((C?2;H)>B:F["DPH>`(3 MRA7$/$$H47^=!6:BTXRKC5\^/4KUAL_97$^YA3IK=Z&,ON0&(DJZ$[UR%IC[ M#=69..YDR=4"HCIV?W&KQ0L8=)6>]\]Z]*LDV/K+V,`CJ18S+@T&XY4=K4!8 M;=[;M+)=NQ1IX9J.+W/:'WKLE2,X\]);<2.YLAY#^9L>^UZ9MO06=I*A-<$O M;=YP"6!Q[%?.PJQCZ[:\"`;#`D'6+M*O*@O>9=NIVWGFTB:`/^,9-_8_25'4 MM!5B,/1JU6]#,*XB=J,LC2-[4&4J:EY=DLJ::#H7"B%B9*%.9$1C%K%KGG`E M@'7@#-IP0DM_M.<.G&^-G"F@,#)S]3(=L^LY!B4,I*H1-:.00<_Z:@"LSI3:$MI'SH(1.@CYLW1QV,F_5'\*[8C[9IGYW[S8?ZN,ZS M#IR'#IR[#IRK#IS[#IS;EK-6\#X]:V66`\.V=SG\`W]\.*?MAW-PT7XX!\VW M^OY=T5S,WBO[PPO:W_VP#/X`4$L#!!0````(`&Z'!4<9UK1Q/P$``&D#```1 M````9&]C4')O<',O8V]R92YX;6S-D\%.PS`,AE\%]=ZEW=@$4=<#($Y,0F(( MQ"TDWA;6)E'BJ>O;DWFE9GCTUH%'#>%B7USQ;N4^Z+ZJ:9I1,Z&Z.'#.7A8S/KWFX\NWPV0G_@;#=3?$ MOW7\99"VBQHK.'.WI%&T7/HDD((@O7:HK3D+1YAO8H*%W?L'2#P?U`GILFVA M;:Q7H:3[-42'EQ-7MK:^/:9^1">OJOP$4$L#!!0````(`&Z'!4>97)PC$`8` M`)PG```3````>&PO=&AE;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O& M-H&VM!-S:7;;M)F$[4X?A1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5' MY^@X>?/N+F+HAHB4\GA@V2_;UKNW+][@5S(D$4$P&:>O\,`*I4Q>M5II`,,X M?+&A`T%116F]? M(+3E'S/X%/F7/Z3H=,H%N,!M8('_.;Z?D M3EJ(X53"Q,!J9S]6:\?1TDB`@LE]E`6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS* MVG0T;1K@X_%X.+;+THMP'`3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3 M]WW?ZYMHG`J-6T_3:W?=TXZ)QJW0>`V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H M0D;CZWH2%;7E0-,@`%AP=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9I MTAF6-$9RG9`%#@`WQ-%,4'RO0;:*X,*2TER0UL\IM5`:")K(@?5'@B'%W*_] M]9>[R:0S>IU].LYKE']IJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+`GQ^R-;88C'(CN]WV6'WV3T=N M(]>IP+,BUY1&)$6?R"VZY!$XM4D-,A,_")V&F&I0'`*D"3&6H8;XM,:L$>`3 M?;>^",C?C8CWJV^:/5>A6$G:A/@01AKBG'/F<]%L^P>E1M'V5;SCFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0 MKH)[`?_1VC?"J_B"P#E_+GW/I>^Y]#VATK\>WZV22$KYI9+2,6D$N!LT$DN/R+RO`J MQ`GH9%LE"0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3- M"S-#MW)+ZK:4OK4F.$KTL@'37[]EUVY".E,%.70[@: M0KX#;;J=W#HXGIB1N0K34I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\ MEAW'B/*B(>ZAAIC/PT.'>7M?F&>5QE`T%&ULK"0L1K=@N-?Q+!3@9&`MH`># MKU$"\E)58#%;Q@,KD*)\3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@3 M9ZO*WF6QP54=SU5;\K"^:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON>;G*YZ(G;ZEW?!8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$! M=$4"(Y4U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_ M6-8>^3+?.7#;.MX#7N83+$.D?L%]BHJ`$:MBOKJO3_DEG#NT>_&!()O\UMND M]MW@#'S4JUJE9"L1/TL'?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC? MAT6:&C/5BZPYC0IO0=5`Y3_;U`UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2. MX>V+OP%02P,$%`````@`;H<%1Q-%:&ULS5=;:]LP%/XK0AVCA1';"4G;U3:,0F"PE4'SL+%4I,+"__IZFZ(7]J%*P@A42;8#S="K"#SIL(F6'990Y@"\4AQ;G2`9(42S,J41KI0BG!M)$15`B. MJ*%L(QI#TZ:8TD?SA/[.=[C7.7`^YHY]"(R*UM0'T9A]&=A#];;9'/0H M7K#.NP0Z&I4EW7RCI.`,.[$.FHMF=H@^V$,?AZAE!4LAR;/V-X60:@!+"%98 M*I)N(W\E*A=XK9H*]M;Y/H7';OD]-9W^U'HUN@0_^GB.3FZAAYHE6,[MR^_M MDB;7AZ_,/IUP(/-CJ^8("28U M[72K9^]T[`X%24VH(KR5@,PWUH.137>::=^M-6>V[ANU754HT9_M.UDT689S M5%/UBZR$LHL1[.T?1GXPZ[P6'44$>_LGSDC-W$=C_]\@_@=02P,$%`````@` M;H<%1[.E'GV5`P``K0P```\```!X;"]W;W)K8F]O:RYX;6R5EMMNVS@00'^% MT%,*[*XMRG9;HR[0U$D:H-L-8K?[3$OCF`A%&APJEW[]#J5X.[89H7X2=3LB MAV=&\P&GC\[?KYR[%T^UL3CULVP3PG8Z&&"Y@5KA7VX+ENZMG:]5H%-_-W#K MM2YA[LJF!AL&X2]"[[9GC?:Q)/Q<)P-(FRW MU!LO2E=!!UMN-/[[(C_W0\(@<&"\(50;] M`$NUFF7#3*@FN$MM`OBY"G#E7;/5]HY8F5AKCV$1E]L^66NK:_TSSIO.<.,> MOSBO?SH;E%F4WAG3OA5OM"_1%_#_*S3'H,N]!X-:W<:=F&63(0$?-.J5-CH\ MS[)V;""N9'"PE#;\OT;"ML'9;;%0MA(7-A!%7-MN\R@T<0[T\'75?MA/-0W\ M=95WH>*@S\Y68!$J02-T1E<4E4J<*Z-L"8*!)`/)4T$%`Q4,5/PV:!'H0$MF MH!$#C4X%C1EHS$#C8]`@W?:TWHE/9>D:?\G+:(-44T%``_M><\([X\)WVCTU2&*&_`T&>6!FS?DZ@T3&^2!ZH*X5&5, M`PW(7][S-B'N+3R`;4"LGL45N#NOMAM=BENX.]"?:YLGO:UK'6(N==M!K@0J M"&#+@PEQ;?.TM]V+P5`N(C:*,CK&M29M%H&CN+AYPMQK6[H:Q%(]B8NGN"U[ M8>6VYJ?JFD\XBON:)X3M\TR<+3F*&YLGE'U--L+$0'$4US9/>'MLW0L$WW`, M=S=/R-MGT/[B)#=9IDSNDTB<<13W6J8+\NL:2Q4YH7:O")*79,GEE@FY M^T6XX2@NMTS(W8^ZYBANNDR8WH^ZXBANNCS9]$\)&Q/Y5\WI[T$++CJ14KUP_J?QG#-BX3F_7D\ MYZB]UB-9PWORN!AQ%->\2')#0__AVD`\4=+R8OS>2O_I%: M:,K_*G;7V'Z#VM,RMMQTZ'Z5HW$LFO'\;VK#9UGLE:DM;HSY3-?^L5^=:CO* MCKQKLC_^!U!+`P04````"`!NAP5'-T*/Z$H"``#T!P``&````'AL+W=O2#9L:B0^2GN/,+OM^_.Z?)\GP!P1+- M8,5^ECW*"$ZZ*1=Y]ECN,T7S=:='/)-H2?S>,C@@.[M-+> ML6/O^,!MD+FD/^5ET>$S^87YN6Y%L&=27?7F1CXQ)HG"@R^_`]02P,$%`````@`;H<%1RJ$^<5Q!```]Q4``!@` M``!X;"]W;W)K:LMND%T>*1Y';F[4=2E=1MARYS+K9%?57\N?TFN;S4S<_VX%P7 M_2J+JGU>'+KN]!3'[>;@RKS]7)]MS5QPK][V)VG-9YLV_+ZZH+\\+OI@*?ASWAVXHB%?+>([; M'DM7M<>ZBAJW>UY\X4^9M`,R$G\=W:7]\#L:Q+_6]<_AX8_M\X(-&ESA-MV0 M(N^_WMS:%<60J:_Y'TSZ7N<0^/'WE/WKV-Q>_FO>NG5=_'W<=H=>+5M$6[?+ MST7WH[Y\<]@&/23#$GZS%'?^K;OV#%G M,W;M:OFV$FH9OPUYKA`Q(FM$[A,9$GI&XKY^KPAQ+4*""`'QYG&\O(Z'PB\2 MXNVUQ&I$+#0"$&F$2>]3&28R-DT>:U%>+0I2)+Y:-&@!1"JAO8J!RH#2:6+Y M8RW:JT6#%F^+4'!1U$ M'6M$F$ZH/ID2R9!YGWBU))!"$%H27%HI`668AQOQ6$GJ59)"!DDH`:1O;FHT MH04Q9:VQC]5PYI4S%@]+A-"#C%`)HX9IPK1)`_R%<[\><#BI?28(S,O$&$HS M.F5B&;$HLQE+3(AFX=<,KBH)CUDCHX1EU/R:,*E,P%SG?I/F:,&4,R(C:#>: M*,5#U/AMFJ,)4]Z(C!C6.-D]:IJ)XL.PWE=T8];X)\C!9!4+R."W6([F2'D; M,IQ;0UAQ-F-,A*QBO]5RB[.+TF.Q(N7_8Y[T(":E#-'CMUN>X#2F]""36E(. M4%J8D-'R6RX'IU2DQZ5H!(+V.,12\V$C=W\/YO=<`4:I"'-?(Y.0G>.![FOQ M^ZT``U24ER*3,$MUS4R%C)3P.ZE`^Z.<%!FIR)[!1$E(S_A=5$A,06F1^!^< M,&J-SYAA(7WC]U&A<+U0>H"Q@FMB0+,)8XH%K''AW_(*<%'M;3B>!9#A0BE+ M<-D[QW3(B/E=68"5ZH!=O+CQT>EX9-%M`C+XG4^@7WF=;^H58,@.N47NZ_![ MG@"CTI3G(6/(58U,P#R1?K>38%*:*L,#)@WDJ_ZTDP*^J,ND;FD[#"AEJ&`#O'O&J7UGJ.NSEK(F%M/C3]<@96NV8]WB6VTJ<]5!Y=' M<^E\7_DRWB[>EDOSM.Z;\/N;ON[^S7C%&;]7L5J>\KW[,V_VQZJ-7NNNJ\OQ MCFU7UYWK);//_4@?7+Z='PJWZX:?=I@"<"\)#UU]FJY9Y[O>U7]02P,$%``` M``@`;H<%1XY!G1/ M'>_-H9:Z(RB+X!*W:SK6BX;WWLCV:_\+6E4(:\00OQIV%E?WGI;?3(Y1S-3 M97$J4UP$)YWG!L$&>05D@:@LD5R00-5W2N!;B1@D,$A$MR5Z@Q"0``1E:)ZI M)N8)C\CI$8%'[*J1@0<@X4L8.DV`JES4K$OL=(G!)7%52<`%$!3:SSQ9S9&S M3HG3*0&G=,')(B2/29HY)](J36"$$4GSQT:ITRBU61:,)H2H;[0T21.(DCQ! M3ZP;<1H1R)(M&`&"2)XG\?*Z63+%.,F>6K?,Z92!TQ.SG#OCBY<@%FTN4?F/=P;*8(M MD#AWTLD#/_:X1\`CN#I@!GI@/^EX:'KA;;A49Y4Y4O:<2Z92A"\J5:W>(2Z- MENVEOB6Z!IRJT)!\F%X2+F\JY3]02P,$%`````@`;H<%1V1`_JK'!```"Q<` M`!@```!X;"]W;W)KMFIK#[IG$)':-,5X@\>R_7T&WR,?*;2ZQ39YNZ974>H76EZ;] MV>VKJE_\JH^G[F&Y[_OS?11U3_NJ+KN[YER=W'^>F[8N>_>S?8FZGWUO-^OFM3\>3M7W=M&]UG79_IM5Q^;RL!1+_^#'X67? M#P^BS3J:XG:'NCIUA^:T:*OGA^4W<;^%9$!&XJ]#=>D^?%\,G7]LFI_#CS]V M#\MXZ$-UK)[Z(47I/MZJO#H>ATRNY7\HZ7N;0^#'[S[[;Z-OQ_Y'<_F](@UZ2/C4'+OQ[^+IM>N;VHH:\9TF^"X&(QG%&>(:&LE,RP(*:49O05" M`@`4,RK4)9W(VZ)L4)3%#$Q_,T2DMMP21@A28(:G0"B-N6+8(J0LS)AH$0=% MC8^=*F;H,F*$-8I;PQ,F$FX1$^8V,,55I\>T%#.6H1!A=8)FG5.'3.)JCQ,G M:+UR95P0)5RU,UO=UF,RMFJ&-@AK0Z\R":<-&9D`5XNYQP"X';H@+'7;%#MS MB"7"V'B&.AE6ATYJF)64$;,2(/BY(TZF*3MYA($P@BGRK>=L;,P,?5^,GG98 M@:8Z*T/84@7ZE^$\E1C);4?$\#6K;V[H6V($S#@\B;"="K0NR_DI,2MW9.&< MXQU3G'=X#*QF]HCMA!DYXZP@TK`Z=%7+U$Y&3)HP59T3Y+2QTLC$6567//6#WNP]!MJ$3[_T;N\YF7RX MO;FN+WP4`7HK#^Y9EO0ALXKO!(/E'[#@]%J2-V$R6`F6U$U8/*?DPJ<20/-G MO2LC*$D3KD9RCT$2'BR_,GTV_AUIRJ;BKXLS^G#35U?MRWC'VBV>FM=3CY=7 MT]/I'O<;##>%7YYGXCX7@>>%N-_B+>U[^LWZ7+Y4?Y;MR^'4+1Z;OF_J\1KQ MN6GZRO4XOG,]WU?E;OIQK)[[X6LZ2,*[6OS1-V=_]3S=?V_^`U!+`P04```` M"`!NAP5'L)$ZOX8$``"0%@``&````'AL+W=OSWSLW)+^:^MC?+_;#<+I;K?JGO6NJ_EM[_#B\[(?IQ6JS7EW:[0Z-._:']IAT[OE^\:#N2IU.DEGQ M]\&=^ZOOR63^L6U_3@]_[NX7Z>3!U>YIF$)4X\>;*UU=3Y'&GO^EH.]]3@VO MOX?HO\_#'>T_5KTKV_J?PV[8CV[31;)SS]5K/?QHSW\X&D,V!7QJZW[^FSR] M]D/;A":+I*E^^<_#[@`77'.;F<+N#TBM,_G4/^+$'__(!:1#P=0#],8#V`?0`1;PM*BD0 MJ`@KAK5BR`J;,K+B-3I75K#B16BR""L%:Z7P=\H!" M)?GQ&H/2VB/1LC`V8DNJC'?C62>MJRUIM))(1:*E@B+&#<]-E5-/DAL"9RZ! MI"05%E=K]+8;'IV*N"CFQM"P\T*<*\(P@(ZPP^-3%;22Q>P0'4'"2:D"9ZV) ML,,S5!'[E)@>&]*#A7`8EA==JO+T:TN0LK@``F#,:0D\`($`J*2CFT1+-`JD M11AT1E_'NVT)>$L$0;[J"9:\*!^WA71VD@RRK(C8%\`C%0)2I>,3+DC5@JP, MLLSHF$GCD0J:#$E'*(G&'2C/&5$UTV`B#B[@*TB@$E)%G!/`LQ"H]I.*LFT0 MY=)Q4@:5UA$%/O`PA$`PZ1PE$>0@U`]E")7:F$W!PQ"*4!E+=@(,K9@=4BFT M,7N"IR'8`'C)CQ>AS<7T!+#J"#O(%Y5()`3AR-Z2:)FA5/0$54R)BSQ4D:`* M$E1)9+61)@M#[8D84Q0BCU0DI(*$5!)!;JPT722SFD0D2!@'QIB<1`B05;$EDCU98A4AJU(WB<8O@I+>$T MB+1TAI+HNL*Z;<;PV24"8D2M@SP`D0`H_HX@D7@"DP8+$V.&IQ\2LL2?$202 M4TN`+##F[-4\^S2QC[]8"9=)7L2S)MPDI6$U?-Y'JZN+OL9U+_,%:)\\M:_' MP5_"7=Y>+ED?8+HH_/1^J^Y*?U7Z'F:S/E4O[J^J>SD<^^2Q'8:VF6\+G]MV M<*.Q]-N8KKVK=I>'VCT/TU6CG-"\V![`D5U#9?=,<:%I5<;:DZE*')T4&IX,L:-2W/P[@L3I0#=T*3R+KG>AP*J2K;Q& M*-!6H"8&V@-]V.R/14!$P&\!D[V(2?!^0GP)R<_F0+-@`234+BAPOYSA$:0, M0K[QWUGSK64@7L:+^O4?X1C>N]V8R2!EH^2O>,TP^81]@%P1JE MC5]2C]:A6BB4*/Z:5J'C.J4_7[.9=IN0SX3\'8&E1M'F-^YX51J+@57FN-MNB9.<@=(5)Q..,61',J]]LD=-;]#S2\\_I MVVOZ-CGCI/?O9TTDM"Z$7WQLTI5* MB<-A>2#K*ZW^`U!+`P04````"`!NAP5'#1+J^J0!``"Q`P``&````'AL+W=O MZ:EE42$Y*HD9:5_7SXDQ0Z,YB+NKF9F9_DH)S2OM@=PY$U);?>T=V[8,6;K M'A2W-SB`]G]:-(H[GYJ.V<$`;R))299GV1U37&A:E;'V;*H21R>%AF=#[*@4 M-W\/('':TPU="B^BZUTHL*ID*Z\1"K05J(F!=D\?-[M#$1`1\$O`9,]B$KP? M$5]#\J/9TRQ8``FU"PK<+R=X`BF#D&_\9]9\;QF(Y_&B_BU.Z]T?N84GE+]% MXWIO-J.D@9:/TKW@]!WF$6Z#8(W2QB^I1^M0+11*%']+J]!QG=*?NV*F72?D M,R%?"0]9-)X:19M?N>-5:7`B=N#A[#8[#S=!Q"L3[\WZL:.FB8-7Y:G:;.]+ M=@I"%YA$/,R8%<&\^M46.;U&SR,]_YR^O:1OD\/M[/#A2&D?MTI:NU?5V/N;Q3-[A53GP#GYRTPEMR1&=/]EX M`"VB`]\^N[FEI/?O9TTDM"Z$]SXVZ4JEQ.&P/)#UE5;_`%!+`P04````"`!N MAP5'2$DJXZ$!``"Q`P``&````'AL+W=OV>]LX-.\9LW8/B]@8'T/Y/BT9QYU/3,3L8X$TD M*[JA2^%9=+T+!5:5;.4U M0H&V`C4QT.[I_69W*`(B`GX)F.Q93(+W(^)+2'XT>YH%"R"A=D&!^^4$#R!E M$/*-_\R:;RT#\3Q>U+_':;W[([?P@/*W:%SOS6:4--#R4;IGG!YA'N$V"-8H M;?R2>K0.U4*A1/'7M`H=URG]*1;:=4(^$_*5\#6+QE.C:/,;=[PJ#4[$#CR< MW6;GX2:(>&7BO5D_=M0TSP__H7UP*%$F@^&C$A#DLF/*C!=O#J6U#AJE[9TK:ZW M\SZ/9_(&K\J!=_"3FTYH2X[H_,G&`V@1'?CVV6CG-"\VA[`D7U#95^8XD+3JHRU9U.5.#HI-#P;8D>E MN/ES!(G3@6[H4G@17>]"@54E6WF-4*"M0$T,M`?ZL-D?BX"(@%\")GL1D^#] MA/@:DA_-@6;!`DBH75#@?CG#(T@9A'SCMUGSHV4@7L:+^K4?X6 MC>N]V8R2!EH^2O>"TW>81]@%P1JEC5]2C]:A6BB4*/Z>5J'C.J4_]\5,NTW( M9T*^$KYFT7AJ%&T^<<>KTN!$[,##V6WV'FZ"B%ORG.U*;8E M.P>A*TPB'F?,BF!>_6:+G-ZBYY&>?T[?7M.WR>%V=EA\+E!<"Q1)H/C?B`ES M7#"[?YJPBSU58+IX=2RI<=0N;>E:76_G0Q[/Y`->E0/OX"&PO=V]R:W-H965TZ:EE42$Y"HD9:5_7SXDQ2Z,YB+N MKF9F9_DH)S1OM@=PY$-);?>T=V[8,6;K'A2W-SB`]G]:-(H[GYJ.V<$`;R)) M299GV1U37&A:E;'V8JH21R>%AA=#[*@4-W\.('':TPU="J^BZUTHL*ID*Z\1 M"K05J(F!=D\?-[M#$1`1\$O`9,]B$KP?$=]"\J/9TRQ8``FU"PK<+R=X`BF# MD&_\/FM^M@S$\WA1_Q:G]>Z/W,(3RM^B<;TWFU'20,M'Z5YQ^@[S"+=!L$9I MXY?4HW6H%@HEBG^D5>BX3NG/-IMIUPGY3,A7PD,DL-0HVGSFCE>EP8G8@8>S MV^P\W`01KTR\-^O'CIHF#EZ5IVI3W)7L%(0N,(EXF#$K@GGUJRUR>HV>1WK^ M-7U[2=\FA]O9X?W7`L6E0)$$BO^-F#"'!?/P3Q-VMJ<*3!>OCB4UCMJE+5VK MZ^U\S..9?,*K&PO M=V]R:W-H965TZ:EE42$Y"HD9:5_7SXDQ2Z,YB+NKF9F9_DH)S0OM@=PY$U);0^T=V[8 M,V;K'A2W=SB`]G]:-(H[GYJ.V<$`;R))299GV2>FN-"T*F/MR50ECDX*#4^& MV%$I;OX<0>)TH!NZ%)Y%U[M08%7)5EXC%&@K4!,#[8'>;_;'(B`BX)>`R5[$ M)'@_(;Z$Y$=SH%FP`!)J%Q2X7\[P`%(&(=_X==9\;QF(E_&B_BU.Z]V?N(4' ME+]%XWIO-J.D@9:/TCWC]!WF$79!L$9IXY?4HW6H%@HEBK^E5>BX3NG/=J'= M)N0S(5\)7[)H/#6*-A^YXU5I<")VX.'L-GL/-T'$*Q/OS?JQHZ:)@U?EN=H4 M7TMV#D)7F$0\SI@5P;SZS18YO47/(SW_F+Z]IF^3PVWJOLL^%BBN!8HD4/QO MQ(0YSIC=OT.RBSU58+IX=2RI<=0N;>E:76_G?1[/Y!U>E0/OX"&PO=V]R:W-H965T6CG-"\VA[`D7U#9?=,<:%I5<;:LZE*')T4&IX-L:-2W/PY@L3I0#=T*;R(KG>AP*J2 MK;Q&*-!6H"8&V@-]V.R/14!$P"\!D[V(2?!^0GP-R8_F0+-@`234+BAPOYSA M$:0,0K[QVZSYT3(0+^-%_5N;$9)`RT?I7O!Z3O,(^R" M8(W2QB^I1^M0+11*%']/J]!QG=*?^WRFW2;D,R%?"5^S:#PUBC:?N.-5:7`B M=N#A[#9[#S=!Q"L3[\WZL:.FB8-7Y;G:[/*2G8/0%281CS-F13"O?K-%3F_1 M\TC//Z=OK^G;Y'`[.]Q^+E!<"Q1)H/C?B`ES7##%/TW8Q9XJ,%V\.I;4.&J7 MMG2MKK?S(1XB^X!7Y<`[^,E-)[0E)W3^9.,!M(@.?/OL;D=)[]_/FDAH70B_ M^-BD*Y42A\/R0-976OT%4$L#!!0````(`&Z'!4<`DPCWHP$``+$#```9```` M>&PO=V]R:W-H965T6CG-"\VA[`D3U#9?=,<:%I5<;:LZE*')T4 M&IX-L:-2W/P]@L3I0#=T*;R(KG>AP*J2K;Q&*-!6H"8&V@-]W.R/NX"(@%\" M)GL1D^#]A/@:DA_-@6;!`DBH75#@?CG#$T@9A'SC/[/F>\M`O(P7]6]Q6N_^ MQ"T\H?PM&M=[LQDE#;1\E.X%I^\PCU`$P1JEC5]2C]:A6BB4*/Z65J'C.J4_ M13[3;A/RF9"OA"]9-)X:19M?N>-5:7`B=N#A[#9[#S=!Q"L3[\WZL:.FB8-7 MY;G:%$7)SD'H"I.(QQFS(IA7O]DBI[?H>:3GG].WU_1MRI`M/%JV-)C:-V:4O7ZGH['^,ALG=X50Z\@Y_<=$); M0(OHP+?/[@I*>O]^UD1"ZT+XX&.3KE1*'`[+`UE?:?4/4$L#!!0` M```(`&Z'!4&PO=V]R:W-H965T6C&-&\V@[`D39;=,<:%I6<3:DRD+')P4&IX,L8-2W+P?0.*XIRLZ%YY%V[E0 M8&7!%EXM%&@K4!,#S9[>KW:'34!$P(N`T9[%)'@_(KZ&Y'>]IUFP`!(J%Q2X M7T[P`%(&(=_X[Z3YV3(0S^-9_6>;$9)#0T?I'O&\1=, M(VR#8(72QB^I!NM0S11*%']+J]!Q'=.?]4R[3L@G0KX0[K)H/#6*-G]PQ\O" MX$ALS\/9K78>;H*(5R;>F_5C1TT3!R^+4[G:WA7L%(0N,(EXF#`+@GGUJRUR M>HV>1WK^-7U]25\GA^O)X?>O!3:7`ILDL/G?B`ESF#"WV3]-V-F>*C!MO#J6 M5#AHE[9TJ2ZW\SZ/9_()+XN>M_#(32NT)4=T_F3C`32(#GS[[&9+2>??SY)( M:%P(O_G8I"N5$H?]_$"65UI^`%!+`P04````"`!NAP5'?>B;%:,!``"Q`P`` M&0```'AL+W=OQ-W5S.PL'^6$YM7V`(Z\ M*ZGMGO;.#3O&;-V#XO8&!]#^3XM&<>=3TS$[&.!-)"G)BBR[8XH+3:LRUIY- M5>+HI-#P;(@=E>+F]P$D3GN:TZ7P(KK>A0*K2K;R&J%`6X&:&&CW]"'?';8! M$0$_!4SV+";!^Q'Q-23?FSW-@@604+N@P/UR@D>0,@CYQF^SYD?+0#R/%_6G M.*UW?^06'E'^$HWKO=F,D@9:/DKW@M,WF$>X#8(U2AN_I!ZM0[50*%'\/:U" MQW5*?^[SF7:=4,R$8B5\R:+QU"C:_,H=KTJ#$[$##V>7[SS. MFB8.7I6G*K_+2W8*0A>81#S,F!7!O/K5%@6]1B\BO?@W?7-)WR2'F]GA?PAL M+P6V26#[MQ$3YK!@-I^:L+,]56"Z>'4LJ7'4+FWI6EUOYT,1S^0#7I4#[^`' M-YW0EAS1^9.-!]`B.O#MLYM;2GK_?M9$0NM">.]CDZY42AP.RP-97VGU!U!+ M`P04````"`!NAP5'^5:(=;`!```6!```&0```'AL+W=OUVA)BR!4'-C>I`NI-::4&M M"W5#3*>!5H$D.$F39$L$91(7><@]ZR)7O>5,PK-&IA>"ZL\#<#7L\0I/B1?6 MM-8G2)&3F5H_O5[M#YA$!\,I@,&=[Y&L_*O7N@[_5'B>^!.!0 M6J]`W7*"!^#<"SGC_Z/FMZ4GGN\G]5O;%*3!2,!/V(*Y-A'>+)73+2E@GI2$A_$$@T"F7^H986 MN58#,AWULUOM'%Q[$:>,7&W&M1TT=6B\R$_%:KO)R7J>O+^GK6.$ZNJ^SZP*;2X%-%-B,+69++4;,8<)LKYMDBR;9*'#[ MB\F$N?MA0LX&)T`WX7X:5*I>VCBW.3L_@?LT#/X;7N0=;>`?U0V3!AV5==`0VW]]M;M=;RW,;"JFU[A_"LHO@!02P,$%`````@` M;H<%1P;4@+WI`0``J@4``!D```!X;"]W;W)K&UL MC93;;J,P%$5_Q>(#:D*X)!%!:CJJ.@\C57V8>7;(":#:F+%-Z/S]^()I4J'0 M%WQA[[V.9?GD`Q?OL@90Z(/15NZ#6JENA[$L:V!$/O`.6OWGS`4C2B]%A64G M@)RLB5$+G:1^$I@2@4"J3 M0/1P@2>@U`1I\-\Q\Q-IC-=SG_YL3ZNK/Q()3YS^:4ZJUL6&`3K!F?14O?'A M!<8C)":PY%3:+RI[J3CSE@`Q\N'&IK7CX/XDT6B;-T2C(9H,F]`6[D"VS!]$ MD2(7?$"R(^;N5CLM%R9$)R-=F]3'MIG"'KS(+\4JW>;X8H)N-,YX?`NOT M6404S-DC:X^6[>M;^]I5N';T^!O\^#8@=@&Q"\C"N2,ZS<%KO@%)9B')&!#= M@7C->AF2SD+2,2"^`_&:9!F2S4*R,2"]`_&:;!FRF85LQH#-'8C7;)'SUF!B(RO8,B4K>M\J]I6EW:DN/]O7B3WF1=Z2"7T1432O1 MD2O]I.W+.W.N0./#AR1`M6Z&PO=V]R:W-H965TU#;W:'(B`BX%G`9,]L$FH_(KX&YV^SIUDH`234+BAP MOYW@`:0,0C[Q_UGS,V4@GMN+^N_8K:_^R"T\H'P1C>M]L1DE#;1\E.X)IS\P MMW`;!&N4-JZD'JU#M5`H4?PM[4+'?4HG=]E,NT[(9T+^AJP'3QZ5A2 MXZA=NM(UNK[.^SS.Y!->E0/OX!\WG="6'-'YR<8!M(@.?/KLYI:2WO^?U9'0 MNF#^]+9)3RHY#H?E@ZR_M/H`4$L#!!0````(`&Z'!4=]C2)HL`$``!8$```9 M````>&PO=V]R:W-H965TMM=V.$%.V(*BY4AU(=U(K+:AUH6Z(Z330*I`$)VF27!-!F<1%'G+/NLA5 M;SF3\*R1Z86@^M\!N!KV>(6GQ`MK6NL3I,C)S*N8`&F8DDA#O<>WJ]TA\X@` M^,-@,&=[Y&L_*O7J@Z=JCQ-?`G`HK5>@;CG!'7#NA9SQVZCY8>F)Y_M)_2%T MZZH_4@-WBO]EE6U=L0E&%=2TY_9%#8\PMA`J+!4WX8O*WE@E)@I&@K['EL>Z1QPJ*W?WKB]CO=BZ\B;9SH<#*@LV\6BC05J`F!IHM?5QL=JN`B(`_`D9[$9/@ M_8!X#,FO>DNS8`$D5"XH<+^<8`]2!B'?^'W2_&P9B)?Q6?TY3NO='[B%/<'R!:81U$*Q0VO@EU6`=JC.%$L4_TBIT7,?TYSZ?:+<) M^43(9\+/+!I/C:+-)^YX61@UY.+O%QL--$/'*Q'NS?NRH:>+@97$J%P]9 MP4Y!Z`J3B+L),R.85[_9(J>WZ'FDY]_3E]?T97*X3-W7R^\%5M<"JR2PF@3R M6R,FS&["/'P=DEWLJ0+3QJMC286#=FE+Y^I\.Q_C(;)/>%GTO(7?W+1"6W)` MYT\V'D"#Z,"WS^[6E'3^_/3;I2*7'8GQ_(_$K+_U!+`P04```` M"`!NAP5'AAR6.:P)%W);4]T-ZY8<^8K7M0W-[A`-K_:=$H[GQJ.F8' M`[R))"59GF7W3'&A:57&VK.I2AR=%!J>#;&C4MS\/8+$Z4`W="F\B*YWH<"J MDJV\1BC05J`F!MH#?=CLCT5`1,!O`9.]B$GP?D)\#.7U*-UJ!8*)8J_IU7HN$[ISZZ8:;<)^4S(5\+7+!I/C:+-[]SQJC0X M$3OP<':;O8>;(.*5B?=F_=A1T\3!J_)<;;[E)3L'H2M,(AYGS(I@7OUFBYS> MHN>1GG].WU[3M\GA-G7?W7\N4%P+%$F@F$?``MH@/?/KO;4=+[][,F M$EH7PB\^-NE*I<3AL#R0]956_P!02P,$%`````@`;H<%1YF!H]JE`0``L0,` M`!D```!X;"]W;W)K&ULA5/;;N,@$/T5Q`<4QTG: M;>18:EI5NP\K57W8?2;VV$8%Q@4<=_]^N=AN4D7J"\P,YYR98:`8T;S9#L"1 M#R6UW=/.N7['F*TZ4-S>8`_:GS1H%'?>-2VSO0%>1Y*2+,^R6Z:XT+0L8NS% ME`4.3@H-+X;802EN_AU`XKBG*SH'7D7;N1!@9<$67BT4:"M0$P/-GCZL=H=- M0$3`'P&C/;-)J/V(^!:<7_6>9J$$D%"YH,#]=H)'D#((^<3OD^9GRD`\MV?U MY]BMK_[(+3RB_"MJU_EB,TIJ:/@@W2N./V%J81L$*Y0VKJ0:K$,U4RA1_"/M M0L=]3"<_LHEVG9!/A/P+@:5$L&7B:[.^[:AI M8N-E<2I7]]N"G8+0!281#Q-F03"O?C5%3J_1\TC/OZ>O+^GK5.$Z9=_>?R^P MN138)('-U.+MM183YC!C[KXD86=WJL"T\>E84N&@7;K2);J\SH<\SN037A8] M;^$W-ZW0EAS1^?_S^)(:%PP[[QMTI-*CL-^_B#++RW_ M`U!+`P04````"`!NAP5'NN#V,;,!```4!```&0```'AL+W=OFGV2 M>@L@H+:>@;GE!`\@A"=RPG]GSD])#[SC4>A M8/,'LZPJ-4[$#,S/+MNYTVPC03;0.`NY763*M04T>7V M?YLL5B6*62+[AT2Q*D$OQB9!=^%V&E+CJ&R&ULE9?1;ILP%(9?!7&_8AML(")(;2C:+B95N]BN:>(DJ(`S[#3=V\_& MAB:10]R;`,YW_O.?8S`F.['^C>\I%=Y'VW1\Z>^%."R"@*_WM*WX`SO03OZS M97U;"7G9[P)^Z&FU&8+:)D``D*"MZL[/LV'LI<\S=A1-W=&7WN/'MJWZ?T^T M8:>E#_UQX%>]VPLU$.19,,5MZI9VO&:=U]/MTG^$BQ*F"AF(WS4]\;-S3YE_ M9>Q-7?S8+'V@/-"&KH62J.3AG:YHTR@EF?FO$?W,J0+/ST?UAFZK8R-^L=-W:FK`2G#-&C[\>NLC%ZP=0WROK3[TL>Z&XTG_ MDP`39@]`)@!-`5,>>T!H`L+/@&@V(#(!D6L&;`*P:P9B`LA50*";-;2ZJ$25 M9ST[>?Q0J1L0+B3>*Q&I[,G^O><(H"QX5T(7#!J8)\W$^#92 M:`1.1"`-6%T@WY8!:1>W$ZPT$9,9#W=%GN^+E$8$WZ\DO*PDU/T,33_#^P+1 MI4"D!2(C$%V:[`8FUNW23)B`&-RF"B>J-%1,4@?+V&H9&\O8E@9KRYKY!D-$ MT&VL<,/*$8-I&M]W3:RNB2[339P!MVL*;'6E)B:'*8QM3YPJ?L#!X'5PC!\ M\Y$S?340C`">P0HWK!PQE$8NOJ'=][AV)PX2R-H\B+[0O=#N(G3IGH9B"U4:BD38X9Z!]D46CJMLZB"![:W#7VB=?06"Q*5U&H(D)'.+D!M6CAB. MD4OI]G4(FK4!.CSU,+%W+_E"]U*[BW2N>^9-:2`AP@4JQW281%>6@[-] M5TO[W;!%YMZ:'3NAMPG3Z+0-?T1JWW8U_@07*V@9+^#B66^R/^7S[%#MZ,^J MW]4=]UZ9D+O%85.W94Q0:1@\R"G?RP^+Z:*A6Z%.8W4OZ*VVOA#L,'XY3)\O M^7]02P,$%`````@`;H<%1Y5SM;3F`0``504``!D```!X;"]W;W)K&ULC93=CIP@',5?A?@`B_C=B6.R:].T%TTV>]%>,R..9D$L M,./V["-T4'N@TZI<0>A/':$8?G`1S+H M+RT7#"O=%2>157RLZ+]0)X%D&?&L/C]1"B? M]@$*YH&7_M0I,P"K$BZ^IF=DD#T?@"#M/GA$NSHS"BOXT9-)7KT#PW[@_-5T MOC7[(#0(A)*C,@E8-Q=2$TI-D)[XE\_\.Z4Q7K_/Z5]LM9K^@"6I.?W9-ZK3 ML&$`&M+B,U4O?/I*?`FI"3QR*NT3',]2<39;`L#PFVO[P;:3^Y(7WK9NB+PA M6@PHV33$WA"_,T!'9NOZC!6N2L$G($=L-AOMM%R8$)T,=#%2KY/-%':EJO)2 M10B5\&*";C21U3QYS<>*VBO210(UP"I%=$OA!A\CZT<)NA\0WP8D+B#V9;R# M'*PF=V4X3?HICS\6U4Z4Y5%Q'R5914D\RNHLJ4-QFJ(H-D1UXGF3[#Y*NHJ2 M>I1D`\5I4)K'JVOG6;RJR-+_V*)L%2:S$3':V"$O"=.BV-BB.2C^YW^#5R=@ MQ"?R'8M3/TAPX$H?)OO/MYPKHE/"!UU9I^^XI4-)J\QK;DIVQ]YU%!_G2VRY M2:L_4$L#!!0````(`&Z'!4=;9YOJD`,``&`1```9````>&PO=V]R:W-H965T M%ZW.="Z MZ![9D3:\9L?:NNCY;;OWNF-+BZT(JBL/^W[DU479N'DFRE[:/&.GOBH;^M(Z MW:FNB_;O,ZW8>>DB5Q>\EOM#/Q1X>>:-<=NRIDU7LL9IZ6[I/J'%FN`!$<2O MDIZ[B__.(/Z-L??AYL=VZ?J#!EK133^D*/CE@ZYH50V9>,M_5-*O-H?`R_\Z M^S?172[_K>CHBE6_RVU_X&I]U]G277&J^E=V_DY5'\(AX895G?AU-J>N9[4. M<9VZ^)37LA'7LZQ)?!4&!V`5@&T#B`H@8P`*C`&!"@BN`CS9%3$0ZZ(O\JQE M9Z<[%L/R0`N.MT,2GMGAO>_XP(JI]:*(D%D,<<1 M*"928M+;"6)PD<3VBR0!%20R`?8-JT0SR#!DD@E\Y/N&(8.H6<$I*#A58@PS MLY+,0Q`&!BT*PHG%["$?U"**;ZU9!9$T"L!]IN2,6()L!"%8D#(=3"Q2P+:# M[O`=!!L/(O"BF@Z+A,SK!8#FQ<"V@@*+!:.@AR0TB5%0C"S$P.:#0IL%(Z'K MQ\]4BTID81P(MAZDO`=;."F"S0?=X3X(MA]DXS\*@A]3>M"4M1"#KZ\UE-@L M)]A^T(S_3`6G%H*U29D5:\IF!V#8I;"-2RG(M!D58C-X&+8GK.W)YJ5HYJWH M#GO"L#WA&7N:3.$(F>80C_9D'#>`FM<,NQBV<3$%/4218:;7FD(7U+PP MC8\IB!!B4B.AA%@\L3#L9%@[F4U_8"?#=S@9AIT,:R<#M[-ZF=90[!NH-43- MRQE]JE%"A@+S<0'V">*#KC4],$@FLG@$$M@#B/8`9&I&0Q;/-X+A=C"\@:?M M*(A<[TSOXMQ8TW8O#N"=LV&GII`V7C@GF-^);@?GY*%H?9'6,]Y?WT'_EN.]!B M.]Y4=-)P" M``#5"0``&0```'AL+W=OBJHSFN'TW MX)%U9`PH/JS#1[!Z`HE$%/&KPQ=V9A*5_YBDUYHR\/9\ROY-M2OTMXCA#>E_=WO>"MLX#/;X@,X]?R&7[]CT MD,F$.](S]1OLSHR380H)@P&]ZV,WJN-%W\D+$V8/2$Q`,@?,=>P!J0E(KP'0 M&P!-`/QJA M156^54D*RNA-)OK`)(JI-9-G;J31R#5))`2L%DEHJY!H"W>!C2;RA M/B5Q:J8?-5,]6:GN$GZA3_@Q`=0)H)GM.\E1,;F>"\W`.'8S&\T`']-H9NEC MGHS/#>-L*+,VE)F&4EL1'5AK)@.YFVD^,TZ116A)\+@PG8"%QT1#!2P\)I\9 MITEN-3BF?U: M0S#/K&^M<;%`3A<06V74L+1)/(5J0V70]U8U-LKM`ZS_(S"MP]"G8Z`$9EX? M&^862NQ"9C6UO\5FJ3)06A2%U=NL1%9,"T4WWZP!TZ/:+;!@1\XCUZOP/#KO M2![5AN1NO`:K#;",-W('H[Z1U_15>4)'_!/18S>R8$NX^-*J#^*!$(Z%ZSYHL<'+D]S.6EZUZ$O.#E-FZAY)U?]`U!+`P04````"`!NAP5'?CL2 MY)$#``!U$P``&0```'AL+W=OB2W;3`"Y(,?IOR\@R8V=M;R^A`\_6KW2 MOMI(S`ZJ>^VW4NK@O:G;?AYNM=X]1%&_W,JF[._53K;#+VO5-:4>'KM-U.\Z M6:ZF1DT=T3@645-6;;B83>^>N\5,[75=M?*Y"_I]TY3=WR=9J\,\)*%[\;/: M;/7X(EK,HF.[5=7(MJ]4&W1R/0\?R4/!)V0B?E7RT'^X#T;Q+TJ]C@_?5_,P M'C7(6B[U&*(<+F^RD'4]1AIZ_F.#_N]S;/CQWD7_.@UWD/]2]K)0]>]JI;># MVC@,5G)=[FO]4QV^23N&9`RX5'4__0V6^UZKQC4)@Z9\-]>JG:X'\TL6VV9P M`VH;T&,#1KP-F&W`C@VH&:E1-HWK2ZG+Q:Q3AZ#?E6.VR<.`=V.0(7(P#*8? MYFF*V4TSM9B]+2A+9M';&.B$H1/SY!AQF2DA$N,\"D1+C$"(28%Q:16 M#+L>(`-]FN%]FH,*8?=!$SS"*VT!TB=QQ>H=R[0NWIVT(\Q6QW.+SRN%MY/L];Z'Q]1Q\^D.S* MC?Q1=INJ[8,7I;5JID\B:Z6T'$+$]T.HK2Q7QX=:KO5XFXY]F*]"YD&KG?O( M=?S2MO@'4$L#!!0````(`&Z'!4>T:K/5D`(```@+```9````>&PO=V]R:W-H M965T386YLFY,K*HL9OK46O M587:/WM"\N.1,#3IHX0]RIJ'!-"U);+3[O[%>PS2`4$(GX6>". MWKU;0OR!D`_1^7[:V:[0@$M\9(("\>:&,UR6@HG/_%N3_IM3!-Z_]^Q?Y7*Y M_`.B."/EK^+$W@H0S M6WPQE.=)"7Q%X"F"Z%%C+2&16H6">"$,-].H3!.%T29>UN(;M?B2PH]-LP1*BX(` M/W;=:536H\([U*26P*@ET(F%RP2AT9EPO3.144$TXXS.1C3OC,Y&](PSL5%+ MO.R,@LRY,D9,:M@8-6QT0KUE`N`:+9'#*ST!P"@"@&57-&8N%?]!IG5`LPZX M[(C&S.H80Z9UF(\/H+=]X*^@\,VN^$^X8MZL(%CA2K"S-.B"?Z#V4M34 M.A#&RQ]9I9P)89B3N"_\G\IY63IT2GQFXC42/YLJU%2'D::O.X?B-_T+4$L# M!!0````(`&Z'!4&PO=V]R:W-H965T96GOJ\HR=15VU]*GS^+EIRN[O MBM;LLO2!/RP\5X>CZ!>"/`M&NUW5T)97K/4ZNE_ZCV"Q@;!'%/&KHA=^=>_U MP;\P]MH__-@M_;"/@=9T*WH7I;R\T8+6=>])[OS'./W8LS>\OA^\?U/IRO!? M2DX+5O^N=N(HHPU];T?WY;D6S^SRG9HL&4Q\KRG?];5J MU?6BWR2I,;,;0&,`1X-Q'[L!,@;HPP`[#;`QP'-WB(Q!=+-#H'-7RJU+4>99 MQRX>/Y5]/8&%Q+O>B?3L2;FX_!+*9Z>^19Z]Y3`.L^"M=_2)@8I9:2:)II&U M1L!(!#(`:Q30M^T`=133&Q2:2&)'#'>=;/YS,ADF^APFTF(A(]:,//%G!U@[ MP,;!39"M8A*MA6%P2*:APD``A]/06D,X!NDTM-$02B)T/ZG(FE2D54WOV\=6 M5>/YJB;6`!*7JMIP91@83S.%9D":3#-KS>`$3S,;PX3X?D+$FA!1#@B\;Y]: M%4WG*PI":P1J^9ZF`Q19*]6(:B!`(H>J!L+$\7DV!D(HFI$6L*>E^Q294>L` M6J4%\`O:(GL0:(ZV!L+(I:V&4.S45D,8.K[2QA+3=%KVW@9T)R$SJAY$=FVC M+V@;VX.(YV@;FRJP]L5!6PW%V*FMAD!$'#UC,U`@G:.-O<&PL!>XV9`,!1"^/8?/K@:.!O: M'=2HS[TM.[="CU#CZGB<>%2GB9OU%5@4P+*^EL.TVP.HLR:6WD4 M5??-3M9EUG:/]=YICK7(MH-163B,$-\IL[RR5\MA[*E>+>6I+?)*/-56>\_VA[0>1.Q*(I>J9OY+XA^S-D;?KX?U1^& M<#OW7[)&Q++XDV_;0^I%.VNH(T7:T'S7JH]FKYMF*^ MNW3>>J$O#!N8M6("[SJ2*(1.A-,Y@'K!;&P&IKRX/D&LB,#7^#`KDLZ+/("( M)M9'0'P^'ZW[-5I7Y=P%`6]>@'\5X$J`#P+111S5@"B[M4)NJ$L(O8[%@(51 MY%ZG$J`89]2[CJ6`N7X4SD?FH9%Y:AT1@DWCJ=`4XP<^[HRB8J"8'T77J634 MXAS-DJ+248L3=SXP'PW,5R5#?8E47`JY(;=40\4?%+].)1/EHHM$4>E$$7\^ MK@!=RP&L90.!$$U,"`*!IN+`,*99%C%`[N7V_E+O48EHH!0@CQOTLP@-*AH4 M.%I'V*`*";H=I=G&B1'U`!3A))CWF!*TD,-P7PB#O4LI&C4=7R::';<&R/7" M4%-,(RHQHE*,NAX:PT.#IA\0`PF\ZU/7?*M0O.]3/KNN'H$)?9>8^(JW8>K! M%KC(ZV?H88(B@WGPKDA]2*O!3J-X`Z+?Z$`4;T'4I`#^?/QMK(4]6JG\O3Z'3&O6?]&>=B?$T7,47&$[I(U0GV0WZU/&9[ M\2NK]WG56"^R[4Y6PP%H)V4K.G_);>?WH3NU3P^%V+7];=`'I,ZQZJ&5Q_%8 M/OTWL/H/4$L#!!0````(`&Z'!4>G_@RV004``!\@```9````>&PO=V]R:W-H M965T]U6S1?3^6QZL=OL#MFQ MW.7'49&]W(__$G>/SC225O'/+CN75^]'3?)/>?Z[^?"XN1]'30[9/GNN&A=I M_?*>+;/]OO%41_Z7G'[$;`ROWWOOZW:Y=?I/:9DM\_VOW:;:UME&X]$F>TG? M]M7/_/R0T1K:#)_S?=G^.WI^*ZO\X$W&HT/ZIWO='=O7<_>7."(S;"#)0%X, MM.DU4&2@+@92]!IH,M`7`]5O8,C`<"-8,K`?$62O@2,#QXT0DT',-4C((/EB M,.VN7WOU5VF5SF=%?AZ5I[1A0MS5\J)Q4GL>U9>\K*NI]5FT]32?O<^ET[/I M>^/HDT:VFH77F+!FZ34VK%EYC0MKOGE-'-:LO28):[Z3)H["F@>O$6'-(VG4 M1\[3>F_A!LO/&ZRZ#9841-YVH#X[T)T#U3K07Q9[;"6NV]A.XJ0P-HJBL'#- M%3Z2,-*1NQ8&4]GPTA>=QFEF M(`L#60ID;CMPL&PLAZP9$R,,'U+ M)C:]2'$+26!J!&&3"(8+S(T8`([`Y`@&.BL18`=LSE#*!,9,]'+63'=M7IU* M3!B=1V+6)+&6,+908M;D`-8D9DW*VU=A22+'14UBU*1'33%<8-3D`-0D1DT: M1MV12/34'=WK0\IP6AA*Z:'4#!<82CD`2HFAE$118L*H+4@46VF82\:H24(M MZ;D2"Q+%TC+W5V'J77F1N[D%6!A."G<-92DIR&MGNB"1U!.<>T*YLV1K*`OG[7#>CO*& MZ`LZ$9-*)I.("AG1J"%PE.'-QX-/44`0_U/HX7<;8--Q[M1X:^1GH1,1JI#ARAJ9,( MQFBB#2P2;084":996TZ16'Z18/BTXQ2)&U`DF#P=5YEM9-H4E?5-DLWEP_[[*5JWKJFW+K?K[L/ M57[R/\=?_D_`_']02P,$%`````@`;H<%1SS2%6.\`P``M1(``!D```!X;"]W M;W)K&ULE9C?*NKIKL+ M]U(>IE'4K?>\+KIOXL";_I^M:.M"]H?M+NH.+2\VHU%=11#'DZ@NRB:*)FCY M]BZ\)],59`,R$K]+?NH^_`Z&X)^%>!D.?F[NPGB(@5=\+0<71?_URA>\J@9/ M_-GL#YV4M3&)`SJXDU]E\WX?5+_,&.&&X`V`&M`W`:)-DC>#:C3@&H# MZKM#J@W2BQTBE?M8N64AB_FL%:>@.Q2#GLBTQ]O!2>\YZ,O5]6=B]-F.YV(^ M>YTGD,^BU\'1&0,C\Z`8EEY'E@HAEHCZ`-`H(,1V@-$956>956>956?:5 MRF9H7IDN#"IKQ3PH!G+T&E;,PH-9>C"KS\S5A'(TH5PGE-QV0&)4*^.RIU@( M08,@Y+9<-`,9N^PZ9WHQ&,MS<`A&8VF2D]BA&(.1///)#O#LP$,T%J(.U5@( M[?U:-A9"F[/6C8681UH)GI9IOYF'"XI+AWY!.GBK(ZF'=`R3.:B%I8A#7TM- MD91:>'W!J)[.O7I M.1DNG.P+PL$;'\D]A)/KGD-2EW`TU7<)EW#T?B1V^%II*@7BD1G$:&80>\C& M0-35;RSDZC<6C0LP*=A^,(X#'C/`X^!6#/]>.JXLRP,!:[!90EF;KZ\=,]EP_3XF%&/ MS/")&'Q&8@.EB4LV!G*TI*6%'"UI9:'+JR'Z\$Q>\W8WO@WI@K4X-E(]9=I5 M^\;E'H9G^HOU!S)=$&1]2:8K]3[EW?U\=BAV_%?1[LJF"YZ%E*(>'_BW0DC> MQQM_ZRN\Y\7&'E1\*X>?;"B]>JNB#J0XF)=$]DW5_#]02P,$%`````@`;H<% M1^O5S["B`P``&Q(``!D```!X;"]W;W)K&ULE5C; MA,)@_M,[%EFPD@%W"<_GVYK*AQ5JK\8BX^ MN^?H=K1B=I'56WT4HG$^BKRLY^ZQ:4Z/GE=OCZ)(ZP=Y$F7[SUY61=JTC]7! MJT^52'=]4)%[U/E>*Y] M>,D.QZ9[X2UFWABWRPI1UIDLG4KLY^X7\OC$6`?I$3\S<:FO[IU._*N4;]W# M]]W<]3L-(A?;IDN1MI=WL1)YWF5JF7]#TG^<7>#UO?-B[Q\$]"&L$NXE7G=_SK;<]W(0H6X3I%^#->L[*^7X1^> M0!@>0"&`C@$L-@8P"&!C`#$S!!`0V#*$$!".`908`R((B&P9.`3P&P9OZ-U^ M;-9IDRYFE;PX]2GM9BQY;.%5EZ3-[+0#4K=CW>>L^M%>S-X7+.0S[[U+-,'0 M'K-4F%B/62E,HL>L`1/Y>LQ7A2%ZS,8BS]/G/%[;)VC'T&G'L*%C*"2@_T_` MI@F"(0'K$U#&IBK+'C,$K@<,H9SH01L$I)42N),,X2`E&*3X),)H!M`:0"Q" M!0^@#0+2:@E1+:'2P@U:0M5W:+^`%@2DU1*A6B*E)39H`1"]G?X3+0A(JX6C M6KC2DABT`(@FAH'<(""MEAC5$H,6ZANT`(C%IGY!0%HM";J,$EB'AEFY3J#% M<1P8M&`HK1CBHVKZUVT2X^P%4&NJB6G^HC"](((+4D:'MAQL!D"1CXXG!^<= M0-P$V@"(4!/J2:'8%4K?,(HW3!EPJ._")8`L/)K@)DT8L!@6U)(H!TY\JP8% M.%4`5.A6&P"5`EFL%Q+B/"&D,!C)$D`V\R["60;'8QS=A%5K`'2U6O0\'.?A MP&/8(9<`(HG5\,0X40Q$U$0T@*+8B@@W-`*.QDV.!B!4B[*/6XB^P,&]C(+_ M<(-IK@!D4T;=&)2JH\"@>&B18K2"R79$J=H;0\-D`Q3C%ML>93@1TQ1*4R)V M!Q%>D-&Q(C.9`:#LB/!JBX[E%EJ\*Z+P#B*\E*)C+86>`!11=`<1;@A4&8*Q MYP`46I2I%/<#JOS`PHEI@D]]5;O8G"'P-/WH,5?4$L#!!0````(`&Z'!4>=)JN0 MA@,``)X1```9````>&PO=V]R:W-H965TA,)@_MLP,"/+$M:IN0_GTM:T5#N[;%"[YP]NP>26\WFX,HL\:31U%UW^QD769M]UCO_>98BVS; M!Y6%SPB)_#++*WX;5Z*JLEEY=1B-W>_TKLG'BM(C_B1BW/SZ=Y1Q;]*^:8>OFWG+E$U MB$)L6D61=9=WL11%H9BZS+^`]&].%?CYWK"O>[E=^:]9(Y:R^)EOVT-7+7&= MK=AEIZ)]D>+H.>M^>2QF[PN>D)G_KHBN,*S'W!L,'<8L M#88-8U8:,X)XT(@X&H:L)TD>ITF>3+7\@O&[$4.'C5T/&]?#QH`@F";@UP2! M)N!`$%Y76?686$O5&!I$A$RG"=`T`:2)AM.L-(82,HQY`)XX9A@HU/5J$!LC M>M28+PEAR;2F$-44@J9X1%,(0Y?@Q4#!&&JPF`@M)H)B+-3$Z$J*@2"=)DC0 M"A)-D*)"50]7]DQ@CCTVG29%TZ20A@Z/^E)C6,)LQI,2-$__6B6RJ)12=$@I MM1]3RO`JP.`I'QG5>T`Q+[9(A/@D-,#E!C?(Q2U%P5/I6#L"4-A8-FL9X(C!6.M(FU@!B@9TDW(#4.#`9E:11D6B[;$(5QO=H!8W#8NA"K3M09<'$`VM3,-PTS"; M;6L-*&)C&H:;AJ4@*1B>P!6`:.CQ$=@:A0T?_/`-CA,H:*37K@!$^<`!QIP0 M,=AP0;BAN3%T9$&!'X-MC0@&Z-QW-#<&-IBS^8AKC:\02V^ M#7*S#8Z=+Y8&97-JX[BCN8VC`433X+]EY'_Z47G,]N)[5N_SJG%>9=O]/NU_ M1NZD;$5'0[SN6'T0V?;R4(A=JVYC==[6?Q_HAU8>S;\AE[]D%G\`4$L#!!0` M```(`&Z'!4??-QA6)`(``'T&```9````>&PO=V]R:W-H965T<>WRQ+UG'^+LH,9;@@Y):++Q2RF8.H=B6F"+QP!I!XO_">@_DZU0@#^%/A3IS-@?:^8>Q=+UYV"\_7%C#! M6ZD5D!J.>(4)T4(J\3^G>4JIB>?S7OVGV:UROT$"KQCY6^UDJ!HXX30$<*!,.09)T2. M$)T(\4U"[`CQO1D21TBN,D"[=U.Y`DF49YQU0#1('Z=@KN!F,90D,/IQ.L+&*6 MWO#PKC29F2+%=E=IN'W`O&E0&P%8B/P=%7)VD!FMA06\B,-IC$K MBWGTIR&%DPF2:!JT[D'1'15)1C>4N./S-%9UBUDZ3.!/8XH><\<)2D>-I$Y@ M]/,[(STFNF'D*\8:@6>7BV)^,&U-@"UK:VF/RQ`=.N=SJ"_G57P9S%?!2+Q0 MG=8VQI-\GC7H@'\C?JAJ`39,JI9@;NZ>,8F57?]!U:14_X)A0?!>ZNE,%\NV M1[N0K.F;_?#'R?\#4$L#!!0````(`&Z'!4&PO MUX//,5R0*I7$5D$5Q7R1?`U1UM]R^ MO92[6M*],`8723))IIK,I'.IZC+TX(^X+Q>8^8GYA/D4?\F<+;;,2!:KNV5C M`#^HQ2(C(R-.G#C[\MNB*(./^UU:_,O9MBP/WWS]=;'5HFY4/P,N4YDRP-KH)B&^5Q\=NOR]_]]FM\ MAI\;!Z^SM-P6\,PJ7M5__4.5=H)!-PSZW=ZH^>,.?NSY?WQL/7^:+XHRCY;E M_ZP_*8/?Q9L$1\`4;Z)]W!CUYMG;5V^_?_EOP\?#HW7]+I7?VQ]X";.DPQWMPJ>167C606\__[?_IL/0G.8 M8T7SO-A%F_JOZVA7-&:\KO*<'DB*)6SIW^,H;WW[U56O?S7HM4%%9GH7'[*\ M3-)-<%M&9=5`CW]O8HS,\"+9Q7EP#6_>9'D#J*^B?!,'\^4RAE$P9L7CVU:3 M[?>`$[=EMOP0!K>$J,';JBQ*P!Y87.L)V(!X`5\V%EL?*4?F'?O'?@/>&2!- M6L#JX5.1[9(5;>6[:!>ERQ@6"O>S@*OUP^VSX.+\,C@/DC1XO\VJ`M;=7$N\ MU/=EV':T45'`G-\T?HZ*+5VE)7Z(_UPE=]$.QC=>\CK*/\1EM-C%01$OJSPI MD^81PKD@!2F"/%[&,!.,#H,TAK?O=MD][0UN:K#*JD6YKG9!I,9GZ^"\-^W1 M2N##*(09BD.\+).[>/?0J;_G;;D%'#$O:2SD97H'F\ARSQIO\O@0):L@_GC` M(RCHG1E-N'1@57_P?5;"01\?=^GY2(30RVI5K# MTC.8"-XVVZWBO/C;7_^+,+%\:%Y^:U4@&`A("J:6Y]U.M]N#H\P#(`E5_&TP M"KO=+OXG+#^(JG(+=^PO\:H3O,G4MP@0F(;.UI#:QAV^ML#E>UN/W]7VOO$D MG`TGX7@ZI#?!GX-^+YR,9^XR:H0$QTWPOT%7/=8;S<)1KZ<>LY;\"!%Z#Z)4 M4>4/:@M1"8=2P&7O36;A;,3KZHW[87\TE=D?F7&^6B4HQ``F((FZ`J*_C`X) M8(;G)E7[:D=<8Q6ODV72P&)[B-RQ;`^GO(6K!Z^7R^''P\*+/X_B+.WXM&>? M)6M`MQ@Y`NP2EL?''BSB\CZ.Z9LB#I`MXDD&P",!8,$*1I19$"$7B9--*M1@ M^1"@0%?L6`2,5C]7!5T5#]*=PG@O;B*D"]NX3("W7Y[,B.?'N=SQ&Z!1/[@` M%L((4-P%[.9+=NU@=_2V(-B+Y\P5KW'#RT? M"PXNL:\!WD*4JUH4%RT2%(A3H#EF(#BC,*[V`=_B M9U*#%0!.FAJ4+Y@N$=$#[_D>+1]_\9X;<;XK`&>\(O`"@+SC4%.*:48`4J(N M8H9GXBH23>./>3D^NU+L:)VD()G@7E!(;4#U399>T=X5%L8?EWQI-U'21#_Z MJ:C!B-1*`L%).J11WRT]\(A.?T1[/*(WO3GE4!_#L02`7CR&"#<5L)@(%P9P MWY]B+GD=E?++R8\X+SEXK0VM$(#A=T!B5\'B(;@0<%QZ]_88/`PR'8-'GBWC M>"6/('MDDF_DS*`"$I$'\?ZPRQ[B6+X\R!:#`PCEQR>-/\;Y,BEH8GXX.W@Y MXFO@O/MJ3R3\/BFWJ)_@\LD2!,M9Q-MHM\9IU&(*DN'QVN7)LE3R'-K)/9?' M!V$?C!IF2E""EB3[Z.N&1LU@*?<++_RI!CIN&(16_BW2[Y&+P&!@58E\;*,"#A+%"J(]H,T5>&(X)*0W&4'\-M[X"-';?!.EPIM" M2RI0C-.>$E_Q@N$-2&$)#>W:Q1=9C@LH77[(1)Y%FJ._B(-M'*W^7$4Y("JS,3BR5;6D MH>MHJ`5,NTTNR,=)-C'*])WX.ED*20/]U0"[2!I";5RARAT\;>__B\8=ONWO_YO M4(-*9YT6T`'K*S[IS#R+H]5F@5OK';JD&N>C+.:X`P,KH0;T8HW7P?S%O]%?>F\(W]N'`FX?;0]^-[O[\?FK M.=RI["-"D![;Y-&ZI('X&XXDO'/?`7IEE<`9?#CZ)CT*9SFRI5NU);Q]^"(A MGN[<"K*W`F[K16H\3L5?\QMO49\G#')>35`DWS.]6V%6<,$`9=6]1,5,V6J` MU@+Q(%_4):H9VZP@FVZA+)\_=&X[/&6%E)OO*@PLMTF^NCI$2,J)J:618.T* MS0C)HBJS'*ZV2!TT%QI*X1\0H>+FVG-RRI+7@PPQ=;"Z&$(:.5MF+A(X2/AB M$<'=6@+R[1,0IM"IA_8_5M]!+6'!YY#M'LH8CFZ]J[(\B\OM`T@!().PZ`>4 M0-O(4+TO@K/XYOV+YW"Y&'V`R8.8`+O$T[FEV;_''S0Z722X'&9BM'0$^BK> MP>5">R2=82=X2W;8Y"/33_2.,5\,R%>FB+(<@4MXHOKM)<`PD530+@@@Z0J0 ME"ZRN8;T!?<`\A#)`W++0`+""-8`IG6%4#7#-9B-)V?W$`+R!:#0U$Z(S!!X=(B0)2YY M"7\BN//XBJX[NK"1BH"@L;CT2S&T>><>M)A=O+(4(2),^D<6178/$K:![/,% M4+4`HU1@Z7?HEXE3Q&*@1D:"S%?D["!\V+"E$^9`>G?`=XJ0R?@/Y#$Y[&)# M]$"14N8@VM8&<^353I1],M.]A8@80D1DGO8L/L*P,`JC0!&I;B-X0O0=((T M1L8)H"+A$255DI\$P.HTD-)%-\(79GM-KJT^(PC*/?#-0]"?AN;>6GN8&Z)\BP[)*%\5P7<9_`]H MY(OY[7>DQU($AW?H#P>$"JICMS\$,/9-UJ'W7'5G87`F'CZVSF&8#&KJ(C%< MP]7)@,@79TJ$R=$X05[9E!@T$A(VSF_2Y"],B*,]K@'OD@BM.(0?3]@UM62; M_H*9?+FSE$\B2R!KBE4$F`'\R&Y&TKUR5GOAZ:5:'*,<;@Z#LU!DWD5P`?89 M.<(2M@:II:8"71#4$HI"ZC7;/.EH M>!M[4!$R8'?/(Q1!HL-A1Z0>?DD*>5&)D3R@[Q!?$`\>$?D\V9#8[NY?(=@] MW7]#LMP]3>K;=DTJ""`TR0FEVIJE;Z.2,$3PGC&%WI*QIK&TZ8>7SC)%E``> M0[#=%:#0B!M^B%&4W;$@'35!AV2>!@.BK>(2(89ZA;5D02)]?++.+-UDN#F; M,4G<+A&2.8UQA MSP^229Z>L%5I`/Y!"X:1CG^/2M;9LGMF`8A*M$'T].9H"OH+N=O(\-X)WGB^ M558E=`/L"2AH1!659FG4&1"4`)JP*D"#G.GA0AN@=V@\1G<,*(0+`"&@$$BS MI42-BLJ-,LXN9DT#M=NLB':AD?/Q6HH,C[A@N$T=S2Q1HK"\-M$:Z(*1*O#\ M$.T<_40D,?;2%`;`6>%(*$4#'<4>A^A;%+!9==IP^!'A)8S1*WXZ4H("O+ST MV.KKM)),OL:]2YBLTA`*>8;N2(*2]Y)%$8_J3-3*M-M:->RP@V!=8N\I):Y,@RJADVR&A'Q.U(K9<6J!/ M@Y(*G`+-%#C>][8=L(XK-,^LM-\_CVV'A5+.ZUZ:'_AR/)?[Q`3GMMKO\?+` M#[<)4/8U"```+TL`O0$$\44Z>X8<<1%]YLL)X5A#TN2_Q9*`2(WZ&5(OHSQI MTM:FD1*EBSX8>B,F9""P>_9L,P)'BN#'QJC+DC+1$G\H1NC@B,*-L(7DU^*S MK'F(%T3H8;EB\0'#@XJZS=3:E'`KI):P*KTUF_8PD;&X/%H@E]D.A9Y$F#LN M2,1T;0CYELV/(&9KX7,IX82)R0$)X$19#113YK=B9#2!QQ)_2,2);!`ZYT*@ MB8_<72H&H17\Z*,-;7-L\IL%-I@`GG<-B(?H02>S^:+BG,?)-GH'JS9&Q*PJ MR8T-3^&HC7"(VPKXJ(5"Z!>CF",4&?6YP"']7*V8+#+K+0'U"C;5"H`#(-T( M0Z3]B#$`3:3AO%Y@$U5A(R>F`:1X$COB>T@V+6/''M32%<5]L[#EK$2OEBEB MI/@AD"US/X&W`G4T=]2V,,H=#8,#N=S9R8"8A&HZJL=GGWG[SQ!?@YL(=/B7 M+\/@)9JD02;=ZKB,=_%E8RL$1 MKQ0[6V<8L`_P^,;LV#F4&^.6MY*Y]MEN)60S6Z_1)[2N![UAV!T- M\4,_G`T'1!$KE+VVH'A18`"!/%N7],+1&G\+[],AA-!H"*H_&P M!:XZ\P7V/)C"=KKX81*.9X/`S5.Q`B4O>H.P/^X'E_"I%\YFD^"R=7J4UL^# M_C"<=J?X8013CP,G[E*8&=VREO`7U]1Z@L4[N`>1\KS7Z06@_^V4F?6\VQGI M+^K914J6.]&F[H+DA#W0BOJ=OKNB7J?;NB+T'%G)D,[GI]^'=]&]ICRPDF`4 MS@`YS@%])_UI\%.6?[A*TBMR90%"3L/I=(!CAF,T0":@?2OK&^+RH!_TIN%X MU`LXCMM>VCF^>S3%XX;W#OHCT@"^MQFT28H,YLR`W]M;"%B^%6V]T,P=B3AF M3*'[*6`!ML'JD0P?^]VY8)&%XG;H;QL,]28P%.4<[;23[HP_3,=C>UN2LDL9 MYBT+@DWGT2I&O43[A%9QD$9[`F(?YI[J_[]HF^,9*SPH>,7+;8IQ&@\4YG(> M#+MAK]LU'^8MNPTNAD#TX#;WIZ/@TCNCNLB#63@&C*`/4[@-KX""(MZ?!_RF MXZ^AZ2\F/?A7'E3SPE2PTYFV,XN7`9!\FQP*`?=P@/`83H^]`@9>X#C\'ZSE MLF5&]=Z__?4_X5^:D:1[D"FV68K^DP.240QD&."K>Y3*J/[?_OKQ>$)DD?[7 M-J<&Y@#OWQ3^;2`.YBHH\5IA_Z5Z;H@HT2>`A,/QB#;]=\K)(\SZ*:(`\!TL M%<05HS*NDQP8B<3&(5T".CE00=B:LN0M"3VXD+:;HLR,RPQ=T2O;D<)Q-Q%E M/.PQHAC3&J,JA=%"&95.?]&,%KI$<&=(Q,V42=$@&IU@[@AG9)=03D+/>#:3 ML+E[@P=OXPA*=3OC_[;7FNB`O-`RRV!)D%6E7"-L;T2L?&Z1#`86_(YGU-[H].7+8J;UQ?1;%_-<6QM;7\.7!<,)JR5&Q.,M9YN?Q$V`HDHFOPMQ MEBG'=E3+$/&L5^X)W`6@!70U7\2+G*S5=!WUQ6F]+W)-),P.)N`KQB&RA7!I M8&WO8HQP7&F\0!(^ZDT(0X/9<,9NFG[8A[>B%RH8D%@)'V?!,)R,NO"QWP49 M8PCCX6,O^!_1_O`M:TR\_WX?9.NQR!C$=&:S87"QN@R\)2U(#%$^?E@XZ+*K MJS*[VG.NQH,_3<,.EG,D*92-FQC4U/R^J8V2VP'0Y]Q'_I?"Q'\DHDPR#VCU MRP]DD]8+`68`FH3B2L*;X)OYAFCR(DM!_!H0"\(?\3_^ZUI')_.8/HAF4_K] M`IDM_CFAB!HY\$-T8.A.IKU@)(/PKQ&(.'=QGA)=L%8V#&?C7M"G*?'SP)S) M,.S3HO&_"U0*^#O0#YJ0^@S(`/(0N[1AP]_5-X_R:7?"NT=!H(9UI'",9W_[ZW\5DGK@!":M@G$3 M'[`1BK,/J`4/8E@*A25+FF%]6%H-T0>\)%(#S"-\SZ:Y2@+CZV0 M\B!%NO`U,$:KVJ/#SD13-Q7(9#;$$6-T<+55Q'8DT]&](!$DQTJY!4XT%*+- MKHGFI&0`7T9D\E\\F)0Z.O/UKD)+E8E>PC@G\KV*>47QLB4Z;N"AI/B@7:H: M]+6`_"QFYRU'Q'.TXVY7>X9-C:6*>"+CX`.;>&UW(#+!B.+M(WB+1VM`R:;>OP+H$?IO]1M(0`4GPD]FE^0A#3W.=3L.>$ M'QNH;FV4`$(_Z)!:@PN]OGHYXSLP7`!`M(D#/15,/]`8+_17CD^5\A)[.SI ME!WA$IE&)GAO=%T;O[%2CO:64S8J+:<9Q9*@&W/S3?#'*J,`+^WVM,VEG(9I M?\-4L$'H6G/$D!2/@>3/ZO29OWR\Y$[MN1Z:B[KFP[ST0.'8:OKC<#*;UF:5 M+S]E-6.U&OQ0OVQ7>QOI4(LQI],PV1ZY68Y#J@6AV(%$;RZ?@EUU$J&"JPJM M(+Y"30P#&OA#'\D&?QS8E_DO&3P?0F0X,RQBCR^JT[3.M_ MI]?/L=,_:4QG&9]FWEIX5&G4^'EF651S5O;.?Q4SQ58O_<,W/?['_)W^NXS*UH.&NX MY``?Y/61D@//',^O/5)[;2A>2^HH2A&#&W9@'O/BM"W`$9>T):A@^NFID:#5 M7Y6S0B<<7;<*#EXV" M-^Q,:A1_^21WG391A'3[;'7[/!IX"/4%;19X`:Z7U0(4<3L?!8`#RPO&2/$%_.``1`<;WIP'J MBYZ:/,%T,`O&PQ$PIM%T`O_V0/]O+\P33(?]8#*$983CX1`?@B6U5>S+GK[8,MA;S@BQ7(PG&EEL!\.Q1+?&Y(Y/1SW9C1J,AKX4OFISL\-"E6^ MXBK/HQRCNJP11RY@<[K@3:-\"^$*`'HI-ND%^NKO$K(KZ2(IBP="Q?LXV6S) M.B5R=5H1E;;*.S2J7CU=2U!XW/F":*OW?4X>2"PY>$G:>3B;#?AC?QCV>R/^ MC-8F5-P_JS`.%ADF M\*,="$C'L-^%_T_@__WF.*H'$J"&TH/;CU:L?K./M7%AP! M@%`1LP5M4N=@*8[945%>+E&U)0E%-&+%#\SM2]9V:#BL<(^F(;5Z43N<[`!S M@&VJ1Y,86&2`@N%E/>V40-$!?D/A2,OW*EW+(0J\5`,-?0#.ZHNZW%ULL_M4 M&^ZV&+:%TMK]EZ4Q=8@QJ`84N]#\UPOSQRP)I\"=^9"'!K.G$$-X3;XB)NY9 M1E2=:6&(,LJN!;IE.T#Q[#"ZF;M/28EX2DX>A:BC1Y"3N)$*8LABHU@/6UI? MZ&(HC3H["=?W<`<^'!&#&E,^IN^_M>AQCS'@,VGR(R]LH\-\`VKTE&R?6=H( MZ9_"F9,M%&C"+J&@!551:Z4$.)V&DBON4,\QX3IL(HX<5-$MY_";1G_0\\<: M#!I5591\G:"$DI,@*3A`\32C(=NC2JEA`YU.Y2Y4X!WQ'R.)2R6CVA8Q'5A5 MN31C1+]S((HI.7C7ZR93MJJ1#1?]JW8E+!D?:C&U-B5>P`WYP@SHT1C`L"-= MDZ*14CI+=?JH*5/,#WW-Y58BS!Q75;+,9!PM4=CUL\Q\=I)M8[?J92]H!J<" MEWXUY>1P+9(-AU=K+N6ND2\%%6UQ5FT%CFC$POE^HCI$+Z)\D\%,Z8

*,J MF\PEEH(B8636]WE5E+',20>A<^991*43EA(3F>?2MAR-"$-52HP#U7X0;3:6 M@0`'89BI#`1>DJ/B8P=N:PIHQ`HI"H$'L8"S2L4O43(AITH@&)%1+3AG2/(E MVF:V5_TMA?/%?Z[HG$]:C$Y9I11Q7IG9L'>-:!8N,F>!WU+XG5TOX^>*EH6! M/ZG7F^%_A90`^5A*.HP3?T_*!=NLF95CVDY%L0MFCF_)=4^"'47!5EQTPEH/ MIKUZ=NTLQ*K6PQ%S0AD*E'DI;*9.*WE35O4&EUZB?(N`@P?C>-^\;\`*>'F- M#"S*ID`)MBU!JZR]1EZQ)G<2"KGH2\OI')R@H@:U+3GG\\!"-F;34C4>$131 M^$<0C\B;E30*"#7E;LHR+BEP&'A;EPMKD=OHH<"X$R8:K&]0A`2<*N+/I;)K MX9H'7?LG>PY)1$/C`.FS4K--'UVHW)^9!#ZJYY(]%C9CIH0!MK$N[$(.+>1E@5?*Y$E2F"F_RBR+$<9,*@^1 M9L!WNMG`6,B[1_;>*N3[HZVZ]8X6U=GQFAR^S[Y+" M]?J6V^]8WZOV\?-_-H2]IV<3J;-"C1=9$-;"KZ]-LO MU-W$KSK\P9ZB1L.^I5*-P\N@.LA4A&XF#>L-,=&BL/ M&B\U?Y/R4`:KG3)A).333:`:J;E[AWSX%[BE*VCWNC(?Z;%^B:F.-*8X=8VT MY[I@C6`Z+Y)PBVOSB#B!&%AQ2[DV56#T'#O"PKF[^N/SNDYU\JS<%TPE=6):$5WVB M.*FM19\N3QY;)`N8[VT0DQ64X@PYOQN-E&PG8=,/D.5(&8*81G/AE74$C(S/ M7>+G?5HS'WO*3]H/GG3J$J'!=MJ*=F@5.A+3A+HCZOSQ6FC);?05^5&.>FJ( M/UG^NH;O9(6Y,H)-3SC+E23[*\.7S7H6#^KFNG8#D"TY3'B9'1[4;[+1RU9@ M@DY12+60(7-EJA,-ZJFJ!7DLFJS^S&^O@RG*+F?/0$#E&M2\G=_' MJPV`^8S5:E6AU"JEQ,XJK\C-O/QTCNVJ-HXI@BHVUFL-TH/6-G7U&"$5?&5Q M;\-)]ZK?I>TMA!A8;ADJ\D[7]2V[@,]NZ7EA"J,@!H-X@I'0L73# M0#NSBH73*I@30A?I>#9Z!:U1A]&3-Q9Z9]+@8KD..`.#JS_5*"R(@G8H<%O6:U(A6H M1D\$2UM_IW?G*O;V.+I&A5LC+13>A`0JB*HC9?H0M'.$]]A@<[R M.:XC2FM!/][`REK!H>1>,&?ZM)LNQ1F43"G3]#>#7]Q!QM6UU%%&CU>J5M%IMQV:":2-VV>4GV\CI>FOH)/>XGO2= MK$^.?FP!+H[OUY)$=S9M<6_`>PK.Y[A^2Z0YJ`#=52V5`.#=405KFL>BLKU3 MHQ?G),<3$3T?61<%5G-N$R&5'ZQTHTYP#>HK!@>@IO/>UD;]'G:/6B=B&D&G M33ICSY(TA,)6@Y5.,@(RBHB&=T\JL3$5$^N7]CO'N5O&RG4M'DA\@LMUE<8; MD)SI+):\-Q3T7$U;>2_;-D\!5K0Y=('B0J4">AB\ZDB7('O=)+!5T#E?Q`"J7/)>;_8H%Q)5W*:ZR9N*86,G;RJ9HAR)H9NXZ\15MQ^.*'K10 MIR*NRR.P>`12[#%60KC]BX,DM0B+HP*8F*)E#;Y-Y"G(Y#=J5U$SN9(="Y2IJ4 M2[9?B[QA!9H]!'LJ]HHA^,HP+&7'\@^<'T*I%=:;3<&L$U:L$RQ-YP/3TH'H M52UBC66*KS.\46M45ZT`/VY-]F!MVD:BI'!402H0F%"+1LN M$-F\TZ4Q\4\[Z<2*)7O48Q59V8H&"1V4;@,I>8&HI0G;_\2,#HS^0]W%T3J# M*G20^.D3/BR6TU,<2VCI0(O>?4P&[7\87)3GV59<@.F8A9_W9YUN/]`-&BB( M,L55EUR(CPQ!-11TQE*1$:KHR(B)[A'4$EL0E#@T47LT[X>UJ`["(GK<`9>] M#6?Y)Y!DVXHLBVW96S%VA6QA7D=U7DDQS3NU-%+,< MHMU^>&@;54X%79V>:]S'5+`7"9)_E1>T3$L$H"/+UM@9QW#F$ST4M?M%:-Z,ND8C; MCR*K`9,-O*=@CM0A=1(;BKH<>Z(7>S1"U]07<`;[-603S(;2$5K@L060E*BO M.#_#[J->0U<[DU2OW#+DANQ0$U[*J0F.L__14V.K'ZLCY%UF(Z1\J]V%ITZ[ MB`E&>M)&=H6;S'X!PNO/8O-7?@D#H(+#:]TTW1:)71K)`7)%2S+]%$X@?D0U M>T^Y6LWX,\\-:6<.;#E(,\/L%`10R_?SD_?;V%%6X854BMH)F!VH9A]VB.Y. M0NVE^LG+-'B[+#/.4L*N+ZT*,]I%Z0:J&X$]])TSUX-11Z0!0:N`1DJ^EVG6*:%&4PUK,.DL@GZ&G'$ MMK9Z4^RV4O%Y&[5,!`[S."5$94;&Y:G&E3,Z)LEDZ!QGMN*.WD&]M3H01`JV)E9%/)5;*4MR;/(77 M(M8TB*698Q-K3"-Y%(RC?JB0"W8G#0G)FKAHJ4RO3)%(]P_L9T+S%E42K]CH M3Z55C[U-^Z--,0WCA6;1L^Z?E)+EJF$K(,M>>HZKL"HZ+UQO'U`P-&YZG`6S M_1/QJ.ZSE00FR8,2$TU=BO@;IZA[TXOMWY1T*Y8IWM%JKF579Y=,4JB8.HK8 M:,\AQHE,Z0HKF>OD(JNL9*H:95LERZD2VDH2[3VU$>,Z)^):<9>DRO0&%L8= M*?OGA%F.OH5[/;#NM2Z3<#3!F`NJGP]&GB=3O"G.HR8.S#S/$-7IU0:8QW`K MVA6Z61AVD=NP[<'@%Q$=(IEBD":C[(KJ2Y/&3F9GBKRWH@H0>F-K)Q'6O$+B M8TUH\M>Y1+KE`$'?1]>^ZTXT+#?6>_2N*[^UI$@#EFI_+@YK`$KJ:'CN&)?_ MH.C])Z>-LP4ROZ@O*"R^U32O=9Y?\&%@3F:HU"SO`L]>1I^%'RBTULQ3V;`?`V,ZJL):= MI&(TM$N#7'[T^SJ.M8OJ2"P&?V8[,UPP/,U2]`#%@([DIU#LO.7U(1>B#3-O M04A.('M;PS;W=EGR+LDJKD"EKF<=O3DP[1&.;'NI\B9_+E2BXR/GW:F+GG6) MXVU0VV'P.=)CB]T$4^C>SI4`^62A4*?AO9T_7:3S//0I`IT-HTGPI:2Y7M\,B@,U#M5.ZBS%NW2?A3YV%+QZ^=W;=^0^$Z]U4M@*1N3(D,:3 M"[O:J?PC\6]RD05J[BW-?:RJ@J&0,\=ES_4Y=PE(5BN68/E5,#V_!C#ZAQ0X M"MESX*M7-%1*YR-#NCC[X=7\[#*XY9`^[*+T4C8_ZS6/+DWAGFDDY#:/A>/`4Q?KD MVG%52W)QKY$D*,<@K]V!K$V-8E8;.%"I&V!5!55,$<-^D&%;):Z1#Q#J(*?D M00017`T^QG>2"-!_V8NZQ$,@)]N68W^2O4FS5U&3)!U3^=H+"LW.M.F*+;^. MM4E,MWHYFOQC]^C)S3L81JH)F;BK*92O*1`T$ MOSA8%/D)P0+N=I%QP=!8>H_BK@FO<5E8.5_Y*6E;27H98]?-S6?)25$:KD>RU362F_TN<5S4OP-.8)<;S2-Y1DO&RK1IEB+AT.$ M!JI$[4319U;1`[45"7G1]G2CP(7JE`QO_C[.-GET`,J']?B39FD^:\`BO65S.)?7<(V4R#B;] MSNPK_',2SF;]8`(:*_XY&H2S7C>8=#M3^K,7SJ9='#S^2LK.8V7Q<#J=!BCH M?<5_4;WXSO`K:AP2]@;#H#?CZ7O#<-CMX:^]KZC@$Y+&G[)\AQVRW[W]Z>SR MF^`5JM%:RL7B;_U^+QC@$_C'H#N#/VAR;'/4#8:=`:T\Q!)Y-&Q>)-'7-Q'F MH"VQR-QL"(-@<3`3;&;0Z7\%CTZ'HV"$W_9A3S@`ON7:4K`.F@\;J$SXM?UP MU)L%8]PV[K#7'04S?NV(YIS@'^KTJ1#^<#+#)!&&R6`:#OH3\_=D'/:&UN\3 M7&1/_F[45L$8R])TD-4%BS+AAC];=\F0-3@R>O40'/\C2)6`9+Z^4$I468]>B[K-@C M:0]I=6^(JX#PLV)W-Z8&*:&4S33$-WBO;4E%F'VGC3L2#FJ\0KJ;5!E]9'\1 M@#=2??R(DB%)1/$80_$E-+))6'52AVY(Q?S2U'RUEFI\Y?6PUIH9"CUM7*)! M64RU5P,(#_7+X]>PM1&-",05Y#B)*JO`"':H.K$Q*-30)!S,JPF6MQ"MOR,% MW,E)CWM2],/!>*"Z4@P&/3V)^-ZQY')%VM_LFY9J_1,:W0H&[2^^:VJN]/W M55BJ601J%X)!8/21"^Z]V!W5]W6?%&ZK#S=FL=>? M4?`CNTXQU0(SX&.T.XEJS$D7QRHJY/0%'RIK%!>G6"L5XR#! MRR04IS6R&HY&ZHE'!AO!S\Y;!D,5P9_7L0/6=I6CBKBO40+ M*2AF]<+!!!/;;B\*$&U6459]B*!8[Z*EF-*,Q*,+QS`66*C!Z[$"-I*B@8UR M3+2F\[$5L0X/(('?@0Q]A;F1<:W#XP7)_4)=1?-$(D4)V9=:Z5H;NRKF[JZX M,-LBIAI025G;BR7?U@*I:-TK]^)8ET`Y%4A==S!\-"$$M_#:?V-"038=+]M@ M9&28J]U#I!VHG;J+A2,AA2Y5P0^%)OVU@IE#'0:N5#(NL!7,06_>6?9[`R/% MB@W+38IV'MZX\2"6U3!G#>`44@\M2=`%;6>,SJH(C&3LM,H)+TBFCMGFZ9IM=BT[-RE]@V5F%:BN-_(?"[*ERV5VV`RD%`?G>3$9!^LKJ M$K)Q$0L8&@.7U2$&?3]Y5K>)JMPXS#^@O$&!&YF%K?"[F'.V.,L"XZV`$Z,7 MEDHMQVF-JJG=D;Y-GA+E&RZ`*N<*DD'+OHPEZ?$-A";T_,AR]3J16-W#0AZN ML//;%U[VIQT`VCA>`47;!:\C-GG_Q)DRG$2`9F4QQ$KR,NDCP;- M(H8YE=43!:ETHD&+QBZ)[U0>3KZ/5#=Q;#E(^?`$UDFFL3$C*5;$.K$L]!O6`^M*QY:WB]M+J3=2(_P)=%1XCZ\2:I<$*'=BCRX M\<=@+5V\S?:Y.82ND&>9!O=D%TJ%D'!X@E6N"Z-ANG8E M$D*KB$A-7J+W,\JYH`A63L#E\M,_`_G%TO5@^H`PU:"%8$HNZ5&4CH$1&13"*;GE$;M[*Q&3 M9_CY+DIVG'W^*EG'-]BS_':9,&1>O;H.[CIHML'FKF_,VP(LL/* MW,`(8/,H,F\8[!;K0J(C=X6:,:%H(3/?1!2A_B8#]!^%P^D,=+51&(S#7F\2 M]L83_#CH(E,?A]BW>#:`0:R\C<+Q9(Q]IU506L29H?&&#N(X4%&'7U(1,T"Y0R)H*WBO;11H1]53S5V153E)_AHA%[SI'FK`ES M5YG8PID*<:1`;,"0I2KTG06I`T%$DHOBP/0JNTLV&5P:-%MC@F)J/.$DB3*! M4D&%K$RT=1LM*0+"%L/&:JVR3B?-0G)0LJHD(4('_7."4M`(J3#%OQ!&)K!! M=8H+)0F6C0%63(2JO[)&:X`=WVW)UM%=EJQTO6(F?R8/=Y58N35`^R+Q%,$+ M82UT#9A&6#<R"(M%?@@"Q+]#7+]OC=+SS8J<$4ZG-""3(8*$D3TEUBZ:99WMGUQQG]B@)]%)/E+KFEJ9=*1)W"E''.TM>>``1^#GT!^)A-E M\/LXVL$&?N3:*@6_AH(0=34KI3.)+SC'SMG2$-9^6<>7_MO5P),GKJ76W3-` M7MZ?O7\64E1(S)XAX8*?@&Z."\"D7%ARP/*B0Y5CQ$1IQXAIN;5^DF(2<@LO MB6$HYI*+E@W,FZ3SFWJ*B*[^+@MHAYR8+CFFK@&ED`5K?1PL)>LR$MB@Q\JM ME=()3!?4]D(W/UZE?;E>8UQ?:PI2;7FIPMPE>=,%F/4HF!H7#M9(RM`/:8Y8J)2@`;Q9\)RLFY"ZR(*1FN MH)IFP*!>MWDC]%;:#MQ"<7-,=JA;`_&MD-AF^13B][Z#P@(LN@4?BW/H=K16 MS*=0IP/&,HMG2;*#NCFZ4IP_;ZI.R/7],(R*6[!PY-T)-,%[++S@\+&'51WU M1H)BXW(;-NI6!&5>0OVVZ*(JJBI::XVJW_#73)NK$@/&U3MS+XO&%*0W=#I^LQ]GW+3\:=IK>(--'>?'(<7O12/J*,0?D6HN- M!%W*58LK_'N=<_X8QA^;4WU,R+)MZ50>0^P0U+.O"8!;U62(U$H"@YI M2OI^VG'I[%+[`"BBO:4U2Y8[Y;4XV#W7V8A2(A$E8[96V/5\["O6AH'$DA0OD'Y@ MK![S-4^DE2$L+MH=YX],$+/:WR`2%Q3-5$9X7S^9.3_H:$_6&\"K(W[R> MNYS55SL886DK)<GFUU(1'5S*;J, MLU/2PECS5ZJ867%YE%%_V>W450469:6XO>;@0X=!&[-_ZZ/"W?WUU5RETGZ, MB4MRG5K,. MY'31+4&L^0`<;9MQBXI'<>]"E?=A=YCJ*R^-M*_0OLX]Z@87\:66X_R8LHAVQ)-`B<;:4+#T2^64NP-**=%T1_9+7)YHL?9J^->P93E%RMA8 MNJI==NO(T:E2'H55;E%!V6,54IRT,9'U9J)64NDZ%OH0<^D01N;(ZHV.+0<+ MZ85@66/L8Y3^'EENM4RP$YUX%^O5A6O<;>MNTVZV;W%\RH-Y''T$.(5@UC/+B MY&^.#"Z^X]@1H&S7NL:Z#;YV4[]G-EM:),L7*3N6;2?B@I=&"L+4=@I10E/Z M\_?O2/[3)(^+])M&L!&-)Z-/H?+%*6LHV:OKV`A"3G M[3I><>HMW+.*#+WZZ-#K]PA6U%-!LW M!E"3:O$X9T;]F>)DD]:^U08$W>8VXDJDI@23#NT+)/E3EX#%'7&"G(M%&$E@ M"#$)!$KBN7## MIFJ\9=U6RJEJZ40\'N.QX!)R+IY$NZ54>;&QG%J--\DUM:,#;"U:G8`=`0*0 M>\;,RXE#H<8YL+55"WA(!O>!QU9%5,Y/<>Q,E9_8WZY_IJ"2>SW M:(`6&J!*D5`.(H%-4%"@G:J;E*N6/9 M>1@EW^KT@MMX0]N\N,$L-,""RX9WV3?-28-4?`X?&;[M*5V0"28PZ1^U./6. M,GVUX:+7O?JCU9#Y@#48[91(20"\2\E$9KAR1M5IG[36&%R#!=52NE]9F2 M."9L,D?TXN:,EH!O.IG+"E#XM>V]S3<;6-B+?])Q=()K83NVJ9=+U&0EUDDG MW9E3U]0N=CI^DZ\N2Y_>.W#LBN.]M/!LJ2D-6ESV24GH8!MUGU^W7%Z[*703 M4 M".:Q2`H-'7M3S0K%W*S7C?#-5+//OI0&JK,-PX<*YD/M`Q2CJLM\G.JC1O%9 M*AE/)@U4.Y%UMJ0ZZE1JH>`NS2K8P,Y_,CD7<2B9WQ2<2U=`H@V?_SA_QP3] MQ_FM]N'J*X,%675(!BYGB:A/07/%)Q"ZT%])1(5Z\+:9YFG9G8BAQ*-X^D&@ M=0!5$DG=N6W(8HVW40[CCG.,6,Q!KF!E;2J>UY0.V&)T2Q:C.;,)0"(@%;O@ MXCUWE:X_=*,R,@G(*IWRZ"B3=.G$&;&I6QS>WQC(.E@L=GB\>WH:./QLMQ(N M*@DNZRI/JM*?T4VG#MX2M@T#-SGUYM9SVB>?[%6'>A8)#MXM M<9"Z[^V7P6@RP!SI\3#PPY7:4E&C`$J&[DZZ^&$2CF<#/-9J7_%*5FB`U3WJ M>YC@W0\NX5,OG,TF\*EM>I2)SX,^VE"F^&&$\<3U,[^5V%D\VY' MVOKI$_#A772O`VD+2A"?`7#.X?@F_2GFNG_`ABB4Y@`',@VGTP&.&8Z1)'.` M$6;4%'26@S[ZC\:CGN2SVDL[QW>/IKA=>.^@/SJ^7;BC&]+1YW(%`8#?PXM0 M^ZD]&7S<[[XI0,>._^6,>']^%Y_][KV]^X`I@NZQN9&90BJ=L\8,2=10.=M# MOUII2L=_=W`SLK!#VMT0=K2!7VV)ND]S>8/NC#],QV,;#ORR;ZB97D]"YBT!@W2JBJB/9Q$Y(HM'M`]#=_:6GS&E2-(@&U7&S M.E@ZY:X]XVUCV"9)71PQ'A52Q.VU>R%D<`)YK3:#ZVU;C[-8_H@'$WI]POD M6?CGA"QD@@J'Z,!PGTQ[P4@&X5\CD!3NXCREZV6M;!C.QKV@3U/BYX$YK6'8 MIT7C?Q)<3NA'>/_+2'4N^LN7T0+D8# MW#YM"O\P.#@"*0'8/7S`74UI5_C=>%I'.6OQK[G=AJ0NO#.6)+(?I-JT5)_" M%2$M+_(V`44<.,Y#7:YT[$$+=&133/\^^IF\AV6\R1J9.UP=T(B2=G*I;A3B MMC$@_[NQB+'_W6?5:[L7+\Q<>P,`L6"?!/\L,1?.@YQ'4'GQ-"[S[%SVGR8EQXH'%M- M']2?V;0VJWSY*:L9J]6,FSYS\NA??1>Q.6V/?$IDOQ:+@<,;56F#6]!ZDJ5$ M!EXM&K.%:,BVVHV^,Z$.-QPK?XW)C/[%\71+>W&*H=H6-]5:CQ5"BBHFBX(V M6VF;C5VZ]:E&\.#7K#=WW=P"''Q_3+E22$F'DR'I/T/+N:2VA4RY113%HE`] MH.+#Z1BD=+@*.Q!,E]JV;>2N-5YS8!3#`6`_C`D!3#<-R;T:C):%!')EWU_0;I!<4FGH3C M49Y2@07]&#O]EDS>L)U9O&K2[B^%$F]4MX-S,O%TNSWB.A=3S`KGCWW@J[T1 M?T8Q"_F21,^3(5:JX%>EHM9+21JFI9M^"B9F5O=O(%Z$$(RI;,W"J!Z&Q^[C<9JM0\I6<)5'TPB*[<[JX$'?T M`,KJ$XGA_QRK8?FU.3K4=,.\B[\LO;$3P21PL!=.>WWZ=Z`_ST"8QPJ46/X` M13#NN'4?Y2A8`2$8@BS?&TS@__WFN"I%MR>RTA[<910+0>"7.XR%**E`W01+ MVO6[^.\(D&U>D!.K*@2!*:!R'-8+&-6*M$D,\?ET;+<;URDSOF:P_4Y_])6J M]9NP"D`MK;CA,%H42'\Q.2&FX17GQ:5<24'2$DITDE/5[$#U@)564VX'KU`2 M'*P67E)W6'I'A2J1SA;4J`L!A\1S2'9X:N,]JZSNLABG[2'.Q1D50$ M3B2T(M+P295EJ>\M(W2H*Y3$1;57T3F-_=>;9S'=,EO0VJM)`;4:0\I(E35D MY`)%IF)%&\SMD[P""1Q1L4)J]=)[7D>5L.)\O(UIX2$&=C,G>$BMIYT26#%; M;.>R5!Z=9.L0!0F]KS5ZO:NMWITI(>_H?:J,(\LM=I)<@-!P_V5I3!UB#*H! MF>,;_SZI2G`;_W9C__Y9/?B?U8._0/7@5FS#4;D4IWIKU6E_P1[]?T>/_FME M:U(B3L-@\,_*L[/>)]10.46$UZ5;K#HG!%GK[[`U#)X1>*C5WS60Y&D88T5#?`J:.)$: M]1]K@1H-WN;$:CQMV3I$`0'1",SXE)U\KZ,O.`B!@ZU">8$*;Y`0K&8HR+$; M0=RLZ7TZV1G>O`K-T`4?<'T^YOJX/_4;RVWS^S?0GX,;FLE4OE"$YDO\40.- M]0V:X&R-)VG"N#TLI8&L_W3W_X/=_4T=[Q_E^7\:+;(C`#Z%\LP],0%-6-2$ M[_H`K[/\:?OX/7;>`GS52HG7BV[O\/B^'#E)0%&T>N-!F.QH05)&'Y/>?U]W MUUO&X&/$V'B5KSW2"/N8?TAU;M?W`/9'!Z'\W.[J;:S`[[9N#+/\^$V9PO%B M^Q16VWO=Y'4>MWW[.["/WY&!C9.HC>>6;K\$X7K8XS=VK9@:%K:[U4R^D M/9<5Z?G*\H&_5CYPN++MOGM1.(ZA8\.)'7'>+P>?9FQYQ("E(?H'E! M&A[P;(&AIY(72:4(Y.'^T8>KM/7!0>-!-)8'7XE)CZWECOE36\M_\;CHG[#` M%XX&;;KZ(+YYI&Z]F&>(C[\$?Z]EDN)M=?C%.^0#6:Z^`S4N/E3+VF?`?NXD^9E7W-C;%'Z^3 M\=%AY&-LO-!I?4@FW#93CX,_@IP&-^G3<8&F.W">/45$,O-[HAJUB#1ZPHRK M]BEOXT-C^#')K&W,*VGV7&];?(R*/%.YVYS@%ZO&<&F6BI[@U7YOE`T]39M4-C7JJ2MZ6+GD4X__]7O[Y^TGUHS]*8I MK10%3!Y]_%@\CSSRDE;._Y(#!)0]FZ\LS/<8Z2+!(B'SGM0J6JH2%1[3)#=+ M)@YA!Q:T2R^*M+IA"&WTYEV\DIJ*IM@:MLZ*-@T<(3=7T\_U8Y(I?W1NVB'I M/K9Y0+5WENS(UQ"1/O/UP3^DD5;M M5)6P8QA@S-.&(7#@,.O-DT=<[>P(MS'G`!9?DUP#6; M^MYO=J2:'#T1BLYC]4=&G,/1$-M(I1#5\E?8ZMP4HKR)DM45B(*`P`GZ5'^% MMRE>]TOP&0Q`'GBF&3IV[<$6Z$QO%/D,,>*"V]#,O73V10;:-Q9>/+Z:$WD< M!GVT,5@IEK`4P)+"LR*O4M.@\"47]2*K&I?+>H$YC2]^T#?2V,FHMA*/<&PY M`JU?83FGF'R>J,H_S4KPV`*/!RD]7:>WK)]'ISXF=%NC8?E(PH6COTL*1+C; MR.,;<4?F.+*=WY_T!OB_&P?U"ZBA@#0-&&)85)-J8W24Y]MN9^KYMM\9-[\] M=97LB6E:VWWOQY"KYK<8>>4=V_OT5=4"M]Z]_>GR&P*A]G`TH.![W=@'F5EG MX`&B[\M35^O&DQU=YL"WS($/K,//69$3GW9T04/?00\Z_>:77C%WZ!OY2#S9 M4]PKJBNU4)!U^7__#YM05,/8HVX6BB`XQ8*P(UVK^(]L_1]+8EO''FKSWI@0 M&PJ<`#HMT6V*96G-_AF2=&^<7+LURA--UJ3'IA-XPS"I@W"L3L._!&U@-#8! MN[LNC(<#:,B-,3P?H]J4)9M#^E!K^*+;8CU.HHC11_B7P8N03$0<-Z,$[J>>:\PO:\<;+ M26K-OILBH-T7^D4+CGQ7);N5)X/SE/#%4VWBYS5SN!GPFO,<6LB&]"(Y9N]L MA-7QDV/_DT\.'OS3NVRWP]0!M.1Z;(.UT,(C[_M"`8:>[;;_^"9V>SXUS[X9 M6WI4+C-70HYPZSM*-G0[MK\!U+]+OL_I,>5ZUG/O5Y>3VV+_JL]_LF.`8KH[HUY'[3$^VI M$[+RU3A>NW"]3S@Q&3-WO@"&ZV:#@--!Y2:-;Q\.J)2Q=]O[,K?*?NN>.`RJ MR?2:!;V?K'<]U\6X32EEKU,7RU5WOVK(/5BZVO/UBT;!Z$>F']1DT:^+HOS= M_P-02P$"%`,4````"`!NAP5'YW\Q-[D!``"=%P``$P``````````````@`$` M````6T-O;G1E;G1?5'EP97-=+GAM;%!+`0(4`Q0````(`&Z'!4=(=07NQ0`` M`"L"```+``````````````"``>H!``!?&UL4$L!`A0#%`````@` M;H<%1QG6M'$_`0``:0,``!$``````````````(`!=`<``&1O8U!R;W!S+V-O M&UL4$L!`A0#%`````@`;H<%1YE&POSI1Y]E0,``*T,```/``````````````"``;<1``!X;"]W M;W)K8F]O:RYX;6Q02P$"%`,4````"`!NAP5'-T*/Z$H"``#T!P``&``````` M````````@`%Y%0``>&PO=V]R:W-H965T&UL4$L!`A0#%``` M``@`;H<%1RJ$^<5Q!```]Q4``!@``````````````(`!^1<``'AL+W=O.09W(6P(``+4(```8 M``````````````"``:`<``!X;"]W;W)K&PO M=V]R:W-H965T&UL4$L!`A0#%`````@`;H<%1["1.K^&!``` MD!8``!@``````````````(`!+B0``'AL+W=OHH M``!X;"]W;W)K&PO=V]R:W-H965T&UL4$L!`A0#%`````@`;H<%1TA)*N.A`0``L0,``!@````````````` M`(`!FRP``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`;H<%1RT6J5FC`0``L0,` M`!D``````````````(`!_S,``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`;H<%1WWHFQ6C`0``L0,``!D````````````` M`(`!CCD``'AL+W=O&PO=V]R:W-H965T M&UL4$L!`A0# M%`````@`;H<%1U4W=(2C`0``L0,``!D``````````````(`!;S\``'AL+W=O M&PO=V]R:W-H965T&UL4$L!`A0#%`````@`;H<%1X8< MECFG`0``L0,``!D``````````````(`!#44``'AL+W=O&PO=V]R:W-H965TZX/8QLP$``!0$```9``````````````"``<=(``!X;"]W;W)K&UL4$L!`A0#%`````@`;H<%1R`+E9;Y`@``R@P``!D` M`````````````(`!L4H``'AL+W=O&PO M=V]R:W-H965T&UL4$L!`A0#%`````@`;H<%1_G1QGB<`@``U0D``!D``````````````(`! MQ5,``'AL+W=O&PO=V]R:W-H965TT:K/5D`(```@+```9```````` M``````"``6!:``!X;"]W;W)K&UL4$L!`A0#%``` M``@`;H<%1SGBBXLA`P``D@T``!D``````````````(`!)UT``'AL+W=O&PO=V]R:W-H965TG_@RV004``!\@```9``````````````"``3AD``!X M;"]W;W)K&UL4$L!`A0#%`````@`;H<%1SS2%6.\ M`P``M1(``!D``````````````(`!L&D``'AL+W=O&PO=V]R:W-H965T=)JN0A@,``)X1```9``````````````"``7QQ``!X;"]W;W)K&UL4$L!`A0#%`````@`;H<%1]\W&%8D`@``?08``!D````` M`````````(`!.74``'AL+W=O&PO XML 14 R33.htm IDEA: XBRL DOCUMENT v3.2.0.727
Revenue by Geographic Region (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Schedule of Revenue by Geographic Region [Line Items]        
Revenue $ 39,479 $ 38,327 $ 76,149 $ 71,591
Geographic Concentration Risk | Sales        
Schedule of Revenue by Geographic Region [Line Items]        
Revenue $ 39,479 $ 38,327 $ 76,149 $ 71,591
Concentration risk percentage 100.00% 100.00% 100.00% 100.00%
Geographic Concentration Risk | Sales | United States | Direct        
Schedule of Revenue by Geographic Region [Line Items]        
Revenue $ 28,776 $ 27,992 $ 53,910 $ 51,980
Concentration risk percentage 72.90% 73.00% 70.80% 72.60%
Geographic Concentration Risk | Sales | Europe        
Schedule of Revenue by Geographic Region [Line Items]        
Revenue $ 7,888 $ 7,816 $ 15,134 $ 14,401
Concentration risk percentage 20.00% 20.40% 19.90% 20.10%
Geographic Concentration Risk | Sales | Rest of World (ROW): | Distributor        
Schedule of Revenue by Geographic Region [Line Items]        
Revenue $ 2,815 $ 2,519 $ 7,105 $ 5,210
Concentration risk percentage 7.10% 6.60% 9.30% 7.30%
Geographic Concentration Risk | Sales | Latin America | Distributor        
Schedule of Revenue by Geographic Region [Line Items]        
Revenue $ 1,221 $ 1,309 $ 3,260 $ 2,226
Concentration risk percentage 3.10% 3.40% 4.30% 3.10%
Geographic Concentration Risk | Sales | Asia/Pacific | Distributor        
Schedule of Revenue by Geographic Region [Line Items]        
Revenue $ 1,594 $ 1,210 $ 3,845 $ 2,984
Concentration risk percentage 4.00% 3.20% 5.00% 4.20%

XML 15 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 16 R25.htm IDEA: XBRL DOCUMENT v3.2.0.727
Balance Sheet Account Detail (Inventories) (Details) - USD ($)
$ in Thousands
Jun. 30, 2015
Dec. 31, 2014
Balance Sheet Related Disclosures [Abstract]    
Raw materials $ 5,973 $ 6,728
Work-in-process 8,883 5,946
Finished goods 15,732 18,651
Inventories $ 30,588 $ 31,325
XML 17 R9.htm IDEA: XBRL DOCUMENT v3.2.0.727
Stock-Based Compensation
 6 Months Ended
Jun. 30, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Compensation
Stock-Based Compensation

The Company classifies stock-based compensation expense in the accompanying Condensed Consolidated Statements of Operations and Comprehensive Loss, based on the department to which the recipient belongs. Stock-based compensation expense included in cost of goods sold and operating expenses during the three and six months ended June 30, 2015 and 2014, was as follows:

Three Months Ended

Six Months Ended

June 30,

June 30,

2015

2014

2015

2014
Cost of goods sold
$
226


$
197


$
474


$
404

Operating expenses:











Research and development
258


185


486


335

Clinical and regulatory affairs
243


365


428


262

Marketing and sales
839


645


1,587


1,194

General and administrative
842


748


1,644


1,558

Total operating expenses
$
2,182


$
1,943


$
4,145


$
3,349

Total
$
2,408


$
2,140


$
4,619


$
3,753
ZIP 18 0001013606-15-000120-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001013606-15-000120-xbrl.zip M4$L#!!0````(`+*$!4=*)6#]@_\```?R#P`1`!P`96QG>"TR,#$U,#8S,"YX M;6Q55`D``P]TPE4/=,)5=7@+``$$)0X```0Y`0``[%U;=Z,XMGZ>6>O\AQP_ MGU2X7[*J,XMKMWN22BJNFNY^JD5`=IA@<`M(Q?_^2-C88+!C.]@61OW0*V6$ MI+WWMZ\2TN=_O8V#BU<`8S\*?^FQGYC>!0C=R//#T2^][X-+;6#T^[U_W?S/ M/S__[^7EG_KC[849N>D8A,F%`8&3`._BIY\\7_SA@?CE8@BC\<4?$7SQ7YW+ MR_E;DVO69=0A)[)`$3E!\`1%Y%F.4U1U"(2A)TK_]W;M>8KTY#$LZW"B(#JB M*C*<*BJ*)_,.X(?2K+>W)QCXU_C_%VCB87SM1FF8P.DOO>%'GV+@ M?AI%KU?SAU<Z]^9/\8M"^44/^/7OH`ENT M__GSYR<0>E$0C?RW3VXTQB^(C,0SB^9O[G-]]_A)3?]^^`KBI/Z5V;,:XOTX M$CA6+LTK>S."(]2OGE#W"4V++4PJC M,$S']6-X";Q*IA-PA1I=HE8`^N[BO?=?*K\`P7`M)=(5>IHWC'VWG@3TH(:` M.)G`->W1DYH7TOARY#B3Q3M#)W[*)C)_4"-L]`1&`8AKW\F>U+^$^5#_4O:D M[J4$@M%:/JE7Z'G>%#_P5G1BP<_9PU+3I+:I.&N:%)OZFP`:QHD3N@O(O54@ M^I//6K.JJEYE3Q=-X[IVJ%?VZL^[VX'[#,;.LJW_?N/+Q620A?K'9SS6=9P] M>03#BVSLZ^<,=]@:7.8Z_^DM]GKSQU@.O_1B?SP)$$E763\S4^=&80+>D@O? M^Z5GF_C=K]Q?W\QLJ+P-LL5^,LU^R7_R/?SCT`?P(IL**)&10]/H_[MWPR!B MD(F0&.GSU>K+LU&N*L/,1YD@S8J\TL"($S`QD5NXP7/%J&+8O(/EL^(;R"(6 MVDN7/+,2`C35ST.G_R M$1[8F`G"5Z$-Y`N7+'<(\I':M('\%0UH4OH_YH[EQR!!2H4#."-PXOA^.$@B M]T5[\^-%"R-"H0-,_*<`/"##!5`TY&6M[L#X"2VSO)F_R#K6?KVH'F\_NJCH]`J%/94^X[`^A M]V:F]]S7MD0+*`85=HD6A.:CA3S":@W/Q!UY=H`(*\=9:Z)28<>H]!`XPW:9 M;T=$QA_(+0GMB,B$(T1D)GA*^JACF-75,G>,4\6B+QZ`T(_@ER@!L9<"]+XR M@^3V_!*PA*;G[1IA].TB3.&G#KN[P#3IS" MS)G:$/R=XNI8?7^%EO$CP)4T/QRU+W:HBJ1W@V5RO85,-D8-.\QA.Y$N@YD- M,CW`E-9!HF8^&S!Q5M'UG?/?"'[#-;7[(0:0%GK6WRF:Y@`3[2<^B%=B;3B) M('(FN/&R3?NT94O"BW'W!LI;'76O8J(CMGW1^#8*1PF`8TPW1L2ZY!(_;Q_0 MJ5L@P"WL,+$Z--9F_TLX4NO3/NM#30@U(2>++(^AQ[8?^@FX]5^!UP]1]R., M$BV.01(C?N'H*ZMQEIUM&B?1&,!'$#@)XG7\[$]:&%ON0'K!LJ^GO?6X*%8. M*"[:AXM#9:(?Q<6M[V(>AR-M!,',I'8$%6LI[RPFLB`1M4(Y/'1>!L]1Z(=G M#H8L!JLEN?4H^&@D02W#Z2P#:5%$9AE,G`!$$^!]`^YSB#>T3L\<$)EU6$MV M9RT$]1.G\!.D99S4)IS2)AP##?W0`\,](H=OT/'`V($OL19ZV3^^..,VKG#M MR(!E!+&1`ZW'2#&*H!AI-T:.D8/NO4*N1Z'7S17R.LH[C8E,FW3'?0'=0L0& MNCN-!R,:CP%T?2=X<-#@'4!"+<6MQ\!'=E)A(]D%&U"@L_6Q8R,[YVA<<+8[ MYZ@?(-L/D(@!&AM2FU#$P_?!K]$K@&&VU6H$0ATH[@GZ7X;Q3_+,7_$?R(\> M2,$!C1[(CQY(P0J-'DX=/1P""0H+^MMPEB<0MMQ`9ZEP!XC^##@H#@"PIV@LTCB`$N.R(VSC]8QTW/ M&SE;T'Q$\)!U4\-.X+E'`SGG;VGJR3RN?3GYQ13+*^8H1`B$"`$WZNWK@GX% M(6)>@*RQYHW]T$=A'6KT"LX;,5M13=T0C6':$,,0Y*!VM3[405'[0AU4"QQ4 MBVT,KDU(1WM3M&%"?WPX$3M/$0A*W`4J&P MFY6:;8$QNQD*F6;?S33L$8S2P$DB.-6&0\>'YP:3V:U+[]+;3=!LZXXH:`@` M#2FA+ZW*D%F5(25*V0,BM.I+0-67%/#0$)>D$)>@Y)F&N&V)5D@!S1X),ZVX MD%!Q(25'VB&6H5:'`*M#2@RS:P!,8Y@N`&,/=T37C>@^O#U@0Q/J4R?4!(&' M.B.2G!%!E=RB5=$0(9X?I#CJ7YX9;KVY0>H!SX;1>/9Y;\;-^Z'EP!"9YO@! MP,&S`X$^K>]@U2HET'<3X`V2R'UI'[@.R*22':MRJ8/)^TH8?0*`?@_])'X< M?*=`W0:H96YU,+P_O46E@&T+8$FQL,<&K#6>!-$4@$P`]Q/<$P5K+5C70N!)!B44^_$$`!2B1`"+HL%RW\53.!F#E&\"QGY"\/J8_"40+@ M&'=;=QIUN]%295:^<7TG;FW$T`[3J6/V2>%+G+,$2=6KM543BT'[@*Z%J:J8;`NY' M\!H%KRAU+;=9!:P?@OMA33>9%NA.^!(-M3&:J>O,WC2CL>.'RU&<<%1&^9T? M^N-TW#YT;PKP-S*S,3ROD<5MXOE26C4P_3$9.?@*IU;4HH[HHEYI/;)K MM?MO/Z-.10B$N>;F:O<+09YMU$!:[;Z_1RY["Q+$T]QTTQ0VQUH-6TCUE8U7 M6)9Y:&.7;A?ST%.5Y,\%FR0$=/N5VMN1IQ&Q?D3!VGJPDK9>4RQ#$%/,VW:= M].QK#(3F`TT'W<=:;:4%A`.8#O9KTQ7,ZDX]NNYVA!)DX_OJ2`\!3KP#KQ/G@'4XA@D,5T"/.028(71=-GO');]]BG'==G%45]"?H'N`^7B MLR]UG+!F?);EN)6M>71_*2TH'&G?GKK;OCVVVV4ZYXV6Z>'BIIAHC)8CC MP0RR<<$(^\AU)4@/09BNAGN+UY?Z4)A'<-<;-6VBQ[SR@M''HNU3E2%.YQD/>>K@G-SE4 MYDV&)D)=,B]=3X2(J+UT=7$[>_];E#C!(XB3^^$? M$1+\8_23VAUJ=PYE=[+QUV*N@\O9+4B=Z,?5'3`7)'Y<34I"0J,#&AV5*4BH&+8@):$)"[39M=Z<[^G M(6`Y8F^G*%T9C7C`&[N:%_.`92\)YL+*'1V8#]MC9X5O3=UN(BQO-VD' MWX3L;I-==*[QF^5*.K?P`P_8Z\)D^A`@/&NA9_V=^I,LL*_ZC#LG3(>.FZ30 M#T?ENWW:Y"VV(+EX#>M:F@]KL@]K?#X.!CWU$>WAZ,SE7R:SS2+'=I/)[&;A M%O@\?==U,PS<3.<=%EM2/)H2I.EI:S4M(L4YE&1_''%H:!NOG*!1"[O5KE8MC_@/H(/ M6E9J,0]L,F!ULB&X74**+.)1>?+T!K">U6$M'_`$ZJ(?:VL>4Y M@FG'A.-8\6&3,=H*_IJ(T3[@@&D>VP5'=J3,UP]IYDM&YEN4Q/G&BX?-?)OU MZN>(Z1.6!P_@16OE31<#SDN>-'L[>?;6O-33T)^)/$PKUMN.,C?,&>W3MU7::)A",KLT]^ON.@KP'Z_$'@EL*D6J# MN#2`Y[\B,)3D@5_]DHXQ0J)25+`%04P01F-\ M-/>Z8>:LS"?^[E"K'>;/ED2^*]B_A_52G0D`/]Y#!FGL/0`X>'8@:`_SYUJ- M)WT,SD<3;(_6:]3L^5ZZ6@O\[3'V[@`9BS88F;4\W`(WM=UN1L![O08@20", M?T3#'RX$GK_!C%6:[C'<<+XA:/TH>8N]:'%BL&G^Z/$VW7K`O]:0Q?:PU;8# M9W0Q]RJ/8%BJI_1F!1;'32XE1C$LAK%LR;8,C=$EAK45P[`UT;08Q91Z-T,G MP,-7.E\,::00XM_\V'6"OX`#K5ERO\7HHLQRZ(',J8K*\[;$VSJ3CRY:C-&[ MN5DRIF\=BE,HL M9C/<7BJ#0JROY8%QUXOQK"Q@,P#>?!WT0P^\_1M,MT&CQ/*, MK1JRS@J*IG":*@OYP)PMF.4(=^U(J_-8E@\RYQG?IPF."/%FL]*D9IMV^-_3 M8,JSO0L/N/X8Z1YZ\,4NS-(R#94U%80-664-@[4U6P23".+X&]=,M@*S(ABB)>NRQ1NR9'&JIMO*0I(: MQ_5N_L(NY;V15J9CH\`>&@A@HPAN(U:6Y6T!"580)4VU5)GC.#F?A6I;6N_F MUH$C<*&Y+@APH`&\BVR,XLQ*@ZY,Z!&,\!=P*,C_XHRW0KB@\RK+J;QN:X:@ M&9*F+Y1]O[W_M_WG1_V)<7)G657$RY0&SV62>HB8%7I,R:8GM M^/`_3I""WZ:3*'D&"?Y2)_NA3$!S6\D*B+X4"]PP=4O!-E:U3%U#7L@2V9G: M2;IJ,Y9>`'062["\PN#_/E\U2/0^3#2"*,Y`BG3H`?HNR./C(W"0*_IP!5DE M2;1T0Q1U5I(EG6-S!B(;II09N`SB6?$3+^S,Q;54;\G"8-J/X]1Y"D#!!,T5 MO\HXX:M0`@Y?H)L115,P!4&R114K$RM;7$ZW+JE\!3B"M#5P-LWR((0BA*PE MU.9$T]1-B;58V6!-25.T!:&LP%E50K?7D$,1^B4*W0U"76C#0B7UZ5([?80U MZ#Y/;\$K*'\CNFC3#R?(864-V)7%F4*7=[-P.8N2(/@[!:$[K>^OT#)^Q)D4 M7.YY7R<77C-4!?L25M=9DQ=TUN9G-RV;8P2>-W1)S/F($D:[A7PL!D9M=@62J&JB**-DE==TA=%T MS3!ST7`J4W'1'9+)R5R!IIF\95FBB%)/A9$M2YX7$K!,!*YB=CHDDY.Y`E$S M6)3^!YUJPR$R4S7%WMFIOFOM$XO"(8;C14%F&,D01-50YKZ7Q67JBGWB9(Y; MLF+35#XPX;\V3%BP5$U215GA)%;AD/0$4910.J]9AF)SDKHZ84$]](3%S1R> MX4Q158%E-4Y2#$ZV9ASF#,[4*M$-+ZKRP2>\B<.&*9HLSUDJ7D(Q34;15"7C ML,FAJ$"H0$)FA)TG;((G!/A7$#IA,M\)KX5AZ@2&,_$3)[#>)B#T_`2YVUH" M!&Q?9@VY2M0N=G3)3,S2-XC8)7 MI+CE-BL=W"([<3^LZ2:;T!\@"&+;@:-(=\*UI[`-7,0D-,'R(5/S'^T(`M>) MDW=,GFV*&L/JG"(@$R<;O,I(\[JDHN'";`6"3-'>[2(KDB7\[1F"5<=R-B*6 M6(%!]MI@99MA5,90>5W.1$PQ1T$2.M\Q<&)*A58.==PUA@\+@J<';Q>")`HI(-$5FLQB0TWA! MLG)9BH:@5<.J)F0Y^[0EW_Z`0_62*&='R"V.0N-)T8+RSA1!-S2>E4W=%&25 M$2T5!WVB-Q#\LRS*AHJ(V1IKC.[$TS&CM^ MN)YOAF;*@BV;EF+^/WO7^MM&CN3_E<5\WSD6R>+C@%N`SYL`F7$PV3U@/VIL M949WMC4GRYED__HMMMPMJ=EZRP_M!@CLV)9:5;\JUH.L*EJ;,D*.+&/V7*-W MQ@_A!M_C,;@M%S5EA9_'L_GDE]MQ6TIWD_O?YV/ M9W?E?=5TLQ5RR]]WJ;A/"05WG))9GT`!??-+Z^!7(UZR#:LRVA_Z0T16DOOQ M]>-\\GG\37J=])8K2QD,@5MIE1'*1,-=)RZ.V7[WEP_X][V%M`'L3?(J/\7Q MI]'C[?Q_)M/;9O_E:I9HJ<[5XJ*5H%GFD`,8\!:?BEG+:M$V#A@V]CT?7C7G07,IJTRV4=_NO^U,.4>'L;S!W=7J@__T3RGR5`>QJ6X]F.9;>_N*?P9S\:C3P32854\ M-AB0D?FQ/OAS&KQ1:<$`AG+>@I1)@ MN^.W!);U^44)I[$[^;+D[X?Q[O'S-KM52<@;D/&70&#-`4OB4 M:DOO4UA-M5?;0=038(=QO$3J/9FQ\?@]!?D4^*SN+"_CUM*`\/!^=']S.YW= MO+O[?4;Q1F-L;F^G?XSNK]>-U/K,YXUQM@])9T[1MO$L2XF)L^Y4A`-4&PMK MYU?G(/IP"%HH?Q[?C_\8W5XUCNMA(%)?#GO>*&U&ZU]F4#HZKQBM#A5LRW]" MLUHPT'85P8',#Y.[9+O]^]6G3Y/K_F[9P.IFJX%0E`EBT#E&[W/F(7/7DF^\ M7=TN'VC5X4^<]"A8DM;CI`NSR8[MJ6MKEC>6C$Y19JZY)3JQ[%FVQ&:O5E=6 MTSL'W"YU;0LM)Q)\CGF\JSRO%@7GX'RV'(21KG@:8;7=(*`%SX7EM\GQMG'4 MF\_'/9/H(FI6JO]!*F>ZTSB`7+&/^D2)/Y9=S*<,[,/H:[,@X^/8TQ]I`5(D M0\H_6GBJ3%YM/S5>MQE6,4BBU$D$,I&626DZF5H*+@;C*28V<'4@P>?A?/HX M.X9S$UCVGMDLF;>:61`BM)PKS?CS<4X$GX7S)A@;;8P>]\1!"!FX8\D'Y[15 MTAHN6APBPM!6`>$@3\>A)O\\J/2"RGUA<$E9C]:Q0(J!EL74+82@'3R;.JS% MF"<\I]E"/8;SP!30*HA>98V6\TRA0\NY8%$\&^<-Q>?A_8_I,9QG8I#\MK;` M'?(B?MT%C`;=\YD`HO=@OB?WI"GES;NCJO6<2:-AT7ARU]%:E1EE2B[);'2, M*&-5O4ZKWVSV6SN)V\A7&Y@]N;Y)+SK<4V1@8Q8^<>>4339RHU17^9356I': MLL&:#S-34[23^.:G]&52&OKZ,?KJQ2(;Z>=9TZTSA+<2W( M;7JX83OQ*Q0UU+>#3=SU]?21A$-":LKNCNF&TIY;HQ-ECA:!XG'PL"@.QQQ] M#E6Z#<#X(N;93L51A&[M9BJ*[%-T%(8F[2@P#4]-WRDE'55-J%;L6$)_)B%/ M/I=7_32>'X6KX8Z"#2!"O4.GP8%R+;D4AE5%#EQ!4]=5DSM$RPE$;\,X!(H0 M&";79`%:2,=L2S3F4+7&<;OHJCR.Z-EX92OFX,JK5-+'Z*-):+5R'L%TA4RE M8*C2!_54>;6)@@/)VU&VE`!1!$1G9>FOYA#:*G(>"->Z>45+>QAYC^.;MBZ/ MS-I12II="%I33NY52-ED9:UHY2V"JW93R(%62VJ8CF.IW::=``DYHC&4S82D MD9PZMM1JF:L^%DFYZW'4/MZ52K&RX?W[C&AIM@SI_[>-/"CM7-U*W)B2'B8* ME\BJ&I3!:QF$<>3]GD)T]*2X5<4,@+65'3X+W2\$QC9)(TFS'+E$$Q0M#*:# M,2T81OFZW%]P52WN9P7C:DX939C>T:-_*_/&/H\I]IO>CV]=BT!Y&9`K9LQGE90V,K;:3?ZB\F^3G;)DWA%0483#((*>@D M7-OO6M9M8E5TJM@9&;NY:=H41K M,F"5JT0C-%>B9WJ&Z3B.UFU@:^\CA9]$(RK/0[(V=VJ$+E857L(`/AV@'$3K M[>WTNDBDJ0@O^<]-$0O)9+3+J6^M_]9**ZZ=93(#IYQ&LJ>35^T2Q"H:Y2![ M#FDONL[(2K?=N%#$KJCH?7GFVH3,;:7(.[8EH\ZD9X%P40&P>&NGNC.QQ*I8 M1RB\`%26!U_E#NZ5JU*($I^I*+LEHZQMEKX6IH+PJ;+ MC/<#(R$$GLG3:(H6`D>E@;5@"'15.1Y8*2X(C9_'#^/2MDFJ$DM?YK2)5?:# M!A7FQ'.VY,68$Z7[R"TG'0S$5N:2;,G',K#W_E<"YL?1[/_&!VB,DU(QX5A& M0,,9[_8)E?>B-K%*OB8L6QMFO%6"6T/!BK`FR\9Y9$DQ98R.0UV*JO$U=?_O M+^1#64`E/"85A>,BQ""R++!@,MPS-[`APR\`E<-]J,7L%67/2:F@F5865*,> M*)VS`< MZ$1I?5!.&I3AP6:@>`L]:]!PV7"4E:8(T=_">M-HG.)$R<`&';F)GH&A)%!8 MU,TBV5N\C!,UT4H*S6GAV."$HR@,%JZ'*X4FUV$7Q5VOAE&4&7D%"%PFA?-.5FEBAL% M'3-EX#EV\Z;HE]4FCI&O%FD=@,4)RK`R<2R39H)&STO\X:[3-3)&IK7"[:.0.9H)^JML=DE@8'R3FM*J6]J M83'"52=!IK_5_**P;,M$F0I5,HJ`DAKM`/*Q)K@,?",BE=Z+_EKZOWS9:(YLQBRUB$QLH2454B=&ARX M52S4(9;4KQDLOFPFZKU.D$M*#H*5HGE2DF;I2)&\KHT`)6J7!,Z!3M2`#WH`LU9CHJ:%J$\G<7IXR_S M3X^W=3W484?/RFI%$G4FEXVI`"FV:2B+5N=Z8-_`;OUNFL["QM;B/<%5E#%E M%QFQY,G"IY:-P'1MSDBG3V5CI;SCZE.>W-/;2X\^N:>'LM`F#XNW'[R_SG*P M*E@F.:=L1C,/4G2%9Y[5XW1MSWWO2=B9N-D1H]'JD$0X,>(8:G0*-+3U4-K#8%6I&284(H36&FU-Y8'KL62*?KB?Z,;>&A3\ZIE/?1 M7Z/0AU38Q\4YT_/2J/9/:V=A_9J#/JDQW[IW!Y%-,XZBI`4 M>@B><@HA(IIVCXY"@K6.X*>1DESH7EAP#LI?#HLN8#CQ4_S7X0>L!27I[O?; MZ=?QN!GON6B/W;4)I)%2VU+[#UQZ4CQM)&90?*1\Y!%`(Q!MD*)S@P)!?IG"Q$R6JTQYG%`9 M.84MY&73$!0<)5PR%F_!!?U-(L]C MOX4A>RVM]!@AY8P(K)&&RDH&$P;M-_\FC&>UWTI*YYEU'E'G9JP'A91%*.5H M%((>,EK].O]+$@X1DI0`X7@B<=NTT`:,70/!5>7*Y2MK;O292!W1@A`)-,AP=O& ME<5HF%-^T'ZS"]T_P8N(OYWQ'BD[3PZ-!\<"68HR\39+F50>M!B7;+_?=OSM M@E(Y"Q$C&6M*!@*]4!<:#+T^L+8TWZC35E&$7W.I;@F"*&; M30-F!:?E,K3%R/'9A3*P0[_KQ!-#<)8,+T\N>V.53]@UL-+7JNJ<2T-,KC,R ML!._@9*MTS`X4!*CT4G@,EGZ;-M-P]"^[@;@`D0_S]Q$R5'C&AS18449EQX\ MBNA"2+HER/"Z#(+R$*WT`$P^VT[4-*,.MD`:89#[8D)QAI@/*V5A=@D0P MV7Z'ZD:Z!NZ<6XQ1?4<4DA[/%[.)KV;M[7/-Y7CTO,FO][T)/H4/UDSP`;8R M&+%Z_K+*ZZ=2?_!EUQ5>J%00CDMP.EF!6IEN3F0&K`^W;?\P[#0>7Q2N/6]/ MVWX-_1I\1N?(,""E9LQ$M#'R;MQ39'7G'717)[P&?`_]9RV&-%U]6ER-MOAK M-3?J&;0NEV&.RBOAI<(RMBG(;I1JUFO=.:W!%_WCX_-P^Q(`RJ>Q8?KT:_PV M(NJU*&5VSM!:#BGX;',W)5&NS^WJ7*A^%42;UWZ@(*$>!GB^!;L,2,JDX-YH MU>:*DAK/U5&R&+%<;`/:>6NSC2*SY:ABB#U'WD81W_U%?H_;`5UR?P).I%`? MSWDGY`Z0SG5WY!K`Y%IE!A,B9"%U*!.;.GW-_6ZK)<#Z7P7@Q8C"YP-8&HI" MHQ:TJE02`HI9Z`;Y<;$18'$BP.&(JSS?W2_B[ZM/&][2W>$)!Q>4*"UTTFBR M%UQ89;7)V-[*&88N[-.]T40OQ-B;`7-K^:#EZ!!R"(Q1NA:=*`=7Y&@4K5]F MJJSBSX;UZO__K=#<<=9"VIA8#L!BCB8)#A0.M:J)(=?3+#;XZW\7++=JIN3: M!H.0E/5_>K>).^L2U".1@@A5.B"R[$<0FIGI8+GL3 MXFXO%C^O5X"J'8E41R,V0.QSLKVU M,2-[2$X+%YWU*6DE13?:,'%3;[[(?CGT^=@.HX?2`E6^E9SY\^BVJ)2;A]%L M]I6>UZA(S9[8MF/*)$8C=90N*JM":1%HNQN`U9=G601<#UWW(NH<;,AM$S1C M3AY`K=*>"6%D;F>-E\LK MZQ%,NM<[\V)L;+V1+2D02B5SM]TMS-`TQOY)^;G8R*/)K'EM:;.Y MG9;[=@^:@:-,,>6-E$F#%]W MM5S;]Y;,PIDQ?S53'(%X(0LXF.8&L)_P_KSU8W`G>WL45QXOOA\_1E=Y9*Y.50@60/`:';=)%N7$U MS/#/2@BV#U?#])V1L1W[O"[;D+WCD:,S)A*#JDN**9VN`FDK-9R)K>G=W63> MJ%9Y?[M-<-V_*&R922[78&GA42B""K$#J:5'#9G(=2"RU,T-:[*+C7++5TT)=^6+:;CJ<-O0^CV=6L MV0*\:32^/4WGEV.N,*.L%F'*E,_XFAA!_S\_(HB##/YX+"< M.,/4,],]4/^S&VORP@:,=,C('2/9AY@ZFC/C0UBKDX@?"O8%)$8!K0,T<>@M9?T8TNXLB@'"=?T M3_R3O6OM;2)9VK\(U%U]_W*DOG)68A<$K([XM/)Q)L%G$QO9"6S>7_]6CS-C MCWM\BQWC0!!B(>M+]5/354]55U=M>IQW$/P1"5+#?%">X)9C'F%UDC+2)$@] M$<6QS4IQ[^J7[RG9YMEK60@:!,GW;@,^KTXW;D\&**H6I-Y+LM5Y3OV#IG8H M55%H;HV.N:&H8,A)@TMM&J]5)QXX5Q" MD3G/)^\A0TMC,2SP%4.R_?12;ZF]2-Y&RPAZ9C#!&H;+5$WM1;2VX)&O,&JE MQ1/[)&)O!#L$ST$Y$D'R?"R*,70-MD#7!ZSH%H643^O'HCT>(LF<'W]]&,W^ M1LZ1?S"XJM9682V?*'??[.X=W!]'-:]Y4DZOIX.N7 MT;!X=1GO=0((H5#1@7LI?-WWR8@'DVH,\O/EQ[69J4Q?KP"X'IB?"<'R<+\Y M+OU87,*F[JTWO__KSXSIM(8OV(8>N MZ.^B\Y+*9N"/0;UU;F+\7;97:RK>T_GMW.YGNJ[+Z_9\FMX/K?-7K MW>5_)M/KBP^3[YLWG5+4"HX^PBI`>F`=TO-&C5H%UZM&PN!%C4^DQN85=C8: MO!\,1Y>CX68-TNA2'FEJ74P*E!;4M1O1(6M9HT'^HL$GUN!;_/JQO:FF^'\" M;LF',I;-V@1&B9<\,&1N0(P!XEMM*BE"OS:E?-'F!DW$NSR(=S/PFL1(C382 MP/%DA)')M<"#[=]&0$ZRC3Z?%?!K#1$%K9*/5"@:\!?D("Z)R`$YL/3B1_*W M\T+P+/B;YYS&9)W$V!!_>W3WJ*U@(\8Q(O6Q;>1O\E?\)/PMU]2C7OS-\,T6!.H9(D'"23?"LT:)!1_ M9#OS*I;Y&WW1X#GR-\)LBC%IK;S@2G+O(7?YB4C,F:)R#7]3[$6;!_(W18FT MWB1!0%B2@(7DLS_SD>FH8_\V`O+TVTB<&W%>&WIP8I&Y(>/5W$3*M;*I8ZEGI:_G1V"Y\#?M,0`A2E&$TMH6JRQT"9N!/7]B1L%YD5;9\7?B.?,$NJE MIY8X#/:3@D:-P88U_H*_;+JSX6_>$:""2I#$!>,]SW/I&K.9S+H,ZB_H>)X# M?TL&&`T8"QLI)5&H0&7:-)#7;`U_>]'FH?P-,`R23*`9C%%R`B`?&K0A\!:2 M7\/?3F((SXLXKT.0>0%YAGJ*`0)+^1Q:Y]"#>2>CZ[23/SE_.R\$SX&_Y>9V M>8JY0X_!=6(>A*SS;R)%I3K=3Y;X&]$OVCHK_@;>6H?Z4I1&'RT#Q62=O3'. M)1W[DM[H+\3+ICL;_B83@Q`"(:@S0%^/^LMF,R05./<4UC#PI\_8_.H:?!1_ MLU%IQRV)5AON.'7!0IT/#TX9XM9D4\V+-@_E;PR-&B05N4>PM1,^1%'GWX2F M+O+^>B!J'IF/Z&L$437=C9O#OBMJM-AW0V_*/*S32;IBM]0ZF7.Z=( M3IFVX)V(&-8[)^VB&ZGVJ6SZJU?;(!VRZ%7TOE73VSQ;\(_);35[/[C??X"L M3AR]FTM$1DZ\E<`$;0IW\:?%+29%.%FMT>P5XW&B;NRW['5,7"@7I;72!]6, ME,QMA+M3\N:B8C0OGT34A[8B^+C5#\OR,S>M+D:W*&[=R&2E.T_[P:'Z[^V6 MYTP)@=O0)@K2`3'1:R/:D23*%_UFM&3E<[;#8C-!>C.97,P^3JXO]BZG#IH+ M1]%&"*$BHIWH0]FWI(%B!%Y<%=.P*F1'@+V%VS@G+9E0K;8XGW;8I0))HXFF^]R-X$#33S@8ZXW5Q1YH*QE0[U1A')^Q`VX#B**C#.0%["Y=O4L"$H)O@]Q-_NT(#=Y%;0;? M3R?#JKJ8_8ZV^'8PO=]Q<,J&?8>L97+]+<\<[KQFQ7>^1?KS[K+G8VH?X0;C MOR>7#Q1F_LXPN1F,QHMOV=Q^=.T^YYP3:8-D``9`$8OF-1DA;)3:2%9RH(INBW\9(\>YNYAZIL1E(8BJDW*/!]?R',_R\5`UNBUO%/9RH^Z$+ M&)<^_F,U'DVFM6&:7TQJC&DVK:NZF8RO;JOI3?[8@A[M9U:-L4EK-%DRN1BH M9\X\7*W2%CUAV8K>K)K5QP"V&^*+M]6M7VFO=SQ/C#LW8*.G,D9&O#..>X+1 M=&@@1FN\`O'B9B;PU\M%>#O#=`1PU_OSLT69*6.IE`S-!0=B/:-,-BAK[NB/ M1OE#-D#;HZ>SPG?Y/CE'2QR\9,'S0`A-NCV5U=8IZ"O'XO2U)(+N!>XP?)H.\AW#,+A?.^C\J;#N?MR'ZJ*ZJ6_Y=Y#? M_-)W1:O+QZAQ40_IN,*@-42*86R.6)-J3;S)]9#_>L](V$%+6_#^M97VZ?OD MF$H#DF(TW!OB"7%4@Z:D45K0*OP@I2T2%P_]5FMC^&DZNKJJIL]6=\?9:@QG&7,#S33'FJ;.N71-!]U??T-=N%7^VFE!<%'VUS]BO8,F&]THD*8BA- M.?`G"\<84F]ZT.@?I>"?P=8>>[]V&R`(,(HB-?<,7240(4&V3(=!YZ)2W=1] M'TT^WO+^#'H[]C;LZBW/T*`@D9]"5(%XWHZ11DM+.W6R3Z0W%*-O,.(SB::Z M:$;'63!.)"N4)M9RW0S+T39J7R0+M:S[0JQ%=8'-1@`?,OS/*-3O9JDMEU8F MQA-73!.75#,56%OO>=F0I&[KM@FU!T`V@-9,RL+0J9JW:UKXB\VM1P])SJ\T M;S)4VNBM!RUD;L3*96A'5(NXYJ@90*Q;^*9%'0V+QS]3%W<5OE^O;[!XKGTR MGR0S`(%Z$Z645".H,MK6[IH0UAQ,'U_W55P9)VA M?4;\]"GS`%$&PE.001EKP#K6CA_-S"#T547F&M9UZEH+_G-0V#%YJN/64I-; M]*BHI>8AZ$7>7[E>7(\)ZI_CP)AAM<#\;#ZN.7JKI] M.QG6YY+=^KZ+BWKHX>#Z_6!T\=O8#[Z.;@?7&Q_Z<^+`7+#<'O M5'ND&'UQI+@Z(&RFA"@' MTVUVZ4^L@O/%D7!TJLSGTC^7#('$.;2I/:N+^3MLLXO=CN-E-<60+(W&^9G, M!2.SQ>BG/ZH=1E5U!UX[9=#I!-R',7&J#6NEMV#*RKS5PKRM\O1*_R&G4.K` M\K&CQ93S'I@ADE.@BG+JB6Z[>L+JG-YL0&2_X'VB'"#SQAE'0!R)Q!NJM%8* MN`JBJ<73,19@:Z+T83)_&OS3#`@;5;/'8FVT1+5;AX$[34`)`>$;N7F"HI.F M5J97['72'"CZ)LA=BA$XC=QY%$D%'FDKN@IEK=V!HG]%5CZJ_<-.58&=(AN- MSS!*:K7CG"@AFYI2R?/)4-'X4Q0;$P(#9 MR)Q%BQ%366E%5PNM'BE63QU@9_*F-`;WLS+>,HX&EWB9&K"4C$6E'5T=4?MX ML3:A)84DBJ)F?+0R>`/)0T9+*RTQ"BOJ3WNLZ0YBX=^OJYJ#C"_LW%GLKMR. M#453%`G:>8+!(0\VT^1VD!^G9:TG4+96W'52'6$96\HNA99>60%6R5R!S_)U MEF89QI>C%\"P@Y?1U`TB[^Z?U/[\"A:XCEP(AP[4>^K:V-.$9>?TY\?P MU_OXX:]<*C"M#6(&]36!94A7$>H`&`?3\6A\-6M*K-Q@-AHBXF%T?7>[VOJ] MWW@NQ\V),>F%3!@U6Z&IIR;1=I:Z57Y=7=K@%7Q>OP+++-&< MH:7GA`%(FABM^R<'IG`I:RLAOSF:_&_>/@MG;O*,+0L(&.@(Z<:6YXFIAWH4IAMV]@NZ4UGV$.^*J MM@W:$1SW.K51)0W:,A>;$7[@`Z-%W/I*,'',9;7-R9$2YK?Z^F;2'6K\W=>' M6TG]BUK9.YTV*/D"4=#)YVL,D"22F03/\QWY.BG)?X2=UP>'=S5W_(>O)?C$%= M_WGN_O?!_R;3^D+HTCWL?%P^^8KQ>S7\,IY<3Z[N>])Y'8A"$HP#)TGD6I4H M='PXJ&:>45'D.F!EBL7^2SXOQ/!5=Z/;Z>#OCU\F2&.VH,6C4MYR@>%C5([F MT\;8H,59S\V@E>$ZSQBM-LRZF]VB\9G6.R+[HB^CKWWWH3M-%X1ER6J:B;*M M?;_T+6P)BN-TOI(F^`E@>XLAX7B&3MQ>3:MY%J[Q<\)\*L?U,F4>6ZAQ5 M+"4GI5&+RQ3,)U).OI;G9\H>B]8AILQR)!3<&X8DE[K@--)\7] M9+#M;\HHHJ98<)Z;?-L3_VQ.OQ$TS0H>=CJ.L?2>^,]77!8RO7QE&_GVN\LT MF@T'UY^KP70_VAF\-3**)!U(*;5S8C%47G!:<"I!=]]:.PI\``#Y[0E?N^=L M/XYD47CB9$!.Q"VS34HR]SPI<^M"@V"NM+ODST;QNB8DC?@I=:6,J,==\TZO3%%BPW#S:'+_#[9=9%OII-9_U3K M4Q*KI'A.0EK-<@L209-D;8PH0!7'?)RL'C]N6^*/Q&,_VA24,4@O=:2X^X%: M[XALL`C2EBF%U0/B,X7B$$ZDDL9?7D5&0#F?7/YW0R6#+P[-N7Y6D.S/=W#U MP=KL`T$*G\_'76KYCK+%=-`3;Y<3QV4>(S'">$I1&PO&*4O:N(R$4%C8DYN/ M$T9=`2DA"\F(4`_P`4U\:THMTT5[LE.;CQ\14A'!$S$A,2DTE2X&XMO=@B%J MZ5YV#ZG.`9+]S0>A,E"E2&YC&94"97V;+K/@BP*/I]HNO=65)^8>^0Q7,!8C ML.@D*/QK&V\3ELIR4PPV=HX>5\LU3XK%?H:#*)585!XP@&0L:4-3FPVTQ!2& M0[.=V?B/0N$@R@'2YX,WQ4P2WB05?4LYG(]EG>/..^1'H[&_N?!*<">]XT$2 M+B-31+2'$AXY:F]E^TFPV!1WI7PM.'*JN+$&;1P-(-M`NN=LCAEC=L[7'D'P M4QHYDW14R)*"IVC[(V?XNST?4:J(M9F17#X++/8S<@:]?9ZAEMMS1XP@O.R62KOE:7O(=KPU;2E.(^AL-(]<406X M0Z.GB^(T":(\1!+B*&MZ4XUS04RN6;ZX0?7.ZC[BWZJ'+-O>+8KQR1(D<&^3 ME%;%E$]=FV).1WGA0H5A7>5L$>A@X3&#!9H!!DOH2HWFEM2UM([EVTZL M+&MG9,63/JGT6UH<>X:,#8D\-=KF!@A>J=AVAW8EDY-ZY>#@J87?6(H/F9(' MK2E+W#-)92[*1^A!."-C>5T$R;MYO/23R<7WT?7UGC5]I1J]EEUPTW[NC,)M8'X9Q#)F>8L#KZ0&6&]D(0RR41E`K8G80)H>U M[Z>3RU%/BX0M>S_;*0H0M796*Z&Y:)JDTF`B*R+,7`'5/:];^O:]I-KT9&GO MJ(Y&>J.%BB`,!5?WUI9:DIB*I(@`3>!PJ;9L5DFY38+8Q*FG*0%Q#S?ZZE;N MHB#M@,_[<:3:V,,=D:)4!&>"X2Z0)-F\#SF/A)(R)R\H64DAK9/JW]7UQ:?) M[[D_\^CV_F-[_V/IV/G/\;0:3J[&^0;KOR?7N2-6]EW[[5%GHU-6&VD"8T[; M1-P#PQ'Y(E_9MZ(C_>.E?,K%+O5K01Z8K^O,WEWFFSEHZ^:S*Y:^HCO+!ZF9 M&PS_KBX6K]B6#Q`*G8A*0:JHT)5+`&@`3$P4%/'G1<]/;C#,R!W&WP^^5M-M M1696H6]004A&J`4DV`V!$XZ*,KWV4S]X?C+].D'W6[G)>/='SS&J7=+4D8Q= M4CXXV4#X_^Q=VW(;1Y+]EWWG1F7=ZV4CZCJK##)K*JLDUEY07-=6>J7K;_!D`T3VA606<@< M=,R2>[F1U&35,P;FA6^6QZ[L-$C#,>C7HQB;FRZ:ZN`A?L^SM8SV33#=<0HO#.1Y;:!@;:=7=AKH?& MO'B;?IKJIMCTZ(P&H+3%A'0LHX)D9]-=RI6E^W'U]]??_[+XVBSG;?WVAV9^ MB1^@GSM:E6#1`_"4^BD+4U(30^LN#58GS/*7LQM_V9=.,B"LE=$(EK)&AXR7 M%&-W]#QZ'7W/4J<*^\ONB^Z9A7U>'I]8YL4Z85PL(J,S!/;AX)DJ=?;'U=XX MFT\S16+2EBM&3CD]&CPPBYA_*KU-,?@I*IVHQ4MQGAMFE2RE.[C>UBU_7OK! M'>+Q&@R3/H5$!?":"B&UZ$RR+%74_APF^:F%?58KY2R]LRM()4$$AF[SIIY! M!*1@\`C5(]QSZC*31M. M:FFY?G5OV[R^^SB;OVMN:.!2Y4U(QZ6)0W869 MHH(',R,T!*82%Z987YR3&?Q&%3G5]?A"=\4S81GFOF(SK)`;YD_T"16SQ?C^,??\7WS_/Z@T$`]BK.A]C`Y@IG[T?1[LJ>#5B$5)J0$I%"H]_@HI0F2JV)D^/E_W58>F+$W MV"B>9PDI:&:5HU!6UKKCAU[U-/IP5A^WG_IGW$V#_ZSWK&>LB(B6BRE`*Y8] M=YT)BUI7SWU'NR(O0B/CS+D"YF*V+DMJBNX4]ZFS-JB**MV#W`?]/2ECB@G6 M(0A%;;I\T"`%TR5W$1#0]0L?*.W<\RIEL%U(-%Q192[^364.'M>UHSZZ+K9# MFJZ/"XF=$_ZS'GDJ/9#(5X!S&4"XG(U_./*R\ER.I=8O0B''T.'"(7GM"C4_ MC1HRNF^=`M``5+[%T73X16A@)(5ERN-&B#3S&WTNAFKIKL00ZH=HHK#')2"] M$&5,L7D2S3KD3.^%6J'EIR[7G5(`ZHD-^GLZ(L>_*VQ-6N$T"]BKC"8B:9$3 M7@B;=P4E8WTY[LZ1>M$Z.9D^\P#..YJ-0,70R`MB?G"Q3:@>_Y`^G\*CUAVE MZ;&@+!EX8;PD+ZT$ M%TIA-*3;QJ"1MO-J@UT(M4-D?DJM'BB04@6LXD)&@VS0I!#\YJ$+$HNJ\GHO M@+>UF/]6Z^!FS-LT%('$/U1/43I3JW%"'U.IH M7HI'`@DBYFR93VTO`42KM>1U*C6HOFOP2*S-BB;MCEYZ7C@Y0A=@6UJTSV601XVUPVUU\G+8(`FG>K MJ+[8O31&C.7=U@B5T:NA\23@5L)[13G/F-`V=:O!=.TS4FGK83%V4)U!C`.K M83C"-5&B>Z>#EJ9P)39B2&$K&WG18R1/%6/_8)O1JT(=;9C5)K*`YC5(5C;] M&SE-OJJZ5U&<\(`X^]&=4:P#JV0]\S'B-6NS`6D8Y[P32^.^JJF\MNZIY")V M.;]%-CIA?23WH7@A30"MH^?%J^[PQ[0[J;"="5SQAOUP3@%^B.]XX042R,@4 M4\GQE!\&^FFH*ZLOC#BT`,<#?[-LON`EOQF(?$^9T`5H'QO7[:/&+T6$X(1' M`8K/VCFI0'4]H'+L.2KVT%(<@_-)1#VP>$)"=$7ZG&3FWG-T6#I;S;.OXPL2 MGD94?V/NUNZM-XM8CLW=H4>X#JT]Q`J&^VC*6&" M3R@'UTIE[R%HH6FP%K`4T9H\DGG5(L&;5MD>PC`=\Y/+/[3FP%5,PE&E`A(, MI9UUBN0W$;?Q=O3C^Y3_@"_IHY(Q628">A>E%,=B:->?R82Z\#^"_`>(C51& MXN*K8)S31GG7KG]@+LJM1GW/)/\5.KA[N__E/R\_W[7UPD.-M;J8_H%OV]OP M\-UR=M7S2G(+D5K$BO@"\O9\ZYMIG2^3O(ZL^:J%I/'[;/]?G3AZ'XF MIGTQPNN,-TPWA!.4`I%`I"K,1`LU$ MG0Z&J[(;#1@O1!NVG=H4,N'='1,4:MF/7ED;QMI$!FVQ]?!3*7?WT1:`T>`& MFSYF8($7DR`9RQS76;7]X2+>.R;'GD9Z%3<^`=R!>S!X"S&Q9%S.F5EGK.G: M::8L*^(.LO(X3@,WZ-=IO(RT]NAW:R>HX1^(MF7_>B6CMCWZA#[^IC&7BT^"Z1G8!#W=/ M18S8M9,31=C7SGZ_BQ<\`U!35Y."6Z!Z>D(KVH]T+Z"3\0^IFC.CT+J3G^LT4BWT?+J\-YE-%<=4M668 MAO]OB^4G"@V M?36-WMMP!/1WJE"8W@V!]^.8#G;P*0N5)@POE-G(LW9H2%++&;+60M4N!?!Z MGYP1[:$P!!3B+$48G;ET`=WR3K7XO^KA33RI:@^PBV@57M.@BE:K=G!]VQT$^PO%#]&%?-N&%<;X`X\S%BFXP:*P@(P1??$2DKF/:`:' M/*-B%[L)B[TH)N+ACG`9<#,C6J-%V$2X[&ZS/$MWB9*)S??W@GPAHSSY] M#%3$[$)$NJ,=^NI(T#)G&X7JGN:S^@EQ#BD4MR.5?J.1*IYG(64.D13*`NZ% M5,_A:`KKKT1CWZ4GS#^UWK/`;FC]FG]\URYLM,4@* M\;_\?^[F`!>4"?*(#_$0M&?>"4\M#7,!N5$R@\+_X[_>J+\_ACH:R"1!Z`=_ M>T]I6$M$>:0L@GOIT25W%%AF08)RI9/%QXRRP!1AML%LR[/O!?%@*T#JO&FX M-R9Y$1(7,72=[H&G>@8DETQMN^C[G@<',0VQ!:=<<#Z'@$Y%<4R58%S7?5_) MGHTLUVG7HS#A1O_]=G'YZ>/B\U6S7*V3Y,8ISTCDDQS]7Y$$XM-&WC=>0*!H MU.J'?HG7PE[E]0(Z$?V@F@/>MU);EV00FM+^@6W09ULW>>'D&/&SH(_M))61 M?IP+TNB02T:=HY_O#7K%:[PET>B!.B*B=U[P:P2C`0ZR7!:$RA$D@I%($)1D MW;Z-LNYOPG$WV'$`YPT:@&5S=7V+OY$^^>WU[,_KF[N;L%@N%W^@J8BS+_@G M>_;"0S'$UG=L#SYJ;F]I2OOZ(^L@]J.I2#6"AS%:83;_M'CO;]!#NIRM?S(M M:.S[8Y6]^K4\SLI(:']LQ&,C%!.<*9.AJ.*\R5[[FE?=3QK=TMGQ2GE^;;YM MOBX^?Z5OVOX]3ZQ6CE;'I`6K$\)>@%I?M1>J3,UE M*Z)XXLWZM^;SYU69+3\L2+_U8\VV0I6F5W(D^MHA.^4%.>I]"QCKF:R3/$P[ M_H?]YW>GT7-LV'&J]8)'HJG*1J-=S-PEMU&M\G5XXYQ[=3'_0*R*'F>/+#^F MC[Z:KVZ7=VW15"?S^JWWEAY^?F_FUXOEKXO;9G5UU^#/VQWM=;\J?.O^[W]? M(]=;7G[\]@O-9=Q:DNXSK^9?[FY7[0?X_J]\C63Q;OTX79;-/^]H9%G_]SWZ M)"5(XHV#BCI0$">R"E%D#R:PQ#DNEO:;@KCHI3^I1E>6R"?_9E M,>AJ6!#(>+)!']IQ%=EF60*K7U]M&Z,=MRRO9\M/39O:L"_YXB!ASI*FJ#%K M@E4NDA:U?5E6+H]AI^C%`]Z,XFU*$8J1>I M"!8TB]FP7"B,UV7P"EGG`G')GU*F+GQRPD(QC3L.6!(JH8G-(DO9+13AK].K M&6AVC%`]Z,XFU*$#I8VCY#^1+47?0U:IR^\5>(OTY(P+*\\DU$-MXNC'&,%* M%@FRSKSX(JSHF"*D@/Y-75SH=C(VMG[_2&2#E2O@Z%TN`V1)[T4E%G.?$P'H MQ58QX@NA766CIB$[-`NQA))`IP3>"@@J@K#=6H.H;K,+BK/#V:`-%N%QO%D% M>DHBY.@L4H.4V^2@PIA4=1.F"SQO4%U6^Z`MYI>X07];OIDM;^__Q5_^\^YZ M=4UEM(]RL=O_BKX#C$\D+BH'*D[`J]9:QV2Q5)P>L\L.G*SV(TBVLQW'@SR_ MD(?*&QSGA7M'8Y,C^K^45G,OI`9>=_S<(6QG$'&Q,2KKI9Z:*(='-!D6E!,% MC;@P(N6TL1XBA"I:2Q,!*EGZL9R`>'A_&5!&AIR*M%H`&,_:`V(3IXFT%5U6 M.P^Z9P=\P-ADJS5GBF>6;-8R.>0W&Q5G4WLA%\:Q)P<\>!-Z[DK)222:Q:J9 MSK%],8]&@/?U5%UZ7753$-^1]_;;^^Y^_+WY<'2/@>UP27$I`Q7=RF04>E"! M;]BP0)*U].9"Z@"; M*,*1@&LH6X@[>>[5/YY=:`],>R&H2R("1:_#=/6.I>Q51VELPG)GJ?&;5VWQ!^I0%B54/8;><+N3?'DDPA-X M;@++C#(9V:,0>$R4E@^)R:+.6+L0QNS1XAYV="S*P:GR-/0;%Q@)0J$W!H,L MJ-6D$V"D[VMXM)/">!:4AY*\(QERY]&IAB`4*K%T_-?ZNJ;\`M8<\PE@#E8G M1X8>@R"S+@0J$_?C^FBCB([E8A'PUQG$Y2[V[ME\_IZ3F'R-[-O MK4E-8QM-H@>&EE*5DE2RPAL/G/F,1!CY,+=0X1;*N#W':1C6%%$HQ/.U^7LS M6XX,`0:)MAVEX$&$6**45I56*F.=5G76'^=.3Q'J$<")\BWNEA/DBR4S=+5H M8R;+!?K.4:[E$SKPVEWE7.TYN4<#G";?NX_+9LH"9EP_:0%EZJV` M.MN$3*3.;1"3=N5CA!,E_&,Q03XF7.3*%)LE&@X&2?&PEL\%F6,=:A-ZC[$X M%M\4Z=ZA;]?,WM\VRY';4PH('GT9'6CH7U'2NK51$=S:.CI*B:-RBG@/`$>+ M][:A%_@K8J;E>G4Y^TQ:&B=F`:=$1$O/'$\!Z8=P?+V(QBA?/](#-^,W:2_. M(6DI^^^>V=Q_U3H?<'N'5MEO^_IGJLCP;!DD,CKB^A5GN[R^Z$-=+.38GLOW M`+IMD1ZB"I-2C8)PVF1#MC\'M)6TN39/0-[ZNCH#=MJXU0!&XQO:.9!$MD(B MI1%0M,6MW=9O9K7T1[@:T@.$:,!)O"55!J4>WFP2U$GXND?\YQ+NA:EUL!@Q!&F* MR0GIU?^S=^V];1Q)_JL0VDMN%Y#M?C_DRP'=T]W!'C9KPW8N?QYHB9*(I4F! MI&)K/_U5#SE#:H8/\24-J48"1&0X9'5U=;VZZE>,>8,<)M&==XQRC[(%M96) MK4\(YB0Q&0>KX:4B7CHKLS!K&0FT/AZ));8^(?C$)"@F,HYTQBG$/2SVN41I M)>!ETE!S1-Y@4:FW?F'.SM7-;FNO$,J""]8;`C&#`0=`T[+J`[A1.[&L@J*U MG(ZMR5UEN!3X)"8$::4C&$&0HTQ9M\]AX^I%*MN3N[\K&!WU('CK/@>^4"*3 MLPM<&<("L#*VP-X\+>6^!>DK$S1.L"R`%P-N`K$.4^\F2`946X1]O1\?X^>B M?*W2C+>23'H,TDV50EB6P.1F0=&5%.(9*5^9[X9X`8(&$H"D#"'C,I9G&#,< M#,EH[7Y5D07Z?@/*/W7:/3\:M\>=OX,F&_S9V0ZS/,JR\MR!!QR[5Q"$$J*L M@_&F%O-0M4B;+B9F>Z+77?/ZP+B7X/3Z"+^G,9D!H7%7KPEA"X3DZ2078)RQ MA7>K",T@P3!Q#N5I7<=@XWGAN(,FJ9DLIASR1W,]@<+O7W55GWD0VZEY-(<5_!7/= MW[SZ`2)[T(F(2(,,1!',Z``:D9$(MN`XKU4:4D6KMQ0[D'O`=:\Y*4%)8;EG MX+*S&")!&#Y=M]&(X-HE]R$67&1WP+_ZU+F['U[>MD?PV,?A%'0P;\4"%VOR M!KA>G?R=S7&R#0(;S1RBH,U8+-MEN$3DM6@!1'H%D7=+0@^SV'7%`'%\94P\ M*B950+"26:F48Z'>B%"YR=CG6B-@W!`.^SBZTJ/1?1L^'2<)+LK"E0T>&"W- MPSD,^I%2C@G3V.E8'"Z+)@L1<+U_A57R<&L)6[B,+X-I5<_ZLNRGW']SI#CQ MQEGPU8W$WF?E#;VB]QDJY]K&2-J"%N07$B3#)+@H=_'7(X MJ4^.XI+1U:M92MO>EK3.]T32!J]9$)1Y3?,XI%A2G)I23P%7/*)ME_1(6T#` M^V'X.7I45[EE^`CF(P)-KNY1RA^(WYQC%7ZXGBB>Q\.PRK:8QS^XM@\.28Y! M;!57P6$+8EQ`M"-'F*\X,@6Y8`3?(C17U/.T5>Z%,?-=0@=DC(PP!5HI(5T& M`@*&4[.",9Q7<;@/QY@I#NG]^'8PC.-G7TQ2,HF$,%0$C:6U`9F@4,$0"#OG M):5`6>75QK[52]N)"\\D%B[SA`4,GK(A3BOI>5$1B9PFC_I&#\6%:*5?4@Z< M@]B2!%"EVC+&M9[>50$'O-=R`0?6K'VRH*W7_4P[[R$J4$'@"*F,E<3*45*L MFXI'":/]KOO#_1AB\'X$''VQ35=*>\L9AYW&)(Y,#$61*H@]M8O$?LWBYU:U M&P>>:?NI(E9EC$4\>1H@@A*Z//A"L44@TWOAP!;SP7&F(8X/)A"#@S*:Q#OE M$B!1U+*R2^FLMXP^B;95B1/!A5)(RP@JR+`(<&`GV@:7G*\6AX8Y3+$2ZL)WJLTK-[HRJH.^IXH?R9V MK$M>`,,@<:$J2>=L:A4O!V<'9_;O?AH,>OUP_5><@(8 M1P>38P6!"*Q4@IHM\]8^L_4*#LXKDYPWIG'?*UQW.VO`C:!98(Q)'K3(8+GE M"EV]HQO"<+W\+.^XPJA*/]SE@RC]CSAO>U1UL9Z2513.9YDV$F=!(I8%D-@R M7:"R!:`_FBU?T"*2=EW`NDYGQ&P<#R>ECB7E,F2^[`I&P=8O`T4%$G?C!2S. M'/PZK-6:KT7S103<#T.LB3!KX(<*.T/#Q:26"*1PHFB5]A74[$IX:?"6/FL? M2N.86UOXX-5]GCPO/_+;H'PI%@:N68B@_;@IE&+O."( M*?B'E:RAQ-<2^W$H;F-9,_,;OMW=@U-Y$'NI.4RDH,'WX!-6S>?0\2^-00>L3,8#K%!H[=#+Z? MV?K5+6:(/YMP;\J:;34=.,`6;'V(Z#W&:<0T+P4[0W7<,8EDS7%L'@^VT'0D M8,,)I4AHAXFTG'I;`OP;4[M6X_+9K-ZV?-A&T5'%&66$.B2#=YS'MI-27[`% MZ.E@*&M>W.8$<)].?Y">53'4(F M(PYBEMJ-L^*5CK&#$;ZF?%%E,M8K(JRT<"%(*6T)VV%TO=*+5S%_#DGX2HX; MYF*E!9,JCIFA$,+G%:,Y[P.J&UE2G3B\">7C=K??N?)M<`#Z-R-S>7G_[3Z? MWNLZX!ET-U0J2F'!,"4H7EWHB(F0E7/0E*A'`6_@@%9Q'M?3M/,25K:`L@QS M*C.!(4*1./.9*QN0A`AUX",BB:ST(&VXA)A;&7V"G>K?=XIQ1AMK&(A!F1.. M"I193!2#.*R$4(`8I-Y1K2AY'($M(F-K.N==BYC_FY2D?>J._F4?;*=_>1L' M'SZRO?FW5U+;"QZNV>Q?.^"MM.]NNY>U3Z^QW%9AZ6(!GD`6G'V$0@'."[K` MU">5OQZ6U6^Z[/T()'HT*D!49M&%ZPX[E^/I&I<]/OO%]@0-]7)P#S_[\'^_ M?UZ!$9`A82WS)H`(2\V=Y\7V*%XOI2%25]H5T_;$[1E-6F%B=>%F>Y0__V4P M;O?`HHP_7/\Q&/:N/@V^KSE6!BF=46&4AFW+`L6*NV+?A*UW6TV*EM.V[6O; MBD^84;?]L7T9:X;7[5B<]J-,A.0P&C,AL"YW#$*\^H[1RCB*M&-[V;%_Q&Z3 M*6"_RZ%+4\_X^QH7KTE\1 M6`<46'!"4]!:.H^'IHSFJL9HJ;`X$*-7%@DK'.)D%JE-Y@66/C-Y^Y/!S!)< M1R$`[[52D;Y7.ALD$,LOYF*I+A=((DN(R;!E^6A[3X.W+JO75;\>EC7"$Q1, M9YPAJIWSTG"%L>:P/0Y"92,MJ:$-@()3AW(ICGE[GML3A!URTI/8C&D8B<"# ML1&3>^2U0Q"LUCMC*IWW:=N>V1,D7.=[Q:UW2D@L*)^;,4(T#A+5\'WXX2*OIN_>;IX@<#AB+6;$ M!`'>`H[3"^(QB16Q5O(%"-X,'<1?6),$IPY+!,%='"ZG2$17+#)1!8@/>M-A@>0H;XPRL%O:<1\#O8&R!;*2UM;(^7OC5L*P1KB#G/("''I2A MF2*4!2S+8)?BK`YAIN+8\[0]+^T*PG$*R"I+*7(9\\HZ1XM]`Z^O5C4!`=9! M7,'7NFV;NX+!..6P\183"BZABFBAQ8X15$\K84(.:.)>[XYMYPK&D8@6>1>3 M@U1X#V&8*G-5'M5!"53E#O/U[-YNKB`*WCL+)P/,$O4XN(S,;CNXKJ>.5`7- M?'^,7HE?CP/7&1C(.+998T-EEE<5Z!`;;EW-K9$"LT.Y-((:_(<(BH2VQ,4$"532;@(SEJ(1S$*.$\*\EA15F\;I8H=RC*]RFW;W!/D M`MP(IIV##<."$.%C11IW@1*K31V5EA*1#EJ#/$'/++%Q'F7(#`\43EL\;Q%> M@^AZIZ/$Z+6>M]T\04/`Q&0F.*F-"=1'S((\*8@SX#NI@YYQ3#>-<3N]7IR2 M&1LQ8_OE;)K0QO6"TA!LO146SG40'KQ26R)X\\#K_3EZ@MX[1^U28G:A>>7X MVPQY"YS45EF%N,"2LWS:#1:8JCJ$'N6T`J=Z`)K7I6"YH-S08(@"O2F4,J:L M_"9&U1QOK!4CST#S*CY;I#SX4,9G05!D1$2QRRL(0H8UDG4^:\:VX_/"?O#- MAU`D8HP MI>;``OT"O-1JL@U] M?W2Z-[?CSI7YLS-LWW2*Z98YI^<0?D`Q="]CWT>W=S]>`K&PREH%11PVECM' M0V`2'K&EM;)&+Q*&B!OQ>"G;T7JHY:[LM-\_BP8.D^$E8\Q M,F;+K4YC;M!RU_@B6#M/O4*6L$S#=NI2)6&7<4(6+5>*2F*X6&*NFA[X^ZB3((GN7BY54_FP,L=07`2O2.(/GH/.7[.U]YCU1,7BG(< MJ3D(J=E3V3SD<[7S^Y^=7O?';UV(*L:#?F=1)^L\^I.41!/P2K$DF%OI-5>R M&+J%'K?,E98`D4K[UL:+W2.KEL293^'4Q]],R:+D`FKT\FV8U(D].+SY6WGZK[7^7!=Y!KFQJ*/[,/)+]QMX)__L?&]]&GQK]]_G_V_4_7?G`J.[\?NSGV_& M[RN/0Q#1>7.;<^L"$_33^[OV53QN;\:#.WCC[L?[2/";=J][T[_H=:['D]=Q M"FGZ.*?N^.;[O]UB#"NK>Z^7")UE\[D_CH;_!&\357 M\8VK^-=HT.M>Q?[!5IFL&,7?FXZY@P^T0`^U'HW2:<51KF];<:WOXF**A;\# M_CZ%U7.F3SO`I&U;L3]R+"U3LSW0_XNOYG^D/AG"^'N]I_$SYQ>/)$8=@ M^+%YO+FK?VL.;;G]"9/M^/"C>&.9DY>]\[UZ-;R^T>@M> M'8EC%Z2$,)?_]/[K8`C'Y\WEH-=KWXTZ%\4?-4FS/X<)OR"G[Y4S2GQY]P^R;%W[;[$&\Y7.$/\L/+EOV=)=S M1,'+=F_*Z:^#\7CP[?TCL8MJ85ZFYE]//O_HKWN_5\@O'V_\O`^9G9)+CU;S:NI`$\Y@>]^M'+MTOK+!$#X M$+QBK;MY+5K^W+?]T,!_?]JZA$!L.+OUQ>=CK7UR\@Q%65M4\A+A!+9\),\7DK MQF0;"/7>#_U2YD]/16Z#:D>B*3S]CWVQ;JT,KF+A`3B5B^]>6879N4#HX/PZ M"K&)SWT=MBY[G?;PE[,^A#AG[THF'$K-G98VF[,@LR#@L3$IO?WKP3#WX$?= M'RTP*>/;4:L##O!5ZW_N^YT61;D6Y-N8=K+&M&_#\PT,]?Y/*=G?$6V*I+S( M87LE/D4\0'/^Q.8G:0/'F((ZOQK<1]=P%\_XN"W'_AR.=;Q]%1Z)VJ-'LC5# MCT+P]JA%W^59I(6?7_#W?[T[=)IU42YW6O03<;W]#PB&^^U>!D[&X%MG"#_V MJ"XIWA-NGK>5EENF,;&&9EA1GUE;5*E+X\2SY6V+K$-5>XI*JI"2/:=NO^0I MU6\@S0__.6H-)_QN?7UHW93,A7=O8+?.6]_;HQ;\>SWH]>`P7-1D[NCRG=-D MIGXK,:%"8:$D8_M+99)=%EF95NN->K^X\OML--I_3;)1?F8B]HY#'EQ:=HG MUY(\;29/G[L_MI*F5ZZP=KK672U2A[C4;93(%;GSI+A>4'$E*4L*;6\*C9^T MB=S+Q<2+"TRC==7)"]#NE3))@+86H).W=7O34"]04)@$\#0$\,D:;G-'ZY64 M1/S>[Y9M`:.=C_,!2X2/^S[Z0(40]06??AT$4>=2BA?GYU&(W1Z,S1'6C>U? MY@[.QUU/]6Y\/H0LK^GYVF87)'FK?TJB>URBFVQ]LO7;VWIYKC5Y<7X>A=@E M6W\D?$RV_BFVGKY%R=8?F>@F6Y]L_=:LY/12DDM.9.15V M)95\`N*55')2R>G,G`J[&JB24TO8$L9.IM7N2^R>]1ZY*2P\BJOBQF@^>:Z4 M>G&.-45V#FT'FJG%CL^>OO!];W,,,4&I5/OHI#.9W61VSQ5^^3[JILA.,KM' MPL=D=DNSRY+9/3+I3&;WU9M=S,\QW=L0PV1WDV9KA&9K)I\/8'>Q3B@D1R>= MR>XFN\O.&<(OSK*F"$^RNT?"QV1WRW@7I\ZAYY/*5("3"G`:7%%R?&)Q:@KY MI/G52/%**CFIY'1F3H5=226?@'@EE9Q4 M"0E2,@^GP,A&"F2R!\D>I..7^)CL01+(9`^2/4C'+_$QV8,DD,D>)'N0CE_B MXTG8@]=>J_Z/]KC;;YEO\('+]KZD;V>]?@I]78=;\P':L\X)V5MW5E-V\M`Z M-IFDXV'7`2P/W:`CJM&\>1VBU!2M]$KM"T4ZV9>D%$Z570>Q+_M#F$JBE.S+ M*=L7>D[$WB;:-F4GFRCE22FE<#+V99/\6&KJ6,)$,^JVWWUL7W:ONY<;"-HKO)K'YUSO#]@UW<,W\7@= MGU)O)A\/$DVD,22I!NN9[JKQWG(]2=&GLW;"?#R(6T^2HD^*_EF2^HKQI.C3 M64M\?`E%SY-'GQ3],V77M4JIFW36$A]?*'7S=(]^UW8)=.P)^2^#<;O7^O3A MC[V)V2&&YTR^\__9N[+F1FXD_;P;L?\!H1W/2A$EFO?1'D^$SAGOMKO;K?8X M]A&L`DG8Q2JZ#AW[ZSX*)5^L M@,XK$6P;)G::UF[F5++U!K+]@'+]E:F]AO]6J:^'3[<"SRL9>JC-5^GU:SMU%JF M[BRY:IE::C>J[P&])3[<"SRL9>JC3^.M1CW6,K7&LCW`LKV5J8-'R-3Z[E,= M3+-;5*OC:_8O+N0-,=);BZ_Y-@FYDPQ9RX-:'M3;KZ9C+0]JAJSE02T/ZNU7 MT[&6!S5#KLB#SDO*@P=H6C/DM\N0>TC''63(;[W(RV=UK8)46>.[RE%/9W$K MO#`=^^I99SV[0JLM'4UOH-(^),#LC)SN8$MQTFM(LRO,L&T$KP7>ZP//+@N^ M5K-I,0M#S6VOSVV[@FRUF%LKYH9.ISVHQ5PMYMX<\-1BKN:V6LS58@[;#?I. MJUM;<[68>WO`4XNYFMMJ,5>+.1)S6!/"6EGK6LS5P+,SP/-VQ%SI;.[[1`)= MUCZ_YN^_?:_\Z>V[*W>FO-17'R?FE.LR"N<7MS"I0/IG:0P44U%\>O;K9ZO[3_]\OY@=`>?"'=Y+@WNAST6Z<7 M%]U>]_2\?=H^'PZ'9V>7)_W.V>E%]_3@[TLK4Z;Q%SU7L?B@;L3G<"Z#>]>H MU-S7@3J>*6**5KOYW0_+.$.?=>#!JK_K](%M;.^DRI(_LA/^B(^_TPD,VN5N M:35$.!&?(A7#P&6BPV`C>SV&(I7=U^L"2X:7GT7V9* M2-@6^4^7:%EAK>OO"5>:D2OP8:GZ'1$#.=`"P`%HC#@W^< MG'PZ.!(R\.C)*,5F^"E2T]0G;J,6U$WCJB&NE)L"@;1Y[.+6G>KVZ.#LX:@@!%(N5F.3TB,OTAS>!\AKB!'[6*`^.S0IG-.6))I$,8H`U(DBQ3,K7+4H;>N@S3%]<-_@A!8Q:<%@/V2W%46JK$ZJ9U$EI?%Q?86<)%V MCIZ7MC)L`BDD;='G+K\)\#(J(\W%4P")M,W>(;FVSWP`W6D@`5L(;8$3X8L@ M3$2@7!7'`#&`QD!@0-5$`S@88,I0;`)`(,4D!8RY@S5NB)\8F<.%#A`RJSCV M7[$`G4=."2J)VW/Z$E4-=N(`HCF0FO$:<#E"Y)/>[Z#Y,C=I%J@/E`2;VZNX0`/A'.=$,ZF49Q*F%<2"I#TK#04 MM%C6'@B>D3'A\568*,:U+;"V#7?[#]9/5F+C69CZ'K`&+*K,-)[?TX"D+3-0 M%4PRP'RX:^2:#R'JIR3L+,756@"P8$3?I_#]M:=`4M^I%8[,W;M.R+IXPV_>QSZ'G<$6P!I#LP.4/U3#`B*?C`TFV!= MKQ(@XY,!9-WM5.BZ_ MSX%W^;Z^=4#)D`>+Q;_5-*'B?T+IHMZ`+_.094;Y'NNXA6Z**H2,%I^<>5E M#0$+EB&::+$NTUPALFEY!KL?!<Q` M5EXZTK:14L_9X_'Y:$!P9XM MJRB+6>619,Q3H;1"HM-WX+]JX&>TL5;*V`W&)UI<1-MCB>0OS1*#7, M`J&6"W_(A!LODQ(]!V8-O0:!4Y`2\,+;\KUJ&"I_"S2%[W4\@]>DM"5!1,*J M@NI&SR^@/;5A@'.,FU.3$_1W6&;<_1($D/:YL?<]*,@3/PRCS-=*WR\//AE8HA\0"='0@!K*2O-7S=/Z2"-IJ;@E"<[K?M\M*F%CLB88X*?;\,E(" M:P%O39$7R.N2VUNY8GX#S4 MF+SHN*43GU\6@2*(:N.*3,M'*71E1E4E5OK<2.;J6A1Z*0#0/>KD)_ZYJ@2F M":C?^6ZIGE^I6URA( M]%\0ZIQ=`,I&?Q3B._-J5&FW0MJ/OUX5,%65W%\JR.3!:.02-FU8=P8DPY<$ ME6M@LO)R$>'I($P["N=`D1GLNW;6\=`ZZ.:WTU&^,MB&H'!;CP$&/ MHN(##I2J@.`?*1*!7F;%H;ZL#^4#?[4'=70_D8"#R!$BUVKW6K MSA<9!&$:N.A@2^*'62R+_B`M&(^"4'P')3&QJUC3;@SL[N=\[K),LVJ352UE@\ZZB-2U#M/8OQ-3/*LL.SQQ M"H9N&5V0BR//Z%P:#=EKQ2?D="")QK^Z1?U,!6@ZEPXGP\4,R$"'^N0E=O$X MG0\RBY/92O>E/>@5_E[TXX(JER0X>F@>IPLZN[I?!Y0Q<`):I&-8)S5A?X). MC%,H0A]4;JO"4-0TQ`$\;1D-AU<7I"$^A+S`-_@E=(Z'SAP0!?+'S>.]C`D! MW]W`5D3YMI#Z_L/!,LCD![X,PQ6^IMM)1;V\&SN9%AV M8"^;FN4XMLTD^HIH/`!.GT[[L:><.@J@PN73`9`D,DCQJ*,U)&'2VE>A^%-A MDCM+-FIFU<8E6PHW"!'E_(3V)`#-.N-J;1#E,O]\^OEDO<55%W^A./WZ$#2Q9XS[8%?N@33*\A2H;()'PS MKS[M'<9H$%0IQPX>92='Z]5ZNY1=]M.RXXA?;5G?[]I7HATQ3A.*AKMW$L86 MV%=D83\O:=Q9J-?224]YLKZ,$_+&H:Q*[.V2CIW@DI+U`QR>@IXYD]X:IJ0( ML.RD@N3$FOG?K;M8KDM'"J MEM<7]%G\JB?@051&->H)#-29Y86D.'+N/2RUQ!*=QK!VV--2"@;KBO!;PYR` MLR`[]75QBI9KM12-`ARK6$/`D[MYZ"G?,4$([,G$ON'7L1P#GN5ZEP2LS_3N M+!H]"T[`^P%TX`:&WA^@R\_"D*(.'I0)A^8(SUR4>`\/^Z(#GQE@_ZQ]$D;CV=*)71T65S?R:XR'K,*O^$S>,=TJ!>W+]\TS M/QXT#^ASO)!N]OGQ;KRYC*8ZX$'*-`FS+_A.+GUSH[UD]FXT;#2'W?:HU1H. M!IU1M_===BD8XT_D(E;OLC]6=EDQBW+BVOQZ;W=MINBO2'U+(_OQ8-#Y[L&+ MP]6[SJ9AZXGMVKT7>>'C,OZ^VL7V$`:"M_C>S;0'S&TW1C\/R]ZX>9^:`/U% MRCT^)P_Z\&D$'-X;O7R)(/VO#*2?&LIB'>'#OJRZWNDZ_::_L\EZS#;9[N23\NY!KQCH)2Q*D,`*JPJ0P=\RF;[1G2*K[RVO$OIGO9;WYE[X5UWRKMP+ MI_@2=N.>!%ZNP;E:Q4^['SXX/1V.3KMGYV>M[NE%Z[Q[>7&2W0^_N#CO;OU^ MN*5U6>\]*9'+>)E+!'LR*RWA>&])G!8'%\9YW+)XS9L_4N!F.5W=H3P2[Y6, M[7`$[.FB& MAG2]DF^U(R5O*>@4$^&!\4N=4,"EC,UEHMA2FJUMYS5Z9T/"?\L'::W!L--I M#3J]SF`XV*%SM.9+GZ,-=_`<#2MG?B-.A,\*!8+'5]9M^@^LN@=VA5H[<>2P M.S:\TQ[82TN_ZVO_LJ[,MU>\%\"E_PAF><-N?J?3[]C:-KNRNB^_.[X1`0W; MYC&%'+]ZVU@EWVOOITXMAFHQ]-7[:5B+(=HV[=YC*%&+H6]<##VFT.(W*8;: MH\:U6'I`+#7W?8-]"1/I6V.7K<00[D/$UDX5LMV/B,!.SQF\8)7;O6`CBW"V M/X%_6RCENLWA6E]TD?UW6<0B11A]8RY%;Z.(U^X5[]IV!$M>@I"R:.S9,(Y-*%`LRDB]EH0`=1*N&\E;RX&"\L+8W;#IH>4W@MA2F/ MU50'`2Y5GAZ3+]_38N;%(*RQ)>:-M$+U<&'22EKI;@(`:&=<7(+Q-L'<.E@= M&_D@"W;&#&PLM8J4PLPCVI[PLIP]#K/HX9P<#/*FZR*2`4'VH.)&^;XI& M(<E&83F?X8<0MN_<\W&[2SV-U%P;>,EXL MY3WE>E"82&F<)1=SQ)Z3:ZGN.XS5V& MP]6$SQ*C\S'*/S[B9%VL[8RVP2)T[XA)4,KZMT2RGBDS'Z@; M+#F?T"TYUC4L9?4=OL)]Q?&1N)@O_)#SCIP4_,]%9ZG6'=`"*]*^&?0%,^Q2 MC:.R3KO!$H/U%JH@41DBD&U*)6V1(=2M'2E4%2=;!H@MG1R4QBEN\T!MSSE(21 MPE.>CCF/Z1U^6M,E3U2Q(C+%3*VFTZ5JF=!W*?G[3\%UZ*=!@@3]4G1:J260 M90EV.",X%E_,*X%)DS_5U$Q(HM!?*AK'8!0K3$J,ES(S.E(BT"D0,@)=XX[2 MC@?E5+7H$X,U)&;$;,Y5!2^;;:7T1()%7MTT(FTQ!I4URB@L[IEGD0'YX8FP M1OO0L//QHM9T`P.Y.YZ$:;2EX3]I0?87\ER\HCT%#/^9ZY%8FA!8J@^Y#O^OD6&N^4KVM8RP!HEP?:GG+!Y\HB((>:Q'"(0P90^! MJ_`&\(TIW7+-O?,%4U/+VM5()*ZA(,4<6H-MB!XC5!W&)AU#9GEE96/F\BY/ M!IW55/2UP3.'*MD01*4\*+K.[92@VRF5.3![S\RF(<15"NCLDJI$=@S/$E\9 M23#[3#GO6T'*H)D'SY_J')BLT##/4@6`.8(R)D,G"8$Z=.G&>5$SP-=SS0FS M3:U*>(49A8[<=`Z&-)I0>3%>T%@3[:98U@$'3,5H<+C<^G=056.@9Z;"L-RA MAF1?@=(V)@/;T,/35#2)WJ`K)75]>0.$^8TNIT*$?3O6M`Y++M2-PM@G3 MU7/HCV7K@>L*M9W5R3HTV\.#[(>#H[S&$T$.`@?HG!+]:2+-$\S_VKAJB'.T MNF"G@TQ.(]C.^6=`BG,%VY=*D\"V0$_NE#=D25U%A<+@*/8[01/7]/Q)HN(O M/H0`C3VG.QPY[5'/$7VGU1HXK?X`_^PTT1KK._#`:-2!ASC&L.?T!WVG/^IG M);AIK^(8\H+.X0WZQ$'CS";=*.B"A6"4^D-S@>\TP#,H/=%(D+QP'&A!BI08 M3\[EU/B@J0S5\JQ8VG`-+LJ]CZ7$&HAI7DC8FTDHHLV-*LB`.>2IHIPQHQ=$ M$>Z1GH./-)]K/0TC+L[EJ0E^F:T6N;M8>)E2.JYQZ!KU#)K$[DQYJ6_R?L#J M$3855GB?$=@+LY$Z8A;>H!KL\)C)A$\3,AU(J\194:$!B>]6U*/TH`$:MU3T M"N>&5"K*O"W"V&0SX4KHG&PC3PQ/B?&I8!"FJP:6^&'@AC(4V`LN/$OK#L&*=BY(;Q>*81)D$+DD2 M7QDC`*R;C(,RMLOJQ.%\6+O.)5%I`C>X*`'2S-0I*0F=DF@B"I!V[G`1M-4Q M^B&*'>%Q/0)L:O2@S.5;%(Y'H3EEV5/,8C.^K2:M>EP&JDKRJN+WCQ-4YU40 MTV@^<^6.,UPT*K)VBIY)DY,T?DPVJU9_>'G2/6]VSSN]?J=W<=([;7,VJ\') M:'39V^]L5I3@^YB((\KT>[*$VFFM8*ND9%EIQ8HINV1!'X9M.4'5E`JP''.% M([>T6'EXB)&HF(&)&J/HL5,YPQ&5PDH>^IHYZR\@!*,4?A^!A%MH_!HP/@0S MJL$IY#JEYK$V-_Y11.W344238JC-7/2MSU:@Q:G9;[?:@W1ZUNOV^ MO=15K?XS3=+'] MR$ATS(X>7E&*)_WU>TGY&3\2.Y1-R7>``6*;HLC+AZ8?:QA6[5,.I3.GRZ M6CI\VO1"SRM,H^V:G4[#(:@V!=4-C,BW@10JDSX091$GS2B0C-Q:UN/PU0?(0E<5"Y>M]EIB`2J,[8D3E@6HE MHK)8J'RQ5FXUDCP0UV*=A;U'75S/`K'Y#FCW>O=(+S1M\0,IVK8^IZ/;&C,7 MF-/01^50)O4#+G,[HEJB6F86LJ:U23`%5$M42]/MB&J):ID5>*L-?9Z#42U1 M+?=OQUVJI2G@S(4@&@/!:GG_FF<*2#(2%L@9Y`QR!CF#G$'.(&>,PE+!.(/'*5;;]GJ%`_4L M"%:@<&WZ0O(6?G4AGT0S4JT/D&E6\_5G.9%IR#1DVK,KZDT,BXU,0Z9E;[5* M!?NT3.=NQ9JB=3P>*&_%:32`^\2C<1@]$MKK4?Z,,^E#60JQJQ5<]<"50EPI M7-'CU+7U.$@/I$?1Z%&UM2WG(3V0'D6CAUVWD1X:IB5FK@IHM^TG&GUC:7>BR3.4IQU@.:E1:N!Q1ZYI57'@K-M'R/3(L#M.L4JVI[PHO M<@VYAEQ;S36KI>\R5-&YAAM*Y[^,0E&J`))SL;0S(=I^_<1F,%VK:EL.>">#` M"74'=>>9-?EJ&74'=0=U!W5GIRM+=2NC"1CJ#NH.Z@[JSHJ%GT8MHZVZ`NO. MS`+/NYA"#9>F7_+W^W>)>'M/Z>#LD@O'"T42L2^]3NC+PT//_WXP_MQ7EC38*6M9Q[W>,#>]M,X[I9=?J.K M7=7'A?CPGUE,?@N%(&`:HFRSMHG7E7.6U76@L,(G#UQHEK.*Y+1.@,IR>[+< M`RBWD.4F0RH(,,Y)%#[(W2.!TG)9)!*,4\.7<1^2JF)#(@H\I?>,!(E_!QF% M/0"$[X=!FJ4@81*+F`8JDUX8J8<7#+1-^>-^Q%CJJ8)_)_#&N"\(`V,MQI7? M)GL]A?QW$K!_4G]P_@^K7CZOE$M$$D1/`675(;?JZ6)1-P6LVD$+QVJEX[?F6 M6_8XE!,4`O,2E+1]2QI"#:4N2_Q5]B!UBY8=O45-_-??BMTW7)TC[*'2R4[A/BJ^T M]V*H6\:^NC= MR9TI1C-"TP=%=Q1Y[I= M[B7R='VP<$A_FX7CE;Z<=W.:*H-X<(U27=_@Q!1"($%&/4BUK&U%NRA-CL<$5MOVX@6S%S./ M$)AB02,6;,Q9DRF?:O17@UMJ*%%&CH]0E7*G2MD';495PND&B@^*SZ+X5.HH M/C@D0E5"53))E[_=L9SS=Q5K=W45I7V#E/>NLB1!(A?Y%N\.*(49%$\',L'2GZ+.Z';HD, M6<0(^^YXB%+ZV:N,1+)/UKB/Z7M.#*),N MF:_$$WI>0]W:E6ZA+RQ4LYVH&0(-56Z?Q\+090LZ$MJ]*B(JT>D:HK(`J$2M M1%2:ATITNJ9A%-H915%26T/A0&WXZ&*[5A/FXX*W56I:=N;VR\55;0WJF$." MYBA4YF&S-'LO6LA29*F9=LP/2[$OS1^ZS!WLYLJ,>2%IRVH@276@"_=$SJ^9 MB"/NR$N]Z8R4#FGD:IN0OGJ;;:],JZ"CE3PM-^9OC)EK>E3M,M(#Z6&8N8PQ MCE71-DI#>N1Q:&6BM8QA1]76MM!0E/;.9M,L!W?H%N8@2 M@XXI^,C5(M(!#]>*R32KFOW&%3(-F89,LVO9KVLCTW".A40K9[_+6Q2$O&J/ M*`>3KW]2?W#^#ZM>GOGK-HRIIPTA<^=H*X/OQ`T3Z;KA-0=I\[%5:Y=L?6OD MS]KQ(+9LC5Y"S.%`\I#)66GH=F_;1"()G'PT!+CH3>WT?LGD)-!A$/'#Z@ M'J%^F$!684]/J>U3N_9&3VF=,%`DD_01+.!A1`)H!6B8A$G;-\FQM'TZSV_" MU/3\)DTEVTI,OK;.3V2KT8`D`5!O".^+64`&0$ON0+U[4(+@_I3\,0AEJL?1 M>P58/6W7(>!TQC"C>*'3J@QYW%=/R6P\ M]=(!/!C$'#`X3IG6")"9NA2%/,81>D"(`GAFUGTH3RO.H`$=54(_A&_'I3\E MM],?1S::-NSXF[DJ0!:+WDQG_)C*A\;E6>W*=.S(-'V#8#,^54?.3<%*E(1^]P%.1*1"1S^7F^D;!1BA(+B27.1A!)EQY#E.>F(X/?,V>UKR)4<1[ZC@SK*XZ@ED[Q'J M>?"CPX2@D3K3ZO(T&'LOC-*W!@Z;";0N(&/1X\P])>2:]2"W.$Q//;?FYKOR MZ_3`J3SB)T]'PU]J;8/*@Y%='D#&\ACC30Q?^%#+])6])(+'HO&I:BC*Z7K\ MC_Y^_RX1;^\I'9Q=CA0?F^OC3CS^\'Z?J4A[]AWH):PO! M8M$.W-\XO>.>.C?Y206R9^Z7X%J>I90'?R'!YS"(QA\OP*KB5K;()'O58/`! MK/+AJ'LI5_1^M_^\O3PBW(4OJ!._O:Q<-"Z[EU=6Z[)Y6:W9G:M.L]GI=-OU MZD6YVJH??7P"Q5D4/7-T<9E:[13)$L&]T(,N4Y[:[8%]R8,T,.ES%M'(Z3^2 M]-BF/"*LVIL'/7G04R&5WH5)3!AU^L2G?P$0'(#%?0B87'-RF:JV4\>*9?(TE7=K51"5E%+3N-;"3,% MM51!%U?VMLG^;+&4NE4V=X>*LS@Q7'_EB>'*SD_45G)R-!8KB!7$4]%FSW3F MI#!O)\5:VUFOM7);;MJ5=Z>#G=$82`ZLY3`H8H,P4M>IY/B;)`+^7'\#"!&K M;Z.Y8L1&LU&@_3T)Y3QP$'%'W>5;)0DP;9)WW'P:?6/I%'%52BY'?=*VHVG! MJG3'O[$'YA'K1-?"TEZ1OEU+M2.8>J]Z2)#Y%F0V\4`^1,Y?T6S(,AW"O)5EDX"30"O(,`1X+L&^$:. M(G'P?-Z.R?@VR_(E40UG-3.>Q>7/C9HIC9]U/?=*%2-A@9Q!SB!GD#/(&>0, MD4!"^B']D'Y(OUQ9#>F']$/ZY0Q]1:$?[D6;>?'` M%.,?)A1U0>5!Y4GHU#,:\/8ZL_0.U<_-M?`R?TV2W]?LF%XX4R MMTTBV;:NK/9%N]NI5NT+JULI7U[5K322;:=YV:HU\QK)5GU<"/B0&HN`MSWY9)V?R*RB4(;N[:G`O:/XT\$] MH>IY^/&!RU#.:5!I&9Z#^S(2-0]=<9K&OAZ7"@`L`XI`218>4VT`^3%](7M_ M+I]:!%)Y\!8M&>H+U`M%L_4635I11E+6DEO6,8/J%0#5V%0F1FA\SI M6Y9`%`VO,TB[RZ';C`3I1:&OS/K'Z50$J\6!83AL#0C@F`2F[>L700),@Q],I>(@"`">'I6!"7@>5A0*QLF\;_/-UZC&;6T#YD"VCNY`^+!R^&G1_G[ M4J:07WOOAGT63(5Q]H43TXJ):96%P#JJ*:"6(RL1(6FL`"`K%*D7KFMW:!'J M_I6(6,6IAHQDRLUH3H9AXDD,R,D*E#J=NJBW!@Z42T:Z5BT]$IE1.Z:SCV-Q M`B:"BF[R_4E%,Y;&NY'S=36EWV3V?=7MV@W[ MPBYW.JVK[E6UV;'+Z>R[>F'5:MW,9]\Z->;7X(&E`)!QH$F?>2[,CM_"?%1: MYG$4^EDA34RL)8TDN(C'K.F%$BIJRAF;/U#0-@@?^W:8*>@J)P_;9'^V6,J7 M=DN;(N1I1.JL>\P7=.\S>FF62<@MF! MP=(HS8>C\I'Z+&#$,_Z\.76'W(W[\"?4<125U0%:T(%@9^,_%BH_+=3LN;7I MRFM]Z7W(%QQ]4X7Y<%1IO7EV47=^Y7CTH+7M<_:N7[CKYRIY*2BVX%Y;$._" MZMCYG!:^MH=(V*^)>]WP-F(3L:D+F[]$H1"KK/Q',%Y?6I7B%\H7M_\0N?*YR9P7L6H&5G\; M/8U81:QFCE5Y/HJH`U*9CD3-/".JWT^L7$LGLK+,G5EFW2>;C3\DB"=$9Y]K MUAJ9V\.4EMXIC/&T,9(#R7%HY-`W%\(I M#W+GL+BCAE[8N^B8J)BY4J#=MK^$4/U`>2Z;FK)::M6S7\X%8R,0\85BG%R%%E!KF4YM2O6#.XVC*FG#3!S M7I@J@^_$#1/IZ/DU;IA&F2H?T@M^G4PQH[X[F2\UX8XMEL%)Z&K)UKA?_IS= M<@&CK`::"Z4,I>SEF^CZ%DA?:K.-=MES@3O<@D>E M0Z4S7.GD)+2^.[7+!8QP56WO)MS$]7D&EEMO+9U1=HH_53#16H@MQ!9BRP1K M(;806YE8"P=A6@&'D0_'<9;)RO#*B$03I@,'&0D)HQ\B-DW%)D8_S`JY&%'. M,*QB]$/$ZLZPBM$/=0(4HQ]B((Y7;J65ZA4\>KXS2.!I`!0>%)[IV`IOF:'\ MF&='E!^4'Y0?E!^4'Y0?G';MGS"X&;G/@"(9;X+K)Y=5*S7*VBYVF8(`$WN= M8G?2Q64(AGU#FB!-GK]1IRWZU"("LANMXITXY,[^N0.#L'JKA;V+AIF,F>LJ MN0RL42"?8>52K8*N9W'MTMP^JSADT^9>'7F&/$.>X:X<,@X99P3CU#"RCF3+ MQ:5#I4.EF7_/W^72+> MWE,Z./M$HV],/7LSN09_"U6^\$+GV\>??OSA_3CEE^B>!OQO&O,PZ(2!LJCZ MT`[M]..I>VF6K]KO]Y^WE$>$N?$&=^&VWN%#ALTH=-%%GPZCD9SR&]SFC M41L](2M:1UN5YOK.:E-?G7;3(CH+2R;_K@(W],)[_KU$?@V<4W(<]QDYZH0^ MZ/?CT0D!6E!H&8\.:<1`0-*['[*)ACSN3[Y@I,^H^[^$1C&+A"+.(`K=Q%%) M>]3AGA)"`CH$J5W"`_)K]`!U+I$.5+(71@&GI^06WCYZ.7'9`_/"`=`3Q"2! M/&(0._5)"JQ(Z2F8YPG(+0@?H%@/C/C,E9V;?)H[\$+(F<@ZQ1&CL8HT#MBB MTMV;0UPN5*C)Z^ZBD-6!(]"E^0XZ-VNWUT\O3E\.5\`>X2[D%>P(J`R2SC M84@&'HVA/+XX(\?6";R2NES:&MXS*=[;Y<6+V$"ZOCD^NOI/^QJ:&&IU;)_, MIQ'24Q-HWO%X']PNGT/RF\E'Z_RDI(PQ+?=,(T!7EJ0M'T[SDJG'E2>".F38 MYS"^\"D8&/[+)'=>&(*=O7`(J:,PN>^KRLY\[25@V(7V@GXVDO:6-9K:C@>. ME[A,O7B"<]+N_E=]FM15VOOF44"_.E?=_[-WK4]F;7J8)T M`?!MW]PJ2K)2R2:V8SE;M1^'P)!$C`<7#]/<7[_=,P`)/B21U(`$P$ZE$I(" M!C,]IT_W]#1ZX+KMT?[W^]^&8"3"[RAAT"IZ\_*9^(QFYX=#\[OPR;EG]=[\,@\ M+LSF.A#$+."@95]RI&IOY(3@PX#;8!H!(9(KF`VJ"KH(#`%8#K5I&,_0/.`< MBL;_O'F\D4VF43CC4O?APF3J1L[U#&AG(?0T"EBF!:#;2>2.TB2,@"I`(-_< M#`H`3OQ/&ME\N^^@'*"FH.P1L$^0\AOM:`+?6%AT-U9K^/U45E=NEVY/TE)5 MP#,$#T@0UAL7$`L_C!B0C@U:Z+NIKP&?A`MX(D+,#F$)`2(:+;19Z"T2#M@< M>VD8A3R90I>`I=[8H>^'`5!DQ,<\PJMAMEBL7?%/7Q[>`^M(O?'!&$289UN$ MW:-XRL]XP98>O7&Q>P$B1@X%T>1P#U@G@OX)D-YH'P.8V['[71H:-Q&,#HX< M]#=VE]8KP]8Z0[--6A."DM8DAU$L!!0XH)6"X5;\)&Z.^`C'[;EP$_1N!E8+ M_?3B,^>@C#!X@AA MPW1RJ?2S$,6(LLWM%M(+S$*4SM"2-AG9*P;,@!WGR!ZY'D(.I)*C6&`ZENX, MVL`1FP!A2)S!Y:'`6>+B4AC1[@.*W.`OF!(!+L%!?'DCRA?MW;JQRX`K6MS` MJG25LG:!LV9`BSS:)/>U(6'[HP2 MB&G-4MV%^*08J&,5\($OR_B.M@KP2-<'IO(/N:H"??XLG!-<"3R`0Z69QO4? MH(/@;X\X#]#.@",D31X^-'(8FD%!;!,P-I%8LJ"K-<-GLF6@".X$S\R=H3.7 M^UN!B]>(W@@P#8&?8%T%JX:?A\-/5RNG-DKQ-OP6\0EXED*YJ:RN?%-V$.!W%KN,R]$1U='KP>FEC<24VGX:XK@KG M8+J!#^'/@M.NLQG.92H'"EY1`%0K!;*:)F!:]#:R1;!=C/O!^!\R6ZV$8F`- MQ;E<)H,;#_Y8,HTUL9:M!H.)5GY-`[XJ;]LRQ.D`VPD)1W40AXYG#61N&;A= M\)\`;90G)D`N'(H3]0JOZ*3,M$K@1:$YKE]095`"AFL$4+G73G^6\YOM M3HBQ.-S.0E=O45SE@P^H.PT8<(M@6T`B_!"$B19P7.P"Q8@`$D:K1,PD(Z:< MQ=!I9^"+`<O9K#8^8MAL0I@[4:[XQ$&T6"B M,=8B)PI%-@[#!$#'<6V1[1?E(!#P$["0+D,0I+A8W&5ZGW,MT!\HF#=[Z>$` M!F!=G0B>3:,X93`N6!^`I9=.PTH6F]Z#H&>Q.`EWT,2J7V61M6JZJS]9'^W$ MQM,P]1R`!DPJRSV>O]+`7NTAK)-)3I@O-XVH^1`F,MP1<8&5%9S76QU*<*\[ MT"L`@B?]7TO2&H.F,,FZDF;4T%A^`%*!`IXZ">F8YG7HMP=]78H4]0P&^CN+ MP'FU)-E,ZU,="UJ\\R0*V-H]!';0$OUL[C6'=@ MSD-8L<57>80PXO^;NI%8@HFP$;J]Z`?;X22`X!;_Q$GF[FVC\ M^XSC`^"WD0P])5YA4TPXT6,>X>TS#!HC/TS"$,8A]H`BN1T'=]MYYV24"P`ZOB8^2(?W=C(8Z\*UE7!6U,4E<:(-!SL<04-F@^Y1CKA=X!5\&C MEI$P^1P4N,8FX$O(6#3NIET+)7=$B)IY*Q=L^Y%Q-BO_66A7$],CW"3HOI`( M+!OETP(^7]Z#CM_JIEQ@^38G-/XK`W8"CTOR05^VL+P;UK(^KDWQIC06CB)W MD?*RSB91&,^RQJ%M._6%(<5M/_%0.35R&#Y/IB$L7;7W#`,*;#;SA/\)?X). MRBK:*$V$LSKBT%\)CS!R)R),OBZ`'&%S0?0K1V!]4+W-<:_O]:*$OC$O MS,EHC^.T5M%QIUBW: MB+9J&P'D.YS!(DKK2=N6L2]J>4ZJ`)N,,SO71@LX\]'U`?#C10ZR3QOKFGL^ M2K1?8O15;81&G.Q@4`2UGLM&F/^PR+@S6TUQ`0WL MQHAYHJUXR@%]#+>7''B4C0A;YE`@S>/%ZTWJL"@"46'6@=R)V%RJBY,SAA/.MNCB"%W&"5&JR\W4H%+\%M"<7U.82\O:2W-,@$!Q=W9# MAW[G#*<@SW?Y)<`=GC!:Z,4MS.><$%\V@,DT\L[B1BG@=K:,C3!XB",>Q!*Y M<17.I<>!6BBP$8`"R6/&,`-30QR"_?^PX]<\.8*#G^$+/&$N418.MU>A<%CL M`A"A5Z!!D32_HV7B("QC4?E9'`;0\@*USW%MD?V9,8/H'$B,RR`U;O&%,?/T M58@8C4`6_D4U6CDWFQI:6)C$P"-@C$72#!N#%=*6YZOB?*+&KH6VLT4T:*R+ M'ME2P&&\MMZ)MS0Y2RM!S8]C&&P^ZP`")E0:KEGV^'!]+FD74/EZ9'7\VGX' ML>UK%4^Q7VG_>%%)K"=(,A#^GY)5.XQ931`S7,ZPM)"99PF<)N9;VEX7([.P M_`)E%*D!L4P3R+R0+-]21I`+*9=YQB4TE^5<,D_0X$:>5Y:>L&?")>UTJ0P` M+_;89@,A^2>R&0Y8;BD)QECU`]L3[:H?4Q'N*+! M+`^\?M?3O!`3`P!3CC`66?9J(>,WWQ)^5L&WWZ@X]7L2:R]I?!*)8\GBDX&]TK%;?-'NW#]UVJ]=ZL.1K%>W;[OW]7>FO5129T52= M^IZ+2,",Y_+)4Z^XDR-E''K@L('$WRJS^GO(8BUCQ=A(6,'OQ8?(G9&U;#83 MKUDVG+EVX"EFU_QT95R)[S$X1/GWPV=Q[CK)%#["&+,7K6R0%IO%_&W^86OP MJTX5"P`M7[[J[RSGM$<)(=&7GZYZK1]>?*UK_06S[$;SV/N.OK$N]YWF@;4O M#=4_CI'Z.]SU9RU-4T]+?H7\Q+>M%^>V/9>G?/>='DUM7A['E&!,$WL[=1VP M#V6M(0F4*D"Y>T/U&6!N;[12;?1CG+T\)+UT]6"%"+.2Y5J&XS&^*C%.H\#% MY>,YV>#).:G%R^R5.*BN'K40S+9N=/;6[Z/E50O8'!56JV<9W\K9:V(P8K`C M&RV"U7P"_7H08E4UQ7W#*(D?4;A#!\7"J MIQL]96O5JLQ[V<:?;'R#-:*KMSMT6BT%`_:6[6^3N-X2&GE_?6WA-V?\QYSV%,7 M"GE!-E7!(:W<*F0/FZ9/EM[IJML>N1"-*G/E9]3=;.Y.^M/QS0Q\\>&I:IUIX''4@5U6`5N,SMRIGYR]9XTQ] M,%"VB4L:=[@=A)%??!0@X,HB`.6%6'#P49 M*AID(#8C-GN9S3IZ=]`]O\RJ`A^%<8QC3_5\N0S$6M6(1WO*G=3C'\?#('$= M%X]#^U8X$/3]=UFI]B$*?9FJG56P>,\B+.H4?^+1XY1%_)`J$U:O/>S>*E>'4M M75:JPCHT<8H'[B0H1EG%49?53W@V#:OJ>FP$]D0#';*+9UE@53$OC$7).RV> MBD/YN,VP&B?W>]' M`8IXZW2\=>;-C].4+=):ADYL=EXV(Z`1RY7)35,/LT5UK>ND'AIB#D57M$-5A\%>H-+3]]"1/F*4-(*>6':K%5:^F6NACYRS5U+F'+ MMM(AQ!HZDI>LG*W>"0M>D7*2NY?\,8\UQ8SN-8SRQ,M`^A`G7NCI^O./]&-XQ2NWY+3,5WY6[][T]+@,F_761E'#8Y-)A&?,!C)+'(#VYTQ3V-^ MF$)3X5A-KZT;J_.#FM[:82"4#-4GYH$;1EH`LP`3DW*4?5][@[*7Z_P^+$W? M/E_!`FX%:NC:,>PP]""8WVI^S$*]:9,^- MQ=FD^(!BJYK/%MH(^Y,D'G?$86T%`.0/-7OO8HU[W)8GG,+C;19/=5GX4M3# M?.HF>^UURDAC^,O(#40E3;P1&Q*UX@]KZT9[@-9F:30+8WG7LD)G5N739]]= M/_6UO-AF5I$3>I\`K@$Q/$Y]`'W^C?5G] M,9/1:F+S7]:&`$UL5S,MU#'%F_+^/%W*-"]D*I\0\T)-U:RXZ8BO5S6575U) M8SD!:[U?;PGZ&D_#N3AN5W03NI%`RUC%^UF6?HYIGWO_NN954'T63=Q`=I*E M29C_(#T]\8LLE&H:!I5&I=*H=94GE48M4%/ESC5XN=R;#SWU^.NWXYY?,%`] MU(;#J!$U=1M>`+6&L*)BE,19!*X3@^NX//J35/MJ!B*IJ>O[E#AIB?G MU^@MF,J1/RD7*5=U,$+*1YDX]P6[?\B)[)W6W:W5:=_WNW=W]]V'8=>Z[R]/9#=N.Z6?R/YB?ML> MC=8C1ZZ,!+CN:Q/@.HU,H&IZ@AB-K][CJTD*396-=I$&>Y3N5Y^]M]J#2E4] MS7.#JN'Y?[7'649>E+!%E'8B2B.H$=65B;_6&:BNYGD#%4MN:>+)OH3*2TK] MJSTJ*<>*N))061]4TBGH"KS0#SR1-2'.J>+U/OWP;ZI$]YIDTWJ4K'ICMG3# M4%>TZB6!K?3M3")4#K8?3R:[9O";`AM].KJKBM`JP6C5(:V^/AB4?_;(49Q5 M%<00+368EFIA&"O!637QPJRV;JE;U),71G1'=$=T5UFZ:^G=0?E)V\1VM*N; MO'N4I6#3>%E*=I:*HK$CS"<7]6_S4JQ!'GI;EF,])G#\TBOC):<6J%?7;D_O MJG-.JH*+*EK`ZFJ1`FDU6$$LL&?*3AUNT)23@I""9!:DK>YDC`9-.2D(*4AF M0=J&LHAV4Z:ENWM'JN7:J805$6"E0C85"ZH72(? MV5,US_R9%RXX?^31-]?F>3OSU"@8F-_EQB M&O^.G_G:@;`VB`KK;T_"T(DQT<,1X;1PQB-YE&UV$YX2C.?ZBD+=6\@ZIIN) MJ'$C3MYUOVM^*`J3\)V%28YI_M6=S*@@2WH1FNH`SB(AR[=HM58U!E9U*EN& MKNU\-?&H,:!T3C6.G:^N'=-K79NS6(-_QR'HZ#RF`W1?$PL59R.^(JB=!VK$8_N#B\JIG:%P514HCU#9 M+%2^/L6D"JBLM"$F5%XH5Q(JFX7*DHK\Y0*_C#R0NZV]1U6Z7@9B+[TPPYZB M;7[A!LM2EWERK#!K@3D%-JJ&-*D><*7+D=B2V+(L\)J#'K%E);2,S>**12""[(V'0%!D4**%#YE<;IT"!VI!ZG'4TL?2UDX MC]2#U*-IZF%U+5(/!GN&S=$T4^_TU;W"2[I&ND:Z]K2NF8/R3_IK MBJ[1AM*[GWG`HVP_B3F^&[AQ@B\_?>.E*-IYZ\26L%QK*PN'O"2;JB"FT='$ M*DKK(ZKM6+K9/]FBM_+8H7!O3>1(Q$;$]I*W M-E"7.4[$1L1&Q$;$5@4(MG538;(+$1L1&Q$;$5L%(-C26VUUZ;*73FR4#2'# M:^6H8`L`Y83IR./JXMG-(ZIGI%0'0K+TME%2P'^'9*J"A;(]`7*(=UZ( MR;<-XAWB'>(=XIV31I:Z9DD+,.(=XAWB'>*=)P(_O4Y)6W4-YIU"@.?O"8,1 M[KK^9!TK",US`WX]E:>DFY;Q0P6DEGW^Q]_3^'K"V.SMHSWE3NKQC^/W_LP+ M%YP_\NB;:_/'*8OX+8NY3`'KE?()>A@X> M6QY_`:#VP'+<\4,8+8\H M^HW#D^,O.)O+%@&B`>+P,Q__=/5P;QEFYP_K?[[<7VFN`S\P.[ENM_L#8V#< MW?:ZPVZOTQV:`Z-_=_D.S<_7/C2DJ2ON+Z_-8^\#GVN?09\&34G]N MAHML(]+RA.*X@0,#?-O"'U1B0`I3\Z4TM5DF2&VTT!8`"RV%YT8:8./:9H'- M/12GY@G1:G,WF6IP8^(R3TMXY,?P3>/?;1['>/@\`$HV,N?P"!9KXQ#F?A[C M1_CS%LR.Z?^O:<#_@_FS=_]N=HUW+4/7<%*5-/W\T5;/36&!ZFR0)H_V`<*: M+38VYAV_%Q\3A)'/O'6LX#7+A@6+:3!A7G;-3U?&E?@.%&WGWP^'L,^BB1O( M3K(T"?,?I'X3K1<=^NNH9/[QHM]:-9':C>>1]5O\D#SQLEP(@4]$- MV1).;_"9*W@,6&8Q,V4DW=ZIFE2Z0JFM+M4:)@.]M]H<4@9G;[5I3O42T*<6F2$R0WOKTR&Y M%DTV0PK/(*O*[)(9*D]M#MFRNT@S9`WH_",R0_OJDW5(ZDV3S5"K3V:(S-#> M:F.*JG,)7,/9..$16:5G!6;I_3[5=CR563+JKF!JWF78-T?BJ$T"V:C8UJML M.1MU&P4*$G#*D%@)V3D=O3=0%\=Y26ZU@)%".GLZ=V??#)97Y)8\D:WR"[01 M3%RX?_GIT0Z;$$_LIL._73[+,?@IK]G\A-VD[^V'],@Z4HEHDISX)9A<1KET@B MLT1,PU"7&-)_;6)(Z\2)(>;1-];EOM,\\-(#+:\UH44E:KVT;"RA^,`+DGU> MFEL9=O_/WM4V)XX?I[NGAZI'758"3D[3V+>=NEY&]8Z MT&?09[#647!M_N&$=7E<+#LZH]0`4)A2ZV5'=#]T/\S0]K-?C[TP+YB`Y,7, M&?DPQ\,9N;*4[>\ZVJ.J4',JTW:$1MTPZ\K>'ZG+5&(.6GISZ0(E9`5D!NHXLI+G)A#U?U,)_7SURZ0`DI`2GAX"C@#$^GQ85\+:+N M*UP^Q'5\K0CL0OVPK>[-@Y?MA[B,OTB5<>5>J\CZ8A:[<*%+^[2UV@$$$AD2 MF9+GSQ3T)J<+);*+K4U@3J2E$%1]11!+$NA^)41?5=ROZ@OR=TD$0V(A"9DG M2^W1B$\BE:]R^]N72!TF520@?7Z(\*#'`SOK]G M3/'V8/W8)RR7)IB_4JC,1UNMV@N0F'6?(>N^($=6U_.&CEQ<_EX-0=Z7?"@8W)<[0@"J0>I9WF>NE+$I3`. M;K+7(KVI3/I2.*57?5$1JPOH?B5$7U7<#VL"'V^,I<\C0*?^X1.)F'P M0CUR9>/"O\K(NTR1M6G4<2\NINO:F4L7*"$I("D4FU%7(*[8LOA?2$A_.0N& MK5;[5%6O"U\PQ-P<5_X+=&03'1E7_L^=Y6N_]E^*G90ZK=]CA$81BR-R MQ;XX7B*&2X9!X$ZYYUT7F"';`%8W2,0`L$?U$"N58=6L81GMNG4RT^@"!DQH MM3(7$L_E$8]M-%H%/;JSPL23"XN^C2GJ)JF309A,(8CWD_"P&&1.#,"R#HC0GV7N.F;FX79A(T'W.= MQZV10:8C#J)V$P811F)1B/6>APZA&/)CX<#2,01\`/ MNXD3DZM?F.?Q+^3^WS=/Y&D6Q6Q\+2+B`,Z)EY>$B>=K$7.-D!L2P2S`[3H4 MACH1?1XPZ?(7-IQ`1$A-_"`&:`W%,E2^,23Q8^[)D?U6>ZJM#!8NE8W6R%`6 M`P`C9\3!([JB_M^9(/OWSWTP,3- M?UG_>>Z](]R%/U`G?E_OV`W+ONDV>[W;VWN[83>;=N?N[N&FU;BU[LW.NQ_6 M+)\WR3,?`WW_PJ;D,1A3?ZMI=DUEX:AT.HP131(!#@&K&58/`\X(I8.;# MP:![Z]ASUUCQ\/J:@XO/^1_Q@W!,O55LBV,6%Y;1!'&`;+-COG]7?R<_0ZCD MS#_O/W-3[L8C^"?<8Q:E0?3ET4G$/LS_\>KFEX/*EWX645MG8UGK#<4C.9;O MW[7M;[X:#ZX&G]F)YJ'G'7QB6EU?DI\MC2J73?(MAQ-:%YY"T0(RA*!LL<<-NZS,`=, M&0-.)KF[=*MP>K8W0ZRN(#72:Z:*5'0:^P1T#$W&BA1V!&_R;#/G"?1R/F MRF[)0B3EBD$6]OE>0)^O73>:G8+>!E3A/E],D@W-IX&@P?9/OZSZ!Y?[V%]2.(D9#>Y/NS[+Q/F1VSOYM0'L],VK?N;VV:C M?M.\;3[T&HU%<^I=NU%X<^IYNXKOHYB/7S_MD*76E"W9Z5Z`%T:B1,3S^H%56(?V9@*OYCOSCAK&Z7VY0LM.A"T">N:IKH'4>H^\ZR'Z#$ZS#\E>X+N,+,,RB^_5U04/J$,J M7&J?JG=U=<@V6EWL8D,E>K/;[!.V7*`2-8QV4]V;95&)+D")K'WP4ETE:AJ- MO7)#5*(2M*<5[#DFD6O3XC_RO%@"*42A+J9;S;*,1E.9(V*W&DJ<;%@K!E#8 M.G()K2-=H]M]\R,4L'7D-?,<_S#*7<_7.->M;NUT4=&TLMH-PX;B,7>/3#ZC MT!_V>.1X0037V:?)Q;JOMWK6PVVK]V`^W'9[O4:[ES:Y=+LMZ_;^9$TNV&^>!;HC/R-!<.03D;<$4\=!*OOG-M][R)/9XO'+1;5K0.1 M)KD+QL`*L[^*1V\N[G&XO,=0WJ-!IG1W`TQ)&U:ZW5K;M.Q6QVQUVHV&NN85 MZ]CN%>O4#U=KE^0A<-V2C!/MB?;4>9S5M&>Y-U4=\80W):%V7L%,LH[9F[X94 M$0_TU`IRXIFRQ*X;2%QG)"Y$&1*:,D)K5EHBE6S).#M@M.:JR@/H^.43!-#! M`*J\UBECJ#,\3!X!6`T`XC/VCUW7^DVLF;KD*1;OZCO:G0M\/42Y'T9<4)/' M`3UII7_$M=4QVNWS]ZJ5`G8*Q*:$7:=E?]MRP9VFK^UM+QET4>M1ZP\V9=,V MNJ:Z;=2H]4B8Y[ZZ#6EPRZJ/6H]8=KO6ET.ZCU>C@Z$J8>7GT9 M6F_56F_6^G*W1VH!V>H^.ZAH?ZX0")1/_`73O%[=:&BO\L$+*1DI&7VF*N9" M2JX`O)"2D9+19ZIB+J3D"L`+*1DI&7VF*N;2D))Q2]BV%Y/*UWBJ@MU)UY%U M,6$IEHJU8;ZVT2GJ??07^/!Q7.^]B/5>?838JF.K=NG0B;*+LFMTU+U\!V47 MB4T+8M/3SL7(;@-EMV3H1-F]>-DUFX9I%_1F&]1=9#;4W6)UU^SB4TA*AT[4 M7=3=AM&HFV+JA%RI>VE M);R0DI&2T6>J8BZDY`K`"RD9*1E]IBKF0DJN`+R0DI&2T6>J8BX-*1EW#FTQ M[".+8A(,R*<@]%QR]>[QUT_OKC\40=U*#5II3L>%2"U]KT)`0GFH@B&U!"3J M`>H!NA_:$?4``8EZ@'J`[H=V1#U`0*(>H!Z@^Z$=*Z$'E]ZK_C.-N4]NQG"` M0U6A[VA>K\*^KN+NN8#M689E*=N=I[WD5]05*HJKD*T1=U3YA"**&^5%E?;,-J*7NCK2XSJ2/*D10JHR^- MFHWZ4AXHZ<)*%ZDOEF%9RI[6J\M,ZHAR)(7*Z,L^]3'RJ>[`KKL/KZ%[E(W4][5A(-H&O(<$>K!.M59O*:CU(].AK M%;9C(6&]A42/1'^2HGZGT42B1U]#.YZ#Z)L8T2/1GZBZWNU@Z09]#>UXIM+- MVR/Z8[=+U,M>D'\.8NJ1QU\_*8-9$2_/2:\ICGA]05TL>;(7Z)S)8$7H9,=4 MEQ!][=4F9)VRFTH!Z@.Z'=D0]0$"B'J`>H/NA'5$/$)"O],`^I1Y\Q:8(R,L%9`GMJ"$@ M+_TE+X_LA?D)4X:[E:4>>_*%N$'2]]A1:SVZV*J@I>D=5BK#`S#MKM%H%]0G MO<$TNH"A:`9'P3L_\>@L?&:]KO`I#(BV\Z--%V9#F=LH ME#E$&\HE#E$&\H.%T1)R)[A M1F^]P/G\PY_^^(?OMAW_S\#CSBS]_\498$)?V.F1#;Y_]]"SZF;S7]9_GGOO M"'?A#]2)W]_4K7K3OK]OU^]:G?I-NV?>UCMW=P\W+?NNV>MTWOVP9O>\!9_Y MF$7D%S8EC\&8^EMG('>ZQWWV?L3DE)M6_9N/<\C1NZ",?CFC(QH1%Z-\I"+ MPCTKN0X)%C-,?9>$3CG\U6_:-=-XC@)B67AHGQ/&'H>(G2OT:``]D^D&'"H[&< M^0GS(V"P*0N9V(DGX44S_F\$.S MS;_F!4(+`5,NH5'$XHA0^`6@9/F[/$79;[6GVFZ%^:I*;&3]59T8P9'/+!SW M6#_>1QBZ=_?->LN\Z[4:#[-NG53N##D(PA31`<%Q9ORXS3] MX7[@N>F%[D+F\IB`*;@GY_TX*LX-.T_-9ELQ-1(-DZ*&TLYLG%+-9&K"]'^_^J3''#;NLY"8*:G;1IX: M07>C!!A0R;S]I=.JV00.\WC@JT$"'0Y#-@22!@WGOL,GU"-T'"1P*24_(-&L M9JC;7()^Q M""()&GH<_@YQ51(Z$/W!;/9G*W,,EW/2P3$7HIM\M!C"9:4J^BP689+#F!O- MY3,=@PB1)O#5%PZC$8*L""M6K:46*X,P&,MQSX/`>,V<$(D,("^%:%)$@R($ M38#UPRE<47R`"-`1R(ID3.($XS$X!XPN_1P,!O#3<-@B2)G0F8Q)5JU=(S^* MY)=%,J:='Y/%L2N3"W\381?,J/R!W`R+P3/JC,@,9M<@?3;DOB]^.SM>(J!1 M0YY4Q9.O'$]$A\,`7,9?NA/,ZCAU!]('-R-IR"#\<]W#;\77/\Z_SOLX0#`B M43*9>$S$CC^2U5\>>BD7NZEONJL_B*6/^"NV(ZW]BGA=!T!8.`[BR_]D@O\"= M!#X,ZB:*`H?+3Z_NX3E,HIBM_8;T"##_=,3A'S)%D'4F&<"#98(-8H<^4JR/ M1.D?$B!$)Q$S$?1A$')24]H4!UW1Z_F!D&G)ZJ*81^#&-/\/\K"9S[G9_AB1 M02+Q+SRA#\[B"\&;EPN`AX%E(Q"D*!'E4.[/<[EMOY`?_4=RU;\F[/=$.MI> M@V)?>+0H9V0C7!I@XUC]`*P>K`P4!N#``$!51"8K=/6_B1P>_+(4[<'6`6S^ MJ73`@(.LKB$^O5`O64AAEOC*LV7])0$WRE\#AN1>IY6*.$Q$@44FU+EQ06J] MZ>Y7!G(%<9J7N)*N0NJRN09&UW`<_'3X*D!9O3E(YKG+:2A2>RW]H:S..^?E M,9U)0,)$,#9^+2@0::?3O1YSMFHBH8#OTC#JU=>KF87XF>PG1-W-H=$HK8N4I5"O'Z"WD$3)9Q%AJ%T!DXT':6Z#,,5`E$%(X3BG*%P$_B3RB7H5^:;<5!2A1R^6")JYQY!&IJ M<'D"Y/%9V'"0"!Q&<]"XBP6"_$@PA%2F0G\//+'"(J4AJT@(<_-P+;",);?% M?,R68C3G?>G2_02F4`0;65Z]^+R=-I[8)%ZKH$A)D26`-`4+/"^8BF,='CK) M6*PI."SZ0*[,%58UX]:T!_Y!PW!IVTS M3>.-XU7-J(2L9:LPF5K`K9=!W*+V("\B(VI_9U.&P7M]>'YH4NIQ&! M`^$T1$O`8.,`PG#(-OS2*-L&RH?[3/.AK^@>Y"G6PB.5K=,.8&;50V7.3.]S M@="2:)2%<,4,/K-Y?NPK6)S/23JEF\13_E%.IU0`I>M"-_ M\A?6SH>[^RMI%H9'SHBYB<=6`_*52ZP%5A_%P*X:UR299)>2]`0WF%HMFC"' M#X0)G""$P0N[B!:`.%K-*C?H-(2(W#MBV-NI%B1>U(SD,@N/9_)&##+*A2F1 MO(4L1%@/5`:+E14Y>3EK&T0L6X6N!'@V17`T&P:OX@N,+Y7%E[\)Z"TG9+4> M(=*B166!>:+L)@Z94+E`YC+1'1+*^GPJP@`T`8`^S*6H71@D&M&016]G`$"T M^$M?U/LR3TV+(`*H>UT+(:*T$,9]+GJ%UGEW8TPBD^F^HA"C8=9:]>;KYO&# M[F=/."Z$^"^F4:_7-R;AJT6X5.=#)LKL+%T6W62ZA2X6L4IL-6KUAAI[00"3 MVJQ&'I:9'J2@E/LY30+A\"/JI"L8LGXO=4P(#9AF10$WJ0?)@J!-\Y%QS"Q= M0]Q7O8B+==;K+,W[.O16`Y>0 M_9[PD*T`"DZ>-XF\H2:_J2RS:?2+2Z9,D%8>X:=*7WQ<--0<7GW<9:ZT''DP M7D_5CKFNG@MDRIY5($\0F@0T9DR!V=(>B;1_!H)[.N^F22-]86O`.85T*.4= M,-U$Y/L;%FAKTEO\],S\B6]R%IH6=L4(N9_(Z6!<5I[$\5E[P9RKYVXC:%EM M#4U5;QGC&1WLX0)NUJ$][V/*IU+]V5S# M5A?+R96<6R$GD]G\N\SDUUNGE89--8&:$6B;F=Z`?GJ MS6PFW9ND9SXN**IDL4.1:AYV/+]^WZLJ7CIL2R[*I/2"F88E\:AZ]>XS,?%R M27`6"X$XP`BU+3R#)-#\*%`JY*(^()IM1JIEE(U#X^7P%,D0FQF(\`+#.@TI M]:T8"4H4?B&DP;J=%X&_=#`DI$L)E:./2H;*A3#%?"E`E(4E=:0E;^Q"8=_J MV+%?_/)'>#KB0R,SI0):HTQT_U1OC.*7+[6 M8RIMTY=;GL6X02'0CJF+B*-^,$'/A,1W<6-NFW>Q(W]5W%]R8=Q;I]\\-YMB M>V/%WZ]RSA%X]Z^"`_\J7A:>%)5=?&\L,N+6^A''HK`#ZS42PL;,9;&0-&TU MGX3F.@GX1)K;3.@E^!'VOP`\]"(9/5W^5D@-UPI#Z:MR%*24B,BI\\F=R>.! MB-'+E\LC34,"Z5(*;T%FP'&_TC,J,H42;4+EF$I=*MQH4`!!V;FL8TS"86,_ M"*1M$PC]XIOPC@F4%>H^(!=80@#CN?1&RL3#"4?)[7@)<*<6:']I]A`R3B`? M*Y"O$&N=^#+(#NAZCZP(TXM$/A_6\:P!-6J/DCL^2/SV5!XNGGB2N9N8E\N9 MR$5."O\#X]27Y4!6$*"K6BBG`#MG$J=\.#%A\84*>20)+U'NE,LTZR1;*W?^ M<*?<3*/@.2B"1ZX\EP+UH*L&[UVOUQCJS9+.\!25"DW+;`VU)_XK8D<:4IEM M\S&?3(3_>(GG*DK>^+LXCX`C7WLQ20LE$W`](69#*42H-FR?XU'\2SYI>W27RHT> M2#8;@_(AN8*0R]!$_!"5)!(]T1Y7N>VHVI\[WKEM+1R9RO\,SZ%,5TWJ^TCH M##4HBL[KOC-K4K#>4QTNU)8&\ZYO-DRM-"/I>2-'T;9P_>M.RLW7>IU0ET"I M%6!,/6?:J\*`4%C>N=P39'<@+3Q/5A(LZ/@B!2-<3I_Z=8OUS8M(B,EF/J=\/]8Q/RRQK/Q.&=_Z7`"Y8:#CQ)MT*Q`N2P@O24T\KJM9Q,*$TB6UP& M4',AN[PA)4HXPUP^_QIJVK1-Y<.,G/.)X\:"&5J3/^(PDBI?D:@37ZA0'S$? M,9^EO$ZE?!;"DS0>@)&M*(CE:X4_TA+UW\KH1,`^[[\:<]N*9<;((YMS'HF` MVX\D6U-0(_;-.H_\<]D_*[\"Y48!PB2C=&\TAO:"<(7?<8_+LEM`)>%>4#%; M'^MZ40YE&.I-WOLH?*88N\PN$!&;U%P12)0G3BA'V!E7):KNB*= MXF)JY:;\?:%UW*==W?"CPC"9')(F8;V\M,4*`8>M4%0\9\1=8!F;0"M*(^ZP MV9M,CU*YPE'@?%_.Y][X!!E"4$K`JDC75GZ@,]7M)=46&(C'C*$'+M)>W_RD MDLK,?!@(M,EL`YJ@/&PT37TN'`#/@Q^[V#\'PW`S+A*^,7%BB4H+UX(L&XN8 MF:)=3(_'(.`&&A8V@-`=,2O96"KU%X0F;B^<7QZ>!3B26K7_-()$@Q$5K4N\ M5U9W%%BVOUYY2M+TX'L,VJ?F3YC57*067Y(3M,@ELB(Q6P7%:S,Y8BY;DON, M.!FY="=SWIV>8])H:3%NF+RLRPN>FYI*`6B8PQZ+W ME0*$N@H4TZQMVV+D4)`01+A/@QLTDQ*4\)L\B M;P:F//"VP:`C4>=+X.6WBO%F>E6X[*YY87E=MXO9]AJJU-9'6+/6.V@I8BJE M"\9J)`E%X".N8!1^M#T/3)A;H)I0;EAFN0=M?!&)Y`-"3/_'.7.YDR$YS MT0SQ8[%;899Z*%I"8!'(1$KX6SX.8DP[ER36Q6MA(4L^5%%[*O(`@''KB\B: MS493M,#`1F[BEP*F M]9`VQ1?C9L^3?%$G267+ M$[/(4'L(TVA&FF4&5^@\R'ZCJS=P@[(0I*8JA)&;:20)-:+Q;)(!LYJ\`@(H MG[^R\AS59EK)GO5'),IU7,S,`'-.I)F--S3S3W+44!%>R`1V3+QPL?0QEMG# M8!2(Y`#R9^CT9ZP_N+0,3*4`B5AI4OPEW1W+Q3A`!:?.&?`X1]P*7`%SS^?Q MG"4],00=:G/[F0U-78",K+P1]_-G[$>.*F2:^Q/5WT)M0?7;1%U3?9,DO3HB M&W*EC&T]>`6#/+E2C_@BX'*EX'MR)A7`4P>@B0XF##(+\Q!-B//(^B$"L6"- MA.PT+4W$NH'SI*X#`SVJ"4GH3+CB?[ED_C3C8,EN^`RK=7Z-N;7M;EE[\%!0%C:1-7O) M=B+Q_3.@[2=$VPS5&UDNYA/@C0LU3R;DB5P^> M$0@?DB@:TU0MHW@9*@7QS M/6Q]_Q+U(RG1$VE2\P6PV+1T#2];P2.E@ZR3598L`?:R$C0M6SOV`5!)+BW. M8,(*@RQ;`C5Q)4ES+J!$X5M/WV)J@OO(S%:JE;^U%^``=3K!15/%SLH;:)A^ M%B#A6!-TAG*5EI,ST;"`#O-/\A;RWT=712/NXW3)&)?%.V`U@!HU=6PL4N,J M<"7#IJAX.=-'67D!STN<<*A)*H8G7&I"&<)V8%)5.+;B(?+%^OI['6)K7D-23IVGGHE),_#[E/*WB>:)N7/XM\_1` MVN%I1\K5G9AB3S2,!]K[[.>K%43!5QYHL/T"[Q;OD\-+,-VU0,E%OIYSZ@JO M0M$GDTJ&9=XA&Z$\8Y_FZRN"56LU3*8B/7/D1Q)0>>/4\R4G=EF^TTH?P=*P MWE;[Z78OK1TWT%J2#[]JD?^:FGLBK\@TE(1IZ$OEV=$OO"$'(B?Z+G\=+;N& MZ^ON79UU].OH:6_M4\[:-3?OXJHM#[_Z6A[=J)+CN*4=)=9[CK]M.-\R_+R; MW@5J6#'J7.B(FZ_B>_"%Q2D:C:1%%S*K"JVW0H-YV?5H\UOCT+KCD#./V-XB/#ORE?!X^5K*N\BH@9\^B5MPL!<<6]X>.#WY_=/HY(R=%YIW(1<4[D,TWS5W@G[7UHWE M#09[P)0G3V;>Y)IX2S]OSK^JOA'.!`1\Y`1B%!M;N)9WID*#:+:@DC_C;C:! MV'/PA+Y&EFJXA^BE$I***7_*S$FJ*82+4.&'>JWK<&QO"T;('6":5.*1_!); M(3&&L(,*&G!B@=*L0/U?X#1:2/(B<32X&KQ-LJV<7!/Y8=GBSA!+1$W%3+93 M<>8L!(0+A7]<=?@2+F4$E$@83&N%TF3!0D*-RO)+EY7J_OZ#)[.YTL<9B5&7 MP%;-D58@]JRY6+W81"`;YRL&C)F1:',6`IJ"72D"D(W-T)@0,`'F$XI4H$"F M2.*]L&M!>+BL<.8LDK(4L2W'.\/5W9^ISL+96$X1)4"/O*KPT(*R^IK"GW;/ MQ+`#%6VXSQ!/9N`DC3?$A#?A>I6MLL29/\JD50&RC*NH/-AYEBB3794-D1/* M4F;P*@3,/4_TYC:28:BI=9^;#F?=!5SE\L#=V+]>-ERY$'/ILKY8^`>NZ1X] MD)$:$"=S(X7NH2C($4[B>Z`@&;A9[I>U*7M2WB.Y@!@/+D%I[_(.*9Q$&M@3 M<^I6WQA*)YR<00DL2#UCC$U91''A?0%0CI`N%N"X]-;E?!>5<+FQK*VJ\@"K M9H++#H"5?FJYPAKDZBF!YY%R_"@O2U2$-9+>R(Y<"`<5SI0B7POEM1J:?+"1 M&`"_81];3[U?.\.^..8^Z[0X2@O*?D,T!.3>9NQ]\^9JT!ZVVH-FRQRUNKW; MYLVE''O?OFK?MF_V.O:^!W9W\AF-[@NSDUCB*NWJ7'RCTT6RXA#Y7::6WH21 M*`66"MO7>"X:L&)::J[)909[E@#_=1X3M5R9BR=A_5[=1?\,MH]%O"9\(E@P=0U%**6%(=P@NG#`I./"^4=,AY.;(H M0.GWJ;$]3111F8:5RST(L$9/V=9);%#*]L2:0&;O^F$LZR-R>0*YYXC!'5C% MY)W+N19C*W2*+0.*F^(R:Q^E&]KPR=;R>J`SHE15!B$6U-ZCS?)!*8MX?=K/[\[W)[(+ MJQA3&(%V+/HK2FA^D!H<"$8WZ3B+ZJ?U(P_M[-C4;SFP?1`*E.M\YZXS\^6H MJV3L+-Z;KF,]U#\H'0Q6G=6+@4XM'"9P%UXEE:<&<`60\CD4@M-,"PVRW$D#0.8C`^J%R@$F`8R:/,+05@%S@":J(W*]H*G'81XY<AR?ABJB% M)>UUV4U-]2-VL/H_J47.K21=[>[>]6<[8Y?*&VZ3]JM@>D5HE:6,V8^#0@?B MK-):*FB"-!DN2;YT+/:BR>)LVJ>0'7NRP-:JZ(OTS*)J&B^`R&13 M_DO+1;/JZXSSZ#H5>5LIJ+>#X?#JQFQV6X/.9:_7Z_&F@6M05`\@20,I55^$[\:=%7>U%ZN#CWC(*AV%RR$_%S_B4>NN3=HNJ" MUZ0/E@XBF[NNNN;GD^:)^!QB#9KZO#V+>7`FT>P"QZQ\&&.3F>!<1&<6(;]( M_EC9?+:H(/T+6Q;C4KR?3P8G+/`?Y-^M]-KWT23[,UC[!+&6GT_Z[9\*3\B> MO/9IV8VM7>_;^<:ZW+>?%VXZ5X65HE$]&!`*E60RPY(_)>=@01K(?U;)#_FO MA'-=?//L,G.$N9F6![MQI.RV5"EZ6HTI@#I=;/OD:4@I^DR20!8_,+3A3-A? MFN)?&9!\&GJV2)70`[_UZL>JIKE)0JW50#<#O6(HB=Z(*`1:R.U&N2Q_3AG'D6N")8HZWY`8;ST21B]#O5FBE*J!^IPMTSZ+F4R`L M`5("J[6"JM4QFMT7T_?.\*H%VNQD/.K$IB.6U\3!B(/MR,%,8]AI$P?3P<%J M;P"_'H08^(VQR]W,"B8/HN4@!C/\:80?=K%`S&1;E4%+6@'Z MID36ZAGMWJ!T1:\J*$+6:`TDU0%15]?HFT.B+K*47FXIB5DO=C(V'N38'=:L ML-/$6BIDY#KS)&M)%L8LUOK#1:KO6N%X5@K]EA#]>5,R[O;UN4*>@4U5\)`L MMPK)PT.C)]/H]O2%1XZ$HLJT_)IU%YOKD_X,++G#BH^WY%J5U]HJ$1:I3.2C M/3":_=7&L*2RDT%::MMF+W508\E&1ZK6%0><]*.:-LXALC0)XK;1'$M8SC4 M%L0EBMM>#L+.C]X+X'%M'H`B"K8!!2=^C$5XKZ'1RJMN^O3VY\!W$(J]V3$& M37U!]9UA5A7T(2=#19T,Q,V(FSW/S;I&;]A[>YA5!7TT^C'>BP+^==?O;6$' MT42BC02C<[77.=]*T@Q-]#M:K.\N4<)LH.-K\Y/.`1'SF[0\\EVKT=(\64O; M3+6FYLEVV,$OQ#'1SCUW<1C*K4ZD/,[.4QE*3K;D"/I0V&R8547AEO:YP444 MKJ9PJ*J:B=%2%DCI*Q*.ZDMPH=UCQY^L1[2CL_;5(WN+XVO%NTR*I'C M5X\N*UUCJ+&RJ-98LY-!2"'"FN4AUP(5B8%MT:*C;Y;?/*`66/-:!K:]6G98 MVM<__>#[N>.=BYF/82E=.VJ7/CDP!@-M^D%5#KIL24\"_8`I`C3FCK94E$.A M"++H-TW=W4/XNV(J'-@]+HM MHDXRQK3`[YL?6>Z+DT;>.N&\*E#;7UYYG=+'VTVC.]A?,4Q5D(',W`,L;:D* M^XS]DA]*_S$;2C\2 M0^=UP+D:V/JVF;_?\@F^3*;)+@(>8@-5X5K"(\!)ZA,^=3PGXLQU[K$Y:W8@ MEC@0G#S^U.^%UJY6KM6+-?>!1?U+%!^L9AB_?&?#+>4MY2M3OG+%\XZKO<%C M=R1HL((H2Y12ETL"*J$H)3(?8-@SM0I.6]K:N%&GD'+!=QB=0@9&OZEOW,G1 M=PJI49"X5+PJ'8[$W(BYO8"Y#7K4!HEB[!6!WT'G>9;-\0\(":IKJE<2+8AF MCIUFR&^P`;`?E^-13S>S.?KIGF]FWE4%8S'\Q&,GW/8# MF5,!A\P#S#Y().'&5`ZJ3"5=D^RS"@@RHID#I1FRSS95Y036A,^MX+M,%(SP M(_.L>5GE.7KR$^K=UJ.D(,D.M8BU;Q9C&OVRAN)L`!WS>^YZR]`Y$7/[-345M_U:HHZ!)]3G@=MKIOKA)P:O-Q@QI:L1[];4= MJ"0=5E*0'R,AF@-][1Z/FQ!?/UBW57MIN,[&-IC'(VTX5D:Z2!WB\WO+"CF8 MY(_VT.CIFW3S;/9''9"HBL;N8:L4Q,R(F6EB9@-][0>)F97HTJB_%D>F5"6E MQ:$'*,F30>170^P[%/)[E?^B!HZ<3X[-O9"_I:U3%5`<96"/HGIDSUH#LM!?(KH76?4OB0XOB58F!'2H=]?:.KCYL.*8R?FLH4N:^4 M9GTTP2X*=%7>;#UL!8(8&3$R+?UG2IKD=*2,[&A]$V0355(0''I$D%P21'XU MQ+Y#(;]##\A?Q2$LB00Z;6WM&JMRCF2]UQY< M54&EXV0)`XK1OTHQH&)\;TN=XN7*^FL[+-=&F3_5*)E?#;7##D"2U?T&5O<1 M$;*^G#_#,R6J<^5^`QXJH(/ M532.#UN#(-9#K">[3Y\KXE@X#A795\*\.1CSI726?NA!1?(N$/G5$/L.A?S( M)_!A9/\9.P&?L*\SWW,\9BT6@7]ON>RT38%_G9IWG33KEM&D6EPRURL'KJJ@ M$C$%8@KE6M0'H%=L"/Z7HM(?3\"PU^OOR^MUY`%#LLTI\E\B(;>(D"GR_]96 M?N5C_[6HI*Q2=*X>I;CM=GMOS*\.&%1%8_NP51+B9,3)M"0A$"=[^Y!,A4PQ M'U8X=?V'BYDSF7#OPXR+Q[3Z\!RMU:BA=P&9)WX M,2Z`Z8G1QWAKH4Q/E M1[S\PHE@"782ASICU\YTR@/NV9PY'HMFG-U;;LS9F$S98W861187B@K#)DU^2,.HSELI_'D$=0=C.89 M^Z<5LH#;+FB3SM3ADP284R<((_9G;`41#Y@_96:SU6;3P)_#%>>+P+=YB'>& M@++VC%G>A$WDY&8$&\)XZGA.Q)GKW(NG)GIK:+"'F0.WV+[CV!QRZ>,.:&QBJU,SS(T"M M.PQ#Y1-#8B]R7+&RWQM?&X7%PJ/4:@V%91$@8&C/^"1V88F`@0C4WNM13#&X MWI($[%43Z=IG[`N_PRP;/WC,4G<1'&#=Q`X0XG?$PK]9P(R9E00!HQD8Q'>( M:7`"W)L(-!/';+&)$T:!,X[AB2G^^G$`OQ41N--X.I/G5?2Z`-DRMH;B6X3`RDYW>2]`G7,VAU]F(0.H\XF6Q^I9W-]BCV<^A';3 MP#->U1YV6B`R-,08]@`,4LLCWS4;'097N>LFPNR\1EU+:VE=FH&28<'M")B_ M^P@L]U8G4H;`^(\9):V7,P.=V#NH+O::I6)O367&31@Y\]5,@O[4 M7%*?\'/^)9X?S"VWB`5X3?I@8:LQ&[:IKOGYI'DB/H,A:B>?UQS[-V<.A_"9 M/[`O_MSREE?^X$RB&?P)>U0V,-BVKK4(^47RQ\KFLT7E'>NI3=Q9&S1X@6M> MK.7GDX'YT[/6=M&T5S>V=KVOMY<74B[]!N[SA<\MI(M$]];FU=DICZ7J1:'Z MW('[GU6@WPW8;>E+,Z[ZR6OT_1UKHC!Z4;;`EQ_JZQM(DN@())&Y#;X<`TS0Z76V$N#/#<)O?F2YY2`4I1H?0:IQ>V@,AYV] M@:8JR*"1\[P^U3BW49M[(&3??JM/+5?3XN3'U<3(R1G[NQ5\YS(K(.1V##<[ M/'SK]58:F#*72/S[Z-USF;6-2;QLQMT)<*+SN14A(!_9?!UP@12]T`FC).=$ M)I5@'HP5U2,E3,N3KKG-YV/0X'A2E_ MZ.7Y0ZW>*Q.(VL-])Q#M/6-IW_>UZ[)0.L$W/4&R-E^M-A=88?>5;J&2O3\K MJOA@-^@-$EWW08JSL>].,I6(;=2$R.>Q#RQ\;8^2_;0B*"%=7 MK_BD[B9<)5PM'5=O+2=@_\#>$:5JHD<2/Q^)E@FX63YYJ0^;BG\T0><@BG\& M72K^V1M"4"LR8CO$=C+-:F"VS/*IKRH80.RG'G`D]D/LA]@/L1]B/\1^R.AZ M:W*A0.2'T9WHF3KVOBW1"9$)D0F1"9$ M)D=')J1NZ;)+JNDCT0[;*S]8^($5\E%=O M078XM$;Q`*(XHKA]0NVTM3<\RW"FO!B!=NH\(S(D,MR/DDFQJ%)MOD,S[=+Q M(0MK44ZCKOI1D6GT!]H$6E6.FER(E15`M:,0;?-(B#B(.`Z-./390F3R$.T< M%^T(U8NDBPY#I9J>`NVP_<6'[7MBH'&Q8I*\!]N"LF,,>^7[\:J".&6K?-6D MOWK+L\.A-9/HC.B,Z(Q"P41Q1'$'17&H1=+DOU)-N\.RX*H_C$(]5/207NGK M5!4P5FI211D0*R$3NF.8&N/ES\&M%FA4MO)`.@+Q,^)GY2`CL3)B9=4%%[$R M8F4O#Z+K_KA=+="(O&IO#L)M6I^7 M`+FGH:5SRL[AFPI5A!;A%N$6X585H$6X1;A5"K1("=.*<#3Y,)FSS#:.5R9, MK((Y<)23D&CZ(>%F57&3IA^6A;DT4:YBN$K3#PE7]X:K-/U0)X+2]$,:Q/'* M4)K1:U/J^=Y0@K(!B/$0X\ET*ZHR(_93/3@2^R'V0^R'V`^Q'V(_9':]/<%0 M,/(M!XJ4'`373URMKM%O:BOLJ@H&5%'J'+:0/EP*H;%O1"9$)L]7U&F;/K6* M`>5IJU031[3S]K0#2EAO."3IHL&2J:9?I9:#-0ZH9UC3Z+:I]2SY+JLKLPZ' MV+2U5RV/V]4"C31ZU=Y'%FQ_W?5[6U@.:*[C\?.9[&'0,IL_?2BM6T(YR]6Y M.);\&T5L94&[//!OL<>S#AOMIFA0MFH3[?)H@T4SSJ[\.=##8QI4ZG\(F>/= M\S#"VBC7;G,GS)KL0C\'PX\G+N/>O;]S@1@^W%H>1,] M$(`'I5N88KN0N15\YQ&[QZXA96VBT^@SN,H%*&IY8(.-7+>`;>)H[K!5S_+! MP*'.K'O.QIQ[3Q_OU`^8R^&K:&9Y>G:^VA%PIT.;PY>SL,&^`=VM;N^!!YS9 M5AS"5^-'V"-P3@`,$P4M4S>VH]@2.Q0/@&L?K)!Y/K-AFW<<88+T;`=\XL!- M3O@=T0"_RNA"OEJ1/$A1C@^(Q*L`GR(?+H4#*=XC4`V>Z,AK7><[(A3`-LKS M#S@YN'/,6<#_C!U8PZ:GC3F<#Q??\A\+;D=P:]`8(?8 MO"7DV;;Q/[#O%'YWE@/'CJE+2.3Q"G$"O]-RCM$LX%R`)71^J$-E`$"N MB;:K+C@DV2KD4N?_GT6I`3^N\.@<$@AD$3]P0?*`NQG%MLP$II)1>PSH/K`` MQ=-'P>.U[&2UNO!5=%T)%:2J^I'\B)=?.""U'%LY1?@9R_I=L;]S*P2L$%CT MUBLN73O6;F-(W1-Y_-1W7?\!C$>I'4BU8.8`'07V#-@W&A!L`?)%*7G`(.=" MNC!K[,<1XY8]`WK[`_BF#?+GSD^Y\UJ-T<(>6U)4N(XU=EQ)YW-YFJ"J1/EU MX%N0Z<=!@"L$[N[@([21=8F\3VQ1RY.2KL.YA6YJ/[S+XR]VYT8OQ=#<,PK. MG^;BAWR&`S+1DY_S+_$0U]R"MZ.%UZ0/EMAI@_:@KOGYI'DB/H/M;B>?UP#D MFS,'K/O,']@7?VYYRRM_<";1#/Z$/2J7@0UD8BU"?I'\L;+Y;%'Y5);,C=!; MFYGT@FP8L9B?3]K]GY[U4!1])>K&UJ[WM??]0MH@;;"*&Z0\-1U1@_H.$ACN M!KUAHLRN]&W-1/EMINS,,XT6U:"`+]"T!;5G@G9]',*?%R\%-V'LT;<;UHZT M_QO[Z(-9!(XM'*>;6()E1\X]5WY&X5'9=*6#6A_"5ID%FZX[_<3ONVD1H$#JO"&FVAX06E8_Q5>XTP!%/`H'ZS:CW(MXVR9T]Q;QLTAN M'@:2+['S5QP+(?E>D7P3I&-/$X*W"<$)P?>-X%N5V9#R_&$4,?2-LHTNT6-L MPJ*!1I\$2%4.O^Q]4D(ET0S1#-$,T0S1#-$,T4Q%@',4-$,M\YYHF6>%,Y&V M8>,?F)YX;[G/YA?1*`)-T#F,400]P^QI:]19^<,OF^T>">>IHB94>=PCQD/- MWHZ1^]1/>2;V0^R'V`^Q'V(_Q'[([*H`Q5"$^\,5?`8CS$.?9X`]Z+\9*KKM^;PO+`6VO&Z@ M["06@V1Q.JT8"CV*,'SCVFQG`9Z@\31ZFKH2[YH=WU!G*CDKBNG3`U+4Y^Q,N+P[JG M9^PVQ=2/7A@%L:3'SX"57[B-(V@$5N9&>@NL_))BY25BY5OOKZY<\9_I/$E! MAWG:GS(_#O20H=DPNS_I86U7OB`ZP%4$5P$X[$/6"G)_GO3\Z8 M;0&B2"RRYC@K\U\<4Y##B/T96T'$`_<1IP^RB1/:KB]@L8B#A1]R8'8X^YR' MD3.W<*AA$3X(L<(:'%@&AP?.X2`G;/R8,D`Y\4KP8+@&^*@$[0FO.D8>&#L#'"D2H!==V*9X#=^-%A5N-#:?I^JB5P@)A MG>.(/5BAG@-^-S`;`P:7N8[OZ3GH8QO?_F[0:70K"\*2A\LWRA\N7QV&KJ;8 MMP9@!FKEZ,\R\QEW)V"4G@,S0R7L43$-$;;-*6:O9IC%-Z]_R;YX9:93/*VQ M)7__]7T(RS*%I_SY/5YXHJZ/'A=P/3Q::,(G^&SU<'B5N@84YNG/)W^YM>SHO-GMW#:'U[?M M7G?0ZEW>7#>O;@=75[>C7ONJ>7G929[K6F/N_GSRHGO^SQV[Q?7`NZW(#T[8 M^V<7U.N.VK>C06LXZ+='9KO;NNY=)0_OW)J#=0MZ[IY7+:A_.X!_5_V;=M/L M7U[=7N)G]?#;ZZO>N@4]=\^K%C3JW+;;G:MANW=CMBZO+P>=03-Y^+#=,M#(8CBY>UZUH.OFJ&LVA]TK M\^JZ?W/3;K5;$D&[-S>CT55KW8*>N^=U"^H/AZ-+MZ!+L]>^OAUVKYNMZR:\I7DU3!X^:@]NUB[HF7M>M:`;L]UN M79O]MMFY[=]TKD:=82\!?W-D7JY;T'/WO&I!M_U.M].[&@W:U]U6J]NZ[;73 MW7;-_EK&^-P]+UQ0(@9&@UPU+^]`NCW^E>MZVLX_(Z\L7/9;*WC);"DM]CA5F*AECO<2L[4 M7MS?]J]ZP>3, ME,1IEK2F7=[P$I-X&0IR56!U^W%@X[=S%];@W8&I[)W__O7DO_YIA1BM'"BF7CI31SX"VYY(A^>!R+` MX5JQ!U!+;$3O]S%W7^<%N_C'ZRKX^AA&?GV'4SH=[HNR13IA[LXSJ M-=B(A)3KBH#?F-\!<)1WQQ(WQ5[DN&)AOS>^ M-@IKA4>IQ1H,PRXRXS^T9WP2N^@6]P.$::_QU_<%1'DY[FQ#?Z7@SK4SG7+8 MF,T3K)'^JR2F"=^$G$TLY>8/X24``@PZ`'I8"`$.!Z&@8S_*J*@K(6M-_HC# M"'%I=P!MPX)+`=`7?A>[:.<\,FL!V`#@$>?^T8MB!W;['>'V-VL!&&_9?\8. M1I.C6>#'=TA1@&K#;\5";6S#F9+7Z&O#;[^ MZWOPN5E>CV^-QA$2Z!*`27WY(9":.^NFO-^>3O2MHN[J9OGY%?L"O]F#J MFU!/3U^_^G*"WIR\.SAX]=?__L__^.F_$/K'V^-/>^\;?WD.T]G>NQ;L#,+> M=3T[V_M[@.ZWO=@VYWM_;]K?ZBN+T'VMO;O?)O7T-V<[V+OIZA\[?P;G]E/C M[6S^YK/9[.+'_?WKZ^L?;EP[^:%I3_WD]M,X%CB'OYYY?C@V\:@&EH)LUI??.#;\[W>-]<3F?O86;K21(BR_+C60OQ]2N8G-ZDKA.!)<.YXW]967%V>P&O7W7U M^<4D=7Y_7.G>G#?MK/[G7+EW3[K!`B]I:Z-]^&CK]G_LY!)^`=M=MI`YWZW; MF3Z-;K17/S=-N*XGDS?3<#!-Q#RMW03>=!VLW[?^36^TAW^#2?C<_&)GEVT] MN_W%MK^EQTF2$_#Y20UK=_3%;]AH?P^F5XE$33M"QYYO:J,].&J;"VAGMXDX M'_[OLK[(@V+=KO1HF[YOR\GLWM3<+D73.=I3D^S?7U M:BE[5-VPA#W9T+^%#X?5LH(^^1 M;1-T9S"KO5WI#PUL;F,].9FEO^>J/XSO;'?V<=)<#]/`TI:*R'^8+.WI0GT%GYIN_4[U:WZDGMX-P=GD]J#K+O,@S(.TF9[,&O];CY[TJ5Y` MTM[V\B6M%)"[K]U\02.C2-U"J&J8?Q[6573Z'KWMJN3F/XJ(4NZ6L^C-,HOA_2T],3.,VC?)7T(S2]Y1[V M5--X;]AR?X^2)>_C6X[XBE%Z?)_WMS]"FJU;_V- MRMI/TSVKCR'IW&U+1A_F[GTR"+WL[?):FY.KIZI[5=Z`P M?NAF=9H.(<=Q)Y?GY[:]/8PG]>FTCBGFGCYDP-(,W]=[6+/9A3U+T;^_G,QQ M^)0*W1?-O5A[L>;N?7`S2Y4A;/*-*Q=-'H68BY"$F#3^&[#O7SQ?+8NV<_.U MKGF2U<(3)_;K;7^X?5Q_K:3V#3RE6_VY-(,TD#R)- MK(/)ZU=)A*I?Q0H$@'/,(.J$32\W&@E#%(J&BLBIDCBJ;SL\R6N-3?L`^C9Z M_%0I]X[/,9S;.NFA/8P?ZRX1X7_!ML-@Z=MZ%970`-8AHC4@L)#^,L8A*H7W M$*2WC*S"[@EEW[1^KVG32UZ_2M6NH3X]F\U_O6O!MOX[)G^[!'M?8K_+8S>W MB%(7SQ_JYR7ES5&CV05X$P`[1LOF66ZR42#A0+)`@EJ(0A4=:$8FP MXC'0:(T".XQP[$](N(&0[B;E/C:7X\VT#PU6C-OH#>@DI^.(!TBZ84(C("3A MY:)UT@PC'/_S$6X@HCO*MU1V7+ZELA6+()AV:0QB2I"6P!'3-*)`P%#*>3`T M#N.;^!/R;1BBR_GV?=2:GPR0[J2^6<"?X8U56@?P02;3+43R3R,#I(PBR*M` M">52&$6'<4?^4;E3%,U2O,F)O#?3\/D,6K!Q!HNFO=':K@QUBGIND"(44*2! M(A.5NL>!WE>UN=YU8I3IT4VOXPKCTC`*1(6C"(ITN-H`$-D_\YJC87=MEUL[R_/ MLZ8@/+6=`]WKQ8U55#,FM6.(:QFR#VA08)!/:(!MQ1)Q+@F1D24.<)AUQ'ACV MN[QT\\<,:E%E3NN\C^H6F]@=YCB;V M[A#/@U#+I_IEU2I+P-IHX]VB('#*D!:0'7C*HZ,0.?#M3/W/BKTJ$[^\8N4Y MH02,1=BHD,C-)`K.>N1,FL,,8YCJG9[RQU-GLV'<2ECV)Y'I>[A(H6E]OZ7\ M8@+WQ_*>)GF?[>,2/HWUBHIZ+`R!I!*B+!)",A0B`20\@P",42G#3N?K-T:] M+4*\E9EET?F5$1>:>]^'4N:=VYPS'\_D?@+;0??Q[& M,O?NQ6U5`8>$0<)?"%#(&^51BC%"FAF48QR$H&*@QUDM73D_KF M.?(,:Z@"["U.$B&OLYO`>42487>_*YP%:\-`XI0YR+%)XA2#=(\W&@2I)C>,DXMTULB^BQ:)JE1#,,$\LBCY? M62*403$"0YB#UP`X,JIW.6@JNG<["^7LB%*\*5`DP#LQ M511KP0=Z&<4=ST$*^WX;T#@HE>#`A_.+27,+<`SS?4LOL@$KZU9!&B]\&CS1 MJV3HB%7(4T>0H1P3PB_++48T),/J,%9*[O32\OCF8C2@BB3'\QFZER8OGJ]4114]"!]2MP1# M-E]=8+D62(84>4DFG(X#[W\HLZHREMLP*D0EB/"B).V"3!^5(*17%E%N'0(M M#=(X[\P6V'COTH.A_F+QR6'\5.8H>)5@P5%[GUN92[SJ-/*"TE4"287T!PDC M`7&O(N+)MB'K7-2$X4#$P&BQC/NXKJJ^.\`P!D1E$@:/'P-;I???%ZUB#-@8 M;9`25B.N"$,.7)K;B,NWY0A)PD[O9AQ9Z2/@4T+CG]OY17.WO73^?>%*$:,X M!H$<81I%G7QOVYF?I_YL%]VW/+"E MB@>)G1$.66I-BL""10IL0M];1;05FNN5)X&W&4V.;5XV#E\I1W/%2("`@DSXLOR;56C@*2E"E&N.!QZ%Z)XCFH\6//<8$K8F_F5V(N,R/S M`I431%D>">(B&4J'#4=48IV=["@E9E3#2N=CDSWHD59]6JZ2*G(#.C4H8D#< MX31P0=C\)23"G%$>[$!_NDSH/$0MO[=P:P)2Q'[9[BR/I/0C#\\K.YF/K=D[ MV[:W:6RMC)[[U*],^D_BJ)%4F**HDE.@=8@H>I>_L:`$<7\`,@S2Y.\-V(;P M*KDH>PP>DN1YZP#,^B_-+JJ6@@F&B<$BI?=/7]$J4O*EXI#!BXB(C99*@<39&993:? M^.6<&.()=@,74\HD/<93^TCPE%DXW`XLR3MIWWX#Y<.,GE_,/ M(:S6=)_J%:/@@PJ`)"<8!2$C$H+G_0#$24W!.3_PGM:23MU:+-@03H6]O/Z; MYWY?ODJ8&4^9121?7\2I4@@LRYL%M0Q41JW,P'1/25]O+0Z,!]YHO\PYFS9QTESO9WSWXM3=D?0UDTXF/J\3P+> MP]W/%V=*%S=3<>FT$8XB':-`!IA"@7N&A%,IO#?>>;=R+MT,&CD3D;J0?)FK M.F'_]O9+E[\`]K&>)MHD`_?&S^JK5:%"_T8J&913S$F$@U.(LICB(Z4`<:*B MU=%K&)H@+),ZWIS:FX*8%HHZ/$#H/B8,Y\N&AQ<9W^[##;2^[B`L(=3*NA4U M04D1&#(N,B2-Q2A*95$^VZ)\^B>G=OI6S$VI]_L8970@BY#G_F:5CTU[#!>7 MK3]+X^DP?KMC-8W#NP>09[C\9!FEAK58A>39D4@5PHH9Y))[AXP`BY@F^:>D MBJS_F:Q-;B0LQ;1B^)8V7@===YE]J,-X7;B?':\6U^Z.\HF*$,^,,1B2%J8A&G1-8,7_SCG#LL:62#CSZ M5B90WX(I+(QWD>.5,8*?'<84FIZEZNIF:P8*"QJIHL.$ M!1&1`NP1L1PC83E-4;8+VC-+@ABX>[N,5=MVH#`.IB5]O<_-&Y^0:N&%"U6] MZE>1"9LL=$14F>1LQ+L[,1(47$',;H8<>M=AH8_R;DK/S_AQ8Z-9/.1,`RZ- MOX^"9%0*Z79Z[U,I@A4`=BMF M:\BWDOHW4C%%-+'YO+^0%'F('D6:7&'-#4[H>`9X_=U4_XH&;$Q(M^AI/5Y$ MNXZGM:"1RDDG/$VA%+4IJ$KA"\_'_;-!-R%8D6RY'ICA*+/$MVU/:QQ,2S"K MS[?"EG"J3_5*R2@)<3%O9?2(Z@1PBMH]RM^["URG()VM[V>5MU)K*_F[>R(W M@F61VS@6YD:6\&9QA_F29&#:2+_Y71V&%==<$F6D*V0!!6!I,O`#)*. M&J0<9HAIPY'14>=/?_Y_>]?WW#8*A/^BG4.`!,S<2].TG7OH-)/TGC7\6%+? MN';&3CK-?W^+;%\2)Y8361`WU\?$(*2/!9;EVP]=^8%2=*\:=1W;>H^W.PJE MV"RZF?W#SS1R^_@$VT5;UD@10R72K;%58JH(0,$M6-H\-2)PH7`@_ZZ,6U;( MP$;`K8@EW%O7TP6$Z[.-]_-EE_IZ.EFNTH7Z+.29CVB]#3($SB"2JPLJ81&1 MO%U.FYL80ZRD'>C0E^%KE;*W7VGV7%J?/N:3GT3@AC6,6AX8Z!BN1\L-"0.\J5JU"FP[G#]?->(0(QMF'E MQ;0,L_CAMIE6XD?IC+W,XOW5V^B5<%'6X)2/X--B[=)95ZP;;V@E]VYH!H%Z M4]:4"V4G8W*NQ]O)H?;Y'R7Z1*3WG@2U300F&%IS@A`F-(F@2T<3' MVBGAA=9N8-J#>>,VE@G>UUWU]E]0L;=NZTQTNN8<5,W3^LX,:.]M8GDT,DK. M;!AZ:1)[2VYY#B1?QWIVB["_R)!V/Z;551!"T?<+2]O<8)H*Z.-I>Q(DK?DH MO&1#[VA[4]'VS*"^VN2T)>?^TOEIJWI;>V>L0@VTVVV`*Z_(':#=;A($54R@ M#4-#3M6;"LEG`K/0X?*=&%__^?%=N39:]&3V&J2C1;M!^@PM7`!5.>EY"+&1 M`R-*U9N*=A^*6O'TP/MI>6LPZ-=.B^^>?.-]6RF;J_=81/(92IX]M5JA:F2A M4B!U11W#A0%+DSVDZY^9:[S5N/=X^G\R,LN0-\;JJWPC,>>2OG[!Q(5;G7'= MT&1T-Q!7<<)5.4($EY\GLWEBROTUN\8%+A.=Z>%35J*W00%\9&SJX;[8E;P[" MI@C]S$YQ>8X_<':#27YEV:]B]53Q5C(5G&T48*#=O93I]BS%8TH_K94WEIOF MJ%4(!O?2-K=L''!*='LZEO\2NY>\F$_[Q`.V2K:$@G/2"$#I'&CC/8A&,I`1 M7?1U,'$$3=JOMP8(KZ!>NC@V=Y!9NR+2)W023]U)I94*+C@7D)Z%1= M1V4XKP;.YX4Z>^P)?0R(2G3[.2Z1VDE,_E.:D*;S+D5C/V^NMUZK0N4\JP,( M@00:8P9D+00XQ1"953+XHW81#^R]1[>\C(M5OUW@]/)GZNV:-8)U?9W^T[ZG M(DE_BE[B'"\3L//%[;L8[63QU%#?6Z=U6ID*K03.:2*4-<1HZ M7!RNT''T?9P#IR+N'$ZG*0";L@!3[M\=#GU.W^DS$OKQ,:/W"_3>RIV2K? MT%:7EDY$:4#'Q#ZPH@$>R<7U3@<[E&]6AD\]KF&,CU:1TZOY;/[0/]IO%SOK MM)K_6V&[!Z@^A/ M5VDMET%S9]?\7B6I09>(F8(VV=@TVN%`LF*AB/9;KUSRA747_V=N.&JVP6J#1#+PQ#NJF5J!,#"!8RN=T*MIJH-Q; M.9G54:D!8T!4S#=Z@L6S.PF.]AS=7^N>"O__G+*5ET@_7UXN)N^G$ MH+[.5]+U^URM4N_11B.-XXG<2>,/E.<.`OT+R#.)3&JM_=`#Q$+*EYEH5\?> M"YD)ENNU>WK;"S!]K4.>Y;Z&OW-%WM/MW%W\S>_-?NPL-\K2\P M3*X_6K]%@<_>4&Y83W'I%Y.K57+ZQKD\L=CU^_HL,7N#E?;VY M8WJG(X;K;#Z=^)RF]S98FY@=S:<&>)N]=LI MDU:HN=S@/MUJ9F3_3A=+?%A>3V@*Q92L]W\]G1K7H,L_F1__(\B_);7Q\_%CKZ.'3+$F_?(X+=W17)+\6 MDVLWC\^R25PNGWQ=EC>_GIQ\_?KUE[O/^>R7++\Z00#@DU6MM26JWX[K8L?5 M5\<0'6/XRUTQ?7/D[4N+!O(?2_Y:_75:KBH\+TQ/'OZX*EK5?2'Z*UZ6A4*( MD^5?5T6+Y+6"7B@\^>>[LXLE&L=)6I1Q.G%O/%Q'1[_EVGRZW7N+M^^ M<;.K.X\2I(!A4&'TMZT5R_L;]_9-DK?L^RZ==D-I/I]#3UQ+Q*/L^< M+`JWOVW-1?=JX1]N-OV4O8O+19Z4]^_B_(O_VFMRX2;5-XG;V]"=G]"KO:?I MK2=1EG=@V'I1O5KP(<]N7%[>>^*8?RV2FZI1[&M*`YF]VO2I(D1[]5]6[T)3 ME M4V2S9%J%><_YUT#=IA*&T?=#G'OHKEV93.*M\5!+<;U9'Z3NVM?(;EU9UFQOU'-Q'=DZ4,3+&?WIT6Q MJ!IAU4BS]*+,)E\:6-*D^@":-NXO=Y$R@-Y-^\T=A'2B=>ZF26GC23);AG=; M%5Q3O@]=FKIZ<[4N--.NF.3)3=52SR_#19&DKBC"N$A\&_Z0N\+[:]F,?2M^ M;-+IU86[JEKY-NT[$'U@"QNZJ;LG'-C>#[XG;Q);=OB(3BQ^7`>KI@V^DRGO M3]/++)\O5=AJ2H.Z7>AXFOJ/[E-\9^YNJH%SFU[KRO>A2T.:;ZG6A6;O75F% M!Q]WUPG MDX_NJD'SVUJQ5^T:>K5I_5YU;>;IAM6[T'09MOE.WRW#>]\A-.IO-]?J3Z^& MKFY4N3\MFSFY2=TN=/RS<.>7IB@3/QRZ:AYWL9C/X_S^_/(BN4J32S_G3NL5 M,#_"-XT>]A3[JF5Q/JF->_SXW+Y5[BA)RY-I,C]Y+',2S_ZR!K$F.U4GG*JD M%ET:\:QFEPKYS]4L.4N/I^XR7LS*ENJME=.3LMD\3M+]=7TAIE-5EY*/YV[^ MV>5M]7Q-1I=*7GM9^63QV1VO(&FIZ@9)KRKL29*D2=6+G/DRCR4KG?9.=3X\ MSMV5OK*;]OC`K1G'`71HGBA<*;-4Q2LSRR:ON7KIYLNX^+ST]:(XOHKC&^]S M2$[,GN]KSY+X\^-JPJ.2T_/T8Y4#RWU? MZPN\S]*\_G4YI?/@N-/2S5<6S.+/;O;VC=.X?$9D+!1(4TPQIT@++:"4-88**KD- MPZ?&(?/)499/7?[V#:QK/?98.PVPU8Z44;`F&P?F'B+_Q;+C_G4RRWPT]_9- MF2_5=LJGMOU8\PL"@ M0`-C2"`5Q`H3;2PA`@MK%)'!0/3;,`[V0\<=B9!U#N6250,31+\(VQI0Y*%" M)*1$VK=6`0$T5`!+0+BT3`*H8:BB5V/7WLBR-F;^EBK[.6J+U_="YT?R__!^ M?V'(.-T^O+M5EMXZ'UO[GJW2]=V+^<\KWGZU?&0AYDB%<72EWFA8^#%GF1#8/_-\6C@1!&A(3*LB9#!FT M`5;UP*>YWAJYO^ID]*,/^WL#.3PUWL?S[=W^NBH1"92$"&*`L.5":1H075MG M`QV,=^#?QU4;O;XW.C\:!T8W^(_!];NX_-N%]^J;YT/1A4N3+'^?E:Z8+IPO MRM>.[4VK1@'T79^AH6'&`N[',JY1;8'!!(YKF-_?$5FO^`S1J%?C7WC_;-G2 MYNY?"Y=.[K<$`0UJ1T0R:T.%*)"<68"X;R0K,"UNQPG\HT<%W2,[*)M>TWGK M:-&@=B058Y+@P!(6VM`H'Y*;5:>+"!]O\-"I1]>QI7/D?@[6C"[<&#M9QD&2 M8M4!;UV6:%(]"K`V&'`54HMM(`@U@:BMEFILX4NG?FS`D3WA&CB:67W\(W&Y M?_;U_9F[=;/F`HBY.U6.LA/%--T!^[!^IYO M36@U5*V5$VFB;$")I(@H/V'@X-ED04$2?A>A3B>.;M(Y=0SCSTNK,<="XV?3 M`5ETFMXLRF()"&P>#WU;*Z(TY%P$D"L_GDO!!6:KO10!!F;\85`'_EO'DKWQ M.A0G4"M./-:*E"'<2D(E8I)BHD-#:6TC\"UNH-S.Z#G1#J]#<0*WXL1CK<@` M'$`L#(7&F-`J#L&JQ\6^30RTLC=Z3K3#:_B4SFE:NMP5Y<>X=,O3W-,/?GI1 M'>>[VK1ML;F0R$HN(1`BL"8@P$!H286`X1`:&S`TTI'EH#L4>X-WD-TC<7%= M70'@?U1WNMS&LQ>M3B=%M?EQD6_B5V,9D=6A1]9@CA2F/!"`ABN(+<1VI(/4 M0>G5%[JMTI/U:6(Y\:H42T]LN3G`(U+A\>S4^%_SEOO(C$(I=;7`):U"7!F+ M`5WE>+G"[29+_0]Q!V'4T&@/M=GQT^-.L!6Z6_8Z?E,^LD(:B+255!@I?"=- MGG8*&*K;#7N[+Q=^%RSJ$LEG#/GMY.6!G[X.`>UZH][6HT!K>LKZ.;;2WRV? MYHVI/O_UL6<;3O"T%14I2J%"S-+J'\Z08-X92E7.AICQK8S>T4JOU+?:G26W M[J\@KSMBLX>T"$L2H$#ZN3WP#%8"9=I04"2Z1#C4.B9^1!HQ(H$`-8*C!4,>Y&J6; M!B%*-B2>0\096RQXTK_1MLL6TB*E.4'(6 M=8CJ_S.NPF9TB:COF6C#$^Q3'D_=/,Z_5#.(Y2^5NL76%>>-]2(/*:1,8U:E M^30P@3>NMA,H-K(M.KUZ,NL/MT'R$9V$4CM(B0*H#>,6AR$%EA!-&=`U!C0( MVW&GI_-)APBC^L/RP'S:<3#;45*$.%582H241(9J82E7-18>E!$?:.K%X\U9 MU2&:/S?#1AX>]AILC7S7UHD"HTU( MF5$,>'L4DPRM8D(;M"1#?XG-GLG0-5Z#),(719G-7?[1S1XNQK].;K8S8D.M M"$HB&13,2AY"94W(T*K;)&'+,RW]I28'XD1WB+4:`+QMBZ3,XR\7UUF:I)L[ M_U<+1S((.3184>9U]9V:5],^S=1DNUE*?\G"(3K^+H`:HI'7\[4-+;HN4BT. M!8%F@3;`TB#P?)3T:9IO!KO^9K.;!\LO[8G/"%9,S=UDMJA>V-B`!;N*BKA% MH>(>1.#_(UA5]PNLX-2VW3Z4S@.`P=G2,XX'GE3^GC][6-V8);(R60Q7\RJK:#/;\%MQYLUPB++1(## M0!*N&?8AM%(0KD(GK<4X@I(Q,:D;)`_,K??NM6V5S2I&0C%*,-0^Z@X1#KS9 MP0I4K62[WH?^R)S9';5AXIYOM-PMUME>/1($*SU@=X`]D2U?OCO0+>G52[^GBYD[OWRIYY-V9PWN0-]!2@2J\T1`Z4`+ MS0$"`2<@1#R`5D%FMJ_F'PJ';?>7-Y00&>1M#@&RB@A%I0^U*'VT'U@>#)7- MV'@[>2_^S(;`:[3[)Y?K0=5UJL7Y9;6K^_$]S\_MW9+L;R@A0IHB'C(&N!1& M`X"@%C5@"J.A;IO=Z7J.SLF0#8'=$/%'`\VW)EP;RXB"T$#JHRY,M3&A1)9S M5#=F@3@8;S*_FT$R]EE^D^5QZ2HU=VCQ&^M%AJ+`L??\F(B).N;1*0PXI,M80)%FXZA&Q(:TXTOGR^7`2';FRL5Z$ M#!2 MN_S3=9Q^.EVMGEC5'NA$6:$,TJ)X%;)`"EI!%PA!%2[ MR+RW^=EXZ=8"S$/2K-,ZJ8**`^YD:;6 MYX/7MWRN5)/],]LK1TR8$%.*M&4(0P008Z$TF!"$``9JZ\&8OK?-K#6A^;Z9 MS2(B8Q4%2$HF#2)^9BPT5@\(0.M_&>H>J(T;9[ITY-K],IWB--H-,VNM#.^K MA90MFV4:U(XPMH&E0<@-0B%`FB.U`HHBT&Y;]V`;9;IB0=8W<$-$MNO!N&_P MCO8&M2/+A1#6MUM(&(10`@V>;!:;)A-G%[G'?)&[S0>8=Y43>46$!03ZV3\'7%$( MI*AM8S(<*H!I."GJU%O9<+@-E`>_690N?S*@02;\M1H1@QP8:9CBA@'&0UX= M]5W9QMHMFO2VP-L')[I%:)#;35Q(=H9D&-GL`M639\(+(_RPZ$Z$%[J,TGW3=5BY3E@!"EL&1( MR`"&@.F5E=JT>UWF\*%+C[W3[B@-P87GW-[@^^?%(AQJR`3@*#`Z")"6P*ZL ML-2,[$T^/?IZ#U0.D*U;+@CWEJ&K=B\GY3).K]ZD5K_NJMJ@>H!''C(%>.[I M%E>J+"=^KO5?6;I_W6 M5X]"WPHI":DUU84QP`@0\MIRHHP>0\JO*^>M3?=UAL]/G.HC`"/!$*>4,!JJ MZD6TJ@;*(C;4:]];IOJZ8$"+--]NH/T8"1L%5&A1J+D!AC"I&=%!;7/UFKWO M.\W7V*,M,C?MD/LY6/-=IOD.29;A2?(N3A>7\:3:H9=>V7A2O?%S_?7U#6I% MW!@:"&4DMP@*RGE@36TC,O([3/J%DY^+,O>\;3QUVRHI$DQ8`"$)D;60",)71YY\O(;(8.\R:4:2GN8V_8(V M%@)]=!7&WD'GES8I)O'LOUV\J3MI+3/B.I`8"T,L"'AH$`RAK?$)#&VW!CL0 MJ3KT?@N6=8'G6/CF,3M-/WW-*A.:KS8UD!7Y.:40"FL$F%:&!0;SU1A-&!G9 M"UC&Q*]]82`U'+G5%LE1 MLG>\M7C8Y;;8$<%[62V^[Z MK96PB/!`^Y"7FA!B[EM="'B-"#(!:[==HK<#CN.C5DL@6VWX;JA5DEXD=^NH MTDY0I`754FFD.`81 M=I855:_[DL!PJSD0B@D*49WS\5,5UBYD"KY74@V%XXAXM3^;(DT1$M1:IF6( M@0DH0[2V702PW0O8^$_"H1W1&^Q,@DRG'[V*\5QMHHM_9ZF07T'01I]270SPF3)[MI]H2EWQ;,0J5Q,1( M;C"B?O24%-2720:(:-UN)C30+'MOQ_:"42>1Z&,J3/H1J6G,^:Q*)$.)J+:6 M*R$HX=J&N@8",<3:-=>!YK>]>'4/=(;II+W-KE*U>FUSGL?IU<,!I[^8\H.!)J\==O,#8->JEVBJ M6=V'^8'J_\B[MN6V<6S[2[A?'G&M3E5FG$IZSCRBU#83JT:1,I+LM/_^@+)) M*[$N%`B2D"=/5D1`P%J+P`:PL7?U<[:X^;%+^7QL(.E7:U`FCH_:2$>,D@PJ MZ77;;V-\VAG`2"O9/&/-J`"6-!R]=*1^$3*,17NU!<*B"*7&@-.F-]G"WO%A'OOU.U-SHH^4,&D>$O)*%#,5C$E2:F;/YU`@1ZV9WQX+E$B)K'28 M8T6))HRX&A-)HO4O"$^,Y06NB>%^D.3*+G2P98W\KC/-K; MV"G$"56O!A/1B:>W\%I\Y89!:<#\O;]>[!$^Z36>H-V@%D(11* M*L^)@QQF4E8;OZ+JJW::&4%9=;P#28$*BW6V9X'$*AH"0E[[C M:$*E:2O[L'2EVDI`>&QUU8Y3`XBKKC:HN,ZWV#I*@:V/*!R%S2D%9B8QRG[V MDYSKU%8"P*-+:_XXQ+A55QL\1-98#372%H%H47+9G)ICJQ)]`K(?)UVIM"X' M>&QI?9G_/8"R8JV!0JXY$P9$P($$(GZ43;^Y3MSFS7[>=)W"NAS?T755/5;+ MV?+NI#=<_A\)#@,,4#04G&70"N3B?S2H&)%HX6<_L;I2U?6%>[@P2">"`PT= M""G6L]S4V>^6F]5B?E>'D-L/RC3A+W^:K2,@]]5V?CM;'&G&P.&"MK%1OT3? M.G$2]/;A@`P6KLZ"3HEG=1@U'T5FC%?,<0[UV1W\@7MU-MS1+P\&QZQF=>I# M![AV<87,E6]Z0YA,.TW/'-BH#PF_!S/JT_MBPQ:UO3*+V69S\_7+=G7[GS/! MBHZ6B4M:AC"A>$B&LB__1]!7&8;., M(X<<9+T-Y)X1F#%$T+H\^-7:KA[^VGY]6+S$5-U\KFZK^>,9>Z];!8%*9S@5 M6#+!#%8.$.R:GDNFQ[(#N^;)S&<1#H+/&,KX5-$[+`QG-7QPTG;O,T)T5\7O!8&)/A5?`60>T%MQXU@)9[_B4<>(SN!)ZXC*5`CYL-@\7L_]< M*`"+@7?:6$^QMIIJP'$+'`!I$02'RZ@]+/-)F$S%^LW#=K.=+>L@>!=2OU@LA1)H50[^\7/99R;C,1_.C#CK!J^?U\M4VV"#J4#\ES%(4Y: MX`WE5#GK8=-G&F>\,HXS!A!#?G!&%L0%IL")4@%[3`D@ABLHK.`468=:BP>B MM/BB@UV6&48`/4&9A/BS%L"1$K%O5AM(H270:2N$9\RT>*G$`\S!KKD,27@2 M().0W6WB/U4L(.P%JHQ+L5T\ MU2-RO4.W]\Y.]+-39GS2#YOX*FPVZO:_#_--T[FS[@VGB@4/M/9:Q[=*6RCC M^Z4I]P1#X+E@0$Z>[>E`XS?Z:>]3]\Q/W:H*2#E%O&/($:@5X!KK%A'GX5@G M9R>=)?)0>C0'U"!(%>M8<:"W9]PJCI2H4P]3)NI@N`I$7!SQ5#6`6(\3KX4. M[%0Q&.MOTC3D`&T,4^M02^L_U]7Y_#UGRP:/!;.TCO*N&/;1FK'4-_WUWJER M73)Z,]A!$3FP>O\:*1D1QN7NS[>KDSOWM9VG3*_7BV;``04.0!![L`791% MR%VC$6%F9RK0`]EFN:Y8+N&JS'*,&!<')0@ M$+@^]E/$-CVJ3_O+-;HSL'3^CDP:/.^!^.+LYR+XGM3-I<,MJ-^>#91+RH!S MI(YIIQQ3W+?]06B\55+RO:?.A!QW:$F"8@QJ/]>!8,],X>TS`5FD"=;1+K$. M&T&]X:Q%PB9F#KC<([W,*3L5IM%H/OON[CT52)0\$L(K63O94^R=U6T?F'?E M3LH)/!QBLA<.U\EIAU&8S_[;LI[V3%0Z-L/--[7#\<.92;'JUT42T7D93T`FIE)$$@=>-%CG>1L64TAH1OS&G M1;/Z_M=\^=R5PSWWJ^_[+]4OAC_/97[L< MHCM$/JY^=IA0QVY2D(X2[P5&D@!:3RK$R/9D,#52]V"!`0:=B@O'/NDTO4_? MYLM=QU:=._8\U1P6^H2M"0#H^B*@`II1(!V']G47%B%06+R#K!J_'MC?[<#_ M1S3+2AOYZS8%;VVDPD$=9V?`J*%QS&EW7@1),VP&BP+Q?H;^!/"O9>P_HO4I MFQ,8\QA*[SS6CG(L.%.@O>@`1&$I7M_%Z)^`^T3;8;OV?EK/#R:-[50N,`N9 M(+S>ZHL+:(2XQZV/GA4\S2=AL"`;8VUF)0/4:ZC;:\#1->NJ3EO['`.J;MZ) MF%JYJ@ZR/HPPA%*%XS^FN"&O"%B3Z+8R6'2.X<:@\4`<6$9JVVYU_/'T8]7D MP]C]1W\EG:H].$^]H!Y3*KB*KQ)5KUN_1KO$&`;7<6(S'8Y)>FI__>;KF=`C MGU>+A5^M?\[61_,<)U46#+/(6$Z`$D0;18&2IMWC=2[13^,ZSEI&@RW_8'.P M@>9AO=X%S4@87TY5&(R$EBB`/:!,8B&\5*^]!:.%1>F2WVI@.CN/,QGQ+'_G M0WVOHZGO(W[8^H<=C.B!6Q`0(`YK[(T0FA/"O9/M(!$'^[0K0,-DS!U'RV43 ML"?^_,'73D$Z<`:W=74WC];';0W*?+S?F3*$63U11X'LM^BIG;Q/C`PGRP5E M,7+:8.BDMR;J&V!7!_(CQD=CP$\4Q,Q6?VT_+#?;]4.7E&T'G@[$(.0%D()Y MQ*U`U!'_TB\$=>J:\.)QZF0HLDS,K'*C,2LUW%@[HNNG?^S"4NY^WZ^K_SY4 MR]NG,Y4\08H8MU8E\HONC;1B_#5T!B-87ZUK3[4 MYK/7W3J4#I8J`PVAR!#HXBQK$$--GYU3M-P[%ED9/::6[,C];ZBFN%L:_B4C1:OV>O$70I'B*:"EO'I8">64`,A:KI-;:)3D*#[3AFY;GK" M-:I(]*N+WA_SN'9;W]X_?:P>JT5WT^1$!<%R31#34G.*!,'2<*6;GG/%QTHU M5H)UD@^FR4:1MUU(FG2.UA.0XD0BH:71VALJB2#T!0=,A&578;1D(;K+,),9 MQO]=695LU92OI@E5]&'YXV&[V0&"NELV;TL%BB!"0'@49VKKH=6$-4AB!UC: M)O&H!DT&_HZII#=>8VBB#9_RY;9:SM;S5=?84?O/!\D8$P1J:I`VAB#(<&,& M1J.0I[E`#APW*J>]D@.54=A^:=Z_EIL?U>WNRLG9.>-HF:#,S@&)`AF-?A]Z>$XBR%4@0P'?%^M:YN9YOMV?G_<($@L6/< M>B>0,!9SJIULADJL2&(4[^'RI/=GZ`CGO6`9@_#+PDE)I>K`ED`##+77#$G0 MPH&$3$O/,G`XJ9PS>2H2HS%Y470A+QQDT!$G%09$"BZ(;/J@H>+ESM`)/)P( M,Y2&PW5R6MQ<.RZ5XU.8%C$JKOP@)$*".-\8'E>72K58Q)7@:(&_+H\TU)F! MDQ&C+NO_*#PF18RR@'G"B-,>,"BC(6$D:_IA#"LL!DL6'GOT?Q0?S=EBMKRM MOMQ7U?9CC?=\=399W9$B`5,FJ50"6B(`]8@J[5J5(I5F#EU^K7\R,>4Y%-PS8-O%('0%1]OL3UH'%?1"Z3WJH3B[JR09C$__ MS?:^6JO-IMH>3SIS]-D`C)3:842M-QI0IB5M9C4I'"DLGF<.8E9Y(1F#8G5W MMX-XMO@TF]]]6)K9C_EVMCA+]\ER(:Y)L$6.`J4@$\93#!V.,+KZZ.V/YG2\8,,CN,DMLSSUQY3!=($ M<7G8F\ELP.P032^*LW9`E^*!.Z"AE5A(*!SSV@'8S*/2,5JPVTU.2B]22R_D M_E=T4YPE6;I<2I/)S8F4:Q?6$"S'S`&I(1*,4$XMT;B=;RD?32S=S)&\=%ZD ME53(II?+GS]7/>72UA"8UKRV^S@#VEM"81T*_J7OEM.TK.B#6:\3RB45LO'E M.*VXT%(3X=C"6U*7M6EX>D:X0BS4!DO%)_N?L^_GTQ\>* M!&0I1U'!<0H&F$,BB`%-[WC1.;+[4'62]=[HO#<-%&Y53D/])90?B3]C5LO' M:KV=QP'K2[6V.EQ?WI68T&540)W#U5\5*3P_DO1P#B.YBR2A$GI-)78P/:M$(H4ED5[ M#++[X#/&N/YQM?RVK=;?:RSJ--1G3+A#CP_-1W=8.N9; MP'M#,C[)9P?O0X\'P*36'AANA$,8,D%MVRL/4<'G@'TH.LEV+V3>"^_%3=E3 MTST^S9^KQ]7B<;[\]FM[SU^X.%4N4(1$M&\(:H38ZB/)4I[&=D&1BNHV7/,A,Q?O' M.D;O^OPR_$S18!GU'%O*.8]OB.;`$=B.99@4?*;6G\`.BLB`U7M72''V7WG" MR'#X\N]JL=CXV?K;2L^6_SE]VG+HV6BT$(5D?=N?8RPHYLZV;01>%Q;$*!_D MJ[S`))%7_]KJJ_I>K>>WL^>?/?I>GBX0#*90``>U,Y"XV'+O<-MO+0M)6#`L MC;G02>+R5QMD+\;624?\KD6#T%@+C0"`1E@!E=+1GGGI`:&I7K-7$+)[((2& MX/CTN]NI<)`JBEXY3QDF.N+DI&R%SZE#Y=E=^0FZ@/E>J%VK!HJQK*Z!^N$I M/^7O?E'YX+7!-G9`:.B<,\9*T\0D4-#Q0NY=#D'.!;RGPC4$]:=\UR\J'RC@ M0'&%`;?(S/#+"-89@/JU7MU5UM_$1K-_KQ=V?Z]G=?/G-SIZZ MWW\\4T_`M+YL`(#PCD//$'2DQ:$^%B_#SAASZ,B+6!G*J7/J5K&T]ISHQK%"8^9]DIXN#Q!8N)ZR@%>&M%[GU9NONP3(G];S MV]BK^;=O%US@O[CF`$$$)B[U+`6$4BZ5ALUR3TMNTB[V7QZ%J'"AY<1P4KT] M_UGO/7^N8WJ=R@C?N8X`E338&D4,`,0Z(1W$[?MF>)K#PN5Q`SP9G/$SDFH)6#L@/+8.&,X$A8[WB:KTHC;--/F\OLKDVA@>+P&TL&> MI95'$D66PWPJ,2>49Q@IJ"P'T MW.#_[^[:FMM$EO!_.3]@,_?+J=V'N6YM539.V4GM(T4D[%"1A8^0DWA__9E! M`B6V;D:`4-Z,S,#TU\U,=T]?ZOX`.GQ?+5W`%^(#'@NLYS@W6'=/?,6QP7I$ MPB7VG#*CJ2(.64+,!F6%6R93EY MU4GDEK$)=88@8;204GBBN4>NT?(U%^WZO,"+]AR?#M,@F;X;>:YJ![U/GV(8 M[AYAV#$BD;%2I+%0"PB8%B!<-)YPJD7+".0+<_9V`\XPZ\%MM@C4^WP>2^2; MHER6[XKYY#'\.%^^R_:O!P?&)LAZ(!FB1"(CI,:$D#K5U3"L6PK#Q3EDNX5I M^&UB%5B33X(8_WB.?O16L6-\HA0PP""D"<>"(.",KDT\@[ENV:7OHGVMW4`U M2'C":H9E-*P6^=J$#+?/- M+LRYVC5,(SFLJ7S#)Q[6K)Z1:$`1Q%)8@+A%AAOI:$V_E*SE!G,A_M>^X1I& M7&K!-NE#-&7C-8Q+/PYZII&<>"X&\@*RQOPT)&V<[Z;@0_^@` MB`UBFE83WXCXV_Q_C_DT71TRKF+Y_B[FV3)=/!V,I7[ULP+H$"J$J><$V6"R M$PIKB\T@R5JN+Q?F+NT;MM:'-Z;XF@6C:KGNFFQ6)E45FK#O'&;/L(1;$R8? M%"JL38"+$[%.&;(``D1;UI&^$&=G#PB=SMO54G7UD,5#F_G=VZ+<>U*[;UR" M%36.\YC?#X`@7G#KZKE+R%OFSUV(@[(/B+IBKYK/']/9NHNB^_Z0S0/)C\'T M?06K=SXC\49AKX`#AB+.(`)>R9HF[7B[2!UT(4[)ON'Z001^?[-!*DSXR^K' MGW];C_T)L&_?OOT67E_,BKO\^V^3XOY-!9?-RLDBK^*)KF[KX`"=EGFPB-^' MB<;CVHHI\VDCPS?97;2"?IYB]GT9RX9,FWF>8THV;)#YK!SAS-X7LWR29_U- MK9BLVI?,IVZ^#,+\U_RV6-Q7T^GKG7_-PY_9A_1[)=EE-M1[>N;RN]C!MHS! M"C>?TT5O5#U[S7ZB>FY@'"1FFL^J`*&;;/*X"/1DI?L^F3V&EZ_2>.X?'E?" M?77KTL4\2'8S]6;=W&,6=/6*A#I&+,5,(H>,H3 MS]GT<1:VE!,)_7#@3+#;%R608!$TD1B'0Z`1/);7JM&T8K`*LNELMGNK'EYT MBA%A7FW]$;CI\K^365%FTS_^LUQ4<4GK'XOY,JP3;E8E:/_QG[+>G?ON>GX: M%OII^P,.E$OM\:T)LQ8K@#!F`E/A&.+"U(SA3`R5[?VJPE[GDLWGO=I'PY8A M_&7;)WM4V[Q#0Q,O@DU((.?!(`AFB`7"LYI:QO6(R[V.0@:.DLN3X?[5A6QX MX3I0,?:7E*WA9W85_0`TA`!<9^5RD4^6V;2:[1'])[;V-\%^"<@>D?`_3E]&$&"=KNH@>KN/<"9VHCF;-45U#7P?((*;>BFA`29>K&F%W(^L M\&K?`M,M6N>0C/5,KY:?LT7,ZIX5L09YV4)O.?"DQ&!GD-3>(1A[HVB@*:FQ M\%:URZ@?V)MY1OVE6WC/=[)V-(0'4R`Z>7X"8_MB9X&UC$HL*"6:-8NW&%L[ MP-ZDHMM`@U;87E9UB&!N<@8%DV'K1XP)*VQ#&[`M>U8-[)Q]D%J3=D!Y&MEZ$1AQ6MW8.20)QV MG"J,)82`28Y)K;>J6)VEE>STE@QR?MGI"LDA9.6O^635#"B6X[J_+^85"*5: M+A?YIP!2K#Q9;/+B8V6%3\L-97L$ZL0G)U)`Z)1@S@'KF?9(P]J=HIB&[6J3 M]Z8R=<'TXIP`]I>5]"PWHCIV[2W?XSK[FLT?,_WT9U;<+=*'S_GD.KOK,6]F MYPO;Y8#LR`#<''KO?-_;/8D;KWY&(HBC$&I,H=/<016N[4IX$)&$'*P$T):N M\N6D=F51O.X!"?#&8TH%@5H$?1`0J=?+.<(4J9;%DUZ]GFS-CNB1/\4`8(TV MK2&LCE%-6U6OO<[++_KI0YCQH4"9W:,"[I@`91D)!@50*BSDA-7`0&2'"K8] M*F*F+YZ_-+HZ@FL@V_SGV<:Y'HZ0V#TJ$0Q*YI`U@@I+G>3*-;A!BD;86[Q3 MSAV2AI.1^C6E8GSA,R,3AN&%8+,LOICWP=":@V,3`:UEWFHN@`M&);;,N)I> MK]K6^NTMS*8+SA7]8G26A4$_Z6P^^7R?+KZ\7HWX:6CB$`3&4N*4%MP2JS72 M#8X8Z#%%WYY/ES@%L_-(2#WAU^\?SX8F5JGH)-#*2B$`$T`3V\#HI;@HU:(E M(P]*2">8_>J2<@GJQD@$9'C!N$EG67E0Q?CAKH1`*"C&P!D">0`&!)N_H0&B ML2L3K5GRO)A#:T@&86L\*HI^CLT>F,J$$5`ZY6%0M*JF.ROZ M%"5#I6B-25OH"JQ!A&'E\OIQI@=7_9UC$@^UC<1HQ0AW'!G/F\61`CABGT,' M/'LN!1VC].M)P^@V_S$)05OFE]GDM[OBZYNJ1UQ>1[?@'MJ]_3C[> M;.'OYI\)<#;L54P9'@QKRQ@1K-D'PWXV6,[5<=MZ!Y@7)T(P2##KXZ)XR`Z7 M5OCAML18YZ5W"CB&C?;E3YC+WC$J9AS/F@R$#((68(4;#10$T[?TYOP7K=,[U+=`8)'2[S]'TZR6_S MR4'.O[@W01!Z*[WRB`GG@`H;5H,2<&ID!5,ZXLWS`-X34=G/Y1TQ`Q^*93J+ ME1JN;O\I%K/I=?%M)_OV#TBP)9QZ;BFE/$Q;,L,;PP,A-K+$I&YYV"DT@YK3 M=;'>]0IVJ,K@WG&)D8YC!3%RS"F(/!7";>A4[73GUP?&CM*L[@"P`8VI8PVH M]2XG+4$8:HG#/D>Y4]*8C7_1>G@!)O1I_-EN09V$SN5R>[PF\AF9W,%F;?-% M-EFN5ZK]V_266Q,N%`'12I#$":L=<*#>U(@E8U.R6J);=`I"2S:5JZCB8G$D MK[;?GUC%2:"40(NQ"*8#M:0FFGA'1Y9_V0G#.D%BL&.F]23_+(IIN;]=[;;; M$XAYD\"TK['DOF&)!3Q\ M%TQ`RQ3'0B'--\L25R,I'#F<*'0(5G_)&#OI[S:Z.$C.72 MN/82:FL)\X@:I[ASAT^0>D*M^6R;LKS9XFL^R790/*LF5N5"76>3XFZ>_UNE M:N;%M&K_>WP_C@[?EPBJ@:=2::2H!Q1B;E2-K8:XW5E`QVTYAA2AG0TYS@?Z M:!-85N6E&EOP[9KT`QZO/:,2`KQGQ+I8+8\(!@'RJ`:&:C[ROAAG$9&7>9D= MH3M0@N^VV1YTG^P=E\3ZR@I:JR3%FGBEF6$UG1+*$3>VZ(1[QTG$25C]NK(Q M.E?;^$3B'`9B/`,Z+A#UQ;T)=#;F:L1.J`X'?"QUM*:',6/'X17HF#(@#K3HS'M!`X-#KA,4K'`RFK350%!*5IT#,M M"X3VYO_K1Q*ZQZF53]>$6ZJXNODTF/B/LXCTD[J]3?/%[F_\R)$)8M9:2A@@ MSB,.A%-:-]J^ENTZ!/<6Z](MG_O!:)BSLUEXYEV8\]_IXDL66]H>^_$?&IH8 M`SE11G.IL>3`86<:^\\.=Y!^UB^_8Y"&27J=9XM*C-7T/C"@K!R87[-CY>*H M\0F3L?TV1!0@X`W14FR6NYCZT4HX>BLAU8]P]('4$!+2=+\^5B2V#T@4TX(I M@TG0BCB%S'O-0G?%C!YU`,21%TL M:`V1\XQS8)B#C8[LB!PL+N/(\^+SN4E[P;._S%[M5<1LD>.SJGBF0!+M3FU/%R?9L36VI:`EVN)%(#TDE]OSZ!4B1DF6+ M!D"`XMPDCB/Q>[\7Q(,#">"7O]QOUL9W4E99D?_ZROP)O#)(OBQ667[[ZZLO M5Q?H*GKSYM5?_ORO__++OUU<_#7\]-:(B^5V0_+:B$J2UF1E_,CJK\8?*U)] M,V[*8F/\493?LN_IQ<7N6T;[TSK+O_W,_KA.*V+<5]G/U?(KV:1OBV5:-^&_ MUO7=SY>7/W[\^.G^NES_5)2WEQ8`\++_ULE/L']==!^[8+^Z,*T+:/YT7ZU> M&33)O&IBW-AO.5CGOX^+*JQ:O5K/?F M*.ITK?CF>'+)TZ+7[&-OZ4^[3[++#V"XB;Z#Z\&5R7U-\A59M?!\=&TC6_WZ MBOZTV%87MVEZMPC3->/LU5="ZD]DS03'6;5<%]6V)!6ZKNHR7=8+&$$4P=A+ M$M]V$8".YV,_BA+D1K[IV'C17'U!\HLO5YV8YE=:HKT2L>>I\S14L2V7;>M% M9;+VNU7^YYU`HU%H["0:!QJ-OW4J__>7RWV:CYTNEL_=/(VXF[2Z;A3N+*%* M3?N2K.NJ^\T%^\T%,']>]FZ`=0J-GPGG5&94:+M+!?G&1GNK[9I\N'F3?ZHYB&`/4H1*8%UPYG>7DK.IRFB%RE:46.&XLXHMUGSXZHJ,3R@$D5 M=AH]/Y0B]"3")D0W$[ADLVV'JHV=;$ER3U-X8DB?7;G)L[Y-Y*+)Y"GX7QMM M-L\6Z'P:`A7EP=%"3%KL,VLZILW]1)MRA@+@;FS>I>4W4K-05V2Y+;.:CO,/ M)E]<$V$40&39(`HP]*T@[H+&EF.+M![C(FEN#O;BC+TZ0?2/M)*/Y=.Y*`;G M9PT\/VH'[1I@IQJ;9P)#1[OOF;[/T.ELWT=^1E#T; M6WW(/S%%99;?T@^\+_*R^V>85EEU!%8'8-NV/"M,@&G:?F`[,.B4.I[IB##N M#/(T@Y%E9#0I&3O];'J>]K#Z')I1]F$6@M@\1Y'RL7;FI2D&:(F"/#^^U9?` M`///6-PS:2C.Z4`QF[HGV"1%Q6:3U4UEHB*B(J]I?)(OJ<[]^QK]ZQH)#(!O M89OVX1U@X]CR3+<1X0$/T/_B1)/:H/JHKMF`? M4+7I"B&JQV]=%#U?5TW,S+$@%2^5?R:22F0G@U)9$U]D*5G?WB^Z%4CLM2X: MOGYXD]\4Y::9XNPA'B>);R(;FX&-`^39(8*X"YP`YZ4G'.H"Z:N\_4JLYBW' M1J!QH)"KYZ/+W=7N*LW79N;R(VV3NGW$1Y8^HYX#7`@:YG$;\@SFU)MY9K)I M2*C0==]Q\FM%LD4;[!.YS5B,O'Z?;LC"9@MM'!LE.+%,"&PGW,>)XI#K>8CT MQ37WYW:592_*8*HXF23OV##@)S%+C.>B/@WTMBJR_.FV^'Y)LVP[6O2'X_[5 M*0>>0(*,<59P,:/KTWRF7UF$,8AC!&+D00?&C@,2M[\^2$*/%Q5"%]5,B+X7 MSL0(8$',F)=IH,T3R2'@L!T*:OYAPB#1*WNMS:(TYHL M:$?#=2S/I/$LVXJM&,&X"V0'KB]:O<6N/E4];U71`??*8+HDJKR@:_QU7Y]A MDA#@]DHA#QZ9\`(8Y`R;$2$D$W@&%6.LX&(&HE%6+%*R3F\7M&N1)$[@>C%T M$@LC!R5)%\`-PH27%6)7U#'VCA"HW[L5G$E6+=/U_Y"T[%@2VSZ*<()Q"'&`,8P01ETLWXVX MUN6,"J#[Z?!N27,KS&#*9'H'\OZ]C(-)K!-\T"OEF@).G/+B!#)&6S<#>HS/ MH5!X+XG/.+81/Y$[MG(DO[VJTWI;+1QL(]L+@&6;MAW['NVN@"Z>Y6'1B4>Y M(!/-/^XJ2Z_.:.6)3T-*6LD]&ZG?1;E)26$#U3R= ML%1AC`!YDFQ-RHC"[;8H'Q:(7L]R0$+[1Y8?>U8"K;[3Y$6`:Q$U21I!'^0^"0\ZIV?!"4OX33(RQ0:1?4FPV17Y5 M%\MO5U]3>N-\V-9L1V6V6?7"PJ$50A0F00"@#UP?H;XW!#P,!'LG8T)-U$=I M)!J-QM=&J](XD"G>5QEE+W>/92IGY?HMTJ:JZ[\,%T0Z-, MXOF-L'?\3W!TVB;Y#$?`,85/<8Z,>.$YCJQM,Z#+Z!2>>98SS@X)CK0/CW;! M0M?W40B#R`XBW_5Q`/O%2C`$IAQ)1"),S)+=0\YQ-!%R4)0GNLP;1Q0^WY0S MY<`,+JK(F#<[KD@E<9(L\I9(;-'9[AKT+LNSS7;SB6J@\=.'9KU/4I0?[DB9 MLJF@MR2MR)-UT#")7=]Q/)28$'BVA4*G%8=-RXZ$]FV?1I'N9U5%WBPCV-+Z M]^%ZG=TVBPM>/VKDWZ4UV^/DP>@REM[14VO1#4-POJ4F!LU'.\&U.[WM4C#: M'(PN">.F*(T^#:/-X_S[6B@I@&=`?9X"GLG2RHF3/KF!Z'26=0_VOC40;-JL/#''9[5;99&/LTSK??A1+W M!]`S;>G.!#T3)UVNR&T3>!$F#HI=&V'/\4(<`1R[ M5A?0"K'0QFOR433W+5MA#`-%WPNI=MH$NY`CG.0#\S0FBL%V[]^^%W?UHG]: MR'G2G@$:CK=T)H13D$BA^FZ3)%'[HD2[<>4N(N6;$T$_#BT<`QNZ)H:@BQA1 M'LJ@2"+,9"PJ>VUC821CIAB--/LHBZ.]K'/SZ*E!'$`:X>K,B#0FDQ-(&FT. M-Y/0&]N>I^^/V6RI>H#\(#8#F'A^X'N[.43/QBCFW>1J1`1] MU6@ORNA4G6]$=-JA@7JDP-:9U",5F13*[SG1F?'L-L]NLB4[1O!)\,--]!WH MP=#U,8)V`BPS2=H36SP?FI[%M565`R?AA9-GMME"ERL1<$;LR[XZ8^!?IJ<;=,HE5M4-G]44+_L5/^GZ^-O7ACK_Z, MVQI+.SU0YRA:-@X`Z@:; M*':YMM92&$XSJ:@P8],I$X;4>#-Y436ICZ+`ZL]D9V[V^EX;5&$[Z]MJG)Q; M+YDV2"]ECL^&8>HR>D(RQ6:)\^R/HOSV)O]8%DM2'87&(`RQ'SB!&[HABJ/` MA6$7.D@0UVOD*N-I)AI3=I'E%W>M-EFFC3%4$&H3>2E--:;/R')CIW`V7#OM M&P_8%+@^-[*I2.D4VI39)ES(YN* ME$Z139E=XF2CT1:!!UV,$7!-RD_?CW'L]?0T<8P6=5&G:T&$\5Q8B%6]!N%: M)OY`4,P>02*I=D8:/53(N?!"0_-P1,2JN0%#2/LI,H@;('XF]7[R:S\U[\8! MAH$7.A&,;2_T8MMW0\OWS"0"-O!XUTR,BJ&O#AP<*GP@['Q/O89L&J@F2MR= M2;51D\NITWC'&R2QV/5WLEY]+KH5F`>GS;,W]!;8LH`7`BMA:VT=A!/D.%WX MQ/>$)GE5Q=0\=CA<_\B$7M3%Q:9?H-IKW:USY#U73KGQ?&@[A^=BE%-FM^:U MI(/^#;W*H[@$9D)"Y6F=7/&ITC9N/KY+_Z\HV5D6U8>;F%PW!^3]??LH/KK/ MJH45.Y8?NB[P48!C`"PS#KKP$;2X]EQ3'5,S'QN9S6$K%:NS3&E['F2C]5&5 M97)%`:G,>3Y`GL-T,4"J\UL+(3D-'""DZB*8"2&5IU7HO7/5$S(N-FF6+[P0 MFPX='D(GQCA$5N+[UDZ`&5B^:D9R1IT/)5O!&CC)Z[\R4FJP7ALK7W3]7+1L MA8WCI6!!_/,04S0Q<69*6<>_)*VJ2!VFRV]DM0_YCK"5<0O'!A$R8QBZC@=, MX$`0]R$3.Q%ZZ7-,',UD;*09UXTVH^K%">)OE)%\P)O*0S'$-:HN=O8=`JU5 M-OGZOM,F#2!,A;4S@9:25(Z7^"FSAQM,89&ONA`NLB,WH-?",(@L*S392:R[ M$#`!7#OSREQ7-WAN2;Y\,*Z9(D':"+G#1Q==QHC1I%%Q+G8<6##`"AFC9L(& M*>G%^/M$=.E:4=X595H3%NL)<+!C>10VH0V#)'(]RI@(=T%-G+@B-!@723,? M>G%2B!AI(A\TIO-/#"-[ZYBP&71+!HT:@(T:@V>"'T7)'"^E4VB1`*(V&U*R MS=4^IG>DW`6S:!\(F]AW(7O+""4PQCT/48B%1DQR$;0CJ1-EW#%5PDR2<:70>2,\7$VJ!F5Q!/$C+>$&RU?KGXKOI,R9UL1-4,$ M-@E$KNLG:/,='R51;/JF8^$$VQ9RP[[W!;$M0AME034#:*]2?JI&G<%\8#J+ MMV*L^G)E'#C;B6SGJ\_?>>(U<`!JRLM@)IQ3GU>A^>:5'0L^&]3"9N"[81#% MP'1]9&'Z5X]@Z,J-!:4B33867+$Z*W$0^\`"GF^#3H*+(\5OLO+' MG]G^G]UM[(4>^XBA?'3&BI)37A=UUE M[>,FZ:G`:,../?\'645%58?DIBC)A_HK*3]_3?//9,.07SZ\V=RE6\),OB-F=B?R_6[$#IW]B[=(F56"ARL8<2ST,X-`'V.D78 MA5"DZZU1ANZIU+*H*H.)2]<-8Y@H5U^CX@%B'W3A%$<>,B./!!#RTVZP#8VA5;3C8^FN<^\ MWP)%$7,%?!R'5CT6*B0HC[638K)W3(*&XF[/''H2"7&R3=:J%Q%&UK?W3=3Z MF:CMX6_%S?XW[),+#'%DNL"S7==)H.G3'G#<2?`@W[OE.N)JQMJ3BGGTDH'Q ME7Z`DWA:;!]FW[D=%Z>@41?&N^,+$=$?;['8(PA(F?Q)Z-(;+HD#J"N(_B M(*%G18*7UMSI0U=7^/.5S#8'`N[P<4FC,6($:H6<\73B1T8,($72L9G`0U;] M<]L2R)H@"(2H/;"O#Y9`*W("!UI!B)+$-6WD]L%08COB7!"-H/N-\]U!F&DC M[F'4UVP6/'M(06N2B) MJ!L]5%VS3=J2_4#V.D47NZBQEP]*TSLK!JG>U.:'`XFOC;0V.I5GF8'GLFX` M8VJMGPG6%"=UO#Q&@V4"6W66WTC-MDO>3[$L(AA#.["@'P1^0,-$8=P/YR(` MA?9.D`J@&6I[3?*K]^2,X^.7=L_$<'5@UQ6'79HVQWQJR0"&1CDX$^J,R^') M[I:C#>$?I2V7Q98B[!-9$HHS&O,]J7?=N(7GAA[;G2X,/1,X7N3:'NQB6A`* MK;4;%4CWE,Y.FU'VXEX;.:&#N/6Z^)'2.\"X*4IC56ROZYOMVDB[SQJ.+.OL.UD__"0Z^!M5%IQCP*F*07`HV#GZZ:`$J+)^<#CU MB'#`IJ&!H0IW9X(T-;D<#Q/5&<2-N&:5Q3Y@=1#10LA#OH=L.[8]TT/8]_KQ M*0".T!!Q1!C->&L7/NW9)MI]&F,@'Y4F\DZ,2:UM!ZK.2J33%@WP2(&O,Z&1 MBDP*Y3?=F',P8P=%R'=,:-FQY6'JB=L/$NW8"Z2.\N6YL&;:<)V#.9OS'GG- MFDDUD-,^=-ZCF`%BC>ZC2>&%!=PH#D#L)B)TCB;VD2$O M-:UR[LV$)6,R>*XI'6.&W%/E!3`],T*!&V$"(;%,A=F4A MFHAO-O&9?64<.`2=DGB$_/_4G5MOVTB6@/\*@5WL]@">'A99%Q+S5*S+;+#I M).NX,1CT@Z#8="*T+7IUZ8[WUR\IBK1LRU2=NE#,0Z,GP;3.J8_4IZI3-Z^0 MG*:.SSE?;#I/;$QK(GJP3'YH7AB(P%@*GU;50[G:/'ZJWY'N+J"'9AU_PWZ(TX!YO."=B(C\M*4*\/X!-?6/JKKY6B/I^?;?=G0W2Q>9)FI,BYT(2 M7K!$8%QDO54H!NWX]A(P>"&PRW%MTPOQP]3,&J/CA!GE*;V^0E)G&/W4YQAU M2?YE])+K:7"#I5B/W"E6Z]0[,IJ3[H4;1#>F21.$BUQC5GQQ+E$F2 M=,$RA95E51<0(;#&9/G0;*$Z+.BZ%G(A^,"UW$#D7,JY3RF=KZ+[E(-94=<" MXT0$Y-B(MTN[UDB`U=U9*E),*55,(Y'D"2L2VG\ZI]*BK'OR(T>IYSK4<4\S M@11PO>*PJ=R>I6![LE)KC&4BWW1HUD=KL\!&&W^7WR_F7Q9W[3E<@Q;Z>NWD\WVY#4V0#NO).?2)"\]^N*O#K:B_%EWLE$:JMR^."I@@57*Z1=&(*E%A*?M<8FL&7Z;41FVK+E.CU1 M6;?D;36YP0'O_?DT?VP6P':3]#SC29%)I=)FI4[*XE3*?FP7<]#]J)8A`DNH MWVWRT*9EN4\'RLUPA!8>&7#$UM':9W3N/3G/P0P-ZMQ(3D0UKJUX8P>.$Q1C MQ:C[A[OJL2POR]TIS*\=-\-2XC013"G M1L`*[E+MB$[`76_B&>Y8.2*=B*L\-.1U]\H+&H>*T@S%N2(*82TP1C0F1!#: M#Q?K7AYD^LSBXT>92G,7CPTXV_*15V;N9:.SUXI`-2)C>!.1BDL+3M:$@#", M-2++V[(.<',U_WX0]&#&'Z5U-)K01.$\SK"B+.WVB2J>8]`Y4\[!@B_Y:?.+ M%LOKZKZ,-O/O0+FXXS13S:@D8>+I(=:Y/>_H[$Y1.-N:H%/(!MSDC?9$3.6O M/56@U]+28I=U#%'_>[$YB$DP)IHD*LZ1BFFNM,B[S6>J=BIHK.84:"Q[#7^Y M`@"$.2LX.TM?-7E%;6(3T-0Q2@:*4--7D`!%LY?5R$@K"Z+Y>+ MK*"Y3K-,YKP7(2,9J/SM$":PDMKEP/9C-1>`9E(:B1U,22VVYWVGLRZEAG:8 M/%"=B(M\M.38RFH?<(P]5&S7BV6Y7HOJ_LMBN;OP2U3+S6+YM9%AM5PO:HJ[ MO^[2>CQ(2@H4Z[2Y(D9C))N3L8I^Y*D1!1V6%S:3T&N8^DSO'J/%>KW=';=; MCQ3OJV6T;M:4`?46^+F8&7`ZCP0FR2[OZ"#QB^@I]>A9[A>]3A_/*%,GU@.^ M'><93D3)(S6V.L?7!'HA1K7\HUQMFGV!'ZI-V2WNF,DLUS$MB@+%@F`A::J+ M?A6K4*#->;8QPLNX2RM:-GE!+[NP16=FU3&HP7QY"&R74K>N:^S;*XZ3&;"; M*\N)>,NY&2_OI/""Q6;"<49(G!'=W"=(LTRK0G"$]B%TGDEJ.=-X\G-'F6+T M,K5X&A%X3M$K'>O)Q//-(9I-'AI3FH@5K%)_>[H0V'Q`3^/^?K%I#DIJ-M#T M/9_K)F26"I$7*4J:XU422EB<\"XDUK"C`%SB!.]Q]*FUMVT=)@?N?3C@-.V! MC$,2V@MY#E&800S4$WF3T&!OQ)WK1-SCI2FO>B6^\`"N!']S.U\:9=;N(RUV&T#UV+BC-M#0219B5#I/ZSVZC M,-]L5HLOV_92K4U5#Y?.N_7.:L>P!]P3D96/EKRZ-]T3',")M?MIR%WH]M;` M!#.=Q9K71E0)IYK&C'2A&":@\_%M/G_$0LU#EUY;+K^(_CW^.8Y1]#!?17\T MR?X](A=Q'#?_1.MO]1>N[B5L-]^JU>+_RIN?HP]5][=-^;W^F-V*].UFO:G_ M1_T[`[UYR^IQF'DN]).`":[/)OK<@M\E=!&]VV$<_6S;5V@&#.8"CR(A#+%D&2)%H0BDF4%$K@?ER8$S9;EUV;GX96YWBRB&'TQ\O:+\2HA\QKW M/K'.=/--=%VM-Q<18OE%3EI](9I<)"3;2\A-/#:\S=03BK&5?'JNA_H963NO M@0R(QX'>1-3CTH+*VZL$W5-\<[-H5@G,[S[-%S?OEF+^L-C,[V8T90*SF%!, M:KD1G2CQ98S`7:RGM*+FRK2_+I;1=9L9=.^P+4,SKXR!#R:7 M`W)-2E%-3IPB%V;7\'$T`YIQA3D1US@WX^5^82]8C*US66[FBV5YH^:K93V4 M6//KZ^W]=G><@BQO%]>+S4SB>N2(\E0QBBBO>UR"],5YK2EH%L]#N-`N>LHH MNFE3`DK(!U(S'XU,$Z:F+KFHRR[ZZ9#M/L&Q[R/EM4!7LY MX:>S=)%V2^KK`>3#JOQ6+M?U..7=;@?O^VK=7)7P\?9J_GV6:JT*6C`D6)YK M(7'*^RH9SV&W+_F./:+M]@>X'":\W^\,/\'%+W_#WMD9T0-[;0?4VRT]SW*- MVF2CGYIT_])>[5+=-MNFQS\*!D)TJ+,7Z-E,1*/!FO?Z,)F`&!W658356G.[ M8*,(Z&`!^JX:[TU([JS-]#0J9IBLCE\*,;&;(`8LY0WM1)SEKSW`&Q^`H,PO M^RVKKZOYP[?%-6_F%"[+/\KEMESKNN7J>SUT6\[OQ+;^1M_7F?2KS21#G'+" M1*Y)H1.64%4/C+G"*DET(DWO+P@2.]QW\2G=:)?O1=1E'#4O2M3E'/5)GV_Q MI0W:@:]QT"-3PY(](VK@>.PUY?51S-%ONU0'5!H4]TUUO6WVB>PVS4\1^[,$ MSX'_Q2]9@Z+Y?2(Q3>/=KQ,,SI'?HT!TS_P+%*I55=!7$G[VPW7]J-2\\S?KG8Z&$_5[84@QU.L1;B`87T;J#G4BOV4M37I\4X0F/O9V: M@+*ZGR^6LXRBG*I$BHQDS1I?QE4O1$02T(%B+G'.9:Q7\E_+^2[F:94A*JF7!LEBE-$\E M%:H+K'D&VICI'BVPK0Z&)Z^_<$!5>4`++7B.0=6ZNGG$8+^U^9VOC/D&,*.: MI2OLB8C,8X/>K$;Z0>4R*"S*Y?6W^_GJ]UUW3R4H%I)@Q8N,22R+(BEZF:9Q MX3@RA`4;OP/6Y^=MC`C$:SU0#$?6N3=F#G6L(>,S6+!QHQWGB1C-7WM.CR!= M0#GXK(NZ[QQ*SA7EK.`RS[*89G&!95]QD2Y8)DDDE*(PWXN,!:^76YV.S.TIR;7SP#@3&LBT`<8%[X]<.[*R6CSU?\2GVV\L&Z MO/[Y:_7'W_;-:720=G]H3)`>F."IR4>^\A8\SOS=MLFXLG[XP"Z#VJZJAW(_ M'!)2Z5PK'BN:BD(S40^(>B,P#CJ6"O3!@;_!;2[`#@",C-EO?C`HL*]SF\:Y MJA2'$`9^TZU83>1GW"[WRL/+`MV0.]\LEOR^7-7]`EFN-_O+[O9!:8&PX#%) M!$(,I31)2/Q4'A&@^6.W2($%<5DGU"SA_V>UNKN)?KK\^,^_0"]3<"1IYH_Q M(,*$LLLKVB<6'61V+L<,@AJ0CA_`$[&0I\:\W&OK$9'Y\4_KQ?S3_'IQN[C> M!TH0TC+77"+]Z"56G(`.>`)_>F`?/?L^04]J@J,RDT]82C#A-+E$ M^V3.Y9A7/`:\8L]N(BYQ:,#+\XX<49CMS-T=KM'\K'^\W?VH7U9_[J.E$C.B MF22$L#IL3@7K5Q@GB=G)<(XA`MNC(?RW/6+(=D\'9L,&&1$73"/M$2Q'>G\& M3O'*#[`]=AR.=MMA77B:[7]]L_5'Y.L)UQ3VMWIH1>7U';*=$>]N5M^7I=>[ MZ3"1*Y9RE":**HX23;),/07EL-DIITB!S=SE%'5).4Z/V]$TG)\:#23,V<;H MPDZ1'Z-B,DWN1',BG4%/C7EKNMP#(NB4^7Y*+)W9YP4S@RTP(X^.P`HJ MTSXE1Z/:<@-I=01^MFZUX6@JV./-?MNRCIBFH5K71E0^WQRGHT=?GTCWOAY% MOZN'U,VY3XJ@YG95I`JF$*__W"T>PSG&1@N[_$<-/>8U/(`T^JU).=KE['8\ MIM,C,%#[V>@#!]0_%GB7HTG'>@#>3B=U>1"6)Y0.,'KKQR4(YRG\X(1IV.!1 MI?[0P38][\/_HZINFLN+9BI%&.5$,AD3C!CGB(@N5IHBT)635@&"KR' M^NQT$Y&2G[:<.N?%'I!Y M=Z?OW32\[9?Z!&?OO4[-/;;5Y_%2_FQN^O&GN7'O8+>1Y.GD>QVF2TR0C!%-2 M"(;27'2A=4)!6\E\Q`MLOR[%NH?1)-G?/OC0'E!A?W&%%]9F[AL;,TQ]/@@' M,9\!M@'Q^80^$>]Y;5(5[AWU9;V#T^Q%+`J=%#)3L<*TN7A#LBXTBF/0U3P^ MXDW!>G8K$+W0=O1>(-`!O'>>A8P&X&S,9X%]ZN:S:9*I^:QQ&9OOE_ER>SN_ MWFQ7=2]3SZ^;FW;$TPXO7/MXQU@-*`K'V0GHBDO3:G\OWA`+17;Q=U-'6T?12M% M4Q23'&M"$>%9SI(N2HXQJ.\%_.C`\NFR`>H&RL?,,`'1P*32)7(NC3P',6`. M2V(3D85M]I67UP:HA*.UL/?]\@?$$UE@F3"FA6!,:5S$752B4@I1A&.HP,IX MLSC\'KP"RQ=;,[V,B!6F&S>B00PTS&K`2)X@3\10OEI3!7D3G0RVUMNZ1U7^ MLE@N[K?WG^:/NXV+ MUW'KBZC-.-JG''4Y1[)9?Z07Z^:4XW^5\U7TR[SIJ#9#D*XQ;C;T\)QL]#CN M(W+R9;"G,X)93V(V5JV_!S9)]WILWJ",?6/T:N?+LJG%U=P_WK8O=?-.SS+) M>)KF"NN8985*4(%TEQ!3!+1V+5P6P9?,[I-JUB\T*\D#2-<2OS_]ABZUE<9'DN4IG$ M5`I%F4JSOD*)*08=2.4_>F`KU]]"&J;W"R'LM?\;"&XP\=8I1XME5">]\^W` MK1/G[.X^477O\%H\H1](L)8-M.OT6J,,(-3ZK2S;5`BG>'=<3Z(DR85@,4F[ M5+A$H+M[0\0/+U463*H`RKZU&@9P<+$V:4]_AL$;6J]- MUM.V:\_5AUSA#^E'XS#!@^O%GS8&8U9^S;K$'P!C=KG?7$S=IQ]6)6\$/ZX5,K/?1A@\7Q^K%&`30/M!@'6*'W;=29) MDN1$:RIYD<:*$9J0+GS.D)AMFBO*O#KU9$R02?OTC+_BNTO7PKCS-$ZOQO1* M,I`G&TU.TXWN1C3F_V-YT+Q9=O8#8C-VWBXJ7]Y<-J.C._7]H5RNRQGC*9** MQ;PI7--$B$*IOL@B,M`%U781@J_>76ZBLLT%J#5+8F82"P_+55D[:ZH=MLU>VNMUOIU^4ZUDA>(H5SU2:D'IXS$FL M>!<52VE^L8-[J,"V:3-J%J+?]CDYE.YL6,)KIH$QNGKHB:D^%U/[\F=@MK[* MG3#&5I7-UR0,*YD.""=8N71IS4"ETAF2W?S9_L@47H_79[S@"9%:9R+/" M#^\3NXB:U$8CZ#"/%8JDMQDK0Z)VTU('K3>=@+(!-D%AV[5C:%+)'@Q@L+]> MEV43KP[+5ZOZU=E=6KY^D"NJ9;L!60C%*4I3E'-)BYC7/Q_=47P) M$12T.#=0"H$%WV33=(.N]_F`2P9AN)O6%,Z.'/:[T"8<[3..#E.^>'E4?/TW MW<,1)Q].H*J$#=[!LD70YS69ND;85KXJ?(P`U:RW;)I*UWF_+)?EG_.[CP]- M5V`]XZ+NPAZZ)/20AMM+]WC#Q&JZFLVKRBJDT,TFL,_2@,NN83 M>@I!+?WTO/8MB#Y.[WD!!@(3>FYV8X7PS\]L3.$&\JUAQTB/9PHCD[&:6HW_ M]@<:W^RS:7[K9YAJ*NG_5*63;)+: M>>@'E6S1#K=E,BU*GGA^_0*\2/)%-``")#+3#V,[MLYWOD-^Y^!V0%@8L""- M(,[C\+B7Q"-$J8^F#?OV%T+;EYG_Z;VE48T2VV:'-+:(MIHIAY!\'0W)HF.9 M,UX-#&1THO23C6*T7-0^J:HQ2#$]79(G/DRHGI(KR:W(9R==Q` MUR-==N_<10+E-\]-CX$C^FC>K_'MJF.1\:R]HY8/OM]E!MB@TH3QBM M3!1,BXS!Z9W9@F*U=!V\`&=N@*,?[@70PGS/;(&<9=9'-Z!FIW[&.)TZ`60D M7C_3-)`9AW4F@PQ2+9>?A]FGC[>WY4W1K,(`8S_##,6(A$$:1`$3R^HX2"A. M@AA+IUK5#YYM+61;[,7?MVO5NV)3*NU"4J9+(O_99$HME9U(ZK%8I48AL]BD M2"])*%`E)_3/7+RDV;I,N""_VMAK`X^"@8WY[7?L1[DO-BN8Y9$?QY01Q(@? M!R$Y3<\'J5PW/E.V9I1.`1$4+2P#.\F5")50TIFYG#I!TZAT059-^F.Q$9]?9J,=KI*^3^*B;-W%:\BQ2\> M+Z-)F>=G$"8$DSP.*&249"=0L?YV?N-(+"<.IT0!IMV'613\ET:B].#B9;B\YJ=/]EF8=U>9K5! M^,QY]:J[,9-[X5+([.=4&Z%;**/*A-!J/NVY-)Q-52/T$^=295<-9%(]>NWG M47%1RLK#%`5!0*(L2F(_P]`+@AX4\E,\3R:50F(_E\I>K3<3\Y:SJ7'2%\JG MP@^W`C=33C4>P(6SZG@@[>=58=]&9E6*T\^>6]6<-95=-2BVGE_%;3DKDJ1^ MAC(6AEXF>M&P$`[M:%!$H3='>I4"8C^[RMZQ.`_O=I.K<B-D]F M-1Z]91/K>!2MYU5AWD):50K23YY5U7PUE%0U"+:?4\N'8I5#/Z-9"E,_S7R/ M,A+C=,"4$=&??(:<*@/$?DZ5O59S'MXMYU33E"^44[D;3D5MIIQJ.GH+Y]31 M*-K/J=R\C9RJ$J2?/:PK_%`Z0X ME>L2,0<.^QE5]CK565BWFU!-$[Y,/N5>N!2R>;*IZ=`MFTQ'0V@]EW+K%E*I M2H1^\DRJY*JA1*I.K_T\6CP4U;K:G%WDQ9"'/!]3Q+((9HG/^`\&A#299YN2 M!BSK6=;WVFL+KXO'NIIR9L)V>"SG7[N162@="Z?:Z,K<@[AXA&=*UW8CO7#V M5HJX_73^@FL;V5T_H#][LI_@N:G8`@]&(_]-E;B6/JQ]O+`ATB<(2DM-\J;>;54JC&+(H3T23\=S+",F2P0QCH50) MK/O9ENM8`4<<3+T3@$##$2EVPE/F2DY6;-*D)B<#0RT6\&64(2LJ\HR*$?70 M)[G1GIP90RXU,+O(SHBO3.75$90PX_D6J3%0_%MOXNQD7#7=%>DD5>C-(L\KT`>0')/'\PBC(J=?V0&4N6E6@` MU\[<;4[P%.5H(IMRDC0?D6JR](3#,V0+72`_2M.(.IFAUQ&%,N1,;>,)5%F) MI/P?RIOUMKW-_NZP%:P^DMO;=;EK5@&F<9#`G-$D\K(LQ/SKP6`4IO+'2B99 ML3V_TF-KWZ[=$1U8=_!45I6FD2FQ##@;CXH3,`.%'!:/]>ZOXJRV745> M&OH^BS"%$.<$4@1/@VJ62+67,V#&LG`?\;3*W:RWTLV(35`H5U+.Q)Z:7/>@ M6MI.)"Y33%XF:*22-,"J(V6D"4]JXX^.VKM7X"4'5R?BJGDA/V,]*I M.(E_QN13;`LIU1M4C4WW&R+9$RB#:>`S%'B, M18,A&%&DLE2H_NF6%PR_BC\!]8L%@JGK`V^SIKDN8)2PJ>L!2R\"J$S^2Q/G MB*Y,<."MR7Y%*M2UH]O^]+YNFE4*,2+0QW&(H"'RE\]/8DU1/2P1IJL?_8['7P2@7Y<2D1,G,C*BP:!K0J+CPB4I MT:9#6DP^U%7]U%HO7\>E2A9Y,0L"EI(@][$7!'D>'E4,^[G*0&JZ-=M[&/;? MBATH^Q>G+U-^5=W'8(!4.>69ET\U'3K'=I2B'MZORVUQ>).R$9DR1[`HUER[3SREI:N)IA89;EV!JE#=JSF5 M4LF9GOG85)ST:8D<'7+-/0$T2M787)`9CAU1)E/>/)\A,DF2M&ZEAZ:LBJ:A M]?UU6;73L+2NA'E>:O&OFG+3S\Z>7R5/OXDOWU7DOCY4^X^W%_[D?;F^+K?E M_A&N6.9#E`8D\=/RC:Z^2/T,67)^Q@5VR%%;"OP?KF[T/9E.+'BLKK"KV2$NX*7'NY8/`0G+EX M!4Z(P1/(X-Q-_FO'9ZAS53P_E_[T"AS]G3FYS!3$D2SEVF/D2+ISCI;:[;?? MU&K-*@L0"7POC1B/&O4QBD)ZG$T-&%%9`-:W,L\VDE<'#::6:-YF-R@D1:W]:[H M?N_K^D?1_%%6]8[+XS#+0JK-TT]AO`;=/_Y1[+_5F],<;K."'D1AE"8>]R&E M,`SSTQ9B$L-$1=Q[`5.V>N6X\&R=RO?YQDD_];5:BW\7")1:6. M9&Y`MCGC?+;GI]LR=7(5G'P=GHG.`]"Y`,Y\N!H21,O$%6`_]KLU%T9>->T> MP;M]<<]_R%5'#"XYSFV74A9:.ILMLJ-3Z.X]7XZD.R>I>;67G&,8=5(RA]:G M_K23]I7G)2P*,8D1)8FXU=Y+COM0N7FFM1RI9VJN94G#B4Z#4Y6D9(G'*0F$ M0QH6+<$O/:JYAP@7R'E3@_7I=$HO)[CQJK9-I45^EJ+8GVUO^[65;.^::=CJTW[W;:;G-W\WZ$KICCI?!X#,X<[J[0N'D M-CCY?05$SJAO1<5Y!7KOW<@:LP;WK1TQSCUDCF0]1\EY;;^.>RA5^]^_P#^@ M6=',#S*6)0QR`SY$B>>?CJ?A-%6I\J?8L5SS/U5`C>I_$H=R.6DN^M0RR&CN M.$\!3DC_"(4=DU8@K+QKPFZ)'6K+8>E>5U5WSJ=A]^<8?I'3=E#>B MT66Y/>R+S2KD@YLH3K(D)%D:>2&F]+A1$L$$J@P-IMJR7,RW<+J.N!T@LV\S@J2MD_>*'XC7\^>2AVZ[OBP^'^NMA]O&TA?#SLFSU_Y#BLYVAP M1!,61H1E."9IZOL('>]"\F*L=.S5$@3+PM?":\"AX9)75NUTQJ'=`75M7A%M M!4E.*!V(CYI^#H!!CQATD$4MV$?M#/;RTJK'[XCB6@Z8(T)LV\MZUK=`4;:S MLKGADG+@MF]%`R$NI6I::%R-BLUP/>3I*CN8YRD,@@#[:>*3 MP,,A2BC-2<3S2Q++'ERSC,*>0IR`=R<13M!!CQVTX*\ZP?BMQ7^ZWG6Q-B/3 M"!^1C)DBZ8ATS.5MONP,E!\8.(Q0GS\\XTBU%`E>9"3-BSG+`^ MB\OD#P6X?@2_%_7=;OW]&Q\^?R[NU#=G&&%7,G7,3*QB$NC0@2,\<#9"^7-! M^7Z;M3$A-LBY*Y)JTJ47MUV8IDM:YO)UN?M?T=B!-$W!AQS59CAU7!;-'\5: M@-A\Y`,5L2.KNY'C0UWMAF_%I$?3EAHKED/L9R'B0Y/0SW"&X7!$V0LHI$1% M#.=#95DRA2.@]03TL/O#4$?H[?3C.?B^=!MYX9<.I)SNNAE#-76V$CXK>FV, M[1%5GS^BCFC_`H[72[],BGGD?5W=<7V\SXKK_5?^I^1'V:R0Q_PX\Q@+8D(A MHKPR9WD08(1S1@,2JZ0$+0.6U5U@^DV``@+5%1"XP)\"F:IZZ]$G)\36F5/3 M5"W2K&CF:\2,R-\D'AU1LFD^U`8?K(GZDM7WZ[):84+\C"4^AAYD(?;RP$M; M:\2#&4SI%(61-+&(QG38IJJ,+(EZ.F.!/Q-*\R9ULVA-AT)!;139=%1O5+UX M0W&T2%'8GUX]%'Q`SLLF8?"/0BS\KW(8)A'_#T>9)]KVQC#MC849(9G4?>+3 M+%A6G#-0[8NCO"-=BS4YC;%/F)K$/.<*_-E!FEM>7N5E=&?Y%!X=$9>)3KS8 M33Z=$OE=/-S"NZK9[]I;U=O""0=^!@.64IA$)(U@'B,Z#,RR)%.Z[UKCXRV+ M2OMRG"#IC9)T6)/M(W,JRA70$#3'1GI,ZFC+Y9( MG*0RTOS-H#8G?J0U1X-2)Y5'QX]1_=$FYDT5*K9W/\ZKIB]%5=:[#_6^:#:' M@@!:F+&*YE_#:*O6'6J]2*C'VLL3MIKYIW[5VPY);'#^!-BO7S_*$ M\%ZH?^A%R&NU7Y:/5W*`<2H7S@7F_:DM/7.ZVTO2Q[,%]'Q7_'T0_2G:XC@@ M49ZGU`\]DD2YYR>\-#ZFI1PIG9DV8<]RACC#!8[`],;#1MB5*V#G)E8M-^AQ M:G_SRO\MBQS_@ MV^/[XH'S*XI-DL60H3CQ"0T#SXN##!]WU^(T45K$-61R1O$[HIL\G)W$L?*( M=BYZ]95/GEG;@]H1KN3&M2;(=DWM#'EU>71KCK1II=Y+''V]F04TC\.`A'Y` M6<02[VS^D,)`J2>Z6J MQ>%D[EW33;/.R92+ABA45]%WU??#OFE5&_:E:ABF28)CF%!>HA*<8!2AP62, M/*:EF1IV+"OD_QQJT5;K^ZZ\*1K1,5$T)'\HP/UZ]U>Q;\2=#YPV'ISR9KT% MZ_:`&_BE]0!`U7MX)_&M*(N6J=:O%CM@5Z#GKP@G:IALG8L:]B7\JXJ;[E`5?O^ MOO#ZNBEV#VV3I;*%.TB6;T*RI.G5ERP;S)J2+-\ER?*U)$N57H29*'>)/-0#!%F(62,I3E-H'<<+R.NH%,E2];.C))UJ"[*%3(A5]+4ZLN5 M#59-R15R2:Z0EERITNNP7"F[(B%7>O3,VH7I?5D5[37JJYS$69#C#++$1W&$ M&63',C#*`[V:;!9D,\[5=?ZT[7O./!JF\#:@;0A]L0$.AA'.1[[^(<1)9FV7 MW2T>7F1W$,&.?SOI,.(TCN6$?R%ZU53]Q8'%`2<00*]`S_P)ZZ)G&,=('-%A M"Y%P1&1M>#9Z\M$@>?(M8];--Z[+XO_8WX?R8;U]LNAT:NRZRK.4RS)#B4]1 MF,38"].C/N<0Y4IM9(Q9M2R.`F%;9-V(+XH35M4>,^9HEA/(91A6T\T7 M9S"?;$4X09V[18TLA2/J:#X,CHBC!<>>M[>Q1)W<,?'TT/#*M&G(#;?=E.(P M*JTKT>N:H]@^OFN:@YB;I/7]?5U]V=78L]UXC&NJ6Z%0T]@!-CC# M?06>Q&:`#CKLH`5_!4[PW8F3PKEU9^*E=Z#=;MSDCKI/H?"5G#A?6%PX'#^/ MH_7<3[Q&%]RO??_+8^I>Y9@PZ&A;FF+=_:,O7 M^A9LCVU=-^K=*349E!LEV"=/+5L];X![&@8LT/WV!3$C=?XT(AVIZ2:][S5SA]/-T!M>:$%NON@H'3C351 MS(C/?!+2B"4)\2&7PN[&&IJD:2RU##DK(,LJ9N#ZK'GC(U'&NQ@:-8T\OX5Q MB)!XE\'@!3BZ4[EI<,)P*U;Z+8=4K_&<.K]Q(P!"]EP8%[I2-(88H88CZ*8A_G.8.>J""\/$YP M$LO>]C7)Q@SS->>XEKO%?8RED7+8"+F.5,5F?*DM/'W:MZ>_,E/`7_:S[[J; MMWS"2)"SR&XFV%2.6*YLQ>VPHA3W`8)9C2 MF'C<*@ORD`SFLAQA%8G5M6%925][9?7:K6B3J%81VN1O^N+=,OU4+G`C40+J MLNF(4DUVXT+A-XV62;HCOMP50X_]'"51%OHPA21"N4=)%N:#85YY*MV"/=W: M`EIT!0:,NKU.#)"LKU#V^#6QT4"!VMETZPECB@JFQ[;#6J;ID(2J3:%*;MWG M0['=EC_Z@VXXA)2A!*>1'T-(T]CWT&#`3_^?O&M;;AQ'LK_"Q]T(=P1X`\E' M@`"W>\/==E153S_4@T(ET;9V9-$A2M55^_4#7B79$HT$`0J>F8?I[K*+.'D2 M.,C$+9G\F2O05PWK58,%LC@/XT1BP\08'3!Y:6`H5#5R4>AE*$)N M%GEAB(6NNEW#;AH'P-JN(UN;[$2I%9+52-5;?C@IENVF:(M=W8Y2)<-'CS$5>UW!,$AWZ M!FCM6OHF60?>%,>CY,T0O9KD39+9*=7M0!A'Z"#RTA1E)(DJKP>?/9JL@_#JB`29H* M7W()K&&JP)GL"4NJ.:T*7;#DUC!MREDNE#[I?/>MP0.)[PAV+,F`QUA0:.LJ M$%6]^_-SWT[W'A]**/5=[F*AU(Q0EN&X/RR#$JDWB56_;5A/!:)#1X>H@PI- M$DIJF"&8C)Z0HZ2A*BP!!-0P6VKJ"65-3CK?FGI)-T>08H-HCH%?Z.D;$+F\ M_YV\;@;',44Q2D2XZP4T8HG0YJX9PGPD+9<*WS8LEP*1FERJT"0AEX89@LGE M"3E*O@$](UT]NU3UDW0] M+\N[A_J:=%.5UT4H)%Z8((HI91XB07\PD`4QZ,ZR>BNF5R`K/-4YVQJ1VG[* M"`KE%AJG80^XP`@CSLSYXTN\#*PCCN?2DO5##8:\/CJLB1KYW9"C=@Y%<5'* M12#HHM@/LL0E`>M:"ET&V_Z`?WYBM5'MMB+%D`'95^P=>NC([41)BQ'D0\2P@'),HZQOR/.@N*O3KQG=- M#Z\?@?=&P4S)[H6:)`FZ]WG@YUIE'][P,;BUJXTHUTMFP#Q`QCQ!JA1&O/721N.*'AOW`.)LFGD0Z&?&_M*YDN/_M]7F]7S M_KD+)FC(`LS3!/N>[T:AQT@O,0P14-DEV)<-*T`+!CCT@>3(#7YSO,"&?XOC M6@G`"0T#$J!&ER4BH`B^T-%CH$(P_W'<2,Q<1'P?QR*WB#!.>=)?7_$9`I5V M@'W9M!`T8*!"`"-'4@B,\0(4@@;'U83@F(8A(5"BRQ8A4`/_6@A&4##F@8#; M0TDN1&E&*4N,^7]YMN[?N M_]A7VGGW\/EI+G[>_'1&<.`)A$0`#-)`!%?LD%M1"BMD-1$DP_IW+_[\:5[F MSLMVM3C4:*D1CI<^(SY2%LEKNV>\G-XXC0V'/ M4^FN`O,PA3;I6GNUW*C5[ZN^>=+US0^OP77%:U>/&X'*BW%,PCAR4SV._"@BK\E:J+CK)%E:U/_*5X]/NWQ)ON?;^>.K^>1F':7:'U6G!OHG` M+Y3OFUBCP90.R+(Y]UBBQ`8-+*;JZ7K>Y*F/KZX>5@)AV3BH!'L38>9G_?):OK3J-=^1$ MV1K'P/3YXAM`!^#.O&R#;$LJD(]@>O"$[00.M$3!I[%5[LDA$P2/J:ET`2;9 M;JN32)4ZE>E3]:^_;;X\Y?7QI+N'N_UN43P?STDG?_EV-?^V6@O3:K-NB[]G M"0^#+(M]+PE06.4(09KT-S6)VK**=4887Y#IM6MQ#/3&67=0;YI91OQ)\;?B M8HUUK*J7\K(#_P0+1$N M]H^FJ]T.=;6IZI%-XFJ)M2EK>Y\E,[']/+U?H\TRP("G8,88L]K4EA32EC19 M:V4*0C3Q0DH0Q2%*>.2R0SDEST/RKW-9BM^&>;]L5Y?D)WZ;&95Y6<=2Z/^V MTWVW?CDXWW^<'@9XEWEHX_0X^1>6[J."\\$C!^A0]GP:I3M%!4? M1Q\^PAK1KZO'IUG&F,#.79H@@G"8AB+.[>^[Q0%HX\!>*VR(%MM5HB>!]R,L M$\GU#HO7B;1WC`\5.;8+1;\.]K9_GY6BRD[;EHI`'?`_>:T(1I0-BT4*KK5V MM:BV!>/,=Y.,9S[E8>3'$2:HLR5#<6SS,M/>' M#S7Q=PG\\,S_@3J9W8M&VCO;AUXU`H6;]BP;78@>/T2?^@]=.()Q=.65(P6' MCKE[53=Z7]THG6'FXCB(JDM>&4L\+\K\OA80BR/0`Z3C6C(<@-5(FFNTXV], M00B$K8"8YTXQ6#FY[]20>3],YE07F0X\P>XI*?!K61(^TICW;QDI4P1+9H]: MO*"7Z;H0O_I8/[A:X[G/MS6X65(]MI(&84A\\3],HC0XX&*IE(!-!L9TDMD` M<\KZ16&(UDWG#D!*:(LG="CFY2BYK[KE\B-CQT[D6MWVL&5V/R6J3 MND:ZY>;UOKF[AP.DPVWUHTHFGXKU.BNV?\^WRUF*F9>R*$`D#FA*0D22M+_# MSKG\]0`SS1N>M8\&?O%P_G$(Y[1Z3P7>:=&#BK<:WWGJ,VRQIPD-ZDJT79I#C7K`QNF3,,6%I-U:&V)[EE$Z7Z[%3^;I8G+`H+\ M#(4X\>,X2\@!#7*CV4N^717+S[OY=C^-4 MVS7:,IUQ3AB;I$[&O-Z\])+"BM]IL%OB'EVYYV1N,I-NCG"7AOQRB#REE%*+ M-VR8$B>P4CIQU$CJ1#>-R'.QW^R.I_CSQU[TG8_<\]/<4RPZ46$.+UCL;+U2Z;+VK%(-_*W7:^V,U\[F'.:9P&&?9YF(5QD,1IFI$H M"KR,RMZ#'=6&N=2S@E7'&34PIT/F?.VP35T[:HBG@=E?"[V63-EZ;"D,]#_@ MN/K\5&QW7_+M,\N_B7_^V%%AYC]GGA^F+B&^&+$92:8E MDC/6BD)K#X/$X)\73_EROQ;:=B:L*.G/H_\ZNT]QDB]\J>*.`U[LI3S&#%5; M]5&$W92[48-ZO_SY?W]>)=6I2[LD8]BT.*LC`AU"-AAD+7CU*",R],.8FH MZX/>AKL.P@GCGLXLI[6KN1'TR[?*,N?8M!OG8%SU%P_F.8U]3FU@*W+0"NA7 MZ@F22:?UG4`]^IG>_V9R7Q,N&DJ=K]HE;,F\KTO"Z\3=`I=(SWR_;:IW.#Z+ MR+3>%+QMH9`?JW(6H"S#`>/AFRI$_Y2_ M%-N=4V\3?*TLADY*HYPD-[5,Y1_8!-&@L@!4"=9C42Q+IRS6 M2W#96C!?<@IDEBJ8ZG0LU6BJ97F#2$#ZJ).GB6*,L*`-Q5;QU$AK1R? M\C(7O_Q$-DN6?\_7Q4NE6OQ'%23D;=.1YZ,D0TE2YZ1$"%>2]J*59J!#*3K: M,ZPN'41GOEDZRP-(H,9H859.=:8F%:9#)WP>X7-:@->2)@G6!L1*)^>6R)=6 MDPIS711R!B85/ZA>FA#M?LH?]^N*X9_DH7J#J%-6#S/&P@"C@&=>A&).*.V: MY31)I(^R:&C+=.#4(JR'XK;'Z,P;D)"S!#J(E3@?,C&GP`AKF$X)83/#*^"H MQ<3\JIV8&,^SW'&']\FX=&I!(XTV'#[0:4YAIK=!CP+D:_'31]'P[_/M/_/J M3,+IY).F;A20E$8)]9,(<9^G0=/IE-R M:WQ*)H&[W`VTFL(#H5>.:=_C:VC+61?5ED2S^NQYO1&LERAI"?N??)-O:^TD MRV>AH]4%E=WJ>W[:.$Y\ER>N%R(/96E`D_@01!.."43']+1H6,Q:D/4XG)_` M!&J:)G[EA&UZ:F'J=LSJ*<)K2YP4\RGML3Y6MGBU,:`#WU/X$W)--8N1P(3W8E\:.C2\ECFAU+FZ=QJB;I/ M:?&;B],3DRT]:[2GZ/+E>8CMS#7S0IZZ#+D>SW`4H11SM]_!YT$"BE@U-6E8 M_7N436VN5AL6QQK2!K5`9=?%N)QZ7X%LF$(?>+ZHU?P]GHVHKQQS`PJKF7I+ M5%2W5871_@I40S[?;D2\7G9EF_J7=&+BL30,PI#Z(8G2C/LDS3#A`<>QZTI? M:5#^OKGQUT$ZE#R[WB-1E^@9&&2C&;5D6(VWH]#C6B][OV@MEKH,W=,C?P8QY%OD_SR*DZFG-D4WVA[,R('WDQ>1J72^:K]GH; MF+M>P]&&;R#K<,E04GL=WULRAUS+^HN7C:_@!/G$=QPV^O/\!^H[@I@QGR#/ M]W'LAS''7A1W4VP2X1BTCGI-G*93[`NBIG0A^:K^E,S%/X@K@0F\HA?-).WF M*![*]"UPK"5SD!54O%Y3L`&3CMGIC_ESWE[&S*K;F($;11E)"/,9BC/S[H&49*&$#E3;\6PCK5% MP^K])*>H@4$/1(U@4'*%>A+R@$O4_:,@-7,-JFL=C;I(T-`B]6A2+5$D#8:\ M7J;61`WDTOANNUI4.TQ5DVUC":,(I]B+$?%+L*WCC!`?* MI9+P&*1QI`#5R)S_$MC*_[9$C4[)DE=!;VIB2:PFZ#"FMR8F28,)@"0;DR M\PS7&T8&9&8$?99HRQ@+7K_$-98,115I5Y$B@L*P>B<5>5XN(9`-3*XG:2K0:=RIJ8H"VD7IRG37FG^_&$Q[*D`=UI1,8X&-EM\H7W:;S[R2'-,RX M5L^)##->M?$^!3OGI:M/P?/%6)&Z<&FKS/FH#5NK^B%GF)?Y0.#0SJAF%UBBL=K->N=RCQ[:I!7RCWS7E`JX+7NE>;^O[\OG[A MZ%L_C2W;:6S3#C?G14QV9?7W)AYX:AP/C%##3K-D*)NVLIAT).A-%F8Q21(> MQF+FS9+$35%:_4?;K!ME,4P%QK9F?+A3^T;U.YRI!Z?2;%LR3K69`PM&@30I MC[RVN;O=4[YEJW(A.MU>]-0^%DY]GGH)S;CG^C2F%-$PZ&!DC*1CTO6Q;1L. M9"^O`<[7B^HE\^HD\H5%0)HOYF+V=GY[?A&6.'\5^_72^77^O?I)OJDO)O_" MNL5&;9G_:&>JK0!,Z`=1@'JJ\LWEJJQ-O/>46>] M-$ZUC4>>B_UF-W,1]R/.$&,X3/PX#`.*^R`NIJ"EAFD0&5;VHX#7*0\JWZ=; M1_H^[;Z@3:*4@=ZA'-&,856_+W:Y<-!\[?21-7]X MR!=-2=3C)Q84P^TQ#,LI]D3DPF28O97@FY[93;NS9M.#>)=9')!3#=1;HI$Z M+"FT]TN@FOVV66SK-W[GZ^8"<+,D3G:[[>J;4-AOZ_Q+D1:;[T(G:K%E^;?= M`=XLB5V7DQASCEB&:>91M]O5()BZH*(XIK&8/G#;(ZN$4&0PSA]"*:&1K7&' MR"FD3;Z`R>@1]T]YN\QR#=W;%N>GKU(>534=J/+&\CG3!@`9/Y5Q+A'HR M!1'GW0!:+*DP6P<1]L5XM?C;__R7_L:."O'_.`A*Y*%DTOU?;%OD9A MJM?B%'<#DJ>7>TL43[-1;\K:ZJ<,L%S9[:+=/1S7JOB4KZM"%FE1 M[LHWU7W*`ZS02VCHQU[&*`L8P8GG)PTL@90C"EO3-(O%]$&%NM0.?5,"!KR\ M:=@CLFN@]C@#NE#:(6]2]J-B/"UXIT9_#RA(BA*%*-,4O41Q7]Z[AP#`GRCY_4"XR[ ME6CB7K@ZWVY/WYG+_(2$*0JB(`N#.&8\:R5)-.L*.*!W4$:V-HEN!-6"T8X8PY8A'BBNS M8<^M3&EK=?HLT9`E6H'ZV# M9CDIN@+#,'DZ);>#V.V&ELX!Y!7J1[_/W-"Q:+W46R)MNJTZ4S]:.VG2$G@: MM-W/MW?;6G^7_YBO]WEW>GKF_8N[<]MQW-;2\*OHL@-4`%)GSATIBD$!W:E& MI_<&!G-AN&VY6S,NJ[9E]V$__28E2U:=5#Q*R@`!TJDDM7[^%#\M'K1(,R-DM&S_0LAHNU65TV?6 MB(R78WKGT[?J6/Z[V*XR'C5E&.0T!X2D2<;B/B6%*4;Z1%0.-2<)Z_88[;I7 M:T1!=9=UZ.?48$/J=<>2)?R<@'1/G9(FG+;%BR2;?FM&B69HDA');NOZS"," M&@"6DXRR*""41`0D03^Q!D#I4PV#,`L@6-DHM4`O66?UR>7`5#O4NGW#P\F( MU0I1I)6BK0LFE6I+)"BE98X1H0:%`E:$9%G.$$"Y#PF-?)1BW$]^^3^;8DHE MU@)855WE6@"6DM'ZU'+EL1UTW,[9=KU.V,XBFA639<]=3.NO MZMF+]JO6Y:V=2?@V>@S#GNL+X9S5)CT[CF';+AW>/9O8!BR(0A!F"88I39/( MI[G?+]%!7^U^/H,XD_+-=&G,R%!EICGUTH1E>3`/W,6 MW:L+(E9TVB#3?^M6832ILTG%WJ8#2:LM;E-(W2!I5GX_% MNCX??PVBKE`"`?")#Y$?$9K'(4/]=)%E:I?&Z?Q^QV#J)#U&DR*.M'R3HY!K MR]3@T[OU"#\3$^<%2T9`8V+@0OABU(3*WO.D6E3L7)>'HJXYR;Z4A^:;Z.NW MTM?OGX.$I4$:`![8QU&8`1J';72>?<6QTN*0I9#N]_A$S8_B<-K_:N823?7! MX8M=M<*8):?ED#2#R6J4Z@1Z`X6#RR;FK/8@Y]T(SBR;OQ#"V6[5T_)B+DS3 MOO?G&A"$*(]3!#.6PC2F.86`X3P(0\@82M2.7^E'<4P[<2FEN.U09@?*MG]R M0)O&.C6&O534>SYLO>K0"*G,75T(G"PTY(TK;G2MD?]>>O.MV)[WQ=WNX[%Z M*(ZG7Q_YTW;"AVW^KW/Y,"@XP2>5P,ELR[RV2F^\1FMS,6"O5K?`C#7SY7`VB^]J=#.TVT0F^\>Z%Y)MF#%>-:F_7R98D MI:-N&,?E_#V@S,S._/QJ_H>K^:U@KU65IFO?#>:'\Z9RE>0SBE*1\?G$-%RO=0JD;P_T&HA)',<(ZJ5YY4";(GJ, M?)3#SU06JB'HZMY0UEP8&O%H!$4VG%T(CJPTI;+_X*E7NJU/QS8WNSWP/.TK M?P2[F`G'788(R;,\Q2!$&.,^)O&1THTN1H'<[S?WVL0EVP\7==Z[+C]JDJ7C MI5`^I]>^Z&="-^(_?V'6+_Z/_8O$4_^(RZ2/9%.NB;I'->]ZW#.=L!GKY;YJ MTV@*9L'=A8#/3EN>E\FU99#"1_6OK*2^[^MJQB@G013YE,5^`'W@QS'I(@<@ M4RSK9AS._>KEV*;#>^VZNC:X6=JJR'6[#MJ$6DW7B-O*3!KQ.B`3,WDI4-,L36R`-,Q2;X0^69SOC\W MLR]:/!R+3=F>42SX1$S\@0O!]^*BP'\W/W]5Y"K&!*24YY%!2$4E3!HST.E# M`1^/A^*KB/)9H6+Y5-JD1C%J1_&S9DB/Z$%SO.V@/:HUS2?K,3F"+JN7].JB M#WIFV(8;KV]%P]]A.VZ>'MBZ>8SHJ2NH6^J%$8I/WM$+X?WT[7Y:IWT>X\T3 MX#^+TRIC*0C#+!-W9R"<0`)BVL>D>;XZ5:?UWC#]E0FDE/SVFHR3WT,Q-0K& M7-))TE3,7KWSMWMLG7]C>VK'S7^4I^.Z\UIQ=_G*1)O]8`AFM*8IFG&P@!"$.49 MBF13>:,8[D;`]58U<<$V%^8URKS_Z;3-=L/:"SZ-C!,K]BYDW-AIRVOWKYD; M)#VN^,M;Q.(O]^_EMMB27_^HB^WMX8Z_ZM?B4VF\.97?RU-97)7X(,VX95F: M^WZ>L#S+8=XJB=,44*7/QAV$=[VE+P;@KAF`XK'PJDZJM^ZU_I?BZ]M%)\@A M;V;_U4`HOF=M[._D>E]^>>^$8J\\_.;UHKVKZOD@J>[L"#H==M-"@.JRA=5D MS[PZ?&\/F^J^$%]IK_AS!'$:)1011A`.?!RG79`0^MGJ>W'\4BF05>%WJPS: MH0REL;N??L_FD0OC`TS#K>6,'1WQSX>%M@7R^RW;_SW7I^:PVN?J4R$:6.Z+ M1Z$_5ZJC$P5^G@9^@A@*2$;],,IIIQ4@$BE=$SN'0,F[?IU82FWFZ6W+C9ND]K;B)\[B3^P9Y@KQMD[QWHE&_B7_] MMTFC7/32V";/G`_%0EXG\WKP=/-G_@[16JU^;7=J!2E`?@I`DA#L^S&/#8,N M=I3'B>XJMG;`*5>WQ>;0>B#.8)E;WV#UY>])O-5?%A_;IY]QR?PUUR27THU- M7PA.[;9I9.G=DF'R2_*B@!)9<]J*+QZ+0]U&(X#"(*0)BB(61"",@JB?.?@) M5,K&-4,X1EI3*/+W+T*6MQGH4JU.I.F?Y&:&>^L4MS&$H(MKF91K;C8O7O1E M;-O"S,B%4,BT%4^W*FR88E+/]EK)57SAPQ._8_-C?#SR9Z[]&B[[)OYX>^`L M/#=[*B__+^_+]9=R7YY^P17.$I]AGAV"("9Y0E$"XDX^0WZBM@*W%-7.U_9: MR6+-8+D4]$UYM_G'T[F;#,>"_H:A/'O_'S>"VWT-U4CUPI6ZBY**D2_\4%Q1[Z_*WSJ2Y.M+] MR(KQH]EZKBV$>/KZGQ^5-C%"GB&#Z>7=CG$*'C8<9EE5GVH^^Q0EO@7EZA6, M<.-V+]!J5S6)8KW-J?$G:-X8UVSVP%-Q9;]=3#+HQ3AJ/K#H6Y==# M=N;#_K#Y]9EG@?6Z*4'QQ[H\B#T+4NSX?_-Y_7,%6(JBC*``\P>)4$!`X'<2 M8`QI]^&@'"-M1I8:MX\_"U0\$U(=?F^VG'>M:J_XN6FGDE^Y6$4\6O5-N"2KH$7[]]O#W>E;<;QNY=9UT1"\FR671?UG<;KNZ_HQ\$.(*$1)!G&2 M^BSI9.$,*M6:<*W%]3'E!J3UDX,\C>:V@-A5M>JA'N>])$??)760&I$[Y=Z[ M3OMOHI\:^&C3AICG0,]MY'$/71_`]57\N!.F3-;>:9]@8HQ]OVB3] M4[$IRN_-'12Q+[X@@PPE3-P/%B":9%ULE%YS984B&U;B:F3*>@4T&F'B`.=% M67OU0\.-ZP]5%Q;L6*\+;5=VVR1S[_Q5Y.S8?>Z;$EL-;%\L0$W:]"8EC0TS M0.'MX7MQX&9S%*\"&"8@A7D<)X"R,"4P[,\NQC".K#!0)>`T\!LH,L:;DIVZ M7+-NH4V@2;DY$<@&6I0(IF/P8M&EU9@WF:5OD0&L/AZ+AW6YI9==C\M.%$\H MFSRS32]7?LRBB".3041@@`)*&.G4)#ROM$(Q*TJFP=M%:E?^HQXD=IMF0>9T MF;P;P\].]^A2<;HNL8G+KGWK)UXIGS1HS5-5G5[L^J2:'NK8OEH0F;9))$*3'%%E+]2AF=W&=Y[&,6)HP@%J2(QJBO*Y%2I=FU@_"N3U@^*01;=E+M M%X(UZ@0CDD[EOU6B]J(74<%,W5EUR-KHIF7#UDH+Y:!KSTSY*V36ORXESK"H MAW`L/JR/_U>^3\ MY]_68L9>[;S[7J=7]T)5KUBTX[H<8"=T6N_"Q8L^493CHM"[2O3^DC#9S74^ M,KZ-$-.N[PN!I.5&/;WIQX%E*K=I;8IB6S/>Z+_6>[$]_F%]$D%_W>U>%$(` M]G$2()QBEN5ADH9I7W0H2U.D>,.LY>B.L]"+NM(B%>UW@"0A9_5>D987K6WJ M+]0VR\B=7M$7BX"GJJ5C('76/4N!JKL&/K]*S:F5^GGGZY@S9*`/+]YX:)J"&G2`9A[JV'1KR>BB[IN5=U$E-37O MBJ6@U$'+WDI2;9GG8,5T15,![752J^X[7Q]=[**HE<50Z;Y8"#]=M$Q[\5/1/%-^ M]N6:7EA^92!D+(4)C@,21Q%-HJ"OUQ0BM:F^@_`3[SA=Z\E9WW$RZ@0CDD[E MOU6B7@O/+7C':<19=T9T;;W_X<%E?\![XKS-8MG7;H>JKN8OI2Y-% MWJX1HBO;9EPZL6](LR+QVC47S:I%?>/E/S?[\U:\*IIK1+R[!_%OYUP8-ND= MR?7B21Z`A;Q.IF_WR.KRA,;K[?"),7`9`OG/XK@IN9(5BG.*8A30-``I8"D# MH%_MSJ-0J2*]>;1)7Q;%19:@3/M2J-X"A"N3-7;MG/MKM$LWY*W7ZYMS2^XE MOV2WX(R\7B`K#1LTML5FP2KE+356'3\574)WM_MXO'SUWXCAX&U_4'";FI^L M4!`D`*4L2Q(?,['+A_I%%JXS--A?LRUEFLVV#^6AO#_?>Z?U3^]'>?KVK=HW M:5-3B8/G4U^*;^O]3G"RRZ)K44C:$S=\',N-^`JS2[5+Y;HISGI1;9-NEIXS MV[$377#5++JG5WTAL,B2K\+;'\ZT?:?HK\1>GJL>6PJP73?SE5T^M[8Z6+)> MI9B&/HTP3B%A*"09(WV);)#&P,*6GT[8.;;\7EJG=K9,_;;QMI>GK7KN?%EZ ML6O15M:@I?MB(3QUT3+M-6=%\Z2IF>]VQ>9TM\LOUWM\XAGAW4&(XN06?Q-' M-;ZO]P+T*^PSEN>`XH!F88Y9FM&^OG2(::HR][<:V/$R0*NU26>[6U".7*ZW MN13R%W?6B9$NLJ?F#\55NR),[?:''$YGZPHUH%Y[H1/J":7"_:QSO_E#+N.^ M$Z*J.#G"5"<=LA"JNFE;-<$3K4C6EZ-]+(YEM7U:?F$%*,U0`GR:15'B1XRS MOO]@`T*2JV2D5@-/D).6?5&2[;`HB2VBVNT'.:+.U@5J1'T5FS=>J]5[H6#, MQ$A5L7($J4YZ9"%(==.V:H)'V@I2,<^AC\=?/%W^I[C=?$5\S/PD`!A#'T84 MH3#HM\9"&.'50R/ZK]/Z>#(AJFIK4;)35LS2RS/%[CB*,BY$D8CB(_@`#F23^SS:E/+N,U M/TC>LVDGJOIH[03:&*N%J'OW_WJ4ROK_MQJETHW2&J5JEDF/TK_.#P_[0BSE MK_="`=M7/VX/N^IXWYPWZ4\[^CC.@XR$A*`H20&)0M9ORL8,A2JK/[9B.E[X M&&.P.?/.Y2J];]82W->OEIB5SN*XV(WED>,-'H=$;B)SO MZ+:D>R-DM.W_0MAHO5F5V\=6N5(O)T=1GSZNR^TJBN*,,4@3D&99DB$[J7MRS7=1-&$1IF(0L2!!*$<@"D).\#Y-"I4\L M5'_WQ$@0XL2)+YT"W&J>R9+!G5VJ<&B\::3,`XA'3HPR0L^SQ6!"4_[S\M<& M-BC,K+[4?%K/$Y?\>S.ANY8J3',_#/R8Y!D@&"9I\^$8"WV,(`AEZ]9I_WZ7 M"7PGR6LUS9FOO^S.:()N:.A"QHEY.YZEX%:,D1XYS:UK?_+&\G?0];/WP[8_ M&7-[*NZO*D!&?8HAQ#@`($+$4,*G8E`[J=@C[KX?[&K7S,5#-S1$R.NJ6A?#25>NJ29YM M';9^*M;[O#ZM3\7MO3@/W"ROU*LP8[Z/HY@E81X&R(>0A/TI0\340:H9QS$U MW_-!NN=/E;<3GPEOO;W8M18?L7CE0*4.+W5]58#C!);JD%#(\EI=-]ZME(WN MD/>R1V_QS=#9)<',M"DODBAWY69].%VX^?FX/M0BJ:D.S:[8 MW2ZK#G6Y;2[CJ`Y_E#P_A:LL3F,,PXCXF,`(,X[0_AL3#%*LS#%70AR#CJW+ MH_==R!-[5G\6^WWYT_M0[OFKISH47:V$=X?J5'AHY&C7##VD0,0E=(X.,@>Z M^T1RH/S&^V?7XW\.;"J:?1;W'7=?TL"L_.VOD3N:0R6_U2OU7!W_+@^ M=H*:2J%U*8(/KER_U`_=PA4$48AY!IS!)($DCD@4]5VG4=N*NC)_3V(!\HOO%:WK>BNZK) M4^\2:-@Z`FZ7G;007CMMXM,O`9W;*4UG?%\=3^6_F_?`W>[V<.)/>\D!TH9? M`10`_NNC(/+#@,(D!H3B/`A#'X8($J43$(:A7#-WH*Z[DEB1HJ9>R@%S0AO5 MV/C(0?[:NDJ[L'!B!(X;-4([2PXO!&RV6E,Y>0P5<<7*0WDJWO.$=?LTY%!0 MWH[?3\7]NA2%UNYVK*PWZ_U_%^OC*L01B&)`21R#&&*0`Y!WTF*4,16F3:'' M,?AZ46+,\J$4*5)ODBZ10^/2>D.-GZWZWQOYS^%YXSWBZZ4--]ZC[FO;X8F& M3`Q;"]:/$'G*CET(MB=M19B"`(*:$(Z.8RRQ#%UI32XYV[BGKMR;CLCKW6C MIV.OD+Y\^@J5=OFKU&5_7P*K-=._ MBIX6NT`&D$11E+!/O(@S!=0-736S#_5@N&PEI6W'RMI.NFH^_5*29;L26^'E M4%:ZT4`EZ0!W(@$Y:]1OMXL?LU:Z4Q?"U-]PE?]O[.DR#.2I2%M=B&R/,N2 M-.[58)[[AJ^.!/_PS?W#5\MK;_"%MGD\^*J_,WWXJO\7%KXF^7J[\#5JI3M\ MS4U]%;[EZNZGA90OU<\9PC+.<!.Q%[1X.M$CZ!G"SKQ6-[N$KSEZ>>F]_$7CU'S^IAXU%3Y7"8HK"MY*>>WJB;,J,1)D2&:\R3)4II3 M*64OC.$$^RQQYFK\5[PH^(_Y_<-_!T=1GG%KD1(_%=%O-L8KD$T[VC7N4TZA MWP+J-Y7CUU.CE'HKL"]+50E!35 MZK&Y[[79#?BU_+ECJ^8ZQJ*(9=AL'HH(C2))61%UJS(C641A872"H2\-GH<* MO>SV;JF]\.8&E&Y__$W0BF_[+'OYIL<\^TJ-'ABGD!4S8AHG)/C6:@\:\4&K M?O33YNQ,'F"M[[1-!,+>F_G\*+M1;+7`-EWOJF436A6.+^7B<=.>VE;\[+9T M-Y>E\_K^X7&WWU_U7/U1:8@I3Q$O5('A&>=8QA3W2@E!6M-`5Y0W(NQ/VQ0< M&Q7TK0J:QS4X:==Y(%F7@_%2;EHI)IEM^R("E.@IE1FH#&E5H-$?A\D5I_$= MN%BWKI0,O1<9?Z_KY5_5:M4=:ZC&0>H/[];+\O;2F*C]1,T034A,*,EE&"/" MS+Q$!M&"\O!B\G)I`?N]<1_O*D]_[!SKA+ M;QP\IV$*[QA\-[$>[ZDVOC^DA_G9^4'VZ\/\?^L-7\VW6_JSVL[RK-FR)Q!+ M<$))FM"0A[T,)D*C@RRA8WNNB:_7O>#[KZ#5'+2B@V^-;%WJ>LN(WE#KFLDP MJX(:>7C->$^WGA@Y.##.\96+B0QBO#7OQ:TJ/FV$0NQ1Q,?Y?2GJYJ2*&1=9 M$L6N7'A#F>L\,-'>M MDG(-%I]SUI['3GEZ&TQV:Z(9EP'LU&;SU\U\6=[/-W]NFU4[S1=-S.V'\OY[ MN9FI>A#A5*`TIAR+L"`J4A\TY&ED0F&W2)YY>Q37CE-WS9?!NM%G"%-'/_6P M.9Z59H!\YF+[94M!U2'MQ(V-P4&G!H`'X_!$T`;4F-K'0PBWZN]%;Y9$HD@S MB1C#H4P2T9QTUDO`A!G!"S*N9Y0-+VX#&: D$/>==*@!D`8;T?>Z6AP0#= M1SHF0DLO3=-?D.AH'P1)S_8_XPQS1&D<_W?;4HU]OFLM^[3=E=F]D'+$3!<%KP-%0!>$K3^##/*HD>C-VC>.9Q M)\QTF;2#:7H]T7'\,@/Q05-P%'6MVA^)$I9%!>(X5?%4_TN%DL?7-U3KW8G#K_<,H?[&QJ`3%KE0O?G\Y#OJW7Y;E?>;V<!Y[>F9>#XL-EY=*R]N MNZZ@\V.VY\K`LTO%RJ?]4RAE7MMW;JN5/R.A-@%TFZ6K]5TO>9;)F/%,10_5 M?PGB(A/XH$-(!K@#P#RXYS)XU!MTI:XZ*#:=*X'W76\"Y:J6FPYP#AV+2RNW M_O.@-^@%_]>T5O2_,'1@"L9;;B8R+^.O?68+^5V-A%C,]?=-O=W.L%&6:SF#T]U3/5".:J<9&%];;]7JF\[:JE:. MW6(J,Z7KT\$RF.4&,T"03*8HDX3R* M#E/B0N2S=7G7_*6O,)=X6:K0^HCFW4?TA6"#:>V#NF!^(@_P;B_;+#BCT*OS M?D[1/\D&U MB4+P@HDDI?CP\I%E.)T]E9OOM?Z('""DR8?[5)W)NYO^8SW?#P3+PT#PKA\( MW@3KT0\,U_%O<`0(:/]$/KJP;7HQT@,W3/OC*Q[#G1X5^KY>W_U-_8[[H!$:')5N M#8]U<_)3KP?CVTJS+@J4BUX(=L:J`6"Y&#L1/CDUH89[SDS/P]ZI;D@3Y"=0I\5NA[2E:7J0 M\>^7*68TK?)S`/,Y-P9(XN;>1%CBV(CG)QD#6&)POGX7XY_K[4.YJ&ZKY"I"HWYW+N"!I&`O&^X"2)V9,L8XR$E=N@A-IMCN&';S41,TH-MKAQM1! M3\>_7S!HB$#.IDZ%0NX->7&F.HPUQC22]:9[_5K`'!4I$;+(XHP+1#`K M\KXOA6B2&0VO+$/X?DNV5V-)'%._S'#CT2I;UO22KK79XKPU&I2Q]')BB+%M MQ06^.)FB#1&%.C M*]ZL@W@&S%Y7T`H+>F5VPRE[(_6X,XJ'9N2QM,\+>R[9,T`?9T3!21@: M76?0==DB0R(9^CIA)IFV1(-*5N9H<^G3[D>YV1_!U'7"0I[GK$`Q%I*S$*:_W3.%6D%FMT,Y.*5'&K\FF0'FU)]K#;%>^#%`$WOO)@(1 MAP;44(^1(3+HS.]F41HY+''*G!'A*I),?(F(9&S`(( MYQEW`1'D3=!)]-N>@C":3V:C6RR&=(@_!UAJ<\YU[17_CA9/A'&0;9H M<%T0@%E`M-N/)4D1LDCD*,NCK$@E*\*HG^/*BQ2G<+S3##@%XME-1,'X#4$] M#U9[X-YU9JITG+-FGZ'Q;X)^IFTRXI^584`$_+0N]]U-05!:A#F+XBQ-,,$B M8>C0W<0$$(+Z,3US\,P'4FD#)9Z!OQ#0\V,M//>4SFN-9S4-M,:?>0K>!`$M MFF4$05O;@#CX]:]Z'SYEC#3O%D@:,BD2'(7X$%X0;'23-E3,\3FHM(%RT,!? M"`[ZL1:>@TKG-#EX,-":@^8I>!,825BBC/DP3G6$;DT"45!=%:BN$CKF<> MGJ@-.KE!JS?H!`>]XIN@T6QR@B"T_\.LO+;U9KPT<]WJN%]H^PW.;KQB&NR. M;01/A]YYC68^G:E./MV>PBF-OII6^W]8#7OL?Y1/]>JI6M_Q3;FL=G*^J%;5 MKK^"!\=QAO.P0(2GJ2J'>718`$11&!OMA7"+Y+UWOA<7=.J"7IYA!]W13KUN M^7A.FA67BR9>J_L]:-1`IQO&X(ETM8$:4_MX!DVO[BIWZK/]Z;:+V4]E1$4: MQ3%)BCA+!"^BM&!]K)1RH[N^K0)X1E.GJ3G'H5-E>G.7E6=Z(/)NEQE_GCMU MM;NZSM@R0!LG%R<"&;X>VS/)F_V&C+*V=G1R'7JF"'!K,R>,,GLVJ-!-`>C]-YX M_$^Y6FWE?'-7L_GZS\,8,*%QWIS001#*,"*%.`0*)0NUWVM8_7;/[&HU!:VH MH%%E,D%NYY;&6PCO1IE1Z+E'5F\3[,PR>&?@W32[-P,6YNG-_9]K[Z49?B=O MIC"/[]:`&NHQ,6%I\^OK6WI?;JK%O(NS)S='.,K"(F(%CY)"198%.I";Y?I` MM0_AF:KM@Z[Z+7MI)IQPL$V#K.,X9H;79V8=`&':;W:USX"UX]AH!USM9T\/ MLQ>;>HFU[MY,`;@`K:A!'Q@3]/Z^:.A#.=\^;MJS,4^VT&0,L8PI7R*>B2RB ME!5)'S?!>MM8P()YQO&+Q74G*JTV[<&YK,'LL0TVH_>$O34`^M@>VZ$=PFL] MZFOX<8G_D%9.H1*`MJ?V],P!5H=]7PW"UPH/3;[Q:#(\78.U\`Q7#M$4&-.Y MOSIBM:'9KHX,;5'V8^T;J",6C3*H([:6P=01];#T98R@A$:93`A.))6A#%%\ MF$0+LUCKI@KHF%>H)8TZ2,*9.`Q03SR9ZZ&B-$J]U!03QP&KBB?G/=85S0S` M5):C/;:UQ<+@MU!=;)IE4E^L;0.I,%(]H?TXB:9OW52Q1S MO2TVP"''KR^-.$#8F=CK7ET\.0M?7!JA/FJ+B=UPI<63[?XJBZ;]((7E:(YE M7;%P]PV4%9M6&505:]/<]DZI[[W;E??;&14H+AA'49%+P8NB"%%_/`93_QJ= MK.D6R7,)>7]^;T_PK?U!*Q%DQY2^L\-E9'Q3S:J'FY_C[9/JK3H#-5B+I[Q# MRKPQ.MNC+"VR/!53A2WI??VXWLUP+%&4\CP1F71G@$?.ADX$1>[M M&#R=TMH8;0!]WM2+LEQNI6K:R;%CC8Q9G$52%&DJXEP2Q(2B'NU#BBC2>E\( M$<8'%R[MY2J3,DD9.?>C`:RTHS'OWNXNGIA6+012]$&K!H`$H0 MQDZ$2R!-J>&?.Z?NT4G09J9R^Z->+;]NYLMJ?2?FOYJ[DF5.:!AFLB"13..H M2`XBHC0SNBH4-K)G@ATT!;M.5+!4JISZ4,Y>VW2LQK39L;=U(O4F./J_5QN( M0?]'Z(6]8J5VUPPJ)1/AHJ?B8"T$9*?ZWK9-T."A4:HXWDH%1[ACDJ!(/EY^ M_`#]\V^):UL0M$T(OKZ6N"N1?=!Q)\##Y/+-:..\+:J]F06#[)0JMT*NQ];J`-9:V3,'6>VC=,EYR.UKE?&]GP^4CM&0F1 M@C2C"8U2GI*8T/#P>DPDF=:.!.B8GOEX%+;OUAX[O%!W1YJ:;`/%NOL_21H"-$OWXD@GVVQ6SI_KP;+';;4NM]MN2AD5 M(96(%YR3.!.H(&E_1CV+B=":PO41=[2Q__>]*I.I6B]&#Q/QVA[[&;_WWR"J+'$<12BA/*2V6[L@I1PE5>+'@N6=2I`:M<86?#_7M%C2;-. M#VAU&R--?@N=1;J@BMX%\^SKGVLVWD8I=&ZE656$,=6F0#9?B?)V_KC:_:NJ M5^WS_VE3/*D??;K=_T"4B]5\T_Z(_6KN>_Z'DJRJR\G`,DUS*E.$:,1$%$:2 M<,1[H:JVVQX@.Y(ZSV7U(%T]UD'9B&_>&BP[^3?J#X<&!-]_!6O5A.!'UX8; M\XFS*^;8N"A/,+V.];K]AN@S>TS\ITW0-BOX='O\\4G3`O8K:!H7_*-/O,XD MWE02;UWN)_@``/4$QGT0;'H+,-[K=21&SO/T^AAC&W"Y^W&55%AO.JTV_YJO M'LL9R9$D..4,TZ2(19+PXQY7BE*C_5ZV,3SW$AHAP5.C)%A6V\6J;HXJ<-QL MJFV?S=LQ/\XY%N#6Q595(#1<'&73Z=XF[==>YL9.\C6713->V7%J9XO[HB=6 MKLO;:E'-5\>U!;*<[]2C->,183@E18:;C6:4I@D[@%!]A4#6/[D(\(RMH[3] M.JAV/1,X4E23A9)R=>2,NXRJ0%C;59,0>1IDAR% M;J/N.BHX0RT)_,_U_+Y66OY=+IM:WITU4/`DSCC+\CR3"2,R+@XK&!C)N#UN M;:)Y9NN)I+9/Z'S\B)6C-OST;:8C+$^-%:\:.P(6S_BES4`7KR<)/*<&#=+- MW2H#E-V6FTVYE-5ZKCS@]7:W_:C<>%3?7.\^EKM9+&28IS%.\IAG.4-)DHA] M8)XB9G3XFWLTSRCK!0:WG4+56502;X+U0:3Z3=>DVIK^F=-M;NQ<7 M\,[:CR?6?ARRUA/?7G%LD&]0;D^&;V`->L$W6*LLNVK=<9K5XO/\5_/EN[5" M1+G=S2@-> MF[[;&,XZ]M\.+N\UW@2]RJOVXBXXI]V3,:01+G`+,Q0U@>.BC`T.IG..9IOVNT%=NL9 M>HE!M=?8=?),CZESMUB/>N.Z:T:\4V./ZH)>7M?%&_ODNM?\&N`2>[W8_431C(8XCE&%Y@7L!>9X:CERAHGIFW8FTTS<= M[?Y&^+W>NDX[OMSP:C+D&XV3UQB?AQV_UE[OSD";-Q?629@("STTS'ROMY5U M!FSL4HGNU\S2=2(E>8RE2C+8IE%Z>&E*D_4L-7U-ACKP)Y90^_N-N7=?%<& M]YW"X'LO,5CL-0)<#F/ONQZ@KF:Y&;K>G[\ZYB;8:PT.8@/^JOFCW21SR<@! MY'G)QT1@Z*=M&M?.`!FH#=`N^A'8[ZO_>ZR6\^YPB^[0]P_UNMS--[_VMU%0 M$44T1EB2)!899PF.^C.+>9RG1OTR^.B^NVW=A_JT>W*B.>A%JP_[7O:KU[*, ME14]QEXW(6:@A<^%%]H:6SJ`7'_IF0AW/3:P'NM)-]TLRNNG4\_W@HAJ]7U. M&F-%M34[%B<2]4) MS8>CU1W>.WA%A0\RP:AXKG3T&>'ROCG/G$`C3/WT__S#GK665N[NJ[I>+U!$ M*(24^*'G)6&6P)1V@RY].*C;SLQ(MFU=;7FK#A0H!*K13C1*2UUCMRWC-&=7 M@I[A@?O9!1WK[;:%-6/NF@*/Y`4][EDIMA<'L?#6&4&+#'G4(U$`8S_P,K3L`&`*!YU/;'[4F9P_EP#; M,G.+$+`>Q(FN-4'P<9$PC]9&XN$$%2BL@#JA^K3!'&,?8@)GY"2(9@ZE.*M)Z:-3JPY1A2^(`$"-!&MJ2!E#4Y+S1K M\F;U'E:.OYG4>BG4APG>2MY#"KZU6($$^WWF(KR.D%?J[U;FPY'2NQUNU0P+ M6M,X'UYW>:`X3)=9DOEI1$A`84IP*'G$I-V,#"KB.PO>LH&G MK-Z\\M//;U3;\^FN=\)F:BX?W^^SOA/[C9?>WGW%=B-ZPYS3>&!:.(?;7N+T MJU;QM?<,WLE`IU=9([$J+OZ M5/^)6VC&.=UNV48V\92;ZC=[SH]/`J5@)%`X-=]]%SDT(/"[0;::P711=Y M3RB!@-G>$V;@B;6>P0NN8DH=[SES=@P7\8KK6Y@)1_S:!K/*^C(VXI%OUR=J M,B:T/KG\0"R[J@('Z@Z= M%7BU?B8G=)_/F1UTQ<^0=02P,$%`````@`LH0%1PS9OO+@5P``HB\$`!4` M'`!E;&=X+3(P,34P-C,P7W!R92YX;6Q55`D``P]TPE4/=,)5=7@+``$$)0X` M``0Y`0``[%U;<]M&EG[?JOT/6L^SXKZA+ZEXI_J:J$JV7):R,_N$@LF6A#4) M:$!2EN;7;S^&)3#O+AZ]^;W\V-YKD].WOS]O__S/W[YK^/C?ZI/IT>F',S&OI@> MZ753D^^D=9?PX/CJ&Z!C#G^XFPS='0;]B4H/_0\N?[^*#[]I_Q?/64`CQ=OZWRZ:3_*6& M@2U\^\_WI^=S%8_S8C+-BH%_$VQP=/1+58[\)W]Y%/_\_=/)=PQ\,2Q'Y55^ M]].@'+^-+=ZJ;!2)SZ^]G\K!H)P54^.G63X*0D19?KZN_.6[-WYT=1=4APF@ M&$3%_[:1<'I_X]^]F>3CFU%0_FV[TLEQ64WS?\^=^^W)I+'`:WAUJH/+\NI_ MLM',O_?99%;YB/G):Y6IP[13K7XMR^'7?#22Q?"D","\RC^/O)Q,_.MUJ\^Z M4PU_\Z/A1?D^F\ZJ?'K_/JN^A,=!DG,_B$]R_VI%MWY#I_J>%+JO/'5]#X`Q_YKEM_$3O%:56KP[%2GBPB(YN)_3]Z&I+H_79M".M,70%Q,?WS,I1_DPCMV> MXJ^&N'4Y]"/OQZP*IKOVTWR0;1P/-637F2;GT_#_N>O/+G4VN7:C\FLS#ZSE MU(O\9R'2SH=GWV`\OJG\=2#(;_UI.7F]4O78MZ3IMRXX'=V?3":SV`EC)RV+ M\VDY^%)#DSKD/4A:.UYNPZ4'N>O&S2V8M")UY8?YU&6#?#0?WFT4<$7[+F2I MZ^KU9&U(9OQD4.4WL:>>7:K9)"_\9**R21[Z\,?*3X*_YMTX].*'+EUTHO'#XE:<-H0@,[T_*2[+:CP7 M8:,J-6C;D/&D"#_ZB^S.WMW$Q+E)KE7MNY"E)LPWD+4AV0<_C<.#C[XZOPXC MNTT2K6C>@20U3;2>J@.YZN7>M41M2/7)W_IBYM7]K[Z\JK*;ZWSPR5_5Z'X; M"3N5KJ97Z])W*FL]3]V#1E_G_BS2SN9YB$=^CB/.Y^-QUEU?W9YGE\5^668+%;"0X>N.'E[) M=FO-GNX=B6^:%?XJ3EA/L\_^AT6(E^A&5?4=6=RO$G&_"M*Y0B]Q:U'*&+U; M%?1'ABW*&E),7H:15,NF?9EMZW*?3[.J95NO8MRB[!>^FOAVI7[.LDUYRVDV M:EG>9RS;D;3YZMWF;R_T=]-`[(??MK3#*T?E MX"6]YCI=9I//<\5FD^.K++L)1H'DK1]-)XLG,:238P`?]NS_]O`X?2K-)S^* MSC'Y9#`JX\;I1'Z>3*MLL)S?CZ)AWKT)HJ3;,4BQTT`P@Q`!Q@IM)4&2:^TD M,Y`HF'RO_"C6+)35PMR=:7\^NPE>C?/);/14D2<:7`1'J-&3E<47;+`-FS1) ME%"64PT2I:@"3&FXL(2U$FRRQ%/HR6IP5%9#7[U[`]\S-?QC\>7.>CX8(ZEJ5T"XVR-ZL'/9==_>V/?;V[ M"+"Q"N/`@H)5R$J#K"*:$".X@0I+BPE!D#`(Y6Z"PE,OG%W^6&6Q1NOUA"D0 M&'#&$IP@@@UD%"BST%9`Q?]T';^V^\L.[?RDJW>&*)<7^=2?YK?^6='.4UT> MUND^^7&6AUY>G5VZ8+5L]+\^J];`K@7N*9$)2"@PBE)`H006`+NP&17:-<0F M^M-ALW]G[!^`HQ(77\O6(/O`+S6)DHDCABL%,-,2!0LM[&*IQ`U!BO\":0?F MWU-8AM?[=H$9.:8$(BDA$E83"0$VP#"UL(TSCC6$)OD+FITX8#_!ZWE^ MP3`UT&',''#,*2>2Q`5'+"R#&&@ZWTS^@F87]M]39(:V[2(SM$V)%9QQ"B07 M!"G!.:%H89E$BZ;(I'\ALPO[KT?F\VVC^*2!9.?YW0M(:\XLQ8E#(A%A[*(H M-]H(JY*E49G3#5'&_C0HZ\WV?2$L[KG+8GAQ[2N?70:_M`BX9[Q3Z1)B.98B M6)M3*:1S;F$#E9"-*]\K\,?_PE_'KMAQ*O[@UZVPKB=,,1-(2\0<7#<^*3_&@8Y475Z'!A[*H%K_.ZW;G MQ4/KPD-;[TBM@P*9!">8)\@((Z"4"QMJJ#?NT1S:IQA8Q`RPEC"I(=:8&.L($5BXN*C3=`EM#X&V M`R24K3M@%[`R9=PNV0)8WPA2(24REB,!`;2)`(X`-==,`A@&`DVG@'L(K=V?>I@PFGX5U`#`$..0?6@5V*D M-`=4F/-:QY;MF[,/F$3A3HJ0QK^=(%J?HYXW3@5!!A(;*X>H5!2&\?TR\QMN MFL[D]W"3?/<9ZM7F[Q]0'[+QY@RUBB0E3$N((`8(.RZT21@Q"^T<,PBI+$U&RT\/HEZY[[(R^I#.?63XS4MKVL`RX"KKI_LDCC*O^OF2\&]QMR50WJE$CJG-(H`9)3 M!U"R]PN^DN)E-)W.#P/HY]CE5/#_'N6"0ZQ#GI>`"4[S0D6%@ M#Q!:[?I^%<)>;>M=X0DUPM,#5:HMX4Z21"(J$TR,LDFRT!&$WGJ`:ZF]XZF9 MK7>%)]P(3P]4J06802QL`JVURFD.P3+2XZ3QX-:4X0VWI/&P^?$"0,M1YA18<-896%'ZAI7AN[AR8P]FDGLP'/];T6= M%,&G?C+]E$W]_);?>*_-(&+E:EW56'TFP0)<0B`$EJT36]U&=DD^MXK73X(WXGX#8;?9>S'JOLUM5LU.61.J."92WF M2..$,P$2M32Q@_B`SK+O!S2[\DRC7=G%[;9R$$29Y-&'&VZR#A:)]GARB_&/ MV[6OX9DJ*4U<)I5.(ZZMPR!9;FUSC9NNR>SSP'0G:.S;4WW5/UX\U&DMK;NA M_/%9^]0):2$R3B;"2A&2`WDLKK"):9JJ#W3!^O7QL`TO[.BDR+9?ESJT\R+* M,FJ,HIQ0BBT0@.G%)6$PN&K;\R(K5%E0S_.JB]QA#G_)8H[ MV;A_L98N#2:%"368QLUJ`RP+RBWT!)H>4/%2IR@HN[/YCB\$V"(';\$E9=!8 MRAU6*@&.$!-O'ES8(&&J*>[V:+EL%_FW.P_L&(5;YMTM.:6()QI+B9"6*$R+ MA4OXC')`QV`Z04A]%+9@_48+M";N))5_U8"L7'XM9(F M9=98E5"K*0CZ:"HI6@XN'&L,I#U*@7T!J6U;][([.9M,R[&OYFM#\0NXU_G- M9C2MH4JA)))"09WD"FIG%47F\8L&C<^Y[..>3T]X:L_:C9)6T&V63ZOLR_EU M6>3%^H3U8N-4,L6AQ3JA0=803(.8[G&J(9L.L_=Q%Z:/9-6&D1M!83&/>#Z) M^%'9=05E35FE.DF@1M0E\1\>$C(5RX^E8-HX5>U1:.ESMM:3&_K(8@LMUJ2L M19.X?,>8H-BBCV`^W"Z=VS9BFWW8"'=W@U&LV$8JM5`T+:L M4NZ0TCP8$83_"-;Q,H>E.8UK6OVR1R/KWI'6L0]VO+ST:U5.&JYLSDE3H8QU MD@!'XW()!P:)Y6B"L4,X"-`[XEJV^8X1)@>#V7@V+P-X>G-P,\RM8)8Z*AA6 M3!)N*`[S6JWA\G-SQ!C1^6A_TR='#Q&,[3ACQ_!\U;7/0M.$8&C"C%B%`7!0 MFRV-:K1L&ORV/U'2V;7/^X2W[2W>SW#OF93;#?$VDZ>"0`ZIX,8:;94A5";+ M)1?%$]H09UM_N>/65Y_+0XEL'5A^1V6DO_G1\*)\GTUG53Z]?Y]57\+C^85< M@_@D]SNM)GWA9$*=&M)U9"DUPF+!5**Q(4PQ0SA5B#/H-""`;;P[M!M-SP?7 M?C@;^;/+[SWRZ(=-]XC7Y)!:A`!3`#E-A$YD&`TFR4)_Q]DA;=NV`H,?/V7< MB9G[R#;S%=UXA^SD[#(6O(<0&0\!/15]0ZU*30XI,@GB\9.87`IK`$#0B(7N M&J,#NIZW=324?5A\3]"VL2*E-H^4*0N3,*+#B;%62>0X1P_Z0X'X`2&N=41L MC[A&-N\#<_/!F,H&7_SP4=J-V\-KJ-*$Q+TH@Q5-&(`@P<`L=73$'5!=<0=^ M__%;X*W9N0\LJ;(8;L;.DU8IE413$80-XPJ-D(+0R84.V(&F,_H]6D#O#RO- M[=I+&4I9W915-O51S"TBS5JZU":(!?PK@H73E`78AVGC@Y[0NJ8S]3U:#N\/ M/VU:NA]$C<>^&N39Z&-VXZL:2'JA?8I"]+30D4#D" M8!)BOP-A=DPLA/MER(Z_TYP)X@J]\$K.T7T8\G%[_$BG?*JB'K^ M5H[FNY;K5V*;,TT=CXT=1B.D+0GR8Q5E8>?GX M)+9\`3T-N*06VV`:P`BEB<.0AUAO%GHQW'@1>0^7:+K$4?>6WU&YUTEQ&UB6 MU8[KNOJZ)3#DBH0+CJBB`CM'"<4/APP9B45XNZGU6CCA_E/V-<#+5WDVBB6$ M9Y>?@L>K6[_^SK9-Q*FQ7%E#`OH4PC3,2020"ZVEH0=4X=4V#)Z5>;9LZWZ* MBA^$_D=9?3DI/E;EP$^VA]=JZM0"I2P7B0CV5-)H0;%:Z"QSBCZPM? MK1F[5X#%2NM)2,*QXGE[@*VFCE\39L2!)(S\1?P6(N=Z:4_,T`%=Q-T7P%HS M=J\`6W_`YFFS5#!,K94@WBZA>*RY9\MN`JUI>C7I]O.GSE='^X+,]E;=T9@V MA,T;7TWO'[;1;N*Z[)]A<*OBQT($I&%R$:\FUQPY)RTF!$%'.=HXS.MZ*V_A MEX]!F^E3Y]0_R;">16J=3@"2DDJ+B))(&*P7%@B_',!]Q%U!8N4>7JL6[R-9 MK!18W<H]A%BK"*B+KL:6;K3N&\08S@;1 M%4L!WI>CX20KAF>7E_G`NUE5Y-,0N-=?3K8MGS0((AP@$%K``=<)!%(LH[]4 M!Y0.6_5TV9_->RHEOID%%SPJ4*.8^"6*E$(.K+14U)[ MN,[3!9[:M6X?R#GUV<1?![B?C&^J\K;N7:VKJ5+"J0L34&H3`KD3%"3TH7<@ MX=*5P#Q=RND10>Q;N)_[,OWTY#Z+S-1J#43[W38?5JC%G@S<4J%53A8T3B*,$0`4:H6&F.@#V@; M8W?SNJ;6WBF^-EULMYXPM5`#I+`@">`V)G<)EYI"W?@4UA]I&-[`[741U<3& MO9P]?ZQI,SXX:I#/'1A^'OFY)XOO;CI;J=\:W+7UBC1,3``W(=!C8D1PB*$. M+*PG<&.$UH]\?5UYUP-0=^24G0;(]?MRZ\A2[3@@1&LL*1*2006H66IIK.UM M1M#Y/MTN@N/V%NX#1T_[Q1K^:71 M%L>".)4$2E5FG$I\'NX32F/3$]UC M2SE:,O'Y]1>01'H514$D1"M54Y.)AX#97W\$NAN-;H@)J*56D%]`'?NA:-#Y MD",3Z[+W>YOT$K->+&J_LPO'NDX1+$(Z1=Y=W`(E549Y(&KIC=>YQ[4C=.L' M9MI`B)?FVZO"T[/;ND!K%O4ZSA8`M=0!2@`WU@#+*+&\^0:=S[WU.,+(=T$6 M#@-^24+.[UJ*5/MU.EA\[BVZ7S^JV;(ZFJE]_)I@K8G;""H0E>B,)GT$H);K]7-+H+65O'!<6@_E5/ MEM-EYP6S_U\6*'#1I^9(>P`A$9)0+&M$*8>YN5PCK&,T,''/KIMA8R"IP-QT MM3G+CV]NYK-5?.EM';"SQ#]:WN=)JQW"($?-$SQ.(2E'XEY&`7$6<>TQ1C88"\()2C0=BR3M%'`>#_VS+ MPSDOMYQGE;"`$T&2S@DQR`ILU*YT#8>.NH.9K4-'&:Y^5(M)DF"3JG6[W;"Z M7W/9/SQH@*,CJZEWJ246(0"Y M[OP(Z=4K`S)NN!R'=)D`T6Q]%Q?M=7++_.0FN7"/!Q."6T8%X1SETC@E/(*2 M"L&]JV5$3OUF-UTZ:_Q-9*@OA$NP2*^GF_)PAWMRO'@P>.<8AH!*XBF#5`G) M42V))"1WY1GA>>"07#D)U!+T>'D6Y/)]VQS-_3&?3A_7#E\GCQD^QZRZN[I$S!0 M2"*:DL(18D0NJ'Q77Z1HY5K?@(^%?%^KM*!'U5[=^>@?3^[_MYJT;8O9'1V;Y40O;(G`R&]J&+L7`U8O9I=OW//(G0?2_N,%>( MVX^4!EL$F#6.<8=%8Z<21G+SA$>X/8^)FZ?H8%R@N,9$69C;K6&$^5_CXV6N%D;%3#]?+WHC9C-9H(9PJSC77K*(OL#( M-XA$#_""DKI&Q\M<)8R+EM.?_:V7S62!"&ZCB4^=AEC$+U8#42."'&>Y-Q)' MF.TU/EIF*B&K-E+'MYK.ODU_[:-9WD3!2FJ5L<@(#`12&@)5AZP04#C7K1YA M7M;0%"NB@!&M>M??JT4UN5NU1IV/GBM(0X@"3G@K@#1,4HCJ4%ITZUBNBK^[>=#"L7>?#UQA:!T'*EFT#!FCG6L,")-=QG+TP9C>(M=]P-J'75:W MN-D="D_?K>C?;6#01F'BE'`8T;CC*PKJEMD<$6LOZ"9K/9=JH"* MNVA7^_S9D*"T0M1Z+XR4E`CKM:V!0`RQW&5B]#&(01AQ`K)E-I8H-=W0 M6"PFL[^W]0M?B7%=+1ZN[E+6YX'3U+P)@S%.,8@QE,HR#53\8NJ\!T0-RUV% M1A]@Z'%K*H![UNK4]S>VTV8-RL1U61OIB%&2026] M;N0VQN>>2XT^VM#/&E<4_#$M@SM!TD?4PQKX;+9`6'0WF'*4.*(9E)Y3\11] M4;EY3*./-A1?`/-!/T-X(3D:.S=CYZ=N78\CPOM[IPA$,46T,EYHP27Q6E/6 MN+G>Y0:XC@\P?%3*#83TH+OLY\GL]CYJZEFM:G5_/_\GW10^=:]MFSL@+87% M&'`5[5Z/4GIKG1F#E#"Y64KRXMEV+A5DT;#>\;?=&/9:;Z\>"Y1(B:QTF&-% MB2:,N(2))-%3$H1G7ZP%OP<[3H.SSXC4YF_NUW15[>V8?7AD@*F2(N?1-\%. M(4ZH>C(0B<[.@H"C3VD<-"B5C_"09\DZ_L^T3WZ:W2PV#[:D;/(2&8E M:;XY!^T%7.$MS(\>6)FGF^*<3"F30[`RS1N`-)B0Z*-8)G@T&R`@9"<[CB9C M+B]'M!Q^4%YF:*3DC.A[]H+0\7CFE M:?EM^FL`5L99`X5<KYOBG*Q^5K/) M[+8UB[;_7Q(T-C>@$]H,R]E15G:WNWAF;DYRG M[)Y#!GO-H:%:".PXD(INZR$FE_5PZ91AL'BJ4_&"=MNSL)I\?KYXG9AR?+G_ M$^8/%/OH4%'*E8<8<(*4;K!#Q%Q0PY.!.+6W<%\YK0R]TL2%8[:L$F3+^?WT M-A50?EY3^3Q+S;K_*?=U)\1142^3.;%]PUP.G,TU>/1\\1H9*BI'4RGL&B6*-7,J3[-.A\;$E M5Z'O\N(T&$O0PTR6W],&&/](E==^3NXW6^+*3!:+Q[@A;6K9M]EF7<:G$O:0 M88R-Q(0!;'ATU6JY+86YB:6CI4^VWE^7`A\`W1*L>J]]1PN)WGL\&&PQD0@+ M*86,`AEMFQ79`#Q\O]\/RID>P"RR+VT[:"Z_5C=5)'9\W3^KU0Z#MNVI95C@ M++K^'$`=375`N6&$XUI*A+-ORX_H;&08RO0(:I%TX-7W:O'TKLM.Q-D_*""E MN!)<$6()AUPYP1O8`*`7U+:W7]KT!FD)TC3M(-O[@#]_+-C4%U)0B%%*!W(1 M;]9LK,1F)V".Z/Q@&&*<`&*Q]>.%Q(?6C1H!AC[G1S6,9#K'Q]_46GPLA0] M6QXGH%B"#7NKD[?O(FW#@F/"0`%_UQ<&R_.8SF9"YG(E;$P7S;'C>QTOV[N MUZD#00=.=!D>%,*2:JF,37<3D"%D6\E^PW9&7#%;KJUO(;.TIV.;(W$K4HOAJ8MPM("^K>8W__X^OX_:6"9K M:/78X62OZQ0!I$0#3JW@%(!418YNKWTDZ:/OGMN^<80&ZJ!'PP/A79AMW4^. M]P\*$,;/1P'-,(310<0.H_IS=-;["VH1W+_2][/J-)1+'O)\F3RF"''WXYV7 M`X(2"NGHWSF0HO/8GTDC?:. M"<9"[6"Z:6B@Y]Q"Z&0C'T*YIO0((S7#+$&]P'H>V^)Z27%#6T^"6F]8H(103Y$#$KKHN3IO M9'VHYN*7=9D;U[",Z@'G8D'D8U>H_8."H3PNP]((S:3'0EBIFN^%4Y%K08_P M\&%P)O6&<@D>Z?5R.JN62S-_^&LZVZBON3"U2O>`IK>;ZTOI,M%6HL=.5#MI MWF`-!!ZG`)PGT*8\,]W8!1ZRW*R]$1YN#,[&DHHHX(VPE2OP4G6#\2%/[8R>"ELN3K5)7V^P>/;1\):9F79>VVX=779.RH(;(S4&**4 MR8(8Y0"I6D;BL\_H1UAONL`*TQ?,):B4=8;;@AH&BFIMF(M.+3%*`^_J`*S7 M`N2F!HVPE/3@1.H-Y3(IJCOM;-[ZT'W-=YX.B'`O@%?QNW!(,<\`I[5,G-`+ MJOK0AV+?)*>>"FBI?6L^Z\20UX\&9*F34&.*)<)`4^6;"V`>`Y^;HSK"D.0` M]#@1S1+/MP@,)Q:#GRAC)(A=#0D&9K110.'F"46W[,JK_3 MV>3U1Z3)R;`6.5"]O=UD1J72-=/;3S,S^3&-_D;;<>K[(P+#W!`.*",TZ-SB(R.,)`[`E7Y`+4&8K]5J,IU5MVZRF$53?*EN;M8/ZTT&@:WN MIC?3-E/W\.!@2=Q\2V4TU&_Y":$'K?7 MJ*KOU6PY_5E]FMW,'ZK/\V7*\K^ZNYZ\5U:I1I@7$IO+,&JL>F4 MS+ZI,\)(X!!+UJ!@G\=;/\I+#TH:8*35TFBAJ0#0FCHAPHNXOU].A'``^IR, MYQ@R]$_(S`^.<",P3X`Q:)5T%C??`\/Y'OKQG:`N*L#\<$(",^A!(#H1(8`EH7H8WR82(NL6+GD8K=QX\3H2P2H'WVBG;^$#VSMA#M MFX<#8M$>X@@":R0Q7A`*9"T10"K7/1DS.?*U^CI&>RJ&QD\CC@90#CQE`AA7?Q!+2L$V:[)"*ESBJ+W9[/T`&K1S>ASW>FPRR[4 M/!R0P<(!HR`ET0Q6#'EH:XDXU+G!ME$>`_6[_>1B6"2@5O=!]O.%G:__6MVM M[]^6@VR+HW6:(%#I#*<"2R:8P#+6_#IL-@6WYG(3HHEXM M-K#<;HZVOE2+;]\CEIW3%/9-$%!TSXT346!C.).,:=)(KI'+/7H<\YIT.JL& MP;8\JS9ON53KU??Y8OK?=SMK=QL83)14>`6<=4!KP8UG#9"IQ=#@!]@?GT4G M8GHN]GQ:+M=',V<[*`"+0?X,^D/2IX3`3T+:0Y:/'M&1-FL-I!"2Z#35@C/F&GP4MF= M24=X3V5(LF2!>1:B=#-TVH8%A+U(Z:L<4H\D(%9:74LIL,JMA#+"&RE#4B8? MT>+)X]L7[IH]OGTZ2`X!0!I!B:BVCA$OFYW6&Y0=&3P^M^4CT>1T),^0N-+( MO[RZ2SW-_/W\G[/W"VU>Y+A;R.*_HR0A$%^9_)=)9@U-5=?*:]4L`1LP3@A:1&2ZSB*VD+ M-,"HQ@`RF-LZJWL^QLM:.+\/2X=34@FB1L32>4YEJ^V?$:-4)N$)J&UWN]GS M#AH1Z`[AK1-G#A(Q@`B4%DINH.(">5YCI0S,[4S?IPHX2# M8X.,)C7'2&+*XOZ`F2&R"7U)+"ZH1?UXB'B:#L[#N?TM)8^BW_YI`K&84LVI MC9(3K1TEKOGRI.$75!YR/$SL31UG6PA?-:H\=BU\-3Q8(H&RP$$EE8L?GT<4 M-%)3E9LW/\(;.N,AXT$M"9K1#%!.$>.6X8`@SAK1OCJ1<=I[U M"/N2EDVF&P;_,S(PN5W+OE*#6R8+#GG'D/*$>YU:W4G+9)/I(NPE5I0ID!K< M'^)%[EA/'G-W`J(RPL=#LF-U]>R!]!`F=O]\YNJNEWZ"-ZWR7URV_^8K-+[/E[='D M0LJ.)5&"2(A6VXY?DI_F`>)U(9&]LC[:O-_E#C\91?$8"%2!JIF+68"R<% MA*I!SWJ?RM<19O4,2:T]-F5&Z63W@*HZ`E=/U7"7[F>QN)TN.PKC=?0-DCDK MF<168""`%QZ`UK1VE*0&C7\<#V=H-O8!>TZ/QI>+F^+I>7'[$!?(U?W;#4)8@2Y424'M)M/&Z#4<&@N4+F#B7XS,$'0?#/P<#W?U]<1MMM`KXO%M+S[_7Y]#^..^4PTB*V1'"!K*.6(^K@* MVS,-F/Z@Q/'A.1F>1!R`<0-B?3[&J;AK+Q8O<8/N?*;^D/Y!1YL"<0R4@@A2 M*R7!K=-%($T]W3XZ^N:I%DODP6)U*4P[#>K+H1BC<6&1N*,K2A&&`#K>F@_. MHM0`KZ.KZ*XIYN;#)OV=D6#'`9VE,,KST].L1F,R:]#X-+\O%X^30Q^_/.P+ M`2GFL-%$:TFY`)H2WWKU+!JMB20;<_7=/@DV#,QY0E0CY,5R=3V9[CN.>]TL M4,J,]]!R((SA1BJJVYU8$I1JRH_P'+AWN;X++4V&-5/\=@=17J`QAQW(<",!99!:%2&``GL?9HD^L1K;A4%33FHMY]4FQ0N+,1[Z:8 MS-RRPN?3X].B_+&NIM7%LNV]`C$>(469Y\01+!&$FFPJ@_@+*B0]E/"W<:P7 ML+,1ZNOT^WQZ/[V=S%>_\'E5Z*7V$NOB;)N2;'],XPZ]K^+?*9\-)IH&"A*J MD=*0*A\ET-Y=*2!23Y=&:$7EI&0>:62Y25P/_VIQ/5DTG_6QCK6+U0[RL*I7VWH$686V>FZ<5U)%M29M M4Z*.(XI?BC[*\J[)B]SEG6YH'ZAG'SD.AE%,*088) M:68F<'*LZ@BMHY-E^[LW=SJ<62XSRF7T,.H!?BUG^\YZ?FL9M&$<.N:C,PJE M!U8I*YJY.$=3=<`(K92^J7$:DCE8\<-4J$,>=-AH9I#7! M`@-&53,'SU"^H/;!;]W[9D,ZBEG\HR;E_%<5HH,.=7;U"3@:T-@#820P3D@" MC)'-_(!!EU7$IU>6](5I#L[<1"'%WU/=O=JH`&=EG8O672!\;[\`A&6`8VT9 M`@0#HBQ`S3RQ-]3K3>X+#/E=G9*3"@*4*.20.CK:6@P7"C89U(K;LYQI.+ MWG>1WF#-8L(6\SC_BN;J[C%2OII[E4[5S9Z.G@%J3&7\QV`N!,/,40R:N2*. M4R\K1VC$]$^A?K$]BP%\C.$;E.3<>8`MU`0Y3(!SK)D/9"8U^WR$PT#AI*K""2G&(OB=#<\M;XTD*F*J01,F0PER@9S4R7->7;@3;U M?`\H+M#5-[AHN#M"G(X85B^W$^]INR(D2GU'89QE('ME3]_8Y@G,JRZ@JNFO M1]S$$>Z]LMC>)3#)H&8:*B-@]/@XH+(U]3U6J9IIA.YTCY)^%Z37"[@Y`WZ[ MS=_?6D:EJXGU@B$!H06&"\!;<+R5J409[TL%0_+E%&AS!O9M!^"`0+[M'0/7 MWC&M:53(V`DKI6Z*-'/$!$CUF4;H=@_'GEXASD&F?\_#J\XBB#51`FF/O`&. MJ?;X`TN?^EC&X4<"&=]G&X[@XY3669V$%.<@6((504`S5]6>1A(S:EK\B4N- M'QRA2SD<%_M"-U^^3N7_5O5[UOQ_CN/>Q%RM'RE\E5/R93HOJ_JEC46BYG=O MOU(E3*Y>OA2KARKMNS%S.YXMR#6*``'$E&D!HA"T@93ZS7&SXC`U%>WHY-B/ M=V@R7BEES6S[M9AU,2_VQ[CLZ!$`$(Y1J3@V2A#-*1#M462<:VJ5B<,S9\_P M/-8`1#P5V$R%FPXZW7W3+C!K(AH$"F\LX9!HQ]GFU#NY3IV\_"WJ%!RS^L_S=;2;!\XCC.]NH]+X+IZ"CO^Q6JUF/[]7!<3_U9>U^!W MN=RYQA%8>M?[1<6(!94GQOC=U)N)[(TW MWMDK5"]X6V>%@W%&T9D3`&VN>:1.)N/QI]RO)=O0,-"H5QH455%G-`)7&M,=E&(K4(QLXP@BROBG4+[0Y M:/3?N,\^Q*&I']'+^5[\^?SX=['X56[YZGFU7$WF=W%&A[,K[8-!,B,<9-^DRX+XX$EROTXF9R]US>^HMN-V_%C.WU0FSIH$ MM^7,]9`0_WW=`M"*4&T%A]190"F-]H@PQJLH"R1\Y^E,MIG:Z?)V5BZ?%\6W M"+>>[2\/?=@'`N9>5*D;MGI9@Q(#;/60_7KVAB57@Q[AQ7H_).B^!#@=Y;.N M:UNL)M/9>7)#!JHL<,.8<:1]-[!.D83>"ZDX)W7"P,%BM\^%'?/L^+J MOAG\J_SII7YY]:=O'8^1'_NI@)2+6BTRT1&H%>`::]X@XCSD_Y(E?S`Q?H\K M'Q;OG%?=KX:J?D[WG1;NZ!&\D+1ZN-IP!>(4'?'K%,!J;M;C"\JX'D[L.U3* M:5"?BT;K>@^%+1\GT_F1A'K3-W@LF*4(:J@8]L`HNRX84^$14NMD MB1_`H%.P3-/!S=C0MHFGY)] M#'DGRJ?L!\T\YZI;(UWTR[5:QBK_8Z57]H==%@Y,?A[&@=?M`A711U,8,Q%5'6?,.-G>!&`+ M4HNNC/#$HA<.G(#=F>Y#PG:DVU'8>HET0AU[WGXVB?ZY\[L6&X+S-U#S:._%5ATB:1% MA"F'7'6`;V5KT0IB+ZB:\"!L'!KP,\9'U*=LT_MIG-QRO<+\9+JH5],FG/WX MT(F#/AL=+>ME=*BW5\]KZJ4 MKN6.SFV!I1J1S^4_Q^479!E2D(X2[P5&D@!:*3.RKD5<7Y*J9/-AA([9H.;# MR.66%-!PRMRF\WIBY<$36ZNX[8ODC*,)`&B):/3+-:-`.@[MQCM'"*0>;X^P MGG"OZ^/CB.QB%*@!R*UG-_AQ=0^YA+Y0#([ MTY%E/=[KQ?1VGZN]MU]@%C)!>'4#K*X_#:%4X?@/4]R0#0+6),>=C;"L MVG![7SX!#$Q!M6J/E/[S\E2N'HI5]59?_8/36;COZ\%YZ@7UF%+!55R&5&V. M]HUVR34,+OTF\'PR2.)B^]M?%TK?6K;DIIS-?+GX9[+8=IV7_K%@F$7&<@*J M^JY&4:"D:<_PG4L.H;OT.[QLD/>_R6T=X+KNY;8R-*=],!@)+5$`>T"9Q$)X MJ3:S!?G*L3P5BVEY]W4U6:P&85D.0AR\R_4HD?&?47VDMTD0(`YK[(T0FA/" MO9/M-A-5S06\E)QQ'8Q;>!]]XX;:6U]5YN!$,*^Y!&(3&ZAM:C#:T>$4ZXW; MS8=Y2.?C;-O'R>.L1?;JX-++J;'',88<<>"D`!Q*@)3@=7E#SHFBZN@:>SO6 M_A'1NUL)^S:GN2Y#OJ>0YM"_,C!DG&`65&X3YPP:!UO4..,7E)S3#WG*4:<%H9XAAWU5!#9@(R\ M[KQG'&:F7Q_*Q>I;L7BTQ=^K0ZKL;N\0$*8&*A69#:CFU+/([69V`)M4*W:$ M2[L?(?^>Z=\'JGD7YCG+Y@ZQ/JW0"D@03?AHJWDJ(:/4*^:(\<@HTGG2/\Q, M*SY\FL2E=EW"VM`S$(>0%DM!`1MP)11WPS+ZC3;S`^V,H\6+QEWY#F M."YI5;Y^^5),JD#7:K1^4?SON7JZIB.__H#>05"LK;&4X[@?*<<19;R9,['N M@JI_G23Q;&(KDIGKO&&`I5,VMLD^/(Q\RO/CAP M`+].A#JS,MQCD?F"5V!^X9]NWWD\A23_N_$Y`BA.)A)9&:V^H)((T=BLFPJ:6*ACS M3M83,0[9S'J"/2O]/LV?GE?+&A!TN+9\WRM0!!$"(OH_5ED/K2:L01([P"[H MS&8@V>]BV,E8Y^!36X;PZVTQGRRFY:&5/U^W#Y(Q)@C4U"!M#$&0X<:TB(8& M3\V>&&&&=9\ZL`\LLW#DU_#^FB^?BMLZM[93O>WL$Y2IHX4\O'&30$2<5!D0*+HALYJ"ANJ"7_!+DMJ>\YW&XY9!]6GG/ M:#5#2(0$<2LT/%KF2K581"OZ@B)(DJ2WM[SG<=AEX4!2>4\+F">,..T!@S+J M1R-9,P]CV`65&.N%`R=@ER70>S*;S&^+KP]%L?I'.U>B@6:KDL5KM?/MO9-@`CI7884>N-!I1I29M- M4PI'+NBRN@^AEOW"F8,>ZNZN#IR=S*XGT[M/WXJ=9H[AW0/W`$-K<1"0N&8UP[` M1NM+Q^@%W2KW28&CV)6$]/GY=;7GN<@COQ`LQ\P!J2$2C%!.+=&XW:8I_]>P M[%@J',6S5+C/3[5O_Y0G4JW]0F!:\\K4X`QH;PF%U0LHO^9N.>U,R/LXQM89 MJ98*=WZJ'65PK5_W5H@QY)WCBAL-!2&^50*2NM2SHQ&6@1S.P$H`,C\U_IP\ M%D<:49LN`5G*4>1]-!@`YI`(8D`S._[NJ?;+46G'B78O2Y+13"J?8,KYCV*Q MFD:6?RWFTW+Q9[EJWG6QQ6V]G<5>>/\;V<=])2AF((T[))0R.L"2>LC;[=>Z M2TIT/EVT92Z8>Z3/W7,1FXH4SKSI&AC'T6)#DC`IG:82&]BN**%(*E%&;[8, M0Y13L,VAB#Z7\^^K)LDW_M8.*V5;\T"$Y\@9#GGU3+35CJHFW4)"QE(C($98 MB[=/.Z4'*,]!D$X[97N'8*HJ7AI8(S5R"@))4'O$[E!RJ-0(]<]I@NU@21*: M.7CR:ONKQGK`>^I;V@<(I2%"0$Z')9P)QXTJEE9SU+KOH^PMG:?NN9D(/-3HU//;&O^ M?_:N=;EM7$F_RS[`.;A?JO8/KKNIG3-.)9DSM;]0&IEV6".+64G.B<_3+R") ME.U8E`21%*-,I2IEV00$?/VQ&PV@NP-@4FL/##?"(0R9H+:9E8?HBK9WSQ%I M*SNRD!SD:F[QM9I]+>?W+\=[^+)N6[M`$1+1)#O,333#5$G8G`8K#-`5[9Z< M)^;7-WD[!'6096RQ6J5"D9OA'N3,6X\'"QV#"''BD"#6.,A<'3"GF#)7%%S= M*54ZP'(0AKR5JN>`-[RG2>!60:L9LHY1HKA&J`D(5I[J7*:,L41#IRYQ-WA> MBBV_I#QCB\,.\H&FP3+J.;:4@ M9@D^?5MUIQZ*13F=;+YVKS)H;Q`,IE``![4SD+@X[\4Z`K9 M+!Z\-(G/\CNTWKP\MFD0&FNA(]30""N@4CJ:U^T,",V_*#="_=#%XJ(G7/M@ M1KNV.*IQD"J^*LIYRC#1$2U>X&>P)0LE/O@2MNER)/:!Z\- MMG$"0D/GG#%6FCJ,3T''KR"6I`_!GL"97*C[H$W;!<>3V@<*.%!<8<`M2B75 MXUNVL\O&Y>[$CVB)`L=$0>$)IU$?>^`!1HUB!@+E MG@6/*$/3I:F3#78?Y/'5X^(L[NPZ"-ZP5.,04T,8C2MWR42]^E/49.^LC2CC MRH6IDXWUQ7;=ZNJ(IVZY-545E<7(1(DQ-IC7F&D%[15X61U+N?7Z=3:P MP]/FW3Q"7BQ7'R:K8IU2[S:JS6D2Y?WQ53#:.@G:`4\PAE!90"`6::U7(\#E MU6_]=4RM#J$>@FSO%]6T*&Z7/H+UZDI7"[M:6@4DH+>.,8NDYUC;"&1]\5!; M"'/=M!&MM?NE4W?8#J^LGHTW>03+S]7L]M-BH:@(PT.Z9[`C[\H'U)E=8OV.%B72OT5T\=5^;7HBH!O=QDLE`WK.NR^@E8.R` M\M@X8S@2%CO>%"C1B+^N)?\CQ_ITRY_^L>Z)0\]6EMW0:4^'P3#O)(40$V68 MTM)RP1L7BHAKNI]]$6IU@WL'+$N?;'$W>9RM_EE6L[7`;A;N:_S3S=WV#[:8 MSB:;(O3Z*07M_W><091+JRWL[;L"8U)YAK&"VD(`/3>XSHFNX[N9?;1P]6<+ M8Q'))?PQQEY0%[41]3 M%_/BKIR6D]G.?_'%9/6X.)Y1QW47#.2:,NX$39OG2C'2%!#2\5-VP:V?YCQB M`-2'Y^)O\\E#%:?Q[^+6ELOI2:?R;[0-U!F"A-%"2N&)YAZYQB/27&376OY) M3R3.AWC@#"3KU$OO)T_I?DL+D?:T"#+EDC06:@$!TP+$#\T)"]4B^T+03W.( MT`VPP^BAC3A\.4_YXDVU7"U_K>:IGGA$[]>B70\=:!N0]4`R1(E$1DB-"2%U M'+QA6&<3Z2?:Z.\6XN%-V^9693F-K\#S^RA'F[<][8-2P`"#D"8<"X*`,[IV MI0WF.KOLW$^ZA]\-S(-<$=J,<)D$ MQAY+2S406-3SA0YDQQ[_-)OV74,\DL/']9G#F8>/FSZ"!A1!+(4%B%MDN)&N MKF5NI&391O'J]_7[AGH8JM4OA9E\68^RE5.O'PX(.X29AX1:(IVD.#H>.W,/ MLG/P7/W.?6>87BK.8ULU4E>+1?6OE'AJ\B7^9?5T8MC'OFZ"Y]'.*^F9QT(@ M+R!K]D@,B<8^EUE7O^\^`-J#;!^L![Y[/7XI_^^QO)UL#MPW=X#_4?1AIJJ]%=%Y7V\K' M9N.ZKJ\'M9TKMC0+W)HX^+B`Q-I$N#@1VWA@"R!`-#M%^]5OHO>`[OF\V*C( MFR]%.H2"7K.6G'/Q?I_+9Y!SX6]\GC?#G,XMLJI>NZ_8^>ZR4O[B?S\M_K M,:7K1=5L:]WC`)^/]^9NLU=<3F;K>+_U9HSZ(WK+DVG;DJV3_@-W'#B%A)*, M.^:H4SJ:C[2R-<+PPQO^(\0NG?C-JI0D(#[]L;R?EW?E-+)=3=<'@9$6[V-_ MT[)8?HI4T'$&?_8%<\90@F+$2B\\M-08Y*)QWTDD:N\KJGLT,(-?%]4>MV!' MJTQM=$G*V?(OG;J7D8I3RBR6-$4Z6H&%)GHM:$ZHU/3@D40_V/WZF'*DW-R] MEF?;\-D%[JBPCRG'*M3/`68;J.2+MKB`'VX4X4?4C@2$VI.JQ?BB^5(O5 M9%U7[&B*?=\H1%RHP<)JY"P@F$&'03U#$W',7>C_Q;&>1#!:FU4;X[^,UE[R M.*FU@(09Y)F&TFJ?]ABWZL39@Q&^_6"W%>^K9=73YO]CEN_'=1"(XM`P3Q"5 MEC,4/5RHFMDKF!NY=;7F[&BV5`.(8PC;ME4D&Q69P<.CV@?$4\%-SHF$P@OB ME<2-!K=8Y-+P:BU>+@W[D$;/QJ^:;FI(SV]=?'%63^_F=]7B8=W5B59MWSYN MRS>T6*&CVP;KO8"*."B)DQ%#K;#;P`FX!_3@>77;B[TLIG^[K[[^_;8H-^]T M_.'UJQQ_%3:C^U#/K[2%H<1ZJW?.BGFZJ=KJ'#L\?"=H":Q6PBF.*+:7`LV:\P&??_ M+#@#S/Z$O[EG[>:W-JX^#K#@Q;,A*C-&$8=Q(H@@BZS"MIX!D=F!JB,ZV1Z& M#N>@VCTO5!S2[3IP=C:YW\.'%\^$J+:\IY)QBZE'3E$5P=B.F$E]!0G>^N7! M.6AV+__MS1M?+J>3V?\6DT6[:MCW>+!$*..\T&K]C"3\_KXUC[XH2:!.J((EP`12(@5/.H^4,\'<9>[MAQ1 MV-0@:\LNP.V+++Z<%0L3R7M?+=H=CQ=/!A6'B>+***H])"Q''J-&%W(#R(^?(T++F\?5V[.RBC[_99WCV/!T\QP)IZ5+M)BFC M_V5LHQ85S2Z5-:9T8\/X+N!E\?*[!SI!WR[>7H]EDT`HQ9/& M%=UCU+[;8_]J?LRQ>7ZG00J!N&5&&X:Y4XBDM<+Z)I_C4C)[F;/R9B:[RXG' MG$RV-0L(RLA$"Z2G1%&-H9*JGBGEV7L7(WK)AZ1#U1ORPRJ!2UX!'9LNP(HA MYYU-H:$"*R&($QH)#J/H@9,["8@8KB!G'#H+F4->PQI12I"]@H/5"]*N-SEE+O@9LH"^(Q`(1@XUV*4JDQ4YCE7E\>T7'PZ+C;IX#Z M76+]6JQ2P&YT`]=[2A=96KG)8AZEU`SBB(73OB:!44>C3PPQIABZJ".P]\IA M0J#WC-@+Q16^'NXQ_M'>-@$0Z9B0T,2)"F:C9@3-'"4'N4611N@TNWI\MT4"EE#"8U>)54\*CZLC&?*D0@\C$O,R[R;'Z>?B]O'67%S MIZ*]N"UGZVH,'XOIXZ)ZPO"WW'I0!+=;K\H0(*% MXSPEVR?0"(X%Q5LTI17H"JZ$=D>HU]>P+RF)(1:I9TY+/[W=@?I6MOE7/7YK M8-9B!1#&<;5&A6.(BUK4DC-Q177$+T7.:JS"O-P+DVZ)V^IA4LY/9OVN:?"" MQ)4^Y-PKJ2RV0'A6SY;Q:[B[/RK.',7C;/$,LL7P\&56/17%^JC_9AUX^H\B MAJGE=<0<:U"2W5Q"3,C2!S@)XN+RP=;JX`[["]P\' M)`2%4$95"K15VL!406`[(\I`[CIIA#IG)$O\LV4P/*L.KL;?>CQP!2AU4&"` MD"":<^!@/2N,LNOCCG`)=(Y(6]F1A>0@_-AE]4\I)@^:K3>?#TZX=.V>(2VA M,)P0XV0]+Z)1=JF%L3/D5+'N+U^5#>8/L!_V2YWZM+_-K^8K`G6,6(KCXE/>?TT3CHF)R7]3Y M`==8/`MV>@5+"Y'R.@R<6@.L$@9:@*!U!#NQ1489XW(W+T[V1..H_ZA^<,X- M(H(1V-)\&QI22):C(D+JI80&F/1A.U?(_6`KOFN@6[=87X)7VY'>K#X7BUV` MQC'1!"?V%`QV!DGM'8)8"ZV!IJ3&PEN5&\8]P@VWT:W9NA7-#^!"'ZP$UDG_ M`0*'N4LIG!B5T0&D1+/&;`A]Q6O%SAC5K7><)9>!]PV?5UX_;N?P1:UVHE.- M&L%D7+`@QH05MID;L"[7]1WAALW%U6@W(AB"7B]+S]95LM/U_W4ZV=N(R30) M_;Z]K.NQG02I!(5:48.M]@QJ**"N$<"0Y!Z>C2CIVVA(V)M4!N'E][>K#B\L M]S<*<7+:<:HPEA`")CDF]3I=<6-STS&,*,G<>'C7E12&X-F[^72Q3IH]F6WS MUJQ3UJC5:E'^\;@N]O"IVI7A3D7@_UCM9M9"QC-[#E)`Z)1@S@'KF?9(PWK; M2S$-KRAZI@O"?!\Q/"#X@T;9K`^1?OP@&RB\YX8+()@'!''B'-_&,3DKX$&% MW'>0S8$-FK44CBILD-=C<`YYP*BFD"N8LCF[2,@M/M%+R:WB.<+7_WR*[`V; MZ1/R(:Q3=R?/)S&UJR\+@"K#L''>FY258$[+G75$ MZX"-Q9@HB87F/,Y5N&U"T31ODIWH>82&KE]:'"CAL!PJ MIB@WTM/HB'#$ZM`=A#RR!Q>"KY'94]YH9V_J87TOBGV1XZ=U$(`W'E,J"-2" M:`2(U-N-!80I4KG7%J[EC3]:X-4`Z`]TQ)$V(C>I;SZ4RS_U4RIQH7WPN9-5W,IY\?)HL_3[=M+YH&AR`PEA*G MM."66*V1;G#$X`KR/E[.P)V#]&5X50_X=%/WJFFP2J63%:VL%*DZ`]#$-C!Z MF5W88#R\ZE[P!QEU%L:#;#-/9L7RH(U[]E0@$`J*,7"&0!Z!`9*09@X07;,U MRQ;GZPV:;#@'H41=3'JG;B>S`U9K;YO@C*=,&`&E4QY&2\^DJN>G*+F"+`L# MF:NN(!Z$0IL=R.\-FH M'L^:NM[.--VJ73PETN#Z0^(+?L:7[:_#;Q_?(,;NCP$X&Y4A4X9'U\$R1@1K M%&U4F%>4':$#>55GPC=(1,GCHOI2'$X9]NRQ8*SSTCL%',-&>VZBK6P`X"KW MM&A$CD_W).@`R"'H\$L4REP]%(LX55LLXX?)42GE6ML%IF$*&*7(0,@A9B@5 M+VR65B;74Q[1TJ,_PG2)[""Q/\MR\GXR+>_*Z4'6?/=L0!!Z*[WRB`GG@(I& MMD$).'5%"0@[DNOK")PS$6UGR)YCRT_5:C)+&]:'UV?=#QT*5C>;[MTV:AF65I;+DHIJLMZ=MMS!N/!BX4`6EI+8D35CO@ MP/^7=V6[C=M0]),J[B30%ZY]R4P&&?294&,Y->K8`VDF;?KU)>7(-L:.+,O: MHC[*$&G>6`*#"0LHJ9H$, MS]4I#!88MSV_F%`<8L^KA+XA'^R^[6WDOVVWB^)S5NNYU;Q'`0!##3$(P M8%("HBNI$+I<5W7Z\TF/FCYW%7<;P*-<_!\BN$$-?>J:>9.P8)HI!X9*AKB$ MBAUF529GD$!_.!IU"/1(OO8CQI9.P=5>(L!XK',@%&!`06V%VL5#Z#`_H:MC M4ILN.LZ.ZE@[Z;J4XF+0:9?=>QIKM5LHB::6!\("#7F%AE)L1CN6?LE2NW`9 M1#?]6I.RZH-*BVP1XQ"S35%V,HH1.00YW2^/!_.0K6/&$[TMOA=E4.0?<;A? MTM?=.423S"*W=.R=!E@1*1GDE"3262!$J2[&,`SDN=:P#(R6.A:J2=S?C3U[ M`H4BB$-GE,%&4@'1'B]A6[NW3M#T#$6LDQPM0RIH#/LS9MC@5,V0$8YH"S2% M1MKP0)%(J(/A-UE6J1O'#!VE:ZCJEV7YR^HQ.Q#P6%:Y+@=6QKK'>N9/F]6_ M93*KU78'0//ZMAW^G^=$)8X(J<*D[!("$-.RPE8!-*,PYJ%(^'Y6C]'4-E!& MJK`(W%^:W+U)<>%NLJ:5QTE9;-S&PBF84Y!`!RL9B;II( M)R/R[N*U9FT['VO*26",%`0I[*2BFE9R"B!F$(G;J;:;,:@5ML.<4$8'D&;A M)"?O>F!-#-L+FUIK4<#'$$LJ>2C59O9/MR$Z!$,>@HK"__P9DW!E M+]EZ^RT"8/^)-OFR*W"#UIY%=V:7"%%:9QD0%'J/GFY=AF5")]K]LJA[C%O= MS.KP2GGZM5D\9$\_UE%+KW*Y3%?Y^[:E84L/J3&&8)I@ZR!+N)5*5>.W2K1- MKC=!I^!N.=(/OL,X::U#GT]AS)_2_*\L9D1J:G0N-?5:`X:E5DPH)%ABD=6X MDM;,PO.O7XO3,<##Y(K89'GY"P#C*[G3_>R/-T\[1SO7T]. MF7("*&/V!CQLBMO.D!-SB>=X'N6Z\K@A`M__I.3+`"2V$!8GAE)*P*JDPQD;-Z,QT*#+V M?>W84G7]VK3?BRA@\7WU'+`LPH;IZX_GYS1_O5]^7041EJO'-)C\QS*=1%@/ M?]FN5X^KD&((84Y58B[!(8/A.VDYXCP.",LJIT08&?C4,?&%_ZTG_]);X`L``00E#@``!#D!``#M7>MOXK@6_WZE^S_X M\FFOM!3H8V9;37=%7SN5VE*5SL[>3RN3',!JL%G;*7#_^FL["0F0ER'3T@O2 M2!,2G]]YVM_7CS=H2OF^".@$EURP!)<-"%RB+Z[(%Y0G[,1^L[X"WG%]7I( MA8*KJ7#/A#.$$4982DYZOH0;QD=7T,>^)\]K/OW;QQ[I$W"5%!YH)@L-$H\E MY@.0#W@$8HP=.*\-I1R?-1J3R>0`J,L\-B#3`X>-&H?-UDGSTY%23*E*Q1EX M@ZE%J/T@E59)]*]Z1%?7M^JMPPW%B`>EG1@1725BG#8P=[2[E><<68?IV,,4 M2\9G-^IW.=$\SA=0KF,0+>.IEK'U:1,9#32%@0[DY65*4E4KB(5A(HK-!4@/ MS&7D2%(^!(15BK.>*!O(D3Z-E!Q%$8'F?&+)4X!S,&"O#8?Y5/*9#E%'96); M&EWTHQZ#K"N-S[E*AV:E0VTJX?S76E%V`=<%8BU+1*,O-I<`IL[06H0YD;G: M7`A"7T%(ZTZ2(`NO-^\B%!/'3,4M&TEBJN"R'@.L*8<@CK44$8V^J$`".>;V M(D1$YBI/"$PIDP;)W(ONCL>$]EEX2]W4<_A9-)$_01^9?/4LG$7SL]K&F+,Q M<$E4-[1HV[6,@( M0+H=M^>;G,*;"-+-L*<;\0Y[EN_ M'K::QZUF$]71%1&.QX3/0?T(P9!!0R$<"O"^-)9!EO%]`6Z'_FJNETT44H=- M\BB7QG5YPL6ADTX7WHU\L)9KVB,5PLE_C83!';&YM])`\^&3KC!A/^!/1_N`6N#ZF4S49F+<]&+??W9SM>:&S+L4)+? MWNVKCOF=,7="/*]-W5NE(1V0G@=M(:!"YY?@4=P%CNVZ0,038>JBF"L*V.Y[ MPJJ7OH+G/K-[+'U.Y.P>\Q=U6YFL"XZ^HU**RCI$>5;%_>*37;_0K)%D*&*. M8NXH9K_O'ZM.NU6E+I6,5]D14C"+/7YDY_$$C[U;5UWP&%0,,Q6W]_FJ6YYUN*O`O2%.KB>/FL='S9:=)P/(0)%$R5^C! M1=PB=YZ846CM3I5C)MGLQZ2VT=R*HM._Q&)XX[')AF,S';+`J4>EQV@,CU@? M:0;(<-B[<\GV'55/&3&#V6ZD5!XJ`O(*=TQ4Z.,"/@6./US3\3'7<-I-\$6: M\0[VAR#QD-[L5@A?)QXZ.6&T*YGS8N/O7)R".N13:AT20Z(($P6@R*#NG;5@ M9/N"I!1<05'R*;4H*7+=+E23'\V">6<+PH9[_M!:1_9#N0*6!7L1[524IM*>L4^3JSAM$=5TUGM MBU3!*[>''#9;AZNS0D4])!)A][I(^)6HWD!6.:BCK62RZEO;)"6+`L\$O*M!Q@(`6" M0I1=-[_MQ)E%7U#H_Y*2`:\Z8W>GM@>0>@7Q$7AWB'GY0;%,5U`4-E/&A((P MJY=(@2"#LN/&MQT2&>0%-6$S)3]<=<5^1(16M5S:2J?.7\IJ-5.6LM)8*!36*5C5`0MTY3XE8(AGHS%,.A`&_OFM"PMK&L M$*@@JIVF1+4\1^UN?,NTM&6D*\(IB'FG*3$OWV$[&OW,MH6JPL%L.*MLU:ZF MS"`O6%K\G!+W#%+=0*$DUMXA_($(>ID1(Q4JOE,Z9F96WD)U^D&"(8HXH8OE_[/DOC>73*\([BZ=QCU@%^Q$29J4M1G=NCO M2;(;$,_3XRP"%;[B0J2O1?B=,W]\7C/GQYT1":,:"DX)"$ZY.W,-QJUZH#6K MH:#A6'%A[K-IZ/H\G)T;J_K$\H>+ZVWG;Y\(8\_XQ07]'AAQPQ>^VG+^/?+7 MV9A%[W.:&W-EJT);QS+!G1&C:HKALV73](*74L]KCMES3K-8U%J=2/6@<0B1UXH3@O4'".U5WS`NKE4%\2^J3_8_V.+_7BNAB?M?M]-0^*R#P%;7[@@':AESZ>?`5 M]%00>06JIJY[/"4C?]16#+!WB<=$8L]LSJH93Q57\\%J2;-U@S=/^?G[-,%' M*YD*+[?[($JJD*.$#]/()TV=JF-JL_55'/OYZ79Y16Y5DL7-&S6)$?8\5!UM MR#PWFF2O\&S!=U94ZZM)J(0!\+?05,_[X"BA7F$]I;,!UM<_4JYJ`^A?X8'\ M?Q`6+)IT^+4^J:73#Q^H.<3#`?3%3`?;KTI)X'H3V-$K-`-(MTUEV!N4HQJD M^MEJ4<_$T6:/!KH])1G=):MI.0U=>>:2D?XP+N@(2SFEY"IFOKFRBTM391MO M80I2(/H-\_EB(F)#\/'T[5"P4C?9_N-IJX.WG;Z+%!]0XPFSTS?1?BNU?06/ MC<%]!F=(]2;);%F][`;;J`_AX,CPC8$E35(?;:4.(OC#0(QG*)+Y?!NUR7E[ MO1T2S34KUW:#!:0?--G/=U`Z_8)5X2?F>3>,3S!W(ZW7)7XW,\1JZWT_N%,9 M^\K)J,GSBL/7J?\#F'=UAU7N?1X"!]R7<:^N".L]JMY2Z^QKZ$>F&QC'$&^; M-3('4.*,W4!7<]BN"_TLOG[QQ-]NJV<'ZP;GV?[X.OYC?7C.[IEI*TUU0]=3UFK^RNW^$0] M>ND.&25T<;[/>K@%:[5WH'H1W*FD5_D_N4T4+T:J9R#N,'4]QMW;T9BS5].D M[7EL$OR9M$#-BK"V+>19VRKJMD]`88*]COGZ4MA:*1/E_183,WO_`WAD>D\\ M$%*Y8&E3*NOA%J:Z2E0MZ[+XR7M;,&:CGM'I]XD3;Z&LWMZ^,-GYUIWWA$4S MIS[9`F,OC(U96R6L<]%SFZR[B(L5^<;O$RV+YNL-M'`KYA'/@K^"X<.% M^1LZ5-Y2A^N&.O^\45E7EH;V,#]P*?N'&X+YO`I#!#`?V!"F7,-II5_5H!_9 M2''-MS'*!S:#626NP!`1SDSY?3R&QO&Y8`<[[%[\E ME2!4C6[M4F&I_0+A]KZ/FE'')(^H2U4[M>&[I;!%ZIA?UU-B_N!TKCZ++;>P M>GN\;V^3,]1VS@!K]V95[YKE"Y15!-73C'EO2SYYN"TJ2 MKC,$U_<@/DJK2;8N_25R-]!%PDM<">+F1%43_9%.Z# M]`F1\5U\ID%R"+9Y[^*92>P]J)VXP'S#] M$>&B*AG/WE"+X*/)X`^-JY__`U!+`0(>`Q0````(`+*$!4=*)6#]@_\```?R M#P`1`!@```````$```"D@0````!E;&=X+3(P,34P-C,P+GAM;%54!0`##W3" M575X"P`!!"4.```$.0$``%!+`0(>`Q0````(`+*$!4?&]61O/QH``$4)`0`5 M`!@```````$```"D@<[_``!E;&=X+3(P,34P-C,P7V-A;"YX;6Q55`4``P]T MPE5U>`L``00E#@``!#D!``!02P$"'@,4````"`"RA`5'TJ93RULW``#!E@(` M%0`8```````!````I(%<&@$`96QG>"TR,#$U,#8S,%]D968N>&UL550%``,/ M=,)5=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`LH0%1]:,-@W"E@``+`$( M`!4`&````````0```*2!!E(!`&5L9W@M,C`Q-3`V,S!?;&%B+GAM;%54!0`# M#W3"575X"P`!!"4.```$.0$``%!+`0(>`Q0````(`+*$!4<,V;[RX%<``*(O M!``5`!@```````$```"D@1?I`0!E;&=X+3(P,34P-C,P7W!R92YX;6Q55`4` M`P]TPE5U>`L``00E#@``!#D!``!02P$"'@,4````"`"RA`5'C@&3B4\-``#/ MB```$0`8```````!````I(%&00(`96QG>"TR,#$U,#8S,"YX`L``00E#@``!#D!``!02P4&``````8`!@`:`@``X$X"```` ` end XML 19 R29.htm IDEA: XBRL DOCUMENT v3.2.0.727
Balance Sheet Account Detail (Fair Value Measurements) (Details) - Fair Value, Measurements, Recurring - USD ($)
$ in Thousands
Jun. 30, 2015
Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents $ 36,269 $ 26,798
Contingently issuable common stock 14,800 14,600
Quoted prices in active markets for identical assets (Level 1)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents 36,269 26,798
Contingently issuable common stock 0 0
Significant other observable inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents 0 0
Contingently issuable common stock 0 0
Significant unobservable inputs (Level 3)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents 0 0
Contingently issuable common stock 14,800 14,600
2.25 % Convertible Senior Notes due 2018 | Significant other observable inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair value of long-term debt $ 82,800 $ 84,500
Convertible Debt | 2.25 % Convertible Senior Notes due 2018 | Significant other observable inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Stated interest rate 2.25%  
XML 20 R28.htm IDEA: XBRL DOCUMENT v3.2.0.727
Balance Sheet Account Detail (Held to Maturity Marketable Securities) (Details)
$ in Thousands
Jun. 30, 2015
USD ($)
securities
Dec. 31, 2014
USD ($)
Schedule of Held-to-maturity Securities [Line Items]    
Amortized Cost $ 34,257 $ 59,871
Gross Unrealized Gain 7 5
Gross Unrealized Loss (2) (8)
Fair Value 34,262 59,868
Asset backed securities    
Schedule of Held-to-maturity Securities [Line Items]    
Amortized Cost 857 3,633
Gross Unrealized Gain 0 0
Gross Unrealized Loss 0 0
Fair Value 857 3,633
Agency bonds    
Schedule of Held-to-maturity Securities [Line Items]    
Amortized Cost 3,000  
Gross Unrealized Gain 0  
Gross Unrealized Loss 0  
Fair Value 3,000  
Corporate bonds    
Schedule of Held-to-maturity Securities [Line Items]    
Amortized Cost 2,658 15,707
Gross Unrealized Gain 0 0
Gross Unrealized Loss (1) (8)
Fair Value 2,657 15,699
Commercial paper    
Schedule of Held-to-maturity Securities [Line Items]    
Amortized Cost 22,781 40,531
Gross Unrealized Gain 5 5
Gross Unrealized Loss (1) 0
Fair Value 22,785 $ 40,536
Government securities    
Schedule of Held-to-maturity Securities [Line Items]    
Amortized Cost 4,961  
Gross Unrealized Gain 2  
Gross Unrealized Loss 0  
Fair Value 4,963  
Corporate debt securities    
Schedule of Held-to-maturity Securities [Line Items]    
Gross Unrealized Loss (2)  
Fair Value $ 4,700  
Held-to-maturity debt securities held | securities 6  
XML 21 R30.htm IDEA: XBRL DOCUMENT v3.2.0.727
Stock-Based Compensation (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Allocated stock-based compensation expense $ 2,408 $ 2,140 $ 4,619 $ 3,753
Cost of goods sold        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Allocated stock-based compensation expense 226 197 474 404
Research and development        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Allocated stock-based compensation expense 258 185 486 335
Clinical and regulatory affairs        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Allocated stock-based compensation expense 243 365 428 262
Marketing and sales        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Allocated stock-based compensation expense 839 645 1,587 1,194
General and administrative        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Allocated stock-based compensation expense 842 748 1,644 1,558
Total operating expenses        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Allocated stock-based compensation expense $ 2,182 $ 1,943 $ 4,145 $ 3,349
XML 22 R31.htm IDEA: XBRL DOCUMENT v3.2.0.727
Net Loss Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Dec. 31, 2014
Dec. 10, 2013
Earnings Per Share, Basic and Diluted [Abstract]            
Net loss $ (13,001) $ (8,993) $ (24,215) $ (3,698)    
Shares used in computing basic and diluted net loss per share 67,615 62,699 67,441 62,403    
Basic and diluted net loss per share $ (0.19) $ (0.14) $ (0.36) $ (0.06)    
Securities Excluded from Calculations of Earnings Per Share Because Impact Would Have Been Anti-Dilutive [Abstract]            
Outstanding securities used in calculations 2,220 2,376 2,206 2,541    
Convertible notes $ 72,156   $ 72,156   $ 70,407  
Potential Dilutive Effect of Securities [Abstract]            
Conversion of the Notes 3,588 3,588 3,588 3,588    
Convertible Debt            
Securities Excluded from Calculations of Earnings Per Share Because Impact Would Have Been Anti-Dilutive [Abstract]            
Convertible notes           $ 86,300
Stated interest rate         2.25%  
Common stock options            
Securities Excluded from Calculations of Earnings Per Share Because Impact Would Have Been Anti-Dilutive [Abstract]            
Outstanding securities used in calculations 1,812 1,813 1,812 1,917    
Restricted stock awards            
Securities Excluded from Calculations of Earnings Per Share Because Impact Would Have Been Anti-Dilutive [Abstract]            
Outstanding securities used in calculations 139 420 137 422    
Restricted stock units            
Securities Excluded from Calculations of Earnings Per Share Because Impact Would Have Been Anti-Dilutive [Abstract]            
Outstanding securities used in calculations 269 143 257 202    
XML 23 R8.htm IDEA: XBRL DOCUMENT v3.2.0.727
Balance Sheet Account Detail
 6 Months Ended
Jun. 30, 2015
Balance Sheet Related Disclosures [Abstract]  
Balance Sheet Account Detail
Balance Sheet Account Detail

(a) Property and Equipment

Property and equipment consisted of the following:
 
June 30,
2015
 
December 31,
2014
Production equipment, molds, and office furniture
$
14,054

 
$
12,943

Computer hardware and software
7,075

 
6,457

Leasehold improvements
16,368

 
15,729

Construction in progress (software and related implementation, production equipment, and leasehold improvements)
573

 
2,564

Property and equipment, at cost
$
38,070

 
$
37,693

Accumulated depreciation
(13,262
)
 
(11,997
)
Property and equipment, net
$
24,808

 
$
25,696



Depreciation expense for property and equipment for the three months ended June 30, 2015 and 2014 was $1.1 million and $0.5 million, respectively. For the six months ended June 30, 2015 and 2014 depreciation expense for property and equipment was $2.2 million and $1.0 million, respectively.

(b) Inventories

Inventories consisted of the following:
 
June 30,
2015
 
December 31,
2014
Raw materials
$
5,973

 
$
6,728

Work-in-process
8,883

 
5,946

Finished goods
15,732

 
18,651

Total Inventories
$
30,588

 
$
31,325



(c) Goodwill and Intangible Assets

The following table presents goodwill, indefinite lived intangible assets, finite lived intangible assets and related accumulated amortization: 

June 30,
2015

December 31,
2014
Goodwill (1)
$
28,709


$
28,866







Intangible assets:





Indefinite lived intangibles





Trademarks and trade names
$
2,708


$
2,708







Finite lived intangibles





Developed technology (2)
$
40,100


$
40,100

Accumulated amortization
(454
)

(285
)
Developed technology, net
$
39,646


$
39,815







License
$
100


$
100

Accumulated amortization
(85
)

(71
)
License, net
$
15


$
29







Customer relationships (1)
$
438


$
480

Accumulated amortization (1)
(438
)

(400
)
Customer relationships, net
$
—


$
80







Acquired Shonin approval (3)
$
1,000


$
1,000

Accumulated amortization
(667
)

(167
)
Acquired Shonin approval, net
$
333


$
833

 
 
 
 
Intangible assets (excluding goodwill), net
$
42,702


$
43,465

(1) Difference in the value between these dates is solely due to a foreign currency translation adjustment.
(2) Was reclassified in the first quarter of 2013 from in-process research and development to finite lived intangibles, which coincided with the European commercial launch of the product (Nellix EVAS System) associated with this intangible asset. A significant portion of this intangible asset will not begin amortization until the U.S. launch of this product, currently scheduled for 2016.
(3) Regulatory approval for Intuitrak in Japan acquired through an amendment with a distributor in the fourth quarter of 2014.
Amortization expense for intangible assets for the three months ended June 30, 2015 and 2014 was $0.4 million and $0.1 million, respectively. For the six months ended June 30, 2015 and 2014 amortization expense for intangible assets was $0.8 million and $0.2 million, respectively.
Estimated amortization expense for the five succeeding years and thereafter (which includes amortization of intangible assets which commenced in February 2013 with the commercial launch of the Nellix System in Europe) is as follows:
Remainder of 2015
$
517

2016
949

2017
2,213

2018
3,693

2019
4,750

2020
5,416

2021 & Thereafter
22,456

Total
$
39,994


(d) Marketable securities

Investments in held-to-maturity marketable securities consist of the following at June 30, 2015 and December 31, 2014:


June 30, 2015

Amortized
Cost

Gross
Unrealized
Gain
 
Gross
Unrealized
Loss
 
Fair Value
Asset backed securities
$
857


$
—


$
—


$
857

Agency bonds
3,000


—


—


3,000

Corporate bonds
2,658


—


(1
)

2,657

Commercial paper
22,781


5


(1
)

22,785

Government securities
4,961


2


—


4,963

Total
$
34,257


$
7


$
(2
)

$
34,262










December 31, 2014

Amortized
Cost

Gross
Unrealized
Gain
 
Gross
Unrealized
Loss
 
Fair Value
Asset backed securities
$
3,633


$
—


$
—


$
3,633

Corporate bonds
15,707


—


(8
)

15,699

Commercial paper
40,531


5


—


40,536

Total
$
59,871


$
5


$
(8
)

$
59,868



At June 30, 2015, the Company’s investments included 6 held-to-maturity debt securities in unrealized loss positions with a total unrealized loss of approximately $2 thousand and a total fair market value of approximately $4.7 million. All investments with gross unrealized losses have been in unrealized loss positions for less than 4 months. The unrealized losses were caused by interest rate fluctuations. There was no change in the credit risk of the securities. The Company does not intend to sell the securities and it is not likely that the Company will be required to sell the securities before the expected recovery of their amortized cost bases. There were no realized gains or losses on the investments for the three and six months ended June 30, 2015. All of the Company's investments of held-to-maturity securities will mature within less than 12 months with an average maturity of 3 months.

(e) Fair Value Measurements

The following fair value hierarchy table presents information about each major category of the Company’s assets and liabilities measured at fair value on a recurring basis as of June 30, 2015 and December 31, 2014:

 Fair value measurement at reporting date using:
 
Quoted prices in
active markets for
identical assets
(Level 1)

Significant other
observable
inputs
(Level 2)

Significant
unobservable
inputs
(Level 3)

Total
At June 30, 2015











Cash and cash equivalents
$
36,269


$
—


$
—


$
36,269

Contingently issuable common stock
$
—


$
—


$
14,800


$
14,800

At December 31, 2014











Cash and cash equivalents
$
26,798


$
—


$
—


$
26,798

Contingently issuable common stock
$
—


$
—


$
14,600


$
14,600



There were no re-measurements to fair value during the three months ended June 30, 2015 of financial assets and liabilities that are not measured at fair value on a recurring basis. There were no transfers between Level 1, Level 2 or Level 3 securities during the three months ended June 30, 2015.

(f) Financial Instruments Not Recorded at Fair Value on a Recurring Basis

We measure the fair value of our 2.25% Convertible Senior Notes due 2018 ("Senior Notes") carried at amortized cost quarterly for disclosure purposes. The estimated fair value of the Senior Notes is determined by Level 2 inputs and is based primarily on quoted market prices for the same or similar issues. Based on the market prices, the fair value of our long-term debt was $82.8 million as of June 30, 2015 and $84.5 million as of December 31, 2014.

We measure the fair value of our held-to-maturity marketable securities carried at amortized cost quarterly for disclosure purposes. The fair value of marketable securities is determined by Level 2 inputs and is based primarily on quoted market prices for the same or similar instruments.
XML 24 R32.htm IDEA: XBRL DOCUMENT v3.2.0.727
Credit Facilities (Details)
 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Dec. 10, 2013
USD ($)
$ / shares
$ / securities
Dec. 03, 2013
USD ($)
Jun. 30, 2015
USD ($)
$ / shares
Mar. 31, 2015
USD ($)
Jun. 30, 2015
USD ($)
d
$ / shares
Sep. 30, 2015
USD ($)
Dec. 31, 2015
USD ($)
Dec. 31, 2014
USD ($)
Line of Credit Facility [Line Items]                
Convertible notes     $ 72,156,000   $ 72,156,000     $ 70,407,000
Deferred finance costs, noncurrent, net     2,200,000   2,200,000      
Payments of derivative issuance costs $ 7,400,000              
Revolving Credit Facility | Wells Fargo Bank                
Line of Credit Facility [Line Items]                
Aggregate maximum borrowing capacity   $ 20,000,000            
Minimum current ratio   2.0            
Revolving Credit Facility | Wells Fargo Bank | Measurement Period One                
Line of Credit Facility [Line Items]                
Maximum operating loss       $ 13,500,000        
Revolving Credit Facility | Wells Fargo Bank | Measurement Period Two                
Line of Credit Facility [Line Items]                
Maximum operating loss         23,000,000      
Revolving Credit Facility | Bank of America                
Line of Credit Facility [Line Items]                
Aggregate maximum borrowing capacity     $ 20,000,000   20,000,000      
Minimum current ratio     1.5          
Letter of Credit | Wells Fargo Bank                
Line of Credit Facility [Line Items]                
Aggregate maximum borrowing capacity   $ 7,500,000.0            
Letter of Credit | Bank of America                
Line of Credit Facility [Line Items]                
Aggregate maximum borrowing capacity     $ 10,000,000   $ 10,000,000      
Convertible Senior Notes Issued December, 2013 | Convertible Debt                
Line of Credit Facility [Line Items]                
Debt instrument face amount 86,250,000              
Proceeds from convertible debt $ 82,600,000              
Conversion of convertible securities         41.6051      
Redemption price percentage         100.00%      
Violation or event of default, declaration by note holders, percentage         25.00%      
Fair value disclosure     66,900,000   $ 66,900,000      
Beneficial conversion feature         19,300,000      
Unamortized discount     $ 3,700,000   $ 3,700,000      
Convertible conversion price | $ / shares $ 24.04   $ 24.04   $ 24.04      
Cap price | $ / securities 29.02              
Redemption, Period One | Convertible Senior Notes Issued December, 2013 | Convertible Debt                
Line of Credit Facility [Line Items]                
Threshold trading days | d         20      
Threshold consecutive trading days         30 days      
Threshold percentage of stock price trigger         130.00%      
Redemption price percentage         100.00%      
Redemption, Period Two | Convertible Senior Notes Issued December, 2013 | Convertible Debt                
Line of Credit Facility [Line Items]                
Threshold trading days | d         20      
Threshold consecutive trading days         30 days      
Threshold percentage of stock price trigger         98.00%      
Threshold business days | d         5      
Threshold consecutive business days         5 years      
Other Assets | Convertible Senior Notes Issued December, 2013 | Convertible Debt                
Line of Credit Facility [Line Items]                
Unamortized discount     $ 2,900,000   $ 2,900,000      
Additional Paid-in Capital | Convertible Senior Notes Issued December, 2013 | Convertible Debt                
Line of Credit Facility [Line Items]                
Unamortized discount     800,000   $ 800,000      
Minimum | Revolving Credit Facility | Bank of America                
Line of Credit Facility [Line Items]                
Credit Derivative, Liquidation Proceeds, Monetary Amount     $ 30,000,000          
Forecast | Revolving Credit Facility | Wells Fargo Bank | Measurement Period Three                
Line of Credit Facility [Line Items]                
Maximum operating loss           $ 35,000,000    
Maximum annual capital expenditures             $ 6,000,000  
Forecast | Revolving Credit Facility | Wells Fargo Bank | Measurement Period Four                
Line of Credit Facility [Line Items]                
Maximum annual capital expenditures             3,000,000  
Forecast | Minimum | Convertible Senior Notes Issued December, 2013 | Convertible Debt                
Line of Credit Facility [Line Items]                
Periodic interest payment             5,700,000  
Forecast | Maximum | Convertible Senior Notes Issued December, 2013 | Convertible Debt                
Line of Credit Facility [Line Items]                
Periodic interest payment             $ 6,900,000  
Fair Value, Measurements, Recurring | Significant other observable inputs (Level 2) | 2.25 % Convertible Senior Notes due 2018 | Convertible Debt                
Line of Credit Facility [Line Items]                
Stated interest rate     2.25%   2.25%      
XML 25 R2.htm IDEA: XBRL DOCUMENT v3.2.0.727
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2015
Dec. 31, 2014
Current assets:    
Cash and cash equivalents $ 36,269 $ 26,798
Marketable securities 34,257 59,871
Accounts receivable, net allowance for doubtful accounts of $181 and $185, respectively. 29,138 26,113
Other receivables 121 498
Inventories 30,588 31,325
Prepaid expenses and other current assets 2,592 3,162
Total current assets 132,965 147,767
Property and equipment, net 24,808 25,696
Goodwill [1] 28,709 28,866
Intangibles, net 42,702 43,465
Deposits and other assets 2,138 2,415
Total assets 231,322 248,209
Current liabilities:    
Accounts payable 11,760 11,027
Accrued payroll 11,469 13,337
Accrued expenses and other current liabilities 4,979 5,260
Total current liabilities 28,208 29,624
Deferred income tax 879 879
Deferred rent 8,078 8,060
Other liabilities 349 489
Contingently issuable common stock 14,800 14,600
Convertible notes 72,156 70,407
Total liabilities $ 124,470 $ 124,059
Commitments and contingencies    
Stockholders’ equity:    
Convertible preferred stock, $0.001 par value; 5,000,000 shares authorized. No shares issued and outstanding. $ 0 $ 0
Common stock, $0.001 par value; 100,000,000 shares authorized. 67,947,684 and 67,321,769 shares issued, respectively. 67,767,730 and 67,159,511 shares outstanding, respectively. 68 67
Treasury stock, at cost, 179,954 and 162,258 shares, respectively. (2,619) (2,328)
Additional paid-in capital 381,516 372,639
Accumulated deficit (272,715) (248,500)
Accumulated other comprehensive income 602 2,272
Total stockholders’ equity 106,852 124,150
Total liabilities and stockholders’ equity $ 231,322 $ 248,209
[1] Difference in the value between these dates is solely due to a foreign currency translation adjustment.
XML 26 R6.htm IDEA: XBRL DOCUMENT v3.2.0.727
Description of Business, Basis of Presentation, and Operating Segment
 6 Months Ended
Jun. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Description of Business, Basis of Presentation, and Operating Segment
Description of Business, Basis of Presentation, and Operating Segment

(a) Description of Business

Endologix, Inc. (the "Company") is a Delaware corporation with corporate headquarters and production facilities located in Irvine, California. The Company develops, manufactures, markets, and sells innovative medical devices for the treatment of aortic disorders. The Company's products are intended for the minimally invasive endovascular treatment of abdominal aortic aneurysms ("AAA"). The Company's AAA products are built on one of two platforms: (1) traditional minimally-invasive endovascular repair ("EVAR") or (2) endovascular sealing (“EVAS”), the Company's innovative solution for sealing the aneurysm sac while maintaining blood flow through two blood flow lumens. The Company's current EVAR products include the Endologix AFX Endovascular AAA System (“AFX”), the VELA Proximal Endograft (“VELA”) and the Endologix Intuitrak Endovascular AAA System (“Intuitrak”). The Company's current EVAS product is the Nellix Endovascular Aneurysm Sealing System (“Nellix EVAS System”). Sales of the Company's EVAR and EVAS platforms (including extensions and accessories) to hospitals in the U.S. and Europe, and to third-party international distributors, provide the sole source of the Company's reported revenue.
The Company's EVAR products consist of (i) a cobalt chromium alloy stent covered by polytetrafluoroethylene (commonly referred to as "ePTFE") graft material (“Stent Graft”) and (ii) an accompanying delivery system. Once fixed in its proper position within the abdominal aorta, the Company's EVAR device provides a conduit for blood flow, thereby relieving pressure within the weakened or “aneurysmal” section of the vessel wall, which greatly reduces the potential for the AAA to rupture.
The Company's EVAS product consists of (i) bilateral covered stents with endobags, (ii) a biocompatible polymer injected into the endobags to seal the aneurysm and (iii) a delivery system and polymer dispenser. The Company's EVAS product seals the entire aneurysm sac effectively excluding the aneurysm sac reducing the likelihood of future aneurysm rupture. Additionally, it has the potential to reduce post procedural re-interventions.
(b) Basis of Presentation

The accompanying Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") and the rules and regulations of the U.S. Securities and Exchange Commission ("SEC"). These financial statements include the financial position, results of operations, and cash flows of the Company, including its subsidiaries, all of which are wholly-owned. All inter-company accounts and transactions have been eliminated in consolidation. For the three and six months ended June 30, 2015 and 2014, there were no related party transactions.

The interim financial data as of June 30, 2015 is unaudited and is not necessarily indicative of the results for a full year. In the opinion of the Company's management, the interim data includes normal and recurring adjustments necessary for a fair presentation of the Company's financial results for the three and six months ended June 30, 2015. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to SEC rules and regulations relating to interim financial statements.

The accompanying Condensed Consolidated Financial Statements should be read in conjunction with the Company's audited Consolidated Financial Statements and Notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2014, filed with the SEC on March 2, 2015.

On May 28, 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU ") No. 2014-09, "Revenue from Contracts with Customers", which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. The FASB agreed to a one-year deferral of the revenue recognition standard's effective date for all entities. The new standard is effective for the Company on January 1, 2018. The standard permits the use of either the retrospective or cumulative effect transition method. Early application is permitted, but not before the original effective date, which would have been January 1, 2017 for the Company. The Company is evaluating the effect that ASU 2014-09 will have on its consolidated financial statements and related disclosures. The Company has not yet selected a transition method nor has it determined the effect of the standard on its ongoing financial reporting.

On April 7, 2015, the FASB issued ASU No. 2015-03, "Simplifying the Presentation of Debt Issuance Costs", which requires debt issuance costs related to a recognized debt liability to be presented on the balance sheet as a direct deduction from the debt liability, similar to the presentation of debt discounts. The ASU is effective for the Company on January 1, 2016. Early adoption is permitted. The Company is evaluating the effect that ASU 2015-03 will have on its consolidated financial statements and related disclosures.

On July 22, 2015, the FASB issued ASU No. 2015-11, “Simplifying the Measurement of Inventory,” which requires an entity to measure inventory within the scope of the amendment at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. The guidance is effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years. The Company is currently assessing the impact this guidance will have on its consolidated financial statements.
  
(c) Operating Segment

The Company has one operating and reporting segment that is focused exclusively on the development, manufacture, marketing, and sale of EVAR and EVAS product for the treatment of aortic disorders. For the three and six months ended June 30, 2015, all of the Company's revenue and related expenses were solely attributable to these activities. Substantially all of the Company's long-lived assets are located in the U.S.
XML 27 R35.htm IDEA: XBRL DOCUMENT v3.2.0.727
Contingently Issuable Common Stock (Details) - USD ($)
$ / shares in Units, $ in Thousands, shares in Millions
 3 Months Ended 6 Months Ended
Jun. 17, 2014
Dec. 10, 2010
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Jun. 16, 2014
Fair Value of Contingently Issuable Common Stock [Roll Forward]              
December 31, 2014         $ 14,600    
Fair Value Adjustment of Contingent Payment for the six months ended June 30, 2015     $ 100 $ 3,772 200 $ (8,028)  
June 30, 2015     $ 14,800   14,800    
Nelix Milestones              
Business Acquisition [Line Items]              
Number of shares contingently issuable   10.2          
Estimated fair value of contingent payment   $ 28,200          
OUS Milestone              
Business Acquisition [Line Items]              
Purchase price common shares 2.7            
OUS Milestone | Common Stock              
Business Acquisition [Line Items]              
Contingent consideration, liability, value, low         $ 10,000    
Contingent consideration, liability, shares, low         1.3    
Contingent consideration, liability, value, high         $ 24,000    
Contingent consideration, liability, shares, high         6.9    
OUS Milestone | Common Stock | Minimum              
Business Acquisition [Line Items]              
Share price             $ 3.50
OUS Milestone | Common Stock | Maximum              
Business Acquisition [Line Items]              
Share price             $ 7.50
PMA Milestone              
Business Acquisition [Line Items]              
Common shares value   $ 15,000          
Number of shares contingently issuable         0.9    
Closing stock price     $ 15.34   $ 15.34    
Contingent consideration, at fair value hypothetical value     $ 13,800   $ 13,800    
PMA Milestone | Maximum              
Business Acquisition [Line Items]              
Share price   $ 4.50          
Nellix              
Business Acquisition [Line Items]              
Purchase price common shares   3.2          
Common shares value   $ 19,400          
XML 28 R22.htm IDEA: XBRL DOCUMENT v3.2.0.727
Contingently Issuable Common Stock (Tables)
 6 Months Ended
Jun. 30, 2015
Business Combinations [Abstract]  
Schedule of Business Acquisitions by Acquisition, Fair Value of Contingent Consideration
Adjustments to the fair value of the Contingent Payment are recognized within other income (expense) in the Condensed Consolidated Statements of Operations and Comprehensive Loss.
 
Fair Value of Contingently Issuable Common Stock
December 31, 2014
$
14,600

Fair Value Adjustment of Contingent Payment for the six months ended June 30, 2015
200

June 30, 2015
$
14,800
XML 29 R36.htm IDEA: XBRL DOCUMENT v3.2.0.727
Income Tax Expense (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Current Income Tax Expense (Benefit), Continuing Operations [Abstract]        
Income tax (expense) benefit $ (61) $ 80 $ (153) $ (136)
Effective income tax rate (0.50%)   (0.70%)  
Federal statutory income tax rate 34.00%   34.00%  
XML 30 R24.htm IDEA: XBRL DOCUMENT v3.2.0.727
Balance Sheet Account Detail (Property and Equipment) (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Dec. 31, 2014
Property, Plant and Equipment [Line Items]          
Property and equipment, at cost $ 38,070   $ 38,070   $ 37,693
Accumulated depreciation (13,262)   (13,262)   (11,997)
Property and equipment, net 24,808   24,808   25,696
Depreciation expense 1,100 $ 500 2,200 $ 1,000  
Production equipment, molds, and office furniture          
Property, Plant and Equipment [Line Items]          
Property and equipment, at cost 14,054   14,054   12,943
Computer hardware and software          
Property, Plant and Equipment [Line Items]          
Property and equipment, at cost 7,075   7,075   6,457
Leasehold improvements          
Property, Plant and Equipment [Line Items]          
Property and equipment, at cost 16,368   16,368   15,729
Construction in progress (software and related implementation, production equipment, and leasehold improvements)          
Property, Plant and Equipment [Line Items]          
Property and equipment, at cost $ 573   $ 573   $ 2,564
XML 31 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 32 R7.htm IDEA: XBRL DOCUMENT v3.2.0.727
Use of Estimates and Summary of Significant Accounting Policies
 6 Months Ended
Jun. 30, 2015
Accounting Policies [Abstract]  
Use of Estimates and Summary of Significant Accounting Policies
Use of Estimates and Summary of Significant Accounting Policies

The preparation of financial statements in conformity with GAAP requires the Company's management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenue and expenses, and related disclosure of contingent liabilities. On an on-going basis, the Company's management evaluates its estimates, including those related to (i) collectibility of customer accounts; (ii) whether the cost of inventories can be recovered; (iii) the value of goodwill and intangible assets; (iv) realization of tax assets and estimates of tax liabilities; (v) likelihood of payment and value of contingent liabilities; and (vi) potential outcome of litigation. Such estimates are based on management's judgment which takes into account historical experience and various assumptions. Nonetheless, actual results may differ from management's estimates.
For a complete summary of our significant accounting policies, please refer to Note 2, "Use of Estimates and Summary of Significant Accounting Policies", in Part II, Item 8, of our 2014 Annual Report on Form 10-K for the year ended December 31, 2014, filed March 2, 2015. There have been no material changes to our significant accounting policies during the three and six months ended June 30, 2015.
XML 33 R3.htm IDEA: XBRL DOCUMENT v3.2.0.727
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Jun. 30, 2015
Dec. 31, 2014
Allowance for doubtful accounts $ 181 $ 185
Common stock, par value (per share) $ 0.001 $ 0.001
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares issued 67,947,684 67,321,769
Common stock, shares outstanding 67,767,730 67,159,511
Treasury stock, shares 179,954,000 162,258,000
Convertible Preferred Stock    
Convertible preferred stock, par value (per share) $ 0.001 $ 0.001
Convertible preferred stock, shares authorized 5,000,000 5,000,000
Convertible preferred stock, shares issued 0 0
Convertible preferred stock, shares outstanding 0 0
XML 34 R17.htm IDEA: XBRL DOCUMENT v3.2.0.727
Balance Sheet Account Detail (Tables)
 6 Months Ended
Jun. 30, 2015
Balance Sheet Related Disclosures [Abstract]  
Property and Equipment
Property and equipment consisted of the following:
 
June 30,
2015
 
December 31,
2014
Production equipment, molds, and office furniture
$
14,054

 
$
12,943

Computer hardware and software
7,075

 
6,457

Leasehold improvements
16,368

 
15,729

Construction in progress (software and related implementation, production equipment, and leasehold improvements)
573

 
2,564

Property and equipment, at cost
$
38,070

 
$
37,693

Accumulated depreciation
(13,262
)
 
(11,997
)
Property and equipment, net
$
24,808

 
$
25,696
Schedule of Inventories
Inventories consisted of the following:
 
June 30,
2015
 
December 31,
2014
Raw materials
$
5,973

 
$
6,728

Work-in-process
8,883

 
5,946

Finished goods
15,732

 
18,651

Total Inventories
$
30,588

 
$
31,325
Schedule of Intangible Assets and Goodwill
The following table presents goodwill, indefinite lived intangible assets, finite lived intangible assets and related accumulated amortization: 

June 30,
2015

December 31,
2014
Goodwill (1)
$
28,709


$
28,866







Intangible assets:





Indefinite lived intangibles





Trademarks and trade names
$
2,708


$
2,708







Finite lived intangibles





Developed technology (2)
$
40,100


$
40,100

Accumulated amortization
(454
)

(285
)
Developed technology, net
$
39,646


$
39,815







License
$
100


$
100

Accumulated amortization
(85
)

(71
)
License, net
$
15


$
29







Customer relationships (1)
$
438


$
480

Accumulated amortization (1)
(438
)

(400
)
Customer relationships, net
$
—


$
80







Acquired Shonin approval (3)
$
1,000


$
1,000

Accumulated amortization
(667
)

(167
)
Acquired Shonin approval, net
$
333


$
833

 
 
 
 
Intangible assets (excluding goodwill), net
$
42,702


$
43,465

(1) Difference in the value between these dates is solely due to a foreign currency translation adjustment.
(2) Was reclassified in the first quarter of 2013 from in-process research and development to finite lived intangibles, which coincided with the European commercial launch of the product (Nellix EVAS System) associated with this intangible asset. A significant portion of this intangible asset will not begin amortization until the U.S. launch of this product, currently scheduled for 2016.
(3) Regulatory approval for Intuitrak in Japan acquired through an amendment with a distributor in the fourth quarter of 2014.
Schedule of Expected Amortization Expense
Estimated amortization expense for the five succeeding years and thereafter (which includes amortization of intangible assets which commenced in February 2013 with the commercial launch of the Nellix System in Europe) is as follows:
Remainder of 2015
$
517

2016
949

2017
2,213

2018
3,693

2019
4,750

2020
5,416

2021 & Thereafter
22,456

Total
$
39,994
Marketable Securities
Investments in held-to-maturity marketable securities consist of the following at June 30, 2015 and December 31, 2014:


June 30, 2015

Amortized
Cost

Gross
Unrealized
Gain
 
Gross
Unrealized
Loss
 
Fair Value
Asset backed securities
$
857


$
—


$
—


$
857

Agency bonds
3,000


—


—


3,000

Corporate bonds
2,658


—


(1
)

2,657

Commercial paper
22,781


5


(1
)

22,785

Government securities
4,961


2


—


4,963

Total
$
34,257


$
7


$
(2
)

$
34,262










December 31, 2014

Amortized
Cost

Gross
Unrealized
Gain
 
Gross
Unrealized
Loss
 
Fair Value
Asset backed securities
$
3,633


$
—


$
—


$
3,633

Corporate bonds
15,707


—


(8
)

15,699

Commercial paper
40,531


5


—


40,536

Total
$
59,871


$
5


$
(8
)

$
59,868
Fair Value Measurements, Recurring and Nonrecurring
The following fair value hierarchy table presents information about each major category of the Company’s assets and liabilities measured at fair value on a recurring basis as of June 30, 2015 and December 31, 2014:

 Fair value measurement at reporting date using:
 
Quoted prices in
active markets for
identical assets
(Level 1)

Significant other
observable
inputs
(Level 2)

Significant
unobservable
inputs
(Level 3)

Total
At June 30, 2015











Cash and cash equivalents
$
36,269


$
—


$
—


$
36,269

Contingently issuable common stock
$
—


$
—


$
14,800


$
14,800

At December 31, 2014











Cash and cash equivalents
$
26,798


$
—


$
—


$
26,798

Contingently issuable common stock
$
—


$
—


$
14,600


$
14,600
XML 35 R1.htm IDEA: XBRL DOCUMENT v3.2.0.727
Document and Entity Information - shares
 6 Months Ended
Jun. 30, 2015
Jul. 31, 2015
Document and Entity Information [Abstract]    
Entity Registrant Name ENDOLOGIX INC /DE/  
Entity Central Index Key 0001013606  
Document Type 10-Q  
Document Period End Date Jun. 30, 2015  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Filer Category Large Accelerated Filer  
Entity Common Stock, Shares Outstanding   67,781,092
Document Fiscal Year Focus 2015  
Document Fiscal Period Focus Q2  
XML 36 R18.htm IDEA: XBRL DOCUMENT v3.2.0.727
Stock-Based Compensation (Tables)
 6 Months Ended
Jun. 30, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs
Stock-based compensation expense included in cost of goods sold and operating expenses during the three and six months ended June 30, 2015 and 2014, was as follows:

Three Months Ended

Six Months Ended

June 30,

June 30,

2015

2014

2015

2014
Cost of goods sold
$
226


$
197


$
474


$
404

Operating expenses:











Research and development
258


185


486


335

Clinical and regulatory affairs
243


365


428


262

Marketing and sales
839


645


1,587


1,194

General and administrative
842


748


1,644


1,558

Total operating expenses
$
2,182


$
1,943


$
4,145


$
3,349

Total
$
2,408


$
2,140


$
4,619


$
3,753
XML 37 R4.htm IDEA: XBRL DOCUMENT v3.2.0.727
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Income Statement [Abstract]        
Revenue $ 39,479 $ 38,327 $ 76,149 $ 71,591
Cost of goods sold 15,347 9,820 25,111 18,789
Gross profit 24,132 28,507 51,038 52,802
Operating expenses:        
Research and development 5,993 4,458 12,224 8,563
Clinical and regulatory affairs 3,597 2,722 7,047 4,922
Marketing and sales 19,842 19,167 39,441 35,311
General and administrative 6,850 5,932 14,139 13,094
Total operating expenses 36,282 32,279 72,851 61,890
Loss from operations (12,150) (3,772) (21,813) (9,088)
Other income (expense):        
Interest income 37 67 82 126
Interest expense (1,493) (1,448) (2,955) (2,839)
Other income (expense), net 766 (148) 824 211
Change in fair value of contingent consideration related to acquisition (100) (3,772) (200) 8,028
Total other income (expense) (790) (5,301) (2,249) 5,526
Net loss before income tax (expense) benefit (12,940) (9,073) (24,062) (3,562)
Income tax (expense) benefit (61) 80 (153) (136)
Net loss (13,001) (8,993) (24,215) (3,698)
Other comprehensive income (loss) foreign currency translation 84 68 (1,670) 23
Comprehensive loss $ (12,917) $ (8,925) $ (25,885) $ (3,675)
Basic and diluted net loss per share $ (0.19) $ (0.14) $ (0.36) $ (0.06)
Shares used in computing basic and diluted net loss per share 67,615 62,699 67,441 62,403
XML 38 R12.htm IDEA: XBRL DOCUMENT v3.2.0.727
Revenue by Geographic Region
 6 Months Ended
Jun. 30, 2015
Geographic Areas, Revenues from External Customers [Abstract]  
Revenue by Geographic Region
Revenue by Geographic Region
The Company's revenue by geographic region, was as follows:

Three Months Ended

Six Months Ended
 
June 30,

June 30,
 
2015

2014

2015

2014
United States
$
28,776


72.9%

$
27,992


73.0%

$
53,910


70.8%

$
51,980


72.6%




















Europe
$
7,888


20.0%

$
7,816


20.4%

$
15,134


19.9%

$
14,401


20.1%




















Rest of World ("ROW"):



















Latin America
$
1,221


3.1%

$
1,309


3.4%

$
3,260


4.3%

$
2,226


3.1%
Asia/Pacific
1,594


4.0%

1,210


3.2%

3,845


5.0%

2,984


4.2%
Total ROW
$
2,815


7.1%

$
2,519


6.6%

$
7,105


9.3%

$
5,210


7.3%



















Revenue
$
39,479


100.0%

$
38,327


100.0%

$
76,149


100.0%

$
71,591


100.0%
XML 39 R11.htm IDEA: XBRL DOCUMENT v3.2.0.727
Credit Facilities
 6 Months Ended
Jun. 30, 2015
Line of Credit Facility [Abstract]  
Credit Facilities
Credit Facilities

2.25% Convertible Senior Notes

On December 10, 2013, the Company issued $86.3 million aggregate principal amount 2.25% Convertible Senior Notes (the “Senior Notes”). The Senior Notes mature on December 15, 2018 unless earlier repurchased by the Company or converted. The Company received net proceeds of the Notes of approximately $82.6 million from the sale of the Senior Notes, after deducting underwriting discounts and commissions and offering expenses payable by the Company. Interest is payable on the Senior Notes on June 15 and December 15 of each year, beginning June 15, 2014.

The Senior Notes are governed by the terms of a base indenture (the “Base Indenture”), as supplemented by the first supplemental indenture relating to the Senior Notes (the “First Supplemental Indenture,” and together with the Base Indenture, the “Indenture”), between the Company and Wells Fargo Bank, National Association (the “Trustee”), each of which were entered into on December 10, 2013.

The Senior Notes are senior unsecured obligations and are (a) senior in right of payment to the Company’s future indebtedness that is expressly subordinated in right of payment to the Senior Notes; (b) equal in right of payment to the Company’s existing and future unsecured indebtedness that is not so subordinated; (c) effectively junior to any of the Company’s secured indebtedness to the extent of the value of the assets securing such indebtedness; (d) and structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company’s subsidiaries.

The Company may not redeem the Senior Notes prior to December 15, 2016. On or after December 15, 2016, the Company may redeem for cash all or any portion of the Senior Notes, at its option, but only if the closing sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period ending on, and including, the second trading day immediately preceding the date on which the Company provides notice of redemption, exceeds 130% of the conversion price on each applicable trading day. The redemption price will equal 100% of the principal amount of the Senior Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. No sinking fund is provided for the Senior Notes.

Holders may convert their Senior Notes at any time prior to the close of business on the business day immediately preceding September 15, 2018 only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on March 31, 2014, if the closing sale price of the Company’s common stock, for at least 20 trading days (whether or not consecutive) in the period of 30 consecutive trading days ending on the last trading day of the calendar quarter immediately preceding the calendar quarter in which the conversion occurs, is more than 130% of the conversion price of the Senior Notes in effect on each applicable trading day; (2) during the five consecutive business-day period following any five consecutive trading-day period in which the trading price for the Senior Notes for each such trading day was less than 98% of the closing sale price of the Company’s common stock on such date multiplied by the then-current conversion rate; (3) if the Company calls all or any portion of the notes for redemption, at any time prior to the close of business on the second scheduled trading day prior to the redemption date; or (4) upon the occurrence of specified corporate events. On or after September 15, 2018 until the close of business on the second scheduled trading day immediately preceding the stated maturity date, holders may surrender their Senior Notes for conversion at any time, regardless of the foregoing circumstances.

Upon conversion, the Company will, at its election, pay or deliver, as the case may be, cash, shares of the Company’s common stock or a combination of cash and shares of the Company’s common stock.

The initial conversion rate of the Senior Notes will be 41.6051 shares of the Company’s common stock for each $1,000 principal amount of Senior Notes, which represents an initial conversion price of approximately $24.04 per share. Following certain corporate transactions that occur on or prior to the stated maturity date or the Company’s delivery of a notice of redemption, the Company will increase the conversion rate for a holder that elects to convert its Senior Notes in connection with such a corporate transaction.

If a fundamental change (as defined in the Indenture) occurs prior to the stated maturity date, holders may require the Company to purchase for cash all or any portion of their Senior Notes at a fundamental change purchase price equal to 100% of the principal amount of the Senior Notes to be purchased, plus accrued and unpaid interest to, but excluding, the fundamental change purchase date.
The Indenture contains customary terms and covenants and events of default with respect to the Senior Notes. If an event of default (as defined in the Indenture) occurs and is continuing, either the Trustee or the holders of at least 25% in aggregate principal amount of the outstanding Senior Notes may declare the principal amount of the Senior Notes to be due and payable immediately by notice to the Company (with a copy to the Trustee). If an event of default arising out of certain events of bankruptcy, insolvency or reorganization involving the Company or a significant subsidiary (as set forth in the Indenture) occurs with respect to us, the principal amount of the Senior Notes and accrued and unpaid interest, if any, will automatically become immediately due and payable.

The Company was not required to separate the conversion option in the Senior Notes under ASC 815, "Derivatives and Hedging", and has the ability to settle the Senior Notes in cash, common stock or a combination of cash and common stock, at its option. In accordance with cash conversion guidance contained in ASC 470-20, "Debt with Conversion and Other Options", the Company accounted for the Senior Notes by allocating the issuance proceeds between the liability and the equity component. The equity component is classified in stockholders’ equity and the resulting discount on the liability component is accreted such that interest expense equals the Company’s nonconvertible debt borrowing rate. The separation was performed by first determining the fair value of a similar debt that does not have an associated equity component. That amount was then deducted from the initial proceeds of the Senior Notes as a whole to arrive at a residual amount, which was allocated to the conversion feature that is classified as equity. The initial fair value of the indebtedness was $66.9 million resulting in a $19.3 million allocation to the embedded conversion option. The embedded conversion option was recorded in stockholders’ equity and as debt discount, to be subsequently accreted to interest expense over the term of the Senior Notes. Underwriting discounts and commissions and offering expenses totaled $3.7 million and were allocated between the liability and the equity component in proportion to the allocation of proceeds and accounted for as debt issuance costs and equity issuance costs, respectively. As a result, $2.9 million attributable to the indebtedness was recorded as deferred financing costs in other assets, to be subsequently amortized as interest expense over the term of the Senior Notes, and $0.8 million attributable to the equity component was recorded as a reduction to additional paid-in-capital in stockholders’ equity.

As of June 30, 2015, the Company had outstanding borrowings of $72.2 million, and deferred financing costs of $2.2 million, related to the Senior Notes. There are no principal payments due during the term. Annual interest expense on these notes will range from $5.7 million to $6.9 million through maturity.

Capped Call Transactions

On December 10, 2013, in connection with the pricing of the Senior Notes and the exercise in full of their overallotment option by the underwriters, the Company entered into privately-negotiated capped call transactions (the “Capped Call Transactions”) with Bank of America, N.A., an affiliate of Merrill Lynch, Pierce, Fenner & Smith Incorporated. The Capped Call Transactions initial conversion rate and number of options substantially corresponds to each $1,000 principal amount of Senior Notes. The Company used approximately $7.4 million of the net proceeds from the Senior Notes offering to pay for the cost of the Capped Call Transactions.

The Capped Call Transactions are separate transactions entered into by the Company with Bank of America, N.A., are not part of the terms of the Senior Notes and will not change the holders’ rights under the Senior Notes. The Capped Call Transactions have anti-dilution adjustments substantially similar to those applicable to the Senior Notes. The Capped Call Transactions are derivative instruments that are recorded within stockholders’ equity because they meet an exemption from mark-to-market derivative accounting.

The Capped Call Transactions are expected generally to reduce the potential dilution and/or offset potential cash payments that the Company is required to make in excess of the principal amount upon conversion of the Senior Notes in the event that the market price per share of the Company’s common stock, as measured under the terms of the Capped Call Transactions, is greater than the strike price of the Capped Call Transactions, which initially corresponds to the $24.04 conversion price of the Senior Notes. If, however, the market price per share of the Company’s common stock, as measured under the terms of the Capped Call Transactions, exceeds the initial cap price of $29.02, there would nevertheless be dilution and/or there would not be an offset of such potential cash payments, in each case, to the extent that such market price exceeds the cap price of the Capped Call Transactions.

The Company will not be required to make any cash payments to Bank of America, N.A. or any of its affiliates upon the exercise of the options that are a part of the Capped Call Transactions, but will be entitled to receive from Bank of America, N.A. (or an affiliate thereof) a number of shares of the Company’s common stock and/or an amount of cash generally based on the amount by which the market price per share of the Company’s common stock, as measured under the terms of the Capped Call Transactions, is greater than the strike price of the Capped Call Transactions during the relevant valuation period under the Capped Call Transactions. However, if the market price of the Company’s common stock, as measured under the terms of the Capped Call Transactions, exceeds the cap price of the Capped Call Transactions during such valuation period under the Capped Call Transactions, the number of shares of common stock and/or the amount of cash the Company expects to receive upon exercise of the Capped Call Transactions will be capped based on the amount by which the cap price exceeds the strike price of the Capped Call Transactions.

For any conversions of Senior Notes prior to the close of business on the 55th scheduled trading day immediately preceding the stated maturity date of the Senior Notes, including without limitation upon an acquisition of the Company or similar business combination, a corresponding portion of the Capped Call Transactions will be terminated. Upon such termination, the portion of the Capped Call Transactions being terminated will be settled at fair value (subject to certain limitations), as determined by Bank of America, N.A., in its capacity as calculation agent under the Capped Call Transactions, which the Company expects to receive from Bank of America, N.A., and no payments will be due Bank of America, N.A. The capped call expires on December 13, 2018.

Wells Fargo line of credit

In October 2009, the Company entered into a revolving credit facility with Wells Fargo Bank (“Wells”), which was last amended on February 3, 2015, whereby the Company may borrow up to $20.0 million, subject to the calculation and limitation of a borrowing base (the “Wells Credit Facility”). All amounts owing under the Wells Credit Facility will become due and payable upon its expiration on November 15, 2015. A sub-feature in the line of credit allows for the issuance of up to $7.5 million in letters of credit. As of June 30, 2015, the Company had no outstanding letters of credit issued. The Wells Credit Facility is collateralized by all of the Company's assets, except its intellectual property.

The Wells Credit Facility contains financial covenants requiring the Company to (i) maintain a minimum current ratio of 2.0 , equal to the quotient of modified current assets to current liabilities, as defined in the Wells Credit Facility (the "Current Ratio Covenant"), and (ii) not to exceed pre-tax net loss (excluding non-cash contingent consideration associated with the acquisition of Nellix) of $13.5 million for the three months ended March 31, 2015; $23.0 million for the six months ended June 30, 2015; and $35.0 million for the nine months ended September 30, 2015; (the "Net Loss Covenant").  The Wells Credit Facility also includes negative covenants limiting capital expenditures in 2015 to an aggregate of $6.0 million as well as limiting operating lease expenses to $3.0 million in any calendar year. As of June 30, 2015, the Company was not in compliance with the Net Loss Covenant. The financial covenants as of and for the three and six months ended June 30, 2015 are no longer applicable due to the termination of the Wells Credit Facility on July 21, 2015.

The Wells Credit Facility also contains a “material adverse change” clause (“MAC”). If the Company encounters difficulties that would qualify as a MAC in its (i) operations, (ii) condition (financial or otherwise), or (iii) ability to repay amounts outstanding under the Wells Credit Facility, it could be canceled at Wells' sole discretion. Wells could then elect to declare the indebtedness, together with accrued interest and other fees, to be immediately due and payable and proceed against any collateral securing such indebtedness. No borrowings were outstanding at June 30, 2015 and 2014. On July 21, 2015, the Company terminated the credit facility. As of the termination date, the Company had no outstanding borrowings or letters of credits issued under the Wells Credit Facility.

Bank of America line of credit

On July 21, 2015, the Company entered into a revolving credit facility with Bank of America, N.A. (“BOA”), whereby the Company may borrow up to $20.0 million (the “BOA Credit Facility”). All amounts owing under the BOA Credit Facility will become due and payable upon its expiration on July 21, 2017. A sub-feature in the line of credit allows for the issuance of up to $10.0 million in letters of credit. The BOA Credit Facility is collateralized by all of the Company's assets, except its intellectual property. The BOA Credit Facility can be terminated at any time during the two years by Company upon three business day notice. The BOA Credit Facility usage is priced at a spread over the one, two, three and six month LIBOR rates, and is subject to a covenants related to timely providing of publicly reported information, other indebtedness and a liquidity covenant tied to “Unencumbered Liquid Assets” ("ULA") - (as defined here) of not less than $30.0 million. ULA means the following assets (excluding assets of any retirement plan) which (i) are held in the United States at BOA and/or its affiliates, (ii) are not the subject of any lien, pledge, security interest or other arrangement with any creditor (other than BOA or one of BOA’s affiliates) to have his claim satisfied out of the asset (or proceeds thereof) prior to the general creditors of the owner of the asset, (iii) are held solely in the name of one or more credit parties subject to this covenant (with no other persons or entities having ownership rights therein), (iv) may be converted to cash within five (5) days, and (v) are not being counted or included to satisfy any other liquidity requirement under any other obligation, whether with BOA or any other lender, unless otherwise expressly agreed by BOA in writing: (a) cash and cash equivalents; (b) marketable securities invested in accordance with the Company’s investment policy and (c) marketable securities invested in accordance with any update to the Company’s investment policy so long as such update been approved by BOA in its reasonable discretion.
If not in default, the Company has the ability to reduce the ULA covenant requirement by reducing the BOA Credit Facility, with the ULA maintained at 1.5 times the BOA Credit Facility.
XML 40 R23.htm IDEA: XBRL DOCUMENT v3.2.0.727
Description of Business, Basis of Presentation, and Operating Segment (Details)
 6 Months Ended
Jun. 30, 2015
segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Number of operating segments 1
Number of reportable segments 1
XML 41 R19.htm IDEA: XBRL DOCUMENT v3.2.0.727
Net Loss Per Share (Tables)
 6 Months Ended
Jun. 30, 2015
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted

Three Months Ended

Six Months Ended

June 30,

June 30,

2015

2014

2015

2014
Net loss
$
(13,001
)

$
(8,993
)

$
(24,215
)

$
(3,698
)
Shares used in computing basic and diluted net loss per share
67,615


62,699


67,441


62,403

Basic and diluted net loss per share
$
(0.19
)

$
(0.14
)

$
(0.36
)

$
(0.06
)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following outstanding Company securities, using the treasury stock method, were excluded from the above calculations of net loss per share because their impact would have been anti-dilutive:

Three Months Ended

Six Months Ended

June 30,

June 30,

2015

2014

2015

2014
Common stock options
1,812


1,813


1,812


1,917

Restricted stock awards
139


420


137


422

Restricted stock units
269


143


257


202

  Total
2,220


2,376


2,206


2,541

As discussed in Note 6, in December 2013, the Company issued $86.3 million aggregate principal amount of 2.25% convertible senior notes due 2018 (the “Senior Notes”) in an underwritten public offering. Upon any conversion, the Senior Notes may be settled, at the Company’s election, in cash, shares of the Company’s common stock or a combination of cash and shares of the Company’s common stock. For purposes of calculating the maximum dilutive impact, it is presumed that the Senior Notes will be settled in common stock with the resulting potential common shares included in diluted earnings per share if the effect is more dilutive. The effect of the conversion of the Senior Notes is excluded from the calculation of diluted loss per share because the impact of these securities would be anti-dilutive. The potential dilutive effect of these securities is shown in the chart below:
 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
2015
 
2014
 
2015
 
2014
Conversion of the Notes
3,588

 
3,588

 
3,588

 
3,588
XML 42 R15.htm IDEA: XBRL DOCUMENT v3.2.0.727
Income Tax Expense
 6 Months Ended
Jun. 30, 2015
Current Income Tax Expense (Benefit), Continuing Operations [Abstract]  
Income Tax Expense
Income Tax Expense
The Company applied an estimated annual effective tax rate (“ETR”) approach for calculating a tax provision for interim periods. The Company recorded a provision for income taxes of $0.1 million and $0.2 million for the three and six months ended June 30, 2015, respectively. The Company's ETR was (0.5)% and (0.7)% for the three and six months ended June 30, 2015, respectively.  The Company's ETR for the three and six months ended June 30, 2015 differs from the U.S. federal statutory tax rate of 34% primarily as a result of nondeductible expenses (including the Nellix Contingent Payment), state income taxes, foreign income taxes, and the impact of a full valuation allowance on its deferred tax assets.

The Company has evaluated the available evidence supporting the realization of its deferred tax assets, including the amount and timing of future taxable income, and has determined that it is more likely than not that its net deferred tax assets will not be realized in the U.S. and certain foreign jurisdictions. Due to uncertainties surrounding the realization of the deferred tax assets, the Company maintains a full valuation allowance against substantially all deferred tax assets. If/when the Company determines that it will be able to realize some portion or all of its deferred tax assets, an adjustment to its valuation allowance on its deferred tax assets would have the effect of increasing net income in the period(s) such determination is made.
XML 43 R13.htm IDEA: XBRL DOCUMENT v3.2.0.727
Commitments and Contingencies
 6 Months Ended
Jun. 30, 2015
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
Commitments and Contingencies
(a) Leases
The Company leases its administrative, research, and manufacturing facilities located in Irvine, California and an administrative office located in Rosmalen, The Netherlands. These facility lease agreements require the Company to pay operating costs, including property taxes, insurance and maintenance. In addition, the Company has certain equipment under long-term agreements that are accounted for as operating leases.
Future minimum payments by year under non-cancelable leases with initial terms in excess of one year were as follows as of June 30, 2015:
Remainder of 2015
$
1,271

2016
2,363

2017
2,331

2018
2,258

2019
2,296

2020
2,388

2021 and thereafter
22,884

Total
$
35,791



Facilities rent expense for the three months ended June 30, 2015 and 2014 was $0.6 million and $0.7 million, respectively. For the six months ended June 30, 2015 and 2014 facilities rent expense was $1.2 million and $1.3 million, respectively.
 
On June 12, 2013, the Company entered into a lease agreement for two adjacent office, research and development, and manufacturing facilities in Irvine, California.  The premises consist of approximately 129,000 combined square feet. The lease has a 15-year term beginning January 1, 2014 and provides for one optional five year extension. The initial base rent under the lease is $1.9 million per year, payable in monthly installments, and escalates by 3% per year for years 2015 through 2019, and 4% per year for years 2020 and beyond.  The Company received a rent abatement for the first nine months of the lease. These premises replaced the Company's existing Irvine facilities. The terms of this lease agreement provide for $6.8 million of landlord-funded improvements (and certain other allowances) to this facility, in order to best suit the Company's requirements.
The Company leased two adjacent facilities aggregating approximately 57,000 square feet in Irvine, California, under separate lease agreements where manufacturing was held. The Company exited one of these leases in December 2014 and the other lease in April 2015. The Company's Rosmalen facility is an administrative office of approximately 2,900 square feet with lease expiration in December 2015 and renewal at its option.
(b) Employment Agreements and Retention Plan
On February 1, 2014, the Company entered into new employment agreements with certain of its executive officers under which payment and benefits would become payable in the event of termination by the Company for any reason other than cause, death or disability or termination by the employee for good reason (collectively, an “Involuntary Termination”) prior to, upon or following a change in control of the Company. The severance payment will generally be in a range of six to eighteen months of the employee’s then current salary for an Involuntary Termination prior to a change in control of the Company, and will generally be in a range of eighteen to twenty-four months of the employee’s then current salary for an Involuntary Termination upon or following a change in control of the Company.
(c) Legal Matters
We are from time to time involved in various claims and legal proceedings of a nature we believe are normal and incidental to a medical device business. These matters may include product liability, intellectual property, employment, and other general claims. Such cases and claims may raise complex factual and legal issues and are subject to many uncertainties, including, but not limited to, the facts and circumstances of each particular case or claim, the jurisdiction in which each suit is brought, and differences in applicable law. We accrue for contingent liabilities when it is probable that a liability has been incurred and the amount can be reasonably estimated. The accruals are adjusted periodically as assessments change or as additional information becomes available.

LifePort Sciences LLC v. Endologix, Inc.
On December 28, 2012, LifePort Sciences, LLC ("LifePort") filed a complaint against us in the U.S. District Court, District of Delaware, alleging that certain of our products infringe U.S. Patent Nos. 5,489,295, 6,117,167, 6,302,906, 5,993,481 and 5,676,696, which are alleged to be owned by LifePort. LifePort is seeking an unspecified amount of monetary damages for sale of our products and injunctive relief. We do not believe that we infringe on any of these patents and we intend to vigorously defend against this matter. The case is currently scheduled for trial in April 2016. We do believe, however, that the outcome will not have a material adverse effect on our financial position, results of operations, or cash flows. However, in order to avoid further legal costs and diversion of management resources, it is reasonably possible that we may reach a settlement with LifePort, which could result in a liability. However, we cannot presently estimate the amount, or range, of reasonably possible losses due to the nature of this potential litigation settlement.
XML 44 R14.htm IDEA: XBRL DOCUMENT v3.2.0.727
Contingently Issuable Common Stock
 6 Months Ended
Jun. 30, 2015
Business Combinations [Abstract]  
Contingently Issuable Common Stock
Contingently Issuable Common Stock
On October 27, 2010, the Company entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”) with Nepal Acquisition Corporation, a wholly-owned subsidiary of the Company (“Merger Sub”), Nellix, Inc. ("Nellix"), certain of Nellix’s stockholders named therein and Essex Woodlands Health Ventures, Inc., as representative of the former Nellix stockholders. On December 10, 2010 (the “Nellix Closing Date”), the Company completed the merger (the “Merger”) of Merger Sub with and into Nellix pursuant to the terms of the Merger Agreement. The purchase price consisted of 3.2 million shares of the Company's common stock, issuable to the former Nellix stockholders as of the Nellix Closing Date, then representing a value of $19.4 million. Under the agreement, additional payments, solely in the form of shares of the Company's common stock (the “Contingent Payment”), could be made upon the achievement of a revenue milestone and a regulatory approval milestone (collectively, the “Nellix Milestones”).
Under the merger agreement, the ultimate value of each Contingent Payment would be determined on the date that each Nellix Milestone is achieved. The number of issuable shares would be established using an applicable per share price, which is subject to a ceiling and/or floor, resulting at the closing of the merger in a potential maximum of 10.2 million shares issuable upon the achievement of the Nellix Milestones. As of the Closing Date, the aggregate fair value of the cash Contingent Payment was estimated to be $28.2 million.
The Merger Agreement provides that, in addition to the shares of common stock of the Company (the “Common Stock”) issued to the former Nellix stockholders at the closing of the Merger, the former Nellix stockholders were entitled to receive shares of the Common Stock if the Company’s sales of a Nellix product (the “Nellix Product”) outside of the United States exceeded $10.0 million within a certain time period following the Company’s receipt of CE mark approval for the Nellix Product (the “OUS Milestone”). The aggregate dollar value of the shares of the Common Stock to be issued upon achievement of the OUS Milestone ranged from a high of $24.0 million, or 6.9 million shares, to a low of $10.0 million, or 1.3 million shares. The price per share of the Common Stock to be issued upon achievement of the OUS Milestone was subject to a floor of $3.50 per share and a ceiling of $7.50 per share.
On June 17, 2014, the Company announced its achievement of the OUS Milestone and the issuance of an aggregate of 2.7 million unregistered shares of the Common Stock (the “OUS Milestone Shares”), plus an amount of cash in lieu of fractional shares, to the former Nellix stockholders. The Company offered and sold the OUS Milestone Shares in reliance upon exemptions from registration pursuant to Section 4(2) under the Securities Act of 1933, as amended (the “Securities Act”). The former Nellix stockholders previously gave representations to the Company regarding their investment intent, experience, financial sophistication, access to information regarding the Company and certain other matters to support the Company’s reasonable belief that it could rely upon the foregoing exemptions from registration pursuant to Section 4(2) of the Securities Act. No underwriting discounts or commissions were or will be paid in conjunction with the issuance of the OUS Milestone Shares. The Company previously filed a Registration Statement on Form S-3 (Registration No. 333-171639) (the “Form S-3”) for the purpose of registering for resale shares of the Common Stock issued or issuable pursuant to the Merger Agreement, including the OUS Milestone Shares. The Securities and Exchange Commission declared the Form S-3 effective on January 18, 2011.
In addition, if the Company receives approval from the FDA to sell the Nellix Product in the United States (the “PMA Milestone”), the Company will issue additional shares of the Common Stock to the former stockholders of Nellix. The dollar value of the shares of the Common Stock to be issued upon achievement of the PMA Milestone will be equal to $15.0 million (less the dollar value of certain cash payments and other deductions). The price per share of the shares of the Common Stock to be issued upon achievement of the PMA Milestone is subject to a stock price floor of $4.50 per share, but not subject to a stock price ceiling.
As of June 30, 2015 the Company's stock price last closed at $15.34 per share. Thus, had the PMA Milestone been achieved on June 30, 2015 the Contingent Payment would have comprised 0.9 million shares (based on the 30-day average closing stock price ending 5 days prior to the announcement), representing a value of $13.8 million.
The value of the Contingent Payment is derived using a discounted income approach model, with a range of probabilities and assumptions related to the timing and likelihood of achievement of the PMA Milestone (which include Level 3 inputs - see Note 3(e) and the Company's stock price (Level 1 input) as of the balance sheet date). These varying probabilities and assumptions and changes in the Company's stock price have required fair value adjustments of the Contingent Payment in periods subsequent to the Nellix Closing Date.
The Contingent Payment fair value will continue to be evaluated on a quarterly basis until milestone achievement occurs, or until the expiration of the "earn-out period," as defined within the Nellix purchase agreement. Adjustments to the fair value of the Contingent Payment are recognized within other income (expense) in the Condensed Consolidated Statements of Operations and Comprehensive Loss.
 
Fair Value of Contingently Issuable Common Stock
December 31, 2014
$
14,600

Fair Value Adjustment of Contingent Payment for the six months ended June 30, 2015
200

June 30, 2015
$
14,800
XML 45 R16.htm IDEA: XBRL DOCUMENT v3.2.0.727
Description of Business, Basis of Presentation, and Operating Segment (Policies)
 6 Months Ended
Jun. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation
Basis of Presentation

The accompanying Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") and the rules and regulations of the U.S. Securities and Exchange Commission ("SEC"). These financial statements include the financial position, results of operations, and cash flows of the Company, including its subsidiaries, all of which are wholly-owned. All inter-company accounts and transactions have been eliminated in consolidation. For the three and six months ended June 30, 2015 and 2014, there were no related party transactions.

The interim financial data as of June 30, 2015 is unaudited and is not necessarily indicative of the results for a full year. In the opinion of the Company's management, the interim data includes normal and recurring adjustments necessary for a fair presentation of the Company's financial results for the three and six months ended June 30, 2015. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to SEC rules and regulations relating to interim financial statements.

The accompanying Condensed Consolidated Financial Statements should be read in conjunction with the Company's audited Consolidated Financial Statements and Notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2014, filed with the SEC on March 2, 2015.
Operating segment
Operating Segment

The Company has one operating and reporting segment that is focused exclusively on the development, manufacture, marketing, and sale of EVAR and EVAS product for the treatment of aortic disorders. For the three and six months ended June 30, 2015, all of the Company's revenue and related expenses were solely attributable to these activities. Substantially all of the Company's long-lived assets are located in the U.S.
XML 46 R34.htm IDEA: XBRL DOCUMENT v3.2.0.727
Commitments and Contingencies (Details)
$ in Thousands
 1 Months Ended 3 Months Ended 6 Months Ended
Jun. 12, 2013
USD ($)
ft²
option
facility
Dec. 31, 2014
lease
Jun. 30, 2015
USD ($)
letters_of_credit
Jun. 30, 2014
USD ($)
Jun. 30, 2015
USD ($)
letters_of_credit
Jun. 30, 2014
USD ($)
Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]            
Remainder of 2015     $ 1,271   $ 1,271  
2016     2,363   2,363  
2017     2,331   2,331  
2018     2,258   2,258  
2019     2,296   2,296  
2020     2,388   2,388  
2021 and thereafter     22,884   22,884  
Total     35,791   35,791  
Rent expense     $ 600 $ 700 $ 1,200 $ 1,300
Number of facilities | facility 2          
Aggregate square feet | ft² 129,000          
Term of contract 15 years          
Number of renewal options | option 1          
Renewal term 5 years          
Initial base rent $ 1,900          
Landlord-funded improvements $ 6,800          
Number of letters of credit | letters_of_credit     2   2  
Number of leases exited | lease   1        
Operating Leases, Future Minimum Payments Due, Base Rent Increases [Abstract]            
2015 3.00%          
2016 3.00%          
2017 3.00%          
2018 3.00%          
2019 3.00%          
2020 and beyond 4.00%          
Manufacturing Facility            
Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]            
Aggregate square feet | ft² 57,000          
Building            
Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]            
Aggregate square feet | ft² 2,900          
XML 47 R21.htm IDEA: XBRL DOCUMENT v3.2.0.727
Commitments and Contingencies (Tables)
 6 Months Ended
Jun. 30, 2015
Commitments and Contingencies Disclosure [Abstract]  
Contractual Obligation, Fiscal Year Maturity Schedule
Future minimum payments by year under non-cancelable leases with initial terms in excess of one year were as follows as of June 30, 2015:
Remainder of 2015
$
1,271

2016
2,363

2017
2,331

2018
2,258

2019
2,296

2020
2,388

2021 and thereafter
22,884

Total
$
35,791
XML 48 R26.htm IDEA: XBRL DOCUMENT v3.2.0.727
Balance Sheet Account Detail (Goodwill and Intangible Assets) (Details) - USD ($)
$ in Thousands
Jun. 30, 2015
Dec. 31, 2014
Goodwill, Finite-lived, and Indefinite-lived Intangible Assets [Line Items]    
Goodwill [1] $ 28,709 $ 28,866
Total 39,994  
Intangible assets (excluding goodwill), net 42,702 43,465
Developed technology    
Goodwill, Finite-lived, and Indefinite-lived Intangible Assets [Line Items]    
Finite lived intangibles [2] 40,100 40,100
Accumulated amortization (454) (285)
Total 39,646 39,815
License    
Goodwill, Finite-lived, and Indefinite-lived Intangible Assets [Line Items]    
Finite lived intangibles 100 100
Accumulated amortization (85) (71)
Total 15 29
Customer relationships    
Goodwill, Finite-lived, and Indefinite-lived Intangible Assets [Line Items]    
Finite lived intangibles [1] 438 480
Accumulated amortization [1] (438) (400)
Total 0 80
Acquired Shonin approval    
Goodwill, Finite-lived, and Indefinite-lived Intangible Assets [Line Items]    
Finite lived intangibles [3] 1,000 1,000
Accumulated amortization (667) (167)
Total 333 833
Trademarks and trade names    
Goodwill, Finite-lived, and Indefinite-lived Intangible Assets [Line Items]    
Indefinite lived intangibles $ 2,708 $ 2,708
[1] Difference in the value between these dates is solely due to a foreign currency translation adjustment.
[2] Was reclassified in the first quarter of 2013 from in-process research and development to finite lived intangibles, which coincided with the European commercial launch of the product (Nellix EVAS System) associated with this intangible asset. A significant portion of this intangible asset will not begin amortization until the U.S. launch of this product, currently scheduled for 2016.
[3] Regulatory approval for Intuitrak in Japan acquired through an amendment with a distributor in the fourth quarter of 2014.
XML 49 R5.htm IDEA: XBRL DOCUMENT v3.2.0.727
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Cash flows from operating activities:    
Net loss $ (24,215) $ (3,698)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 2,933 1,213
Stock-based compensation 4,619 3,753
Change in fair value of contingent consideration related to acquisition 200 (8,028)
Accretion of interest on convertible note 1,749 1,622
Amortization of deferred financing costs 232 198
Non-cash foreign exchange gain (655) (212)
Changes in operating assets and liabilities:    
Accounts receivable and other receivables (3,195) (2,108)
Inventories 739 (8,793)
Prepaid expenses and other current assets 413 (1,283)
Accounts payable 2,692 3,855
Accrued payroll (1,689) 1,224
Accrued expenses and other liabilities (207) 2,097
Net cash used in operating activities (16,384) (10,160)
Cash flows from investing activities:    
Purchases of marketable securities (37,122) (74,114)
Maturities of marketable securities 62,690 25,585
Purchases of property and equipment (3,146) (5,743)
Net cash provided by (used in) investing activities 22,422 (54,272)
Cash flows from financing activities:    
Proceeds from sale of common stock under employee stock purchase plan 1,631 1,446
Proceeds from exercise of stock options 2,628 1,094
Minimum tax withholding paid on behalf of employees for restricted stock units (291) (1,395)
Net cash provided by financing activities 3,968 1,145
Effect of exchange rate changes on cash and cash equivalents (535) (22)
Net increase (decrease) in cash and cash equivalents 9,471 (63,309)
Cash and cash equivalents, beginning of period 26,798 95,152
Cash and cash equivalents, end of period 36,269 31,843
Supplemental disclosure of cash flow information:    
Cash paid for interest 973 1,045
Cash paid for income taxes 140 207
Non-cash investing and financing activities:    
Landlord funded leasehold improvements 46 3,870
Fair value of Nellix Milestone Shares (note 9) 0 38,372
Acquisition of property and equipment included in accounts payable $ 71 $ 1,403
XML 50 R10.htm IDEA: XBRL DOCUMENT v3.2.0.727
Net Loss Per Share
 6 Months Ended
Jun. 30, 2015
Earnings Per Share [Abstract]  
Net Loss Per Share
Net Loss Per Share
Net loss per share was calculated by dividing net loss by the weighted average number of common shares outstanding for the three and six months ended June 30, 2015 and 2014.

Three Months Ended

Six Months Ended

June 30,

June 30,

2015

2014

2015

2014
Net loss
$
(13,001
)

$
(8,993
)

$
(24,215
)

$
(3,698
)
Shares used in computing basic and diluted net loss per share
67,615


62,699


67,441


62,403

Basic and diluted net loss per share
$
(0.19
)

$
(0.14
)

$
(0.36
)

$
(0.06
)


The following outstanding Company securities, using the treasury stock method, were excluded from the above calculations of net loss per share because their impact would have been anti-dilutive:

Three Months Ended

Six Months Ended

June 30,

June 30,

2015

2014

2015

2014
Common stock options
1,812


1,813


1,812


1,917

Restricted stock awards
139


420


137


422

Restricted stock units
269


143


257


202

  Total
2,220


2,376


2,206


2,541

As discussed in Note 6, in December 2013, the Company issued $86.3 million aggregate principal amount of 2.25% convertible senior notes due 2018 (the “Senior Notes”) in an underwritten public offering. Upon any conversion, the Senior Notes may be settled, at the Company’s election, in cash, shares of the Company’s common stock or a combination of cash and shares of the Company’s common stock. For purposes of calculating the maximum dilutive impact, it is presumed that the Senior Notes will be settled in common stock with the resulting potential common shares included in diluted earnings per share if the effect is more dilutive. The effect of the conversion of the Senior Notes is excluded from the calculation of diluted loss per share because the impact of these securities would be anti-dilutive. The potential dilutive effect of these securities is shown in the chart below:
 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
2015
 
2014
 
2015
 
2014
Conversion of the Notes
3,588

 
3,588

 
3,588

 
3,588



The effect of the contingently issuable common stock is excluded from the calculation of basic net loss per share until all necessary conditions for issuance have been satisfied. Refer to Note 9 of the Notes to the Condensed Consolidated Financial Statements for further discussion.
XML 51 R27.htm IDEA: XBRL DOCUMENT v3.2.0.727
Balance Sheet Account Detail (Amortization) (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Balance Sheet Related Disclosures [Abstract]        
Amortization expense $ 400 $ 100 $ 800 $ 200
Remainder of 2015 517   517  
2016 949   949  
2017 2,213   2,213  
2018 3,693   3,693  
2019 4,750   4,750  
2020 5,416   5,416  
2021 & Thereafter 22,456   22,456  
Total $ 39,994   $ 39,994  
XML 52 FilingSummary.xml IDEA: XBRL DOCUMENT 3.2.0.727 html 151 218 1 true 64 0 false 13 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://www.endologix.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.endologix.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 1001501 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.endologix.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1002000 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss Sheet http://www.endologix.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss Condensed Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 1003000 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.endologix.com/role/CondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 5 false false R6.htm 2101100 - Disclosure - Description of Business, Basis of Presentation, and Operating Segment Sheet http://www.endologix.com/role/DescriptionOfBusinessBasisOfPresentationAndOperatingSegment Description of Business, Basis of Presentation, and Operating Segment Notes 6 false false R7.htm 2102100 - Disclosure - Use of Estimates and Summary of Significant Accounting Policies Sheet http://www.endologix.com/role/UseOfEstimatesAndSummaryOfSignificantAccountingPolicies Use of Estimates and Summary of Significant Accounting Policies Notes 7 false false R8.htm 2104100 - Disclosure - Balance Sheet Account Detail Sheet http://www.endologix.com/role/BalanceSheetAccountDetail Balance Sheet Account Detail Notes 8 false false R9.htm 2107100 - Disclosure - Stock-Based Compensation Sheet http://www.endologix.com/role/StockBasedCompensation Stock-Based Compensation Notes 9 false false R10.htm 2110100 - Disclosure - Net Loss Per Share Sheet http://www.endologix.com/role/NetLossPerShare Net Loss Per Share Notes 10 false false R11.htm 2113100 - Disclosure - Credit Facilities Sheet http://www.endologix.com/role/CreditFacilities Credit Facilities Notes 11 false false R12.htm 2119100 - Disclosure - Revenue by Geographic Region Sheet http://www.endologix.com/role/RevenueByGeographicRegion Revenue by Geographic Region Notes 12 false false R13.htm 2125100 - Disclosure - Commitments and Contingencies Sheet http://www.endologix.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 13 false false R14.htm 2126100 - Disclosure - Contingently Issuable Common Stock Sheet http://www.endologix.com/role/ContingentlyIssuableCommonStock Contingently Issuable Common Stock Notes 14 false false R15.htm 2128100 - Disclosure - Income Tax Expense Sheet http://www.endologix.com/role/IncomeTaxExpense Income Tax Expense Notes 15 false false R16.htm 2201201 - Disclosure - Description of Business, Basis of Presentation, and Operating Segment (Policies) Sheet http://www.endologix.com/role/DescriptionOfBusinessBasisOfPresentationAndOperatingSegmentPolicies Description of Business, Basis of Presentation, and Operating Segment (Policies) Policies http://www.endologix.com/role/UseOfEstimatesAndSummaryOfSignificantAccountingPolicies 16 false false R17.htm 2304301 - Disclosure - Balance Sheet Account Detail (Tables) Sheet http://www.endologix.com/role/BalanceSheetAccountDetailTables Balance Sheet Account Detail (Tables) Tables http://www.endologix.com/role/BalanceSheetAccountDetail 17 false false R18.htm 2307301 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.endologix.com/role/StockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.endologix.com/role/StockBasedCompensation 18 false false R19.htm 2310301 - Disclosure - Net Loss Per Share (Tables) Sheet http://www.endologix.com/role/NetLossPerShareTables Net Loss Per Share (Tables) Tables http://www.endologix.com/role/NetLossPerShare 19 false false R20.htm 2319301 - Disclosure - Revenue by Geographic Region (Tables) Sheet http://www.endologix.com/role/RevenueByGeographicRegionTables Revenue by Geographic Region (Tables) Tables http://www.endologix.com/role/RevenueByGeographicRegion 20 false false R21.htm 2325301 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.endologix.com/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://www.endologix.com/role/CommitmentsAndContingencies 21 false false R22.htm 2326301 - Disclosure - Contingently Issuable Common Stock (Tables) Sheet http://www.endologix.com/role/ContingentlyIssuableCommonStockTables Contingently Issuable Common Stock (Tables) Tables http://www.endologix.com/role/ContingentlyIssuableCommonStock 22 false false R23.htm 2401402 - Disclosure - Description of Business, Basis of Presentation, and Operating Segment (Details) Sheet http://www.endologix.com/role/DescriptionOfBusinessBasisOfPresentationAndOperatingSegmentDetails Description of Business, Basis of Presentation, and Operating Segment (Details) Details http://www.endologix.com/role/DescriptionOfBusinessBasisOfPresentationAndOperatingSegmentPolicies 23 false false R24.htm 2404402 - Disclosure - Balance Sheet Account Detail (Property and Equipment) (Details) Sheet http://www.endologix.com/role/BalanceSheetAccountDetailPropertyAndEquipmentDetails Balance Sheet Account Detail (Property and Equipment) (Details) Details http://www.endologix.com/role/BalanceSheetAccountDetailTables 24 false false R25.htm 2404403 - Disclosure - Balance Sheet Account Detail (Inventories) (Details) Sheet http://www.endologix.com/role/BalanceSheetAccountDetailInventoriesDetails Balance Sheet Account Detail (Inventories) (Details) Details http://www.endologix.com/role/BalanceSheetAccountDetailTables 25 false false R26.htm 2404404 - Disclosure - Balance Sheet Account Detail (Goodwill and Intangible Assets) (Details) Sheet http://www.endologix.com/role/BalanceSheetAccountDetailGoodwillAndIntangibleAssetsDetails Balance Sheet Account Detail (Goodwill and Intangible Assets) (Details) Details http://www.endologix.com/role/BalanceSheetAccountDetailTables 26 false false R27.htm 2404405 - Disclosure - Balance Sheet Account Detail (Amortization) (Details) Sheet http://www.endologix.com/role/BalanceSheetAccountDetailAmortizationDetails Balance Sheet Account Detail (Amortization) (Details) Details http://www.endologix.com/role/BalanceSheetAccountDetailTables 27 false false R28.htm 2404406 - Disclosure - Balance Sheet Account Detail (Held to Maturity Marketable Securities) (Details) Sheet http://www.endologix.com/role/BalanceSheetAccountDetailHeldToMaturityMarketableSecuritiesDetails Balance Sheet Account Detail (Held to Maturity Marketable Securities) (Details) Details http://www.endologix.com/role/BalanceSheetAccountDetailTables 28 false false R29.htm 2404407 - Disclosure - Balance Sheet Account Detail (Fair Value Measurements) (Details) Sheet http://www.endologix.com/role/BalanceSheetAccountDetailFairValueMeasurementsDetails Balance Sheet Account Detail (Fair Value Measurements) (Details) Details http://www.endologix.com/role/BalanceSheetAccountDetailTables 29 false false R30.htm 2407402 - Disclosure - Stock-Based Compensation (Details) Sheet http://www.endologix.com/role/StockBasedCompensationDetails Stock-Based Compensation (Details) Details http://www.endologix.com/role/StockBasedCompensationTables 30 false false R31.htm 2410402 - Disclosure - Net Loss Per Share (Details) Sheet http://www.endologix.com/role/NetLossPerShareDetails Net Loss Per Share (Details) Details http://www.endologix.com/role/NetLossPerShareTables 31 false false R32.htm 2413401 - Disclosure - Credit Facilities (Details) Sheet http://www.endologix.com/role/CreditFacilitiesDetails Credit Facilities (Details) Details http://www.endologix.com/role/CreditFacilities 32 false false R33.htm 2419402 - Disclosure - Revenue by Geographic Region (Details) Sheet http://www.endologix.com/role/RevenueByGeographicRegionDetails Revenue by Geographic Region (Details) Details http://www.endologix.com/role/RevenueByGeographicRegionTables 33 false false R34.htm 2425402 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.endologix.com/role/CommitmentsAndContingenciesDetails Commitments and Contingencies (Details) Details http://www.endologix.com/role/CommitmentsAndContingenciesTables 34 false false R35.htm 2426402 - Disclosure - Contingently Issuable Common Stock (Details) Sheet http://www.endologix.com/role/ContingentlyIssuableCommonStockDetails Contingently Issuable Common Stock (Details) Details http://www.endologix.com/role/ContingentlyIssuableCommonStockTables 35 false false R36.htm 2428401 - Disclosure - Income Tax Expense (Details) Sheet http://www.endologix.com/role/IncomeTaxExpenseDetails Income Tax Expense (Details) Details http://www.endologix.com/role/IncomeTaxExpense 36 false false All Reports Book All Reports In ''Condensed Consolidated Balance Sheets'', column(s) 3, 4 are contained in other reports, so were removed by flow through suppression. In ''Condensed Consolidated Statements of Cash Flows'', column(s) 1, 2 are contained in other reports, so were removed by flow through suppression. elgx-20150630.xml elgx-20150630_cal.xml elgx-20150630_def.xml elgx-20150630_lab.xml elgx-20150630_pre.xml elgx-20150630.xsd true true XML 53 R20.htm IDEA: XBRL DOCUMENT v3.2.0.727
Revenue by Geographic Region (Tables)
 6 Months Ended
Jun. 30, 2015
Geographic Areas, Revenues from External Customers [Abstract]  
Revenue by Geographic Region
The Company's revenue by geographic region, was as follows:

Three Months Ended

Six Months Ended
 
June 30,

June 30,
 
2015

2014

2015

2014
United States
$
28,776


72.9%

$
27,992


73.0%

$
53,910


70.8%

$
51,980


72.6%




















Europe
$
7,888


20.0%

$
7,816


20.4%

$
15,134


19.9%

$
14,401


20.1%




















Rest of World ("ROW"):



















Latin America
$
1,221


3.1%

$
1,309


3.4%

$
3,260


4.3%

$
2,226


3.1%
Asia/Pacific
1,594


4.0%

1,210


3.2%

3,845


5.0%

2,984


4.2%
Total ROW
$
2,815


7.1%

$
2,519


6.6%

$
7,105


9.3%

$
5,210


7.3%



















Revenue
$
39,479


100.0%

$
38,327


100.0%

$
76,149


100.0%

$
71,591


100.0%